AGE|AGE_ADJUSTED_CI_LOWER|AGE_ADJUSTED_CI_UPPER|AGE_ADJUSTED_RATE|BEHAVIOR|COUNT|POPULATION|SEX|SITE|YEAR
0-19|~|~|~|Benign/Borderline|~|39865121|Female|All other|2004
0-19|~|~|~|Malignant|~|39865121|Female|All other|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|All other|2005
0-19|~|~|~|Malignant|~|39998876|Female|All other|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|All other|2006
0-19|~|~|~|Malignant|~|40165421|Female|All other|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|All other|2007
0-19|~|~|~|Malignant|~|40382360|Female|All other|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|All other|2008
0-19|~|~|~|Malignant|~|40576293|Female|All other|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|All other|2009
0-19|~|~|~|Malignant|~|40670476|Female|All other|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|All other|2010
0-19|~|~|~|Malignant|~|40652091|Female|All other|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|All other|2011
0-19|~|~|~|Malignant|~|40556179|Female|All other|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|All other|2012
0-19|~|~|~|Malignant|~|40478537|Female|All other|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|All other|2013
0-19|~|~|~|Malignant|~|40458251|Female|All other|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|All other|2014
0-19|~|~|~|Malignant|~|40476449|Female|All other|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|All other|2015
0-19|~|~|~|Malignant|~|40548779|Female|All other|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|All other|2016
0-19|~|~|~|Malignant|~|40650115|Female|All other|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|All other|2017
0-19|~|~|~|Malignant|~|40703047|Female|All other|2017
0-19|0.0|0.1|0.1|Benign/Borderline|23|40705737|Female|All other|2018
0-19|0.3|0.4|0.3|Malignant|126|40705737|Female|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|156|201996736|Female|All other|2018-2022
0-19|0.4|0.4|0.4|Malignant|826|201996736|Female|All other|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|37|40650648|Female|All other|2019
0-19|0.3|0.5|0.4|Malignant|165|40650648|Female|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|33|40481966|Female|All other|2020
0-19|0.3|0.5|0.4|Malignant|156|40481966|Female|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|32|40152307|Female|All other|2021
0-19|0.4|0.5|0.4|Malignant|164|40152307|Female|All other|2021
0-19|0.1|0.1|0.1|Benign/Borderline|31|40006078|Female|All other|2022
0-19|0.5|0.6|0.5|Malignant|215|40006078|Female|All other|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic astrocytoma|2004
0-19|0.1|0.2|0.1|Malignant|46|39865121|Female|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|25|39998876|Female|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|31|40165421|Female|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic astrocytoma|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|32|40576293|Female|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|30|40670476|Female|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|40|40652091|Female|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|39|40556179|Female|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Anaplastic astrocytoma|2012
0-19|0.0|0.1|0.1|Malignant|24|40478537|Female|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Anaplastic astrocytoma|2013
0-19|0.1|0.2|0.1|Malignant|51|40458251|Female|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Anaplastic astrocytoma|2014
0-19|0.1|0.1|0.1|Malignant|40|40476449|Female|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|35|40548779|Female|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|31|40650115|Female|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Anaplastic astrocytoma|2017
0-19|0.0|0.1|0.1|Malignant|27|40703047|Female|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Anaplastic astrocytoma|2018
0-19|0.0|0.1|0.1|Malignant|24|40705737|Female|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Anaplastic astrocytoma|2018-2022
0-19|0.0|0.1|0.0|Malignant|92|201996736|Female|Anaplastic astrocytoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Anaplastic astrocytoma|2019
0-19|0.0|0.1|0.1|Malignant|29|40650648|Female|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|22|40481966|Female|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Anaplastic astrocytoma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Anaplastic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|40652091|Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Anaplastic oligodendroglioma|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Anaplastic oligodendroglioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.2|Malignant|92|39865121|Female|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|92|39998876|Female|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.2|Malignant|89|40165421|Female|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|85|40382360|Female|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|87|40576293|Female|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|97|40670476|Female|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.2|Malignant|91|40652091|Female|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Astrocytoma, NOS|2011
0-19|0.2|0.2|0.2|Malignant|80|40556179|Female|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Astrocytoma, NOS|2012
0-19|0.2|0.3|0.2|Malignant|83|40478537|Female|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|99|40458251|Female|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|105|40476449|Female|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Astrocytoma, NOS|2015
0-19|0.1|0.2|0.2|Malignant|76|40548779|Female|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Astrocytoma, NOS|2016
0-19|0.2|0.3|0.2|Malignant|84|40650115|Female|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Astrocytoma, NOS|2017
0-19|0.2|0.2|0.2|Malignant|81|40703047|Female|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|87|40705737|Female|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Astrocytoma, NOS|2018-2022
0-19|0.1|0.2|0.2|Malignant|334|201996736|Female|Astrocytoma, NOS|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Astrocytoma, NOS|2019
0-19|0.1|0.2|0.2|Malignant|77|40650648|Female|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Astrocytoma, NOS|2020
0-19|0.1|0.2|0.1|Malignant|53|40481966|Female|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|68|40152307|Female|Astrocytoma, NOS|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Astrocytoma, NOS|2022
0-19|0.1|0.2|0.1|Malignant|49|40006078|Female|Astrocytoma, NOS|2022
0-19|0.1|0.1|0.1|Benign/Borderline|30|39865121|Female|Choroid plexus|2004
0-19|~|~|~|Malignant|~|39865121|Female|Choroid plexus|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|39998876|Female|Choroid plexus|2005
0-19|~|~|~|Malignant|~|39998876|Female|Choroid plexus|2005
0-19|0.0|0.1|0.1|Benign/Borderline|28|40165421|Female|Choroid plexus|2006
0-19|~|~|~|Malignant|~|40165421|Female|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|31|40382360|Female|Choroid plexus|2007
0-19|~|~|~|Malignant|~|40382360|Female|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|42|40576293|Female|Choroid plexus|2008
0-19|~|~|~|Malignant|~|40576293|Female|Choroid plexus|2008
0-19|0.0|0.1|0.1|Benign/Borderline|24|40670476|Female|Choroid plexus|2009
0-19|~|~|~|Malignant|~|40670476|Female|Choroid plexus|2009
0-19|0.0|0.1|0.1|Benign/Borderline|29|40652091|Female|Choroid plexus|2010
0-19|~|~|~|Malignant|~|40652091|Female|Choroid plexus|2010
0-19|0.0|0.1|0.1|Benign/Borderline|27|40556179|Female|Choroid plexus|2011
0-19|~|~|~|Malignant|~|40556179|Female|Choroid plexus|2011
0-19|0.0|0.1|0.1|Benign/Borderline|27|40478537|Female|Choroid plexus|2012
0-19|~|~|~|Malignant|~|40478537|Female|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|30|40458251|Female|Choroid plexus|2013
0-19|~|~|~|Malignant|~|40458251|Female|Choroid plexus|2013
0-19|0.0|0.1|0.0|Benign/Borderline|20|40476449|Female|Choroid plexus|2014
0-19|~|~|~|Malignant|~|40476449|Female|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|32|40548779|Female|Choroid plexus|2015
0-19|~|~|~|Malignant|~|40548779|Female|Choroid plexus|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|40650115|Female|Choroid plexus|2016
0-19|~|~|~|Malignant|~|40650115|Female|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|34|40703047|Female|Choroid plexus|2017
0-19|~|~|~|Malignant|~|40703047|Female|Choroid plexus|2017
0-19|0.0|0.1|0.1|Benign/Borderline|27|40705737|Female|Choroid plexus|2018
0-19|~|~|~|Malignant|~|40705737|Female|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|122|201996736|Female|Choroid plexus|2018-2022
0-19|0.0|0.0|0.0|Malignant|43|201996736|Female|Choroid plexus|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|24|40650648|Female|Choroid plexus|2019
0-19|~|~|~|Malignant|~|40650648|Female|Choroid plexus|2019
0-19|0.0|0.1|0.1|Benign/Borderline|28|40481966|Female|Choroid plexus|2020
0-19|~|~|~|Malignant|~|40481966|Female|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|21|40152307|Female|Choroid plexus|2021
0-19|~|~|~|Malignant|~|40152307|Female|Choroid plexus|2021
0-19|0.0|0.1|0.1|Benign/Borderline|22|40006078|Female|Choroid plexus|2022
0-19|~|~|~|Malignant|~|40006078|Female|Choroid plexus|2022
0-19|0.2|0.3|0.2|Benign/Borderline|85|39865121|Female|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Craniopharyngioma|2004
0-19|0.2|0.2|0.2|Benign/Borderline|78|39998876|Female|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|77|40165421|Female|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|96|40382360|Female|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Craniopharyngioma|2007
0-19|0.1|0.2|0.2|Benign/Borderline|67|40576293|Female|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Craniopharyngioma|2008
0-19|0.2|0.3|0.2|Benign/Borderline|91|40670476|Female|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Craniopharyngioma|2009
0-19|0.2|0.3|0.2|Benign/Borderline|94|40652091|Female|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|40652091|Female|Craniopharyngioma|2010
0-19|0.2|0.3|0.2|Benign/Borderline|87|40556179|Female|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|78|40478537|Female|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|89|40458251|Female|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Craniopharyngioma|2013
0-19|0.2|0.3|0.2|Benign/Borderline|94|40476449|Female|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|82|40548779|Female|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Craniopharyngioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|68|40650115|Female|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Craniopharyngioma|2016
0-19|0.2|0.2|0.2|Benign/Borderline|80|40703047|Female|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Craniopharyngioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|55|40705737|Female|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Craniopharyngioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|356|201996736|Female|Craniopharyngioma|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Craniopharyngioma|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|86|40650648|Female|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Craniopharyngioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|72|40481966|Female|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Craniopharyngioma|2020
0-19|0.2|0.2|0.2|Benign/Borderline|78|40152307|Female|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Craniopharyngioma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|65|40006078|Female|Craniopharyngioma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Craniopharyngioma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|20|39865121|Female|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Diffuse astrocytoma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|19|40670476|Female|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Diffuse astrocytoma|2010
0-19|0.0|0.1|0.0|Malignant|19|40652091|Female|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Diffuse astrocytoma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Diffuse astrocytoma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Diffuse astrocytoma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Diffuse astrocytoma|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Diffuse astrocytoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Diffuse astrocytoma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Diffuse astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Embryonal/primitive/medulloblastoma|2004
0-19|0.5|0.6|0.5|Malignant|213|39865121|Female|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Embryonal/primitive/medulloblastoma|2005
0-19|0.4|0.5|0.5|Malignant|185|39998876|Female|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Embryonal/primitive/medulloblastoma|2006
0-19|0.4|0.6|0.5|Malignant|204|40165421|Female|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Embryonal/primitive/medulloblastoma|2007
0-19|0.5|0.6|0.5|Malignant|218|40382360|Female|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Embryonal/primitive/medulloblastoma|2008
0-19|0.5|0.6|0.6|Malignant|228|40576293|Female|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Embryonal/primitive/medulloblastoma|2009
0-19|0.4|0.6|0.5|Malignant|204|40670476|Female|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Embryonal/primitive/medulloblastoma|2010
0-19|0.4|0.5|0.4|Malignant|173|40652091|Female|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Embryonal/primitive/medulloblastoma|2011
0-19|0.4|0.6|0.5|Malignant|196|40556179|Female|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Embryonal/primitive/medulloblastoma|2012
0-19|0.4|0.5|0.4|Malignant|181|40478537|Female|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Embryonal/primitive/medulloblastoma|2013
0-19|0.4|0.5|0.5|Malignant|188|40458251|Female|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Embryonal/primitive/medulloblastoma|2014
0-19|0.5|0.6|0.5|Malignant|213|40476449|Female|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Embryonal/primitive/medulloblastoma|2015
0-19|0.4|0.6|0.5|Malignant|193|40548779|Female|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Embryonal/primitive/medulloblastoma|2016
0-19|0.4|0.5|0.4|Malignant|174|40650115|Female|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Embryonal/primitive/medulloblastoma|2017
0-19|0.4|0.5|0.4|Malignant|169|40703047|Female|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Embryonal/primitive/medulloblastoma|2018
0-19|0.3|0.5|0.4|Malignant|157|40705737|Female|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Embryonal/primitive/medulloblastoma|2018-2022
0-19|0.3|0.3|0.3|Malignant|629|201996736|Female|Embryonal/primitive/medulloblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Embryonal/primitive/medulloblastoma|2019
0-19|0.2|0.4|0.3|Malignant|120|40650648|Female|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Embryonal/primitive/medulloblastoma|2020
0-19|0.3|0.4|0.3|Malignant|133|40481966|Female|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.3|0.4|0.3|Malignant|124|40152307|Female|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Embryonal/primitive/medulloblastoma|2022
0-19|0.2|0.3|0.2|Malignant|95|40006078|Female|Embryonal/primitive/medulloblastoma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|39865121|Female|Ependymoma variants|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|39998876|Female|Ependymoma variants|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|40165421|Female|Ependymoma variants|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|40382360|Female|Ependymoma variants|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|40576293|Female|Ependymoma variants|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|40670476|Female|Ependymoma variants|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|40652091|Female|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|21|40556179|Female|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|40556179|Female|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|16|40478537|Female|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|40478537|Female|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|17|40458251|Female|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|40458251|Female|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|40476449|Female|Ependymoma variants|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|40548779|Female|Ependymoma variants|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|40650115|Female|Ependymoma variants|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|40703047|Female|Ependymoma variants|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|40705737|Female|Ependymoma variants|2018
0-19|0.0|0.0|0.0|Benign/Borderline|66|201996736|Female|Ependymoma variants|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Ependymoma variants|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|40650648|Female|Ependymoma variants|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|40481966|Female|Ependymoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|16|40152307|Female|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|40152307|Female|Ependymoma variants|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Ependymoma variants|2022
0-19|~|~|~|Malignant|~|40006078|Female|Ependymoma variants|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|97|39865121|Female|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|111|39998876|Female|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.2|Malignant|99|40165421|Female|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Ependymoma/anaplastic ependymoma|2007
0-19|0.1|0.2|0.2|Malignant|72|40382360|Female|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Ependymoma/anaplastic ependymoma|2008
0-19|0.1|0.2|0.2|Malignant|77|40576293|Female|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.2|0.2|Malignant|80|40670476|Female|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.2|Malignant|93|40652091|Female|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.2|Malignant|97|40556179|Female|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.2|Malignant|88|40478537|Female|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.2|Malignant|89|40458251|Female|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.2|Malignant|92|40476449|Female|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.2|Malignant|88|40548779|Female|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.2|0.2|Malignant|80|40650115|Female|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.3|0.2|Malignant|97|40703047|Female|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Ependymoma/anaplastic ependymoma|2018
0-19|0.1|0.2|0.2|Malignant|70|40705737|Female|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Ependymoma/anaplastic ependymoma|2018-2022
0-19|0.1|0.2|0.2|Malignant|332|201996736|Female|Ependymoma/anaplastic ependymoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Ependymoma/anaplastic ependymoma|2019
0-19|0.1|0.2|0.2|Malignant|71|40650648|Female|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Ependymoma/anaplastic ependymoma|2020
0-19|0.1|0.2|0.2|Malignant|71|40481966|Female|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.1|0.2|0.2|Malignant|67|40152307|Female|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Ependymoma/anaplastic ependymoma|2022
0-19|0.1|0.2|0.1|Malignant|53|40006078|Female|Ependymoma/anaplastic ependymoma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Germ Cell Tumors|2004
0-19|0.1|0.1|0.1|Malignant|42|39865121|Female|Germ Cell Tumors|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Germ Cell Tumors|2005
0-19|0.1|0.2|0.1|Malignant|47|39998876|Female|Germ Cell Tumors|2005
0-19|0.0|0.1|0.0|Benign/Borderline|18|40165421|Female|Germ Cell Tumors|2006
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Germ Cell Tumors|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Germ Cell Tumors|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|18|40576293|Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Malignant|29|40576293|Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.0|Benign/Borderline|20|40670476|Female|Germ Cell Tumors|2009
0-19|0.1|0.1|0.1|Malignant|43|40670476|Female|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|21|40652091|Female|Germ Cell Tumors|2010
0-19|0.1|0.2|0.1|Malignant|53|40652091|Female|Germ Cell Tumors|2010
0-19|0.0|0.1|0.1|Benign/Borderline|23|40556179|Female|Germ Cell Tumors|2011
0-19|0.1|0.1|0.1|Malignant|36|40556179|Female|Germ Cell Tumors|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|40478537|Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Malignant|21|40478537|Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|21|40458251|Female|Germ Cell Tumors|2013
0-19|0.1|0.2|0.1|Malignant|48|40458251|Female|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|23|40476449|Female|Germ Cell Tumors|2014
0-19|0.1|0.1|0.1|Malignant|34|40476449|Female|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|18|40548779|Female|Germ Cell Tumors|2015
0-19|0.1|0.2|0.1|Malignant|46|40548779|Female|Germ Cell Tumors|2015
0-19|0.0|0.1|0.1|Benign/Borderline|27|40650115|Female|Germ Cell Tumors|2016
0-19|0.1|0.2|0.1|Malignant|58|40650115|Female|Germ Cell Tumors|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Germ Cell Tumors|2017
0-19|0.1|0.2|0.1|Malignant|46|40703047|Female|Germ Cell Tumors|2017
0-19|0.0|0.1|0.1|Benign/Borderline|25|40705737|Female|Germ Cell Tumors|2018
0-19|0.1|0.1|0.1|Malignant|44|40705737|Female|Germ Cell Tumors|2018
0-19|0.0|0.0|0.0|Benign/Borderline|79|201996736|Female|Germ Cell Tumors|2018-2022
0-19|0.1|0.1|0.1|Malignant|215|201996736|Female|Germ Cell Tumors|2018-2022
0-19|0.0|0.1|0.0|Benign/Borderline|18|40650648|Female|Germ Cell Tumors|2019
0-19|0.1|0.2|0.1|Malignant|49|40650648|Female|Germ Cell Tumors|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Germ Cell Tumors|2020
0-19|0.1|0.2|0.1|Malignant|49|40481966|Female|Germ Cell Tumors|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Germ Cell Tumors|2021
0-19|0.1|0.1|0.1|Malignant|42|40152307|Female|Germ Cell Tumors|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Germ Cell Tumors|2022
0-19|0.1|0.1|0.1|Malignant|31|40006078|Female|Germ Cell Tumors|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioblastoma|2004
0-19|0.1|0.2|0.1|Malignant|53|39865121|Female|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioblastoma|2005
0-19|0.1|0.1|0.1|Malignant|39|39998876|Female|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioblastoma|2006
0-19|0.1|0.1|0.1|Malignant|43|40165421|Female|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioblastoma|2007
0-19|0.1|0.2|0.1|Malignant|58|40382360|Female|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|62|40576293|Female|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioblastoma|2009
0-19|0.1|0.1|0.1|Malignant|38|40670476|Female|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Glioblastoma|2010
0-19|0.1|0.2|0.1|Malignant|51|40652091|Female|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Glioblastoma|2011
0-19|0.1|0.2|0.2|Malignant|75|40556179|Female|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Glioblastoma|2012
0-19|0.1|0.2|0.2|Malignant|76|40478537|Female|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Glioblastoma|2013
0-19|0.1|0.2|0.2|Malignant|71|40458251|Female|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|68|40476449|Female|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Glioblastoma|2015
0-19|0.1|0.2|0.2|Malignant|68|40548779|Female|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Glioblastoma|2016
0-19|0.1|0.2|0.1|Malignant|54|40650115|Female|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|70|40703047|Female|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Glioblastoma|2018
0-19|0.1|0.2|0.1|Malignant|60|40705737|Female|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Glioblastoma|2018-2022
0-19|0.1|0.1|0.1|Malignant|216|201996736|Female|Glioblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Glioblastoma|2019
0-19|0.1|0.2|0.1|Malignant|53|40650648|Female|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Glioblastoma|2020
0-19|0.1|0.1|0.1|Malignant|37|40481966|Female|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Glioblastoma|2021
0-19|0.1|0.1|0.1|Malignant|39|40152307|Female|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Glioblastoma|2022
0-19|0.0|0.1|0.1|Malignant|27|40006078|Female|Glioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Glioma malignant, NOS|2004
0-19|0.5|0.7|0.6|Malignant|234|39865121|Female|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Glioma malignant, NOS|2005
0-19|0.5|0.7|0.6|Malignant|235|39998876|Female|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Glioma malignant, NOS|2006
0-19|0.5|0.7|0.6|Malignant|248|40165421|Female|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Glioma malignant, NOS|2007
0-19|0.6|0.8|0.7|Malignant|268|40382360|Female|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Glioma malignant, NOS|2008
0-19|0.6|0.8|0.7|Malignant|279|40576293|Female|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Glioma malignant, NOS|2009
0-19|0.7|0.8|0.7|Malignant|300|40670476|Female|Glioma malignant, NOS|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Glioma malignant, NOS|2010
0-19|0.6|0.7|0.7|Malignant|265|40652091|Female|Glioma malignant, NOS|2010
0-19|0.0|0.1|0.0|Benign/Borderline|20|40556179|Female|Glioma malignant, NOS|2011
0-19|0.7|0.9|0.8|Malignant|318|40556179|Female|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|40478537|Female|Glioma malignant, NOS|2012
0-19|0.5|0.7|0.6|Malignant|231|40478537|Female|Glioma malignant, NOS|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Glioma malignant, NOS|2013
0-19|0.7|0.9|0.8|Malignant|310|40458251|Female|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.0|Benign/Borderline|19|40476449|Female|Glioma malignant, NOS|2014
0-19|0.6|0.8|0.7|Malignant|276|40476449|Female|Glioma malignant, NOS|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Glioma malignant, NOS|2015
0-19|0.6|0.8|0.7|Malignant|284|40548779|Female|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|24|40650115|Female|Glioma malignant, NOS|2016
0-19|0.7|0.9|0.8|Malignant|323|40650115|Female|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|26|40703047|Female|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|332|40703047|Female|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.1|Benign/Borderline|22|40705737|Female|Glioma malignant, NOS|2018
0-19|0.6|0.7|0.6|Malignant|257|40705737|Female|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|91|201996736|Female|Glioma malignant, NOS|2018-2022
0-19|0.6|0.7|0.6|Malignant|1237|201996736|Female|Glioma malignant, NOS|2018-2022
0-19|0.0|0.1|0.0|Benign/Borderline|17|40650648|Female|Glioma malignant, NOS|2019
0-19|0.5|0.7|0.6|Malignant|238|40650648|Female|Glioma malignant, NOS|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Glioma malignant, NOS|2020
0-19|0.5|0.7|0.6|Malignant|240|40481966|Female|Glioma malignant, NOS|2020
0-19|0.0|0.1|0.0|Benign/Borderline|17|40152307|Female|Glioma malignant, NOS|2021
0-19|0.6|0.8|0.7|Malignant|268|40152307|Female|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.1|Benign/Borderline|24|40006078|Female|Glioma malignant, NOS|2022
0-19|0.5|0.7|0.6|Malignant|234|40006078|Female|Glioma malignant, NOS|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioblastoma|2004
0-19|0.0|0.1|0.0|Benign/Borderline|19|39998876|Female|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioblastoma|2006
0-19|0.0|0.1|0.1|Benign/Borderline|21|40382360|Female|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|17|40670476|Female|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|40652091|Female|Hemangioblastoma|2010
0-19|0.0|0.1|0.0|Benign/Borderline|18|40556179|Female|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Hemangioblastoma|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|40478537|Female|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Hemangioblastoma|2012
0-19|0.0|0.1|0.1|Benign/Borderline|21|40458251|Female|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Hemangioblastoma|2013
0-19|0.1|0.1|0.1|Benign/Borderline|33|40476449|Female|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|18|40548779|Female|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Hemangioblastoma|2015
0-19|0.0|0.1|0.1|Benign/Borderline|24|40650115|Female|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Hemangioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|20|40705737|Female|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Hemangioblastoma|2018
0-19|0.0|0.0|0.0|Benign/Borderline|79|201996736|Female|Hemangioblastoma|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Hemangioblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|19|40481966|Female|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Hemangioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Hemangioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Hemangioblastoma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Hemangioblastoma|2022
0-19|0.0|0.1|0.0|Benign/Borderline|19|39865121|Female|Hemangioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|25|39998876|Female|Hemangioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|34|40165421|Female|Hemangioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Hemangioma|2006
0-19|0.1|0.1|0.1|Benign/Borderline|33|40382360|Female|Hemangioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Hemangioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|40576293|Female|Hemangioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|54|40670476|Female|Hemangioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Hemangioma|2009
0-19|0.1|0.1|0.1|Benign/Borderline|45|40652091|Female|Hemangioma|2010
0-19|~|~|~|Malignant|~|40652091|Female|Hemangioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|73|40556179|Female|Hemangioma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|68|40478537|Female|Hemangioma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|65|40458251|Female|Hemangioma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Hemangioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|65|40476449|Female|Hemangioma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Hemangioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|76|40548779|Female|Hemangioma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Hemangioma|2015
0-19|0.1|0.2|0.1|Benign/Borderline|58|40650115|Female|Hemangioma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|56|40703047|Female|Hemangioma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Hemangioma|2017
0-19|0.1|0.2|0.1|Benign/Borderline|59|40705737|Female|Hemangioma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Hemangioma|2018
0-19|0.1|0.2|0.1|Benign/Borderline|284|201996736|Female|Hemangioma|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Hemangioma|2018-2022
0-19|0.1|0.2|0.1|Benign/Borderline|51|40650648|Female|Hemangioma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Hemangioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|64|40481966|Female|Hemangioma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|57|40152307|Female|Hemangioma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Hemangioma|2021
0-19|0.1|0.2|0.1|Benign/Borderline|53|40006078|Female|Hemangioma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Hemangioma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|39865121|Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|39998876|Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|40165421|Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|40382360|Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|40576293|Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|40670476|Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|40652091|Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|40556179|Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|40478537|Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|40458251|Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|40476449|Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|40548779|Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|40650115|Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|40703047|Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|40705737|Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Local Extensions from Regional Tumors|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Local Extensions from Regional Tumors|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|40650648|Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|40481966|Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|40152307|Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Malignant|~|40006078|Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Malignant|~|39865121|Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Malignant|~|39998876|Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|40165421|Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|40382360|Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|40576293|Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Malignant|~|40670476|Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|40652091|Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|40556179|Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|40478537|Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|40458251|Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|40476449|Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Malignant|~|40548779|Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|40650115|Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|40703047|Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|40705737|Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|40650648|Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|40481966|Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|40152307|Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Malignant|~|40006078|Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|0.1|0.2|0.1|Benign/Borderline|48|39865121|Female|Meningioma|2004
0-19|~|~|~|Malignant|~|39865121|Female|Meningioma|2004
0-19|0.1|0.2|0.2|Benign/Borderline|74|39998876|Female|Meningioma|2005
0-19|~|~|~|Malignant|~|39998876|Female|Meningioma|2005
0-19|0.1|0.2|0.1|Benign/Borderline|50|40165421|Female|Meningioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|55|40382360|Female|Meningioma|2007
0-19|~|~|~|Malignant|~|40382360|Female|Meningioma|2007
0-19|0.1|0.2|0.2|Benign/Borderline|64|40576293|Female|Meningioma|2008
0-19|~|~|~|Malignant|~|40576293|Female|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|60|40670476|Female|Meningioma|2009
0-19|~|~|~|Malignant|~|40670476|Female|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|60|40652091|Female|Meningioma|2010
0-19|~|~|~|Malignant|~|40652091|Female|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|68|40556179|Female|Meningioma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Meningioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|65|40478537|Female|Meningioma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Meningioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|77|40458251|Female|Meningioma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Meningioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|74|40476449|Female|Meningioma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|72|40548779|Female|Meningioma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Meningioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|74|40650115|Female|Meningioma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|67|40703047|Female|Meningioma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Meningioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|72|40705737|Female|Meningioma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Meningioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|360|201996736|Female|Meningioma|2018-2022
0-19|0.0|0.0|0.0|Malignant|16|201996736|Female|Meningioma|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|79|40650648|Female|Meningioma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Meningioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|63|40481966|Female|Meningioma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Meningioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|86|40152307|Female|Meningioma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Meningioma|2021
0-19|0.1|0.2|0.1|Benign/Borderline|60|40006078|Female|Meningioma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Meningioma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Mixed glioma|2004
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Mixed glioma|2005
0-19|0.0|0.1|0.0|Malignant|17|39998876|Female|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Mixed glioma|2006
0-19|~|~|~|Malignant|~|40165421|Female|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|17|40382360|Female|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Mixed glioma|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Mixed glioma|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Mixed glioma|2010
0-19|~|~|~|Malignant|~|40652091|Female|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Mixed glioma|2011
0-19|~|~|~|Malignant|~|40556179|Female|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Mixed glioma|2012
0-19|~|~|~|Malignant|~|40478537|Female|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Mixed glioma|2013
0-19|~|~|~|Malignant|~|40458251|Female|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Mixed glioma|2014
0-19|~|~|~|Malignant|~|40476449|Female|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Mixed glioma|2015
0-19|~|~|~|Malignant|~|40548779|Female|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Mixed glioma|2016
0-19|~|~|~|Malignant|~|40650115|Female|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Mixed glioma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Mixed glioma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Mixed glioma|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Mixed glioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Mixed glioma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Mixed glioma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Mixed glioma|2021
0-19|~|~|~|Malignant|~|40152307|Female|Mixed glioma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Mixed glioma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Mixed glioma|2022
0-19|0.1|0.1|0.1|Benign/Borderline|31|39865121|Female|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|58|39998876|Female|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|18|39998876|Female|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|51|40165421|Female|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|28|40165421|Female|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|53|40382360|Female|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.2|Benign/Borderline|78|40576293|Female|Neoplasm, unspecified|2008
0-19|~|~|~|Malignant|~|40576293|Female|Neoplasm, unspecified|2008
0-19|0.1|0.2|0.2|Benign/Borderline|62|40670476|Female|Neoplasm, unspecified|2009
0-19|~|~|~|Malignant|~|40670476|Female|Neoplasm, unspecified|2009
0-19|0.2|0.3|0.2|Benign/Borderline|91|40652091|Female|Neoplasm, unspecified|2010
0-19|~|~|~|Malignant|~|40652091|Female|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|69|40556179|Female|Neoplasm, unspecified|2011
0-19|0.0|0.1|0.0|Malignant|19|40556179|Female|Neoplasm, unspecified|2011
0-19|0.2|0.2|0.2|Benign/Borderline|79|40478537|Female|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|24|40478537|Female|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|76|40458251|Female|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.1|Malignant|23|40458251|Female|Neoplasm, unspecified|2013
0-19|0.2|0.3|0.2|Benign/Borderline|82|40476449|Female|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.0|Malignant|19|40476449|Female|Neoplasm, unspecified|2014
0-19|0.2|0.3|0.2|Benign/Borderline|82|40548779|Female|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|16|40548779|Female|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.1|Benign/Borderline|58|40650115|Female|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|23|40650115|Female|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.1|Benign/Borderline|59|40703047|Female|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.0|Malignant|20|40703047|Female|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.2|Benign/Borderline|73|40705737|Female|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.1|Malignant|27|40705737|Female|Neoplasm, unspecified|2018
0-19|0.1|0.2|0.1|Benign/Borderline|281|201996736|Female|Neoplasm, unspecified|2018-2022
0-19|0.0|0.1|0.1|Malignant|119|201996736|Female|Neoplasm, unspecified|2018-2022
0-19|0.1|0.2|0.1|Benign/Borderline|49|40650648|Female|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.0|Malignant|16|40650648|Female|Neoplasm, unspecified|2019
0-19|0.1|0.2|0.1|Benign/Borderline|54|40481966|Female|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|25|40481966|Female|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.1|Benign/Borderline|57|40152307|Female|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|26|40152307|Female|Neoplasm, unspecified|2021
0-19|0.1|0.2|0.1|Benign/Borderline|48|40006078|Female|Neoplasm, unspecified|2022
0-19|0.0|0.1|0.1|Malignant|25|40006078|Female|Neoplasm, unspecified|2022
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|39865121|Female|Nerve sheath, benign and malignant|2004
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|39998876|Female|Nerve sheath, benign and malignant|2005
0-19|0.3|0.5|0.4|Benign/Borderline|164|40165421|Female|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|40165421|Female|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|40382360|Female|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|150|40576293|Female|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|40576293|Female|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|40670476|Female|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40652091|Female|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|40652091|Female|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.3|Benign/Borderline|134|40556179|Female|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|40556179|Female|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|147|40478537|Female|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|40478537|Female|Nerve sheath, benign and malignant|2012
0-19|0.3|0.5|0.4|Benign/Borderline|157|40458251|Female|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|40458251|Female|Nerve sheath, benign and malignant|2013
0-19|0.2|0.3|0.3|Benign/Borderline|111|40476449|Female|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|40476449|Female|Nerve sheath, benign and malignant|2014
0-19|0.3|0.5|0.4|Benign/Borderline|160|40548779|Female|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|40548779|Female|Nerve sheath, benign and malignant|2015
0-19|0.3|0.4|0.3|Benign/Borderline|130|40650115|Female|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|40650115|Female|Nerve sheath, benign and malignant|2016
0-19|0.3|0.4|0.3|Benign/Borderline|134|40703047|Female|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|40703047|Female|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|81|40705737|Female|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|40705737|Female|Nerve sheath, benign and malignant|2018
0-19|0.2|0.2|0.2|Benign/Borderline|388|201996736|Female|Nerve sheath, benign and malignant|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Nerve sheath, benign and malignant|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|80|40650648|Female|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|40650648|Female|Nerve sheath, benign and malignant|2019
0-19|0.1|0.2|0.2|Benign/Borderline|78|40481966|Female|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|40481966|Female|Nerve sheath, benign and malignant|2020
0-19|0.2|0.2|0.2|Benign/Borderline|82|40152307|Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|40152307|Female|Nerve sheath, benign and malignant|2021
0-19|0.1|0.2|0.2|Benign/Borderline|67|40006078|Female|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Malignant|~|40006078|Female|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|39865121|Female|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|39998876|Female|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|40165421|Female|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|40382360|Female|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|40576293|Female|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|40670476|Female|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|40652091|Female|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|40556179|Female|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|40478537|Female|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|40458251|Female|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|40476449|Female|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|40548779|Female|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|40650115|Female|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|40703047|Female|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|40705737|Female|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Neuroepithelial|2018-2022
0-19|0.0|0.0|0.0|Malignant|24|201996736|Female|Neuroepithelial|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|40650648|Female|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|40481966|Female|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|40152307|Female|Neuroepithelial|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Neuroepithelial|2022
0-19|~|~|~|Malignant|~|40006078|Female|Neuroepithelial|2022
0-19|0.2|0.3|0.3|Benign/Borderline|115|39865121|Female|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|22|39865121|Female|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.3|Benign/Borderline|137|39998876|Female|Neuronal/glial, neuronal|2005
0-19|0.0|0.1|0.1|Malignant|26|39998876|Female|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.3|Benign/Borderline|126|40165421|Female|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|25|40165421|Female|Neuronal/glial, neuronal|2006
0-19|0.3|0.4|0.3|Benign/Borderline|140|40382360|Female|Neuronal/glial, neuronal|2007
0-19|0.1|0.1|0.1|Malignant|32|40382360|Female|Neuronal/glial, neuronal|2007
0-19|0.3|0.4|0.3|Benign/Borderline|134|40576293|Female|Neuronal/glial, neuronal|2008
0-19|0.0|0.1|0.1|Malignant|28|40576293|Female|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.3|Benign/Borderline|137|40670476|Female|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Neuronal/glial, neuronal|2009
0-19|0.3|0.4|0.4|Benign/Borderline|143|40652091|Female|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|19|40652091|Female|Neuronal/glial, neuronal|2010
0-19|0.3|0.4|0.4|Benign/Borderline|154|40556179|Female|Neuronal/glial, neuronal|2011
0-19|~|~|~|Malignant|~|40556179|Female|Neuronal/glial, neuronal|2011
0-19|0.3|0.4|0.4|Benign/Borderline|155|40478537|Female|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.0|Malignant|19|40478537|Female|Neuronal/glial, neuronal|2012
0-19|0.3|0.5|0.4|Benign/Borderline|166|40458251|Female|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|22|40458251|Female|Neuronal/glial, neuronal|2013
0-19|0.3|0.5|0.4|Benign/Borderline|164|40476449|Female|Neuronal/glial, neuronal|2014
0-19|0.0|0.1|0.1|Malignant|26|40476449|Female|Neuronal/glial, neuronal|2014
0-19|0.4|0.5|0.4|Benign/Borderline|175|40548779|Female|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.0|Malignant|17|40548779|Female|Neuronal/glial, neuronal|2015
0-19|0.4|0.5|0.5|Benign/Borderline|191|40650115|Female|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|29|40650115|Female|Neuronal/glial, neuronal|2016
0-19|0.4|0.5|0.4|Benign/Borderline|180|40703047|Female|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.1|Malignant|24|40703047|Female|Neuronal/glial, neuronal|2017
0-19|0.3|0.5|0.4|Benign/Borderline|160|40705737|Female|Neuronal/glial, neuronal|2018
0-19|0.1|0.1|0.1|Malignant|30|40705737|Female|Neuronal/glial, neuronal|2018
0-19|0.3|0.4|0.4|Benign/Borderline|763|201996736|Female|Neuronal/glial, neuronal|2018-2022
0-19|0.0|0.1|0.1|Malignant|113|201996736|Female|Neuronal/glial, neuronal|2018-2022
0-19|0.3|0.4|0.4|Benign/Borderline|151|40650648|Female|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|22|40650648|Female|Neuronal/glial, neuronal|2019
0-19|0.3|0.4|0.4|Benign/Borderline|153|40481966|Female|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.1|Malignant|28|40481966|Female|Neuronal/glial, neuronal|2020
0-19|0.3|0.4|0.3|Benign/Borderline|139|40152307|Female|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|16|40152307|Female|Neuronal/glial, neuronal|2021
0-19|0.3|0.5|0.4|Benign/Borderline|160|40006078|Female|Neuronal/glial, neuronal|2022
0-19|0.0|0.1|0.0|Malignant|17|40006078|Female|Neuronal/glial, neuronal|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Oligodendroglioma|2004
0-19|0.0|0.1|0.1|Malignant|24|39865121|Female|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|23|39998876|Female|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Oligodendroglioma|2006
0-19|0.0|0.1|0.1|Malignant|27|40165421|Female|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|30|40382360|Female|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Oligodendroglioma|2008
0-19|0.0|0.1|0.0|Malignant|17|40576293|Female|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Oligodendroglioma|2009
0-19|0.0|0.1|0.0|Malignant|17|40670476|Female|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|24|40652091|Female|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|20|40556179|Female|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|22|40478537|Female|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|16|40458251|Female|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|19|40476449|Female|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|18|40548779|Female|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Oligodendroglioma|2016
0-19|0.0|0.1|0.1|Malignant|21|40650115|Female|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Oligodendroglioma|2017
0-19|~|~|~|Malignant|~|40703047|Female|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Oligodendroglioma|2018
0-19|~|~|~|Malignant|~|40705737|Female|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|201996736|Female|Oligodendroglioma|2018-2022
0-19|0.0|0.0|0.0|Malignant|58|201996736|Female|Oligodendroglioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Oligodendroglioma|2019
0-19|~|~|~|Malignant|~|40650648|Female|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Oligodendroglioma|2020
0-19|~|~|~|Malignant|~|40481966|Female|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Oligodendroglioma|2021
0-19|0.0|0.1|0.0|Malignant|16|40152307|Female|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Oligodendroglioma|2022
0-19|~|~|~|Malignant|~|40006078|Female|Oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|39865121|Female|Other mesenchymal|2004
0-19|0.0|0.1|0.0|Benign/Borderline|18|39998876|Female|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|39998876|Female|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|19|40165421|Female|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|40165421|Female|Other mesenchymal|2006
0-19|0.0|0.1|0.1|Benign/Borderline|21|40382360|Female|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|40382360|Female|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|19|40576293|Female|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|40576293|Female|Other mesenchymal|2008
0-19|0.1|0.1|0.1|Benign/Borderline|31|40670476|Female|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|40670476|Female|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|27|40652091|Female|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|40652091|Female|Other mesenchymal|2010
0-19|0.0|0.1|0.1|Benign/Borderline|29|40556179|Female|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|40556179|Female|Other mesenchymal|2011
0-19|0.1|0.2|0.1|Benign/Borderline|54|40478537|Female|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|40478537|Female|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|43|40458251|Female|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|40458251|Female|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|45|40476449|Female|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|40476449|Female|Other mesenchymal|2014
0-19|0.1|0.2|0.1|Benign/Borderline|50|40548779|Female|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|40548779|Female|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|53|40650115|Female|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|40650115|Female|Other mesenchymal|2016
0-19|0.1|0.2|0.1|Benign/Borderline|51|40703047|Female|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|40703047|Female|Other mesenchymal|2017
0-19|0.1|0.2|0.1|Benign/Borderline|50|40705737|Female|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|40705737|Female|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|227|201996736|Female|Other mesenchymal|2018-2022
0-19|0.0|0.0|0.0|Malignant|30|201996736|Female|Other mesenchymal|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|36|40650648|Female|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|40650648|Female|Other mesenchymal|2019
0-19|0.1|0.2|0.1|Benign/Borderline|47|40481966|Female|Other mesenchymal|2020
0-19|~|~|~|Malignant|~|40481966|Female|Other mesenchymal|2020
0-19|0.1|0.2|0.2|Benign/Borderline|58|40152307|Female|Other mesenchymal|2021
0-19|~|~|~|Malignant|~|40152307|Female|Other mesenchymal|2021
0-19|0.1|0.1|0.1|Benign/Borderline|36|40006078|Female|Other mesenchymal|2022
0-19|~|~|~|Malignant|~|40006078|Female|Other mesenchymal|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pilocytic astrocytoma|2004
0-19|0.7|0.9|0.8|Malignant|331|39865121|Female|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pilocytic astrocytoma|2005
0-19|0.7|0.9|0.8|Malignant|327|39998876|Female|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pilocytic astrocytoma|2006
0-19|0.7|0.9|0.8|Malignant|321|40165421|Female|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pilocytic astrocytoma|2007
0-19|0.8|1.0|0.9|Malignant|348|40382360|Female|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pilocytic astrocytoma|2008
0-19|0.8|0.9|0.8|Malignant|341|40576293|Female|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pilocytic astrocytoma|2009
0-19|0.8|1.0|0.9|Malignant|360|40670476|Female|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Pilocytic astrocytoma|2010
0-19|0.9|1.1|1.0|Malignant|402|40652091|Female|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Pilocytic astrocytoma|2011
0-19|0.8|1.0|0.9|Malignant|358|40556179|Female|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Pilocytic astrocytoma|2012
0-19|0.9|1.0|0.9|Malignant|382|40478537|Female|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Pilocytic astrocytoma|2013
0-19|0.8|1.0|0.9|Malignant|365|40458251|Female|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Pilocytic astrocytoma|2014
0-19|0.9|1.1|1.0|Malignant|411|40476449|Female|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|362|40548779|Female|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Pilocytic astrocytoma|2016
0-19|0.8|0.9|0.8|Malignant|339|40650115|Female|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Pilocytic astrocytoma|2017
0-19|0.9|1.1|1.0|Malignant|409|40703047|Female|Pilocytic astrocytoma|2017
0-19|0.2|0.3|0.2|Benign/Borderline|90|40705737|Female|Pilocytic astrocytoma|2018
0-19|0.7|0.9|0.8|Malignant|333|40705737|Female|Pilocytic astrocytoma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|367|201996736|Female|Pilocytic astrocytoma|2018-2022
0-19|0.7|0.8|0.7|Malignant|1444|201996736|Female|Pilocytic astrocytoma|2018-2022
0-19|0.1|0.2|0.2|Benign/Borderline|65|40650648|Female|Pilocytic astrocytoma|2019
0-19|0.7|0.8|0.7|Malignant|300|40650648|Female|Pilocytic astrocytoma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|71|40481966|Female|Pilocytic astrocytoma|2020
0-19|0.6|0.7|0.7|Malignant|268|40481966|Female|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|67|40152307|Female|Pilocytic astrocytoma|2021
0-19|0.6|0.7|0.7|Malignant|264|40152307|Female|Pilocytic astrocytoma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|74|40006078|Female|Pilocytic astrocytoma|2022
0-19|0.6|0.8|0.7|Malignant|279|40006078|Female|Pilocytic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|39865121|Female|Pineal parenchymal|2004
0-19|~|~|~|Malignant|~|39865121|Female|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|39998876|Female|Pineal parenchymal|2005
0-19|~|~|~|Malignant|~|39998876|Female|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|40165421|Female|Pineal parenchymal|2006
0-19|~|~|~|Malignant|~|40165421|Female|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|40382360|Female|Pineal parenchymal|2007
0-19|~|~|~|Malignant|~|40382360|Female|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|40576293|Female|Pineal parenchymal|2008
0-19|0.0|0.1|0.1|Malignant|21|40576293|Female|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|40670476|Female|Pineal parenchymal|2009
0-19|~|~|~|Malignant|~|40670476|Female|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|40652091|Female|Pineal parenchymal|2010
0-19|~|~|~|Malignant|~|40652091|Female|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|40556179|Female|Pineal parenchymal|2011
0-19|~|~|~|Malignant|~|40556179|Female|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|40478537|Female|Pineal parenchymal|2012
0-19|~|~|~|Malignant|~|40478537|Female|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|40458251|Female|Pineal parenchymal|2013
0-19|~|~|~|Malignant|~|40458251|Female|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|40476449|Female|Pineal parenchymal|2014
0-19|0.0|0.1|0.0|Malignant|16|40476449|Female|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|40548779|Female|Pineal parenchymal|2015
0-19|0.0|0.1|0.1|Malignant|25|40548779|Female|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|40650115|Female|Pineal parenchymal|2016
0-19|0.0|0.1|0.0|Malignant|16|40650115|Female|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|40703047|Female|Pineal parenchymal|2017
0-19|~|~|~|Malignant|~|40703047|Female|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|40705737|Female|Pineal parenchymal|2018
0-19|0.0|0.1|0.0|Malignant|18|40705737|Female|Pineal parenchymal|2018
0-19|0.0|0.0|0.0|Benign/Borderline|19|201996736|Female|Pineal parenchymal|2018-2022
0-19|0.0|0.0|0.0|Malignant|79|201996736|Female|Pineal parenchymal|2018-2022
0-19|~|~|~|Benign/Borderline|~|40650648|Female|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|19|40650648|Female|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|40481966|Female|Pineal parenchymal|2020
0-19|~|~|~|Malignant|~|40481966|Female|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|40152307|Female|Pineal parenchymal|2021
0-19|~|~|~|Malignant|~|40152307|Female|Pineal parenchymal|2021
0-19|~|~|~|Benign/Borderline|~|40006078|Female|Pineal parenchymal|2022
0-19|~|~|~|Malignant|~|40006078|Female|Pineal parenchymal|2022
0-19|0.6|0.8|0.7|Benign/Borderline|292|39865121|Female|Pituitary|2004
0-19|~|~|~|Malignant|~|39865121|Female|Pituitary|2004
0-19|0.7|0.9|0.8|Benign/Borderline|336|39998876|Female|Pituitary|2005
0-19|~|~|~|Malignant|~|39998876|Female|Pituitary|2005
0-19|0.8|1.0|0.9|Benign/Borderline|380|40165421|Female|Pituitary|2006
0-19|~|~|~|Malignant|~|40165421|Female|Pituitary|2006
0-19|0.8|1.0|0.9|Benign/Borderline|362|40382360|Female|Pituitary|2007
0-19|~|~|~|Malignant|~|40382360|Female|Pituitary|2007
0-19|0.9|1.1|1.0|Benign/Borderline|433|40576293|Female|Pituitary|2008
0-19|~|~|~|Malignant|~|40576293|Female|Pituitary|2008
0-19|0.9|1.1|1.0|Benign/Borderline|434|40670476|Female|Pituitary|2009
0-19|~|~|~|Malignant|~|40670476|Female|Pituitary|2009
0-19|1.1|1.3|1.2|Benign/Borderline|489|40652091|Female|Pituitary|2010
0-19|~|~|~|Malignant|~|40652091|Female|Pituitary|2010
0-19|1.1|1.3|1.2|Benign/Borderline|490|40556179|Female|Pituitary|2011
0-19|~|~|~|Malignant|~|40556179|Female|Pituitary|2011
0-19|1.2|1.4|1.3|Benign/Borderline|532|40478537|Female|Pituitary|2012
0-19|~|~|~|Malignant|~|40478537|Female|Pituitary|2012
0-19|1.2|1.4|1.3|Benign/Borderline|529|40458251|Female|Pituitary|2013
0-19|~|~|~|Malignant|~|40458251|Female|Pituitary|2013
0-19|1.3|1.5|1.4|Benign/Borderline|574|40476449|Female|Pituitary|2014
0-19|~|~|~|Malignant|~|40476449|Female|Pituitary|2014
0-19|1.3|1.5|1.4|Benign/Borderline|574|40548779|Female|Pituitary|2015
0-19|~|~|~|Malignant|~|40548779|Female|Pituitary|2015
0-19|1.4|1.6|1.5|Benign/Borderline|632|40650115|Female|Pituitary|2016
0-19|~|~|~|Malignant|~|40650115|Female|Pituitary|2016
0-19|1.5|1.8|1.6|Benign/Borderline|675|40703047|Female|Pituitary|2017
0-19|~|~|~|Malignant|~|40703047|Female|Pituitary|2017
0-19|1.4|1.7|1.6|Benign/Borderline|648|40705737|Female|Pituitary|2018
0-19|~|~|~|Malignant|~|40705737|Female|Pituitary|2018
0-19|1.4|1.5|1.5|Benign/Borderline|3071|201996736|Female|Pituitary|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Pituitary|2018-2022
0-19|1.4|1.7|1.5|Benign/Borderline|636|40650648|Female|Pituitary|2019
0-19|~|~|~|Malignant|~|40650648|Female|Pituitary|2019
0-19|1.3|1.6|1.5|Benign/Borderline|605|40481966|Female|Pituitary|2020
0-19|~|~|~|Malignant|~|40481966|Female|Pituitary|2020
0-19|1.4|1.7|1.5|Benign/Borderline|642|40152307|Female|Pituitary|2021
0-19|~|~|~|Malignant|~|40152307|Female|Pituitary|2021
0-19|1.2|1.4|1.3|Benign/Borderline|540|40006078|Female|Pituitary|2022
0-19|~|~|~|Malignant|~|40006078|Female|Pituitary|2022
0-19|1.9|2.2|2.1|Benign/Borderline|824|39865121|Female|Total|2004
0-19|3.1|3.5|3.3|Malignant|1307|39865121|Female|Total|2004
0-19|2.3|2.6|2.4|Benign/Borderline|989|39998876|Female|Total|2005
0-19|2.9|3.3|3.1|Malignant|1239|39998876|Female|Total|2005
0-19|2.3|2.6|2.5|Benign/Borderline|1009|40165421|Female|Total|2006
0-19|2.9|3.3|3.1|Malignant|1240|40165421|Female|Total|2006
0-19|2.3|2.7|2.5|Benign/Borderline|1026|40382360|Female|Total|2007
0-19|3.1|3.4|3.2|Malignant|1307|40382360|Female|Total|2007
0-19|2.6|2.9|2.7|Benign/Borderline|1121|40576293|Female|Total|2008
0-19|3.0|3.4|3.2|Malignant|1295|40576293|Female|Total|2008
0-19|2.6|2.9|2.8|Benign/Borderline|1143|40670476|Female|Total|2009
0-19|3.1|3.4|3.2|Malignant|1305|40670476|Female|Total|2009
0-19|2.8|3.1|2.9|Benign/Borderline|1214|40652091|Female|Total|2010
0-19|3.1|3.4|3.2|Malignant|1310|40652091|Female|Total|2010
0-19|2.9|3.2|3.0|Benign/Borderline|1242|40556179|Female|Total|2011
0-19|3.2|3.5|3.4|Malignant|1358|40556179|Female|Total|2011
0-19|3.0|3.4|3.2|Benign/Borderline|1316|40478537|Female|Total|2012
0-19|2.9|3.3|3.1|Malignant|1245|40478537|Female|Total|2012
0-19|3.1|3.5|3.3|Benign/Borderline|1354|40458251|Female|Total|2013
0-19|3.2|3.6|3.4|Malignant|1364|40458251|Female|Total|2013
0-19|3.2|3.5|3.3|Benign/Borderline|1363|40476449|Female|Total|2014
0-19|3.3|3.6|3.5|Malignant|1397|40476449|Female|Total|2014
0-19|3.2|3.6|3.4|Benign/Borderline|1397|40548779|Female|Total|2015
0-19|3.0|3.4|3.2|Malignant|1300|40548779|Female|Total|2015
0-19|3.3|3.6|3.4|Benign/Borderline|1412|40650115|Female|Total|2016
0-19|3.0|3.4|3.2|Malignant|1297|40650115|Female|Total|2016
0-19|3.3|3.7|3.5|Benign/Borderline|1439|40703047|Female|Total|2017
0-19|3.2|3.5|3.3|Malignant|1358|40703047|Female|Total|2017
0-19|3.3|3.7|3.5|Benign/Borderline|1426|40705737|Female|Total|2018
0-19|2.7|3.1|2.9|Malignant|1175|40705737|Female|Total|2018
0-19|3.2|3.3|3.3|Benign/Borderline|6689|201996736|Female|Total|2018-2022
0-19|2.5|2.6|2.6|Malignant|5146|201996736|Female|Total|2018-2022
0-19|3.1|3.5|3.3|Benign/Borderline|1352|40650648|Female|Total|2019
0-19|2.4|2.8|2.6|Malignant|1051|40650648|Female|Total|2019
0-19|3.1|3.4|3.2|Benign/Borderline|1322|40481966|Female|Total|2020
0-19|2.3|2.6|2.5|Malignant|999|40481966|Female|Total|2020
0-19|3.2|3.5|3.4|Benign/Borderline|1370|40152307|Female|Total|2021
0-19|2.4|2.7|2.5|Malignant|1012|40152307|Female|Total|2021
0-19|2.8|3.2|3.0|Benign/Borderline|1219|40006078|Female|Total|2022
0-19|2.1|2.4|2.3|Malignant|909|40006078|Female|Total|2022
0-19|0.2|0.3|0.3|Benign/Borderline|116|39865121|Female|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Cranial and Spinal Nerves|2004
0-19|0.4|0.5|0.4|Benign/Borderline|166|39998876|Female|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Cranial and Spinal Nerves|2005
0-19|0.3|0.5|0.4|Benign/Borderline|164|40165421|Female|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.3|Benign/Borderline|137|40382360|Female|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|150|40576293|Female|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|156|40670476|Female|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|138|40652091|Female|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|40652091|Female|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.3|Benign/Borderline|134|40556179|Female|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|40556179|Female|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|147|40478537|Female|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|40478537|Female|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.5|0.4|Benign/Borderline|157|40458251|Female|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|40458251|Female|Tumors of Cranial and Spinal Nerves|2013
0-19|0.2|0.3|0.3|Benign/Borderline|111|40476449|Female|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|40476449|Female|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.5|0.4|Benign/Borderline|160|40548779|Female|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|40548779|Female|Tumors of Cranial and Spinal Nerves|2015
0-19|0.3|0.4|0.3|Benign/Borderline|130|40650115|Female|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|40650115|Female|Tumors of Cranial and Spinal Nerves|2016
0-19|0.3|0.4|0.3|Benign/Borderline|135|40703047|Female|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|40703047|Female|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|81|40705737|Female|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|40705737|Female|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.2|0.2|Benign/Borderline|388|201996736|Female|Tumors of Cranial and Spinal Nerves|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Tumors of Cranial and Spinal Nerves|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|80|40650648|Female|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|40650648|Female|Tumors of Cranial and Spinal Nerves|2019
0-19|0.1|0.2|0.2|Benign/Borderline|78|40481966|Female|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|40481966|Female|Tumors of Cranial and Spinal Nerves|2020
0-19|0.2|0.2|0.2|Benign/Borderline|82|40152307|Female|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|40152307|Female|Tumors of Cranial and Spinal Nerves|2021
0-19|0.1|0.2|0.2|Benign/Borderline|67|40006078|Female|Tumors of Cranial and Spinal Nerves|2022
0-19|~|~|~|Malignant|~|40006078|Female|Tumors of Cranial and Spinal Nerves|2022
0-19|0.4|0.6|0.5|Benign/Borderline|193|39865121|Female|Tumors of Neuroepthelial Tissue|2004
0-19|2.9|3.2|3.0|Malignant|1210|39865121|Female|Tumors of Neuroepthelial Tissue|2004
0-19|0.4|0.6|0.5|Benign/Borderline|201|39998876|Female|Tumors of Neuroepthelial Tissue|2005
0-19|2.7|3.1|2.9|Malignant|1149|39998876|Female|Tumors of Neuroepthelial Tissue|2005
0-19|0.4|0.6|0.5|Benign/Borderline|208|40165421|Female|Tumors of Neuroepthelial Tissue|2006
0-19|2.8|3.1|2.9|Malignant|1167|40165421|Female|Tumors of Neuroepthelial Tissue|2006
0-19|0.5|0.7|0.6|Benign/Borderline|233|40382360|Female|Tumors of Neuroepthelial Tissue|2007
0-19|2.9|3.3|3.1|Malignant|1245|40382360|Female|Tumors of Neuroepthelial Tissue|2007
0-19|0.5|0.6|0.6|Benign/Borderline|230|40576293|Female|Tumors of Neuroepthelial Tissue|2008
0-19|2.9|3.2|3.1|Malignant|1241|40576293|Female|Tumors of Neuroepthelial Tissue|2008
0-19|0.5|0.6|0.5|Benign/Borderline|218|40670476|Female|Tumors of Neuroepthelial Tissue|2009
0-19|2.9|3.2|3.0|Malignant|1226|40670476|Female|Tumors of Neuroepthelial Tissue|2009
0-19|0.5|0.7|0.6|Benign/Borderline|235|40652091|Female|Tumors of Neuroepthelial Tissue|2010
0-19|2.9|3.2|3.0|Malignant|1230|40652091|Female|Tumors of Neuroepthelial Tissue|2010
0-19|0.5|0.7|0.6|Benign/Borderline|251|40556179|Female|Tumors of Neuroepthelial Tissue|2011
0-19|3.0|3.3|3.2|Malignant|1281|40556179|Female|Tumors of Neuroepthelial Tissue|2011
0-19|0.6|0.7|0.6|Benign/Borderline|258|40478537|Female|Tumors of Neuroepthelial Tissue|2012
0-19|2.8|3.1|2.9|Malignant|1183|40478537|Female|Tumors of Neuroepthelial Tissue|2012
0-19|0.6|0.8|0.7|Benign/Borderline|274|40458251|Female|Tumors of Neuroepthelial Tissue|2013
0-19|3.0|3.3|3.2|Malignant|1275|40458251|Female|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.7|0.6|Benign/Borderline|262|40476449|Female|Tumors of Neuroepthelial Tissue|2014
0-19|3.1|3.5|3.3|Malignant|1325|40476449|Female|Tumors of Neuroepthelial Tissue|2014
0-19|0.6|0.7|0.7|Benign/Borderline|265|40548779|Female|Tumors of Neuroepthelial Tissue|2015
0-19|2.8|3.2|3.0|Malignant|1217|40548779|Female|Tumors of Neuroepthelial Tissue|2015
0-19|0.6|0.8|0.7|Benign/Borderline|287|40650115|Female|Tumors of Neuroepthelial Tissue|2016
0-19|2.8|3.1|3.0|Malignant|1195|40650115|Female|Tumors of Neuroepthelial Tissue|2016
0-19|0.6|0.8|0.7|Benign/Borderline|287|40703047|Female|Tumors of Neuroepthelial Tissue|2017
0-19|3.0|3.3|3.1|Malignant|1278|40703047|Female|Tumors of Neuroepthelial Tissue|2017
0-19|0.8|0.9|0.8|Benign/Borderline|343|40705737|Female|Tumors of Neuroepthelial Tissue|2018
0-19|2.5|2.8|2.7|Malignant|1087|40705737|Female|Tumors of Neuroepthelial Tissue|2018
0-19|0.7|0.8|0.8|Benign/Borderline|1563|201996736|Female|Tumors of Neuroepthelial Tissue|2018-2022
0-19|2.3|2.4|2.4|Malignant|4724|201996736|Female|Tumors of Neuroepthelial Tissue|2018-2022
0-19|0.7|0.8|0.7|Benign/Borderline|303|40650648|Female|Tumors of Neuroepthelial Tissue|2019
0-19|2.3|2.6|2.4|Malignant|973|40650648|Female|Tumors of Neuroepthelial Tissue|2019
0-19|0.7|0.8|0.8|Benign/Borderline|306|40481966|Female|Tumors of Neuroepthelial Tissue|2020
0-19|2.1|2.4|2.3|Malignant|907|40481966|Female|Tumors of Neuroepthelial Tissue|2020
0-19|0.6|0.8|0.7|Benign/Borderline|286|40152307|Female|Tumors of Neuroepthelial Tissue|2021
0-19|2.2|2.5|2.3|Malignant|922|40152307|Female|Tumors of Neuroepthelial Tissue|2021
0-19|0.7|0.9|0.8|Benign/Borderline|325|40006078|Female|Tumors of Neuroepthelial Tissue|2022
0-19|2.0|2.3|2.1|Malignant|835|40006078|Female|Tumors of Neuroepthelial Tissue|2022
0-19|0.8|1.0|0.9|Benign/Borderline|377|39865121|Female|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of Sellar Region|2004
0-19|0.9|1.1|1.0|Benign/Borderline|414|39998876|Female|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of Sellar Region|2005
0-19|1.0|1.2|1.1|Benign/Borderline|457|40165421|Female|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of Sellar Region|2006
0-19|1.0|1.2|1.1|Benign/Borderline|458|40382360|Female|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of Sellar Region|2007
0-19|1.1|1.3|1.2|Benign/Borderline|500|40576293|Female|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of Sellar Region|2008
0-19|1.2|1.4|1.3|Benign/Borderline|525|40670476|Female|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of Sellar Region|2009
0-19|1.3|1.5|1.4|Benign/Borderline|583|40652091|Female|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|40652091|Female|Tumors of Sellar Region|2010
0-19|1.3|1.5|1.4|Benign/Borderline|577|40556179|Female|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|40556179|Female|Tumors of Sellar Region|2011
0-19|1.4|1.6|1.5|Benign/Borderline|610|40478537|Female|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|40478537|Female|Tumors of Sellar Region|2012
0-19|1.4|1.6|1.5|Benign/Borderline|618|40458251|Female|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|40458251|Female|Tumors of Sellar Region|2013
0-19|1.5|1.8|1.6|Benign/Borderline|668|40476449|Female|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|40476449|Female|Tumors of Sellar Region|2014
0-19|1.5|1.7|1.6|Benign/Borderline|656|40548779|Female|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|40548779|Female|Tumors of Sellar Region|2015
0-19|1.6|1.8|1.7|Benign/Borderline|700|40650115|Female|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|40650115|Female|Tumors of Sellar Region|2016
0-19|1.7|2.0|1.8|Benign/Borderline|755|40703047|Female|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|40703047|Female|Tumors of Sellar Region|2017
0-19|1.6|1.8|1.7|Benign/Borderline|703|40705737|Female|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|40705737|Female|Tumors of Sellar Region|2018
0-19|1.6|1.7|1.7|Benign/Borderline|3427|201996736|Female|Tumors of Sellar Region|2018-2022
0-19|~|~|~|Malignant|~|201996736|Female|Tumors of Sellar Region|2018-2022
0-19|1.6|1.9|1.7|Benign/Borderline|722|40650648|Female|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|40650648|Female|Tumors of Sellar Region|2019
0-19|1.5|1.8|1.6|Benign/Borderline|677|40481966|Female|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|40481966|Female|Tumors of Sellar Region|2020
0-19|1.6|1.9|1.7|Benign/Borderline|720|40152307|Female|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|40152307|Female|Tumors of Sellar Region|2021
0-19|1.3|1.6|1.5|Benign/Borderline|605|40006078|Female|Tumors of Sellar Region|2022
0-19|~|~|~|Malignant|~|40006078|Female|Tumors of Sellar Region|2022
0-19|0.1|0.2|0.2|Benign/Borderline|74|39865121|Female|Tumors of the Meninges|2004
0-19|~|~|~|Malignant|~|39865121|Female|Tumors of the Meninges|2004
0-19|0.2|0.3|0.3|Benign/Borderline|111|39998876|Female|Tumors of the Meninges|2005
0-19|~|~|~|Malignant|~|39998876|Female|Tumors of the Meninges|2005
0-19|0.1|0.2|0.2|Benign/Borderline|77|40165421|Female|Tumors of the Meninges|2006
0-19|~|~|~|Malignant|~|40165421|Female|Tumors of the Meninges|2006
0-19|0.2|0.3|0.2|Benign/Borderline|97|40382360|Female|Tumors of the Meninges|2007
0-19|~|~|~|Malignant|~|40382360|Female|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|93|40576293|Female|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|40576293|Female|Tumors of the Meninges|2008
0-19|0.2|0.3|0.3|Benign/Borderline|108|40670476|Female|Tumors of the Meninges|2009
0-19|~|~|~|Malignant|~|40670476|Female|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|101|40652091|Female|Tumors of the Meninges|2010
0-19|~|~|~|Malignant|~|40652091|Female|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|115|40556179|Female|Tumors of the Meninges|2011
0-19|~|~|~|Malignant|~|40556179|Female|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|137|40478537|Female|Tumors of the Meninges|2012
0-19|~|~|~|Malignant|~|40478537|Female|Tumors of the Meninges|2012
0-19|0.3|0.4|0.3|Benign/Borderline|141|40458251|Female|Tumors of the Meninges|2013
0-19|~|~|~|Malignant|~|40458251|Female|Tumors of the Meninges|2013
0-19|0.3|0.4|0.4|Benign/Borderline|152|40476449|Female|Tumors of the Meninges|2014
0-19|~|~|~|Malignant|~|40476449|Female|Tumors of the Meninges|2014
0-19|0.3|0.4|0.3|Benign/Borderline|140|40548779|Female|Tumors of the Meninges|2015
0-19|~|~|~|Malignant|~|40548779|Female|Tumors of the Meninges|2015
0-19|0.3|0.4|0.4|Benign/Borderline|151|40650115|Female|Tumors of the Meninges|2016
0-19|~|~|~|Malignant|~|40650115|Female|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|132|40703047|Female|Tumors of the Meninges|2017
0-19|~|~|~|Malignant|~|40703047|Female|Tumors of the Meninges|2017
0-19|0.3|0.4|0.3|Benign/Borderline|142|40705737|Female|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|40705737|Female|Tumors of the Meninges|2018
0-19|0.3|0.4|0.3|Benign/Borderline|666|201996736|Female|Tumors of the Meninges|2018-2022
0-19|0.0|0.0|0.0|Malignant|48|201996736|Female|Tumors of the Meninges|2018-2022
0-19|0.3|0.4|0.3|Benign/Borderline|129|40650648|Female|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|40650648|Female|Tumors of the Meninges|2019
0-19|0.3|0.4|0.3|Benign/Borderline|129|40481966|Female|Tumors of the Meninges|2020
0-19|~|~|~|Malignant|~|40481966|Female|Tumors of the Meninges|2020
0-19|0.3|0.5|0.4|Benign/Borderline|158|40152307|Female|Tumors of the Meninges|2021
0-19|~|~|~|Malignant|~|40152307|Female|Tumors of the Meninges|2021
0-19|0.2|0.3|0.3|Benign/Borderline|108|40006078|Female|Tumors of the Meninges|2022
0-19|~|~|~|Malignant|~|40006078|Female|Tumors of the Meninges|2022
0-19|0.1|0.2|0.1|Benign/Borderline|50|39865121|Female|Unclassified Tumors|2004
0-19|0.0|0.1|0.1|Malignant|27|39865121|Female|Unclassified Tumors|2004
0-19|0.2|0.3|0.2|Benign/Borderline|83|39998876|Female|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|19|39998876|Female|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|85|40165421|Female|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|29|40165421|Female|Unclassified Tumors|2006
0-19|0.2|0.3|0.2|Benign/Borderline|86|40382360|Female|Unclassified Tumors|2007
0-19|0.0|0.1|0.0|Malignant|16|40382360|Female|Unclassified Tumors|2007
0-19|0.3|0.4|0.3|Benign/Borderline|128|40576293|Female|Unclassified Tumors|2008
0-19|~|~|~|Malignant|~|40576293|Female|Unclassified Tumors|2008
0-19|0.2|0.3|0.3|Benign/Borderline|116|40670476|Female|Unclassified Tumors|2009
0-19|0.0|0.1|0.0|Malignant|16|40670476|Female|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|136|40652091|Female|Unclassified Tumors|2010
0-19|~|~|~|Malignant|~|40652091|Female|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|142|40556179|Female|Unclassified Tumors|2011
0-19|0.0|0.1|0.0|Malignant|19|40556179|Female|Unclassified Tumors|2011
0-19|0.3|0.4|0.4|Benign/Borderline|147|40478537|Female|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|24|40478537|Female|Unclassified Tumors|2012
0-19|0.3|0.4|0.4|Benign/Borderline|142|40458251|Female|Unclassified Tumors|2013
0-19|0.0|0.1|0.1|Malignant|24|40458251|Female|Unclassified Tumors|2013
0-19|0.3|0.4|0.4|Benign/Borderline|147|40476449|Female|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|21|40476449|Female|Unclassified Tumors|2014
0-19|0.3|0.5|0.4|Benign/Borderline|158|40548779|Female|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|17|40548779|Female|Unclassified Tumors|2015
0-19|0.2|0.3|0.3|Benign/Borderline|116|40650115|Female|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|24|40650115|Female|Unclassified Tumors|2016
0-19|0.2|0.3|0.3|Benign/Borderline|115|40703047|Female|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|21|40703047|Female|Unclassified Tumors|2017
0-19|0.3|0.4|0.3|Benign/Borderline|132|40705737|Female|Unclassified Tumors|2018
0-19|0.0|0.1|0.1|Malignant|28|40705737|Female|Unclassified Tumors|2018
0-19|0.3|0.3|0.3|Benign/Borderline|565|201996736|Female|Unclassified Tumors|2018-2022
0-19|0.1|0.1|0.1|Malignant|122|201996736|Female|Unclassified Tumors|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|100|40650648|Female|Unclassified Tumors|2019
0-19|0.0|0.1|0.0|Malignant|16|40650648|Female|Unclassified Tumors|2019
0-19|0.2|0.3|0.3|Benign/Borderline|118|40481966|Female|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|26|40481966|Female|Unclassified Tumors|2020
0-19|0.2|0.3|0.3|Benign/Borderline|114|40152307|Female|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|27|40152307|Female|Unclassified Tumors|2021
0-19|0.2|0.3|0.2|Benign/Borderline|101|40006078|Female|Unclassified Tumors|2022
0-19|0.0|0.1|0.1|Malignant|25|40006078|Female|Unclassified Tumors|2022
0-19|0.0|0.1|0.1|Benign/Borderline|21|39865121|Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.0|Malignant|19|39865121|Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.1|Benign/Borderline|25|39998876|Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.0|Malignant|20|39998876|Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|24|40165421|Female|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|19|40165421|Female|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|36|40382360|Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Malignant|35|40382360|Female|Unique astrocytoma variants|2007
0-19|0.0|0.1|0.1|Benign/Borderline|27|40576293|Female|Unique astrocytoma variants|2008
0-19|~|~|~|Malignant|~|40576293|Female|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|36|40670476|Female|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|21|40670476|Female|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|32|40652091|Female|Unique astrocytoma variants|2010
0-19|~|~|~|Malignant|~|40652091|Female|Unique astrocytoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|21|40556179|Female|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|24|40556179|Female|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|34|40478537|Female|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.0|Malignant|19|40478537|Female|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|39|40458251|Female|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.0|Malignant|18|40458251|Female|Unique astrocytoma variants|2013
0-19|0.1|0.1|0.1|Benign/Borderline|45|40476449|Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.0|Malignant|16|40476449|Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|23|40548779|Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|26|40548779|Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Benign/Borderline|24|40650115|Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|21|40650115|Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Benign/Borderline|26|40703047|Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Malignant|26|40703047|Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Benign/Borderline|26|40705737|Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|24|40705737|Female|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|125|201996736|Female|Unique astrocytoma variants|2018-2022
0-19|0.0|0.1|0.1|Malignant|114|201996736|Female|Unique astrocytoma variants|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|30|40650648|Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.0|Malignant|20|40650648|Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Benign/Borderline|26|40481966|Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.1|Malignant|21|40481966|Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|20|40152307|Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Malignant|24|40152307|Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Benign/Borderline|23|40006078|Female|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.1|Malignant|25|40006078|Female|Unique astrocytoma variants|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|All other|2004
0-19|~|~|~|Malignant|~|41889233|Male|All other|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|All other|2005
0-19|~|~|~|Malignant|~|42006384|Male|All other|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|All other|2006
0-19|~|~|~|Malignant|~|42158997|Male|All other|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|All other|2007
0-19|~|~|~|Malignant|~|42367071|Male|All other|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|All other|2008
0-19|~|~|~|Malignant|~|42541971|Male|All other|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|All other|2009
0-19|~|~|~|Malignant|~|42609915|Male|All other|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|All other|2010
0-19|~|~|~|Malignant|~|42572643|Male|All other|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|All other|2011
0-19|~|~|~|Malignant|~|42484916|Male|All other|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|All other|2012
0-19|~|~|~|Malignant|~|42387849|Male|All other|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|All other|2013
0-19|~|~|~|Malignant|~|42339679|Male|All other|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|All other|2014
0-19|~|~|~|Malignant|~|42351811|Male|All other|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|All other|2015
0-19|~|~|~|Malignant|~|42425680|Male|All other|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|All other|2016
0-19|~|~|~|Malignant|~|42534300|Male|All other|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|All other|2017
0-19|~|~|~|Malignant|~|42605171|Male|All other|2017
0-19|0.0|0.1|0.1|Benign/Borderline|23|42616257|Male|All other|2018
0-19|0.3|0.4|0.3|Malignant|132|42616257|Male|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|182|211518041|Male|All other|2018-2022
0-19|0.4|0.4|0.4|Malignant|872|211518041|Male|All other|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|40|42563170|Male|All other|2019
0-19|0.3|0.4|0.4|Malignant|154|42563170|Male|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|35|42391466|Male|All other|2020
0-19|0.3|0.4|0.4|Malignant|152|42391466|Male|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|44|42049566|Male|All other|2021
0-19|0.4|0.5|0.5|Malignant|197|42049566|Male|All other|2021
0-19|0.1|0.1|0.1|Benign/Borderline|40|41897582|Male|All other|2022
0-19|0.5|0.6|0.6|Malignant|237|41897582|Male|All other|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic astrocytoma|2005
0-19|0.1|0.1|0.1|Malignant|36|42006384|Male|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|36|42158997|Male|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic astrocytoma|2007
0-19|0.1|0.2|0.1|Malignant|56|42367071|Male|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|42|42541971|Male|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|41|42609915|Male|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|44|42572643|Male|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|33|42484916|Male|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Anaplastic astrocytoma|2012
0-19|0.1|0.1|0.1|Malignant|44|42387849|Male|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Anaplastic astrocytoma|2013
0-19|0.1|0.1|0.1|Malignant|45|42339679|Male|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Anaplastic astrocytoma|2014
0-19|0.1|0.2|0.1|Malignant|56|42351811|Male|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|46|42425680|Male|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|44|42534300|Male|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Anaplastic astrocytoma|2017
0-19|0.1|0.1|0.1|Malignant|33|42605171|Male|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Anaplastic astrocytoma|2018
0-19|0.1|0.1|0.1|Malignant|38|42616257|Male|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Anaplastic astrocytoma|2018-2022
0-19|0.1|0.1|0.1|Malignant|130|211518041|Male|Anaplastic astrocytoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Anaplastic astrocytoma|2019
0-19|0.1|0.1|0.1|Malignant|37|42563170|Male|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|28|42391466|Male|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Anaplastic astrocytoma|2021
0-19|0.0|0.1|0.0|Malignant|19|42049566|Male|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Anaplastic astrocytoma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Anaplastic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|42572643|Male|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|42484916|Male|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|42387849|Male|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Anaplastic oligodendroglioma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Anaplastic oligodendroglioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.3|Malignant|108|41889233|Male|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|97|42006384|Male|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.3|Malignant|108|42158997|Male|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|106|42609915|Male|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.3|Malignant|121|42572643|Male|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Astrocytoma, NOS|2011
0-19|0.2|0.3|0.2|Malignant|103|42484916|Male|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Astrocytoma, NOS|2012
0-19|0.2|0.2|0.2|Malignant|82|42387849|Male|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|93|42339679|Male|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|113|42351811|Male|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Astrocytoma, NOS|2015
0-19|0.2|0.3|0.2|Malignant|95|42425680|Male|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Astrocytoma, NOS|2016
0-19|0.2|0.3|0.2|Malignant|92|42534300|Male|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.2|Malignant|106|42605171|Male|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Astrocytoma, NOS|2018
0-19|0.2|0.3|0.2|Malignant|93|42616257|Male|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Astrocytoma, NOS|2018-2022
0-19|0.1|0.2|0.2|Malignant|352|211518041|Male|Astrocytoma, NOS|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Astrocytoma, NOS|2019
0-19|0.1|0.2|0.2|Malignant|76|42563170|Male|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Astrocytoma, NOS|2020
0-19|0.1|0.2|0.1|Malignant|49|42391466|Male|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|71|42049566|Male|Astrocytoma, NOS|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Astrocytoma, NOS|2022
0-19|0.1|0.2|0.1|Malignant|63|41897582|Male|Astrocytoma, NOS|2022
0-19|0.0|0.1|0.1|Benign/Borderline|27|41889233|Male|Choroid plexus|2004
0-19|~|~|~|Malignant|~|41889233|Male|Choroid plexus|2004
0-19|0.1|0.1|0.1|Benign/Borderline|34|42006384|Male|Choroid plexus|2005
0-19|~|~|~|Malignant|~|42006384|Male|Choroid plexus|2005
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Choroid plexus|2006
0-19|~|~|~|Malignant|~|42158997|Male|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|35|42367071|Male|Choroid plexus|2007
0-19|~|~|~|Malignant|~|42367071|Male|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|37|42541971|Male|Choroid plexus|2008
0-19|~|~|~|Malignant|~|42541971|Male|Choroid plexus|2008
0-19|0.1|0.1|0.1|Benign/Borderline|38|42609915|Male|Choroid plexus|2009
0-19|~|~|~|Malignant|~|42609915|Male|Choroid plexus|2009
0-19|0.1|0.1|0.1|Benign/Borderline|40|42572643|Male|Choroid plexus|2010
0-19|0.0|0.1|0.0|Malignant|17|42572643|Male|Choroid plexus|2010
0-19|0.1|0.1|0.1|Benign/Borderline|34|42484916|Male|Choroid plexus|2011
0-19|~|~|~|Malignant|~|42484916|Male|Choroid plexus|2011
0-19|0.1|0.1|0.1|Benign/Borderline|36|42387849|Male|Choroid plexus|2012
0-19|~|~|~|Malignant|~|42387849|Male|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|38|42339679|Male|Choroid plexus|2013
0-19|~|~|~|Malignant|~|42339679|Male|Choroid plexus|2013
0-19|0.1|0.1|0.1|Benign/Borderline|36|42351811|Male|Choroid plexus|2014
0-19|~|~|~|Malignant|~|42351811|Male|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|35|42425680|Male|Choroid plexus|2015
0-19|0.0|0.1|0.0|Malignant|18|42425680|Male|Choroid plexus|2015
0-19|0.1|0.1|0.1|Benign/Borderline|38|42534300|Male|Choroid plexus|2016
0-19|~|~|~|Malignant|~|42534300|Male|Choroid plexus|2016
0-19|0.0|0.1|0.1|Benign/Borderline|31|42605171|Male|Choroid plexus|2017
0-19|~|~|~|Malignant|~|42605171|Male|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|42|42616257|Male|Choroid plexus|2018
0-19|~|~|~|Malignant|~|42616257|Male|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|174|211518041|Male|Choroid plexus|2018-2022
0-19|0.0|0.0|0.0|Malignant|55|211518041|Male|Choroid plexus|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|34|42563170|Male|Choroid plexus|2019
0-19|0.0|0.1|0.0|Malignant|16|42563170|Male|Choroid plexus|2019
0-19|0.1|0.1|0.1|Benign/Borderline|33|42391466|Male|Choroid plexus|2020
0-19|~|~|~|Malignant|~|42391466|Male|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|26|42049566|Male|Choroid plexus|2021
0-19|~|~|~|Malignant|~|42049566|Male|Choroid plexus|2021
0-19|0.1|0.1|0.1|Benign/Borderline|39|41897582|Male|Choroid plexus|2022
0-19|~|~|~|Malignant|~|41897582|Male|Choroid plexus|2022
0-19|0.2|0.3|0.2|Benign/Borderline|86|41889233|Male|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Craniopharyngioma|2004
0-19|0.2|0.3|0.2|Benign/Borderline|94|42006384|Male|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|81|42158997|Male|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|89|42367071|Male|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Craniopharyngioma|2007
0-19|0.2|0.3|0.2|Benign/Borderline|96|42541971|Male|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Craniopharyngioma|2008
0-19|0.2|0.2|0.2|Benign/Borderline|83|42609915|Male|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Craniopharyngioma|2009
0-19|0.2|0.2|0.2|Benign/Borderline|84|42572643|Male|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|42572643|Male|Craniopharyngioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|70|42484916|Male|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|42484916|Male|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|81|42387849|Male|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|42387849|Male|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|94|42339679|Male|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Craniopharyngioma|2013
0-19|0.2|0.3|0.3|Benign/Borderline|108|42351811|Male|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|98|42425680|Male|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Craniopharyngioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|81|42534300|Male|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Craniopharyngioma|2016
0-19|0.2|0.3|0.2|Benign/Borderline|102|42605171|Male|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Craniopharyngioma|2017
0-19|0.2|0.3|0.2|Benign/Borderline|103|42616257|Male|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Craniopharyngioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|427|211518041|Male|Craniopharyngioma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Craniopharyngioma|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|81|42563170|Male|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Craniopharyngioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|55|42391466|Male|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Craniopharyngioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|103|42049566|Male|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Craniopharyngioma|2021
0-19|0.2|0.3|0.2|Benign/Borderline|85|41897582|Male|Craniopharyngioma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Craniopharyngioma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|24|41889233|Male|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|23|42006384|Male|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Diffuse astrocytoma|2006
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|23|42541971|Male|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|20|42609915|Male|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Diffuse astrocytoma|2010
0-19|~|~|~|Malignant|~|42572643|Male|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Diffuse astrocytoma|2011
0-19|0.0|0.1|0.1|Malignant|24|42484916|Male|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Diffuse astrocytoma|2012
0-19|0.0|0.1|0.0|Malignant|19|42387849|Male|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Diffuse astrocytoma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Diffuse astrocytoma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Diffuse astrocytoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Diffuse astrocytoma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Diffuse astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Embryonal/primitive/medulloblastoma|2004
0-19|0.6|0.8|0.7|Malignant|294|41889233|Male|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Embryonal/primitive/medulloblastoma|2005
0-19|0.6|0.8|0.7|Malignant|277|42006384|Male|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Embryonal/primitive/medulloblastoma|2006
0-19|0.6|0.8|0.7|Malignant|297|42158997|Male|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Embryonal/primitive/medulloblastoma|2007
0-19|0.6|0.8|0.7|Malignant|296|42367071|Male|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Embryonal/primitive/medulloblastoma|2008
0-19|0.7|0.8|0.8|Malignant|321|42541971|Male|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Embryonal/primitive/medulloblastoma|2009
0-19|0.7|0.8|0.7|Malignant|311|42609915|Male|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Embryonal/primitive/medulloblastoma|2010
0-19|0.7|0.8|0.7|Malignant|316|42572643|Male|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Embryonal/primitive/medulloblastoma|2011
0-19|0.6|0.8|0.7|Malignant|302|42484916|Male|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Embryonal/primitive/medulloblastoma|2012
0-19|0.6|0.8|0.7|Malignant|286|42387849|Male|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Embryonal/primitive/medulloblastoma|2013
0-19|0.6|0.7|0.7|Malignant|274|42339679|Male|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Embryonal/primitive/medulloblastoma|2014
0-19|0.6|0.8|0.7|Malignant|281|42351811|Male|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Embryonal/primitive/medulloblastoma|2015
0-19|0.6|0.8|0.7|Malignant|299|42425680|Male|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Embryonal/primitive/medulloblastoma|2016
0-19|0.6|0.8|0.7|Malignant|288|42534300|Male|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Embryonal/primitive/medulloblastoma|2017
0-19|0.6|0.8|0.7|Malignant|302|42605171|Male|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Embryonal/primitive/medulloblastoma|2018
0-19|0.4|0.6|0.5|Malignant|203|42616257|Male|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Embryonal/primitive/medulloblastoma|2018-2022
0-19|0.4|0.5|0.4|Malignant|911|211518041|Male|Embryonal/primitive/medulloblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Embryonal/primitive/medulloblastoma|2019
0-19|0.4|0.5|0.4|Malignant|176|42563170|Male|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Embryonal/primitive/medulloblastoma|2020
0-19|0.4|0.6|0.5|Malignant|202|42391466|Male|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Embryonal/primitive/medulloblastoma|2021
0-19|0.4|0.5|0.4|Malignant|174|42049566|Male|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Embryonal/primitive/medulloblastoma|2022
0-19|0.3|0.4|0.4|Malignant|156|41897582|Male|Embryonal/primitive/medulloblastoma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|41889233|Male|Ependymoma variants|2004
0-19|0.0|0.1|0.0|Benign/Borderline|20|42006384|Male|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|42006384|Male|Ependymoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|27|42158997|Male|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|42158997|Male|Ependymoma variants|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|42367071|Male|Ependymoma variants|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|42541971|Male|Ependymoma variants|2008
0-19|0.0|0.1|0.0|Benign/Borderline|21|42609915|Male|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|42609915|Male|Ependymoma variants|2009
0-19|0.0|0.1|0.1|Benign/Borderline|28|42572643|Male|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|42572643|Male|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|22|42484916|Male|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|42484916|Male|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|17|42387849|Male|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|42387849|Male|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|21|42339679|Male|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|42339679|Male|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|42351811|Male|Ependymoma variants|2014
0-19|0.0|0.1|0.0|Benign/Borderline|17|42425680|Male|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|42425680|Male|Ependymoma variants|2015
0-19|0.0|0.1|0.1|Benign/Borderline|23|42534300|Male|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|42534300|Male|Ependymoma variants|2016
0-19|0.0|0.1|0.0|Benign/Borderline|21|42605171|Male|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|42605171|Male|Ependymoma variants|2017
0-19|0.0|0.1|0.1|Benign/Borderline|26|42616257|Male|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|42616257|Male|Ependymoma variants|2018
0-19|0.0|0.1|0.1|Benign/Borderline|122|211518041|Male|Ependymoma variants|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Ependymoma variants|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|28|42563170|Male|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|42563170|Male|Ependymoma variants|2019
0-19|0.0|0.1|0.0|Benign/Borderline|20|42391466|Male|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|42391466|Male|Ependymoma variants|2020
0-19|0.0|0.1|0.1|Benign/Borderline|23|42049566|Male|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|42049566|Male|Ependymoma variants|2021
0-19|0.0|0.1|0.1|Benign/Borderline|25|41897582|Male|Ependymoma variants|2022
0-19|~|~|~|Malignant|~|41897582|Male|Ependymoma variants|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|102|41889233|Male|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|107|42006384|Male|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|109|42158997|Male|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Ependymoma/anaplastic ependymoma|2007
0-19|0.2|0.3|0.3|Malignant|115|42367071|Male|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.3|0.2|Malignant|95|42541971|Male|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.3|0.3|Malignant|114|42609915|Male|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.3|Malignant|120|42572643|Male|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.3|Malignant|113|42484916|Male|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.3|Malignant|116|42387849|Male|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.3|Malignant|115|42339679|Male|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.3|Malignant|110|42351811|Male|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.3|Malignant|113|42425680|Male|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|102|42534300|Male|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.4|0.3|Malignant|125|42605171|Male|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Ependymoma/anaplastic ependymoma|2018
0-19|0.2|0.3|0.2|Malignant|101|42616257|Male|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Ependymoma/anaplastic ependymoma|2018-2022
0-19|0.2|0.2|0.2|Malignant|455|211518041|Male|Ependymoma/anaplastic ependymoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Ependymoma/anaplastic ependymoma|2019
0-19|0.2|0.3|0.2|Malignant|102|42563170|Male|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Ependymoma/anaplastic ependymoma|2020
0-19|0.2|0.3|0.2|Malignant|93|42391466|Male|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Ependymoma/anaplastic ependymoma|2021
0-19|0.2|0.2|0.2|Malignant|80|42049566|Male|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Ependymoma/anaplastic ependymoma|2022
0-19|0.2|0.2|0.2|Malignant|79|41897582|Male|Ependymoma/anaplastic ependymoma|2022
0-19|0.0|0.1|0.0|Benign/Borderline|18|41889233|Male|Germ Cell Tumors|2004
0-19|0.2|0.3|0.2|Malignant|106|41889233|Male|Germ Cell Tumors|2004
0-19|0.0|0.1|0.1|Benign/Borderline|23|42006384|Male|Germ Cell Tumors|2005
0-19|0.2|0.2|0.2|Malignant|86|42006384|Male|Germ Cell Tumors|2005
0-19|0.0|0.1|0.1|Benign/Borderline|28|42158997|Male|Germ Cell Tumors|2006
0-19|0.2|0.3|0.2|Malignant|101|42158997|Male|Germ Cell Tumors|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Germ Cell Tumors|2007
0-19|0.2|0.3|0.2|Malignant|97|42367071|Male|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|20|42541971|Male|Germ Cell Tumors|2008
0-19|0.2|0.3|0.3|Malignant|116|42541971|Male|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Benign/Borderline|30|42609915|Male|Germ Cell Tumors|2009
0-19|0.2|0.3|0.2|Malignant|98|42609915|Male|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|23|42572643|Male|Germ Cell Tumors|2010
0-19|0.2|0.3|0.3|Malignant|112|42572643|Male|Germ Cell Tumors|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Germ Cell Tumors|2011
0-19|0.2|0.3|0.2|Malignant|101|42484916|Male|Germ Cell Tumors|2011
0-19|0.0|0.1|0.1|Benign/Borderline|25|42387849|Male|Germ Cell Tumors|2012
0-19|0.2|0.3|0.3|Malignant|109|42387849|Male|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|27|42339679|Male|Germ Cell Tumors|2013
0-19|0.2|0.3|0.3|Malignant|111|42339679|Male|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|27|42351811|Male|Germ Cell Tumors|2014
0-19|0.2|0.3|0.2|Malignant|103|42351811|Male|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|20|42425680|Male|Germ Cell Tumors|2015
0-19|0.2|0.3|0.2|Malignant|106|42425680|Male|Germ Cell Tumors|2015
0-19|0.1|0.1|0.1|Benign/Borderline|34|42534300|Male|Germ Cell Tumors|2016
0-19|0.2|0.3|0.3|Malignant|111|42534300|Male|Germ Cell Tumors|2016
0-19|0.0|0.1|0.1|Benign/Borderline|25|42605171|Male|Germ Cell Tumors|2017
0-19|0.3|0.4|0.3|Malignant|131|42605171|Male|Germ Cell Tumors|2017
0-19|0.1|0.1|0.1|Benign/Borderline|34|42616257|Male|Germ Cell Tumors|2018
0-19|0.2|0.2|0.2|Malignant|86|42616257|Male|Germ Cell Tumors|2018
0-19|0.0|0.1|0.1|Benign/Borderline|114|211518041|Male|Germ Cell Tumors|2018-2022
0-19|0.2|0.3|0.2|Malignant|497|211518041|Male|Germ Cell Tumors|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|24|42563170|Male|Germ Cell Tumors|2019
0-19|0.2|0.3|0.2|Malignant|108|42563170|Male|Germ Cell Tumors|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Germ Cell Tumors|2020
0-19|0.2|0.3|0.2|Malignant|101|42391466|Male|Germ Cell Tumors|2020
0-19|0.0|0.1|0.1|Benign/Borderline|26|42049566|Male|Germ Cell Tumors|2021
0-19|0.2|0.3|0.3|Malignant|108|42049566|Male|Germ Cell Tumors|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Germ Cell Tumors|2022
0-19|0.2|0.3|0.2|Malignant|94|41897582|Male|Germ Cell Tumors|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioblastoma|2004
0-19|0.1|0.2|0.2|Malignant|74|41889233|Male|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioblastoma|2005
0-19|0.1|0.2|0.1|Malignant|61|42006384|Male|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioblastoma|2006
0-19|0.1|0.2|0.2|Malignant|68|42158997|Male|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioblastoma|2007
0-19|0.1|0.2|0.2|Malignant|68|42367071|Male|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|68|42541971|Male|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioblastoma|2009
0-19|0.2|0.2|0.2|Malignant|83|42609915|Male|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Glioblastoma|2010
0-19|0.1|0.2|0.2|Malignant|68|42572643|Male|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Glioblastoma|2011
0-19|0.2|0.2|0.2|Malignant|85|42484916|Male|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Glioblastoma|2012
0-19|0.1|0.2|0.2|Malignant|79|42387849|Male|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Glioblastoma|2013
0-19|0.2|0.3|0.2|Malignant|91|42339679|Male|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|77|42351811|Male|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Glioblastoma|2015
0-19|0.2|0.2|0.2|Malignant|81|42425680|Male|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Glioblastoma|2016
0-19|0.1|0.2|0.2|Malignant|78|42534300|Male|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|72|42605171|Male|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Glioblastoma|2018
0-19|0.1|0.2|0.2|Malignant|80|42616257|Male|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Glioblastoma|2018-2022
0-19|0.1|0.2|0.1|Malignant|301|211518041|Male|Glioblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Glioblastoma|2019
0-19|0.1|0.2|0.2|Malignant|71|42563170|Male|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Glioblastoma|2020
0-19|0.1|0.2|0.2|Malignant|65|42391466|Male|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Glioblastoma|2021
0-19|0.1|0.2|0.1|Malignant|54|42049566|Male|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Glioblastoma|2022
0-19|0.0|0.1|0.1|Malignant|31|41897582|Male|Glioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Glioma malignant, NOS|2004
0-19|0.5|0.6|0.6|Malignant|230|41889233|Male|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Glioma malignant, NOS|2005
0-19|0.5|0.6|0.5|Malignant|222|42006384|Male|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Glioma malignant, NOS|2006
0-19|0.5|0.7|0.6|Malignant|243|42158997|Male|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Glioma malignant, NOS|2007
0-19|0.5|0.7|0.6|Malignant|250|42367071|Male|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Glioma malignant, NOS|2008
0-19|0.6|0.7|0.6|Malignant|270|42541971|Male|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Glioma malignant, NOS|2009
0-19|0.6|0.7|0.6|Malignant|273|42609915|Male|Glioma malignant, NOS|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Glioma malignant, NOS|2010
0-19|0.6|0.8|0.7|Malignant|282|42572643|Male|Glioma malignant, NOS|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Glioma malignant, NOS|2011
0-19|0.6|0.8|0.7|Malignant|284|42484916|Male|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|18|42387849|Male|Glioma malignant, NOS|2012
0-19|0.6|0.8|0.7|Malignant|289|42387849|Male|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|19|42339679|Male|Glioma malignant, NOS|2013
0-19|0.6|0.7|0.6|Malignant|274|42339679|Male|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.1|Benign/Borderline|25|42351811|Male|Glioma malignant, NOS|2014
0-19|0.6|0.7|0.6|Malignant|268|42351811|Male|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.1|Benign/Borderline|23|42425680|Male|Glioma malignant, NOS|2015
0-19|0.7|0.8|0.7|Malignant|312|42425680|Male|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|30|42534300|Male|Glioma malignant, NOS|2016
0-19|0.6|0.8|0.7|Malignant|305|42534300|Male|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|23|42605171|Male|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|337|42605171|Male|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.1|Benign/Borderline|30|42616257|Male|Glioma malignant, NOS|2018
0-19|0.5|0.6|0.5|Malignant|230|42616257|Male|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|100|211518041|Male|Glioma malignant, NOS|2018-2022
0-19|0.5|0.6|0.6|Malignant|1206|211518041|Male|Glioma malignant, NOS|2018-2022
0-19|0.0|0.1|0.0|Benign/Borderline|19|42563170|Male|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.5|Malignant|229|42563170|Male|Glioma malignant, NOS|2019
0-19|0.0|0.1|0.0|Benign/Borderline|20|42391466|Male|Glioma malignant, NOS|2020
0-19|0.5|0.6|0.5|Malignant|226|42391466|Male|Glioma malignant, NOS|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Glioma malignant, NOS|2021
0-19|0.6|0.7|0.6|Malignant|262|42049566|Male|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.0|Benign/Borderline|18|41897582|Male|Glioma malignant, NOS|2022
0-19|0.5|0.7|0.6|Malignant|259|41897582|Male|Glioma malignant, NOS|2022
0-19|0.0|0.1|0.0|Benign/Borderline|17|41889233|Male|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioblastoma|2005
0-19|0.0|0.1|0.0|Benign/Borderline|17|42158997|Male|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|20|42367071|Male|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|16|42609915|Male|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|42572643|Male|Hemangioblastoma|2010
0-19|0.0|0.1|0.1|Benign/Borderline|22|42484916|Male|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|42484916|Male|Hemangioblastoma|2011
0-19|0.0|0.1|0.1|Benign/Borderline|23|42387849|Male|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|42387849|Male|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|18|42339679|Male|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Hemangioblastoma|2013
0-19|0.0|0.1|0.0|Benign/Borderline|21|42351811|Male|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|17|42425680|Male|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Hemangioblastoma|2015
0-19|0.0|0.1|0.0|Benign/Borderline|19|42534300|Male|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Hemangioblastoma|2016
0-19|0.0|0.1|0.0|Benign/Borderline|21|42605171|Male|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|19|42616257|Male|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Hemangioblastoma|2018
0-19|0.0|0.1|0.0|Benign/Borderline|96|211518041|Male|Hemangioblastoma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Hemangioblastoma|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|22|42563170|Male|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|20|42391466|Male|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Hemangioblastoma|2020
0-19|0.0|0.1|0.0|Benign/Borderline|20|42049566|Male|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Hemangioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Hemangioblastoma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Hemangioblastoma|2022
0-19|0.1|0.1|0.1|Benign/Borderline|34|41889233|Male|Hemangioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Hemangioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|40|42158997|Male|Hemangioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Hemangioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|57|42367071|Male|Hemangioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Hemangioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Hemangioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|63|42609915|Male|Hemangioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Hemangioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|61|42572643|Male|Hemangioma|2010
0-19|~|~|~|Malignant|~|42572643|Male|Hemangioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|78|42484916|Male|Hemangioma|2011
0-19|~|~|~|Malignant|~|42484916|Male|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|66|42387849|Male|Hemangioma|2012
0-19|~|~|~|Malignant|~|42387849|Male|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|64|42339679|Male|Hemangioma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Hemangioma|2013
0-19|0.1|0.2|0.1|Benign/Borderline|62|42351811|Male|Hemangioma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Hemangioma|2014
0-19|0.1|0.2|0.1|Benign/Borderline|58|42425680|Male|Hemangioma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Hemangioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|86|42534300|Male|Hemangioma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Hemangioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|67|42605171|Male|Hemangioma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Hemangioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|68|42616257|Male|Hemangioma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Hemangioma|2018
0-19|0.1|0.1|0.1|Benign/Borderline|278|211518041|Male|Hemangioma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Hemangioma|2018-2022
0-19|0.1|0.2|0.1|Benign/Borderline|53|42563170|Male|Hemangioma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|54|42391466|Male|Hemangioma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|63|42049566|Male|Hemangioma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Hemangioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|40|41897582|Male|Hemangioma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Hemangioma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|41889233|Male|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|42006384|Male|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|42158997|Male|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|42367071|Male|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|42541971|Male|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|42609915|Male|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|42572643|Male|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|42484916|Male|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|42387849|Male|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|42339679|Male|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|42351811|Male|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|42425680|Male|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|42534300|Male|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|42605171|Male|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|42616257|Male|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Local Extensions from Regional Tumors|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Local Extensions from Regional Tumors|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|42563170|Male|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|42391466|Male|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|42049566|Male|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Malignant|~|41897582|Male|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Malignant|~|41889233|Male|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Malignant|~|42006384|Male|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|42158997|Male|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|42367071|Male|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|42541971|Male|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Malignant|~|42609915|Male|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|42572643|Male|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|42484916|Male|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|42387849|Male|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|42339679|Male|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|42351811|Male|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Malignant|~|42425680|Male|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|42534300|Male|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|42605171|Male|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|42616257|Male|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Lymphomas and Hematopoietic Neoplasms|2018-2022
0-19|0.0|0.0|0.0|Malignant|36|211518041|Male|Lymphomas and Hematopoietic Neoplasms|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|42563170|Male|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|42391466|Male|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|42049566|Male|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Malignant|~|41897582|Male|Lymphomas and Hematopoietic Neoplasms|2022
0-19|0.1|0.1|0.1|Benign/Borderline|47|41889233|Male|Meningioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Meningioma|2004
0-19|0.1|0.2|0.1|Benign/Borderline|53|42006384|Male|Meningioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Meningioma|2005
0-19|0.1|0.2|0.1|Benign/Borderline|50|42158997|Male|Meningioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|53|42367071|Male|Meningioma|2007
0-19|~|~|~|Malignant|~|42367071|Male|Meningioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|56|42541971|Male|Meningioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|65|42609915|Male|Meningioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|55|42572643|Male|Meningioma|2010
0-19|~|~|~|Malignant|~|42572643|Male|Meningioma|2010
0-19|0.1|0.2|0.1|Benign/Borderline|64|42484916|Male|Meningioma|2011
0-19|~|~|~|Malignant|~|42484916|Male|Meningioma|2011
0-19|0.1|0.2|0.1|Benign/Borderline|63|42387849|Male|Meningioma|2012
0-19|~|~|~|Malignant|~|42387849|Male|Meningioma|2012
0-19|0.1|0.2|0.1|Benign/Borderline|57|42339679|Male|Meningioma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Meningioma|2013
0-19|0.1|0.2|0.1|Benign/Borderline|62|42351811|Male|Meningioma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|70|42425680|Male|Meningioma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Meningioma|2015
0-19|0.1|0.1|0.1|Benign/Borderline|48|42534300|Male|Meningioma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|65|42605171|Male|Meningioma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Meningioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|86|42616257|Male|Meningioma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Meningioma|2018
0-19|0.1|0.2|0.2|Benign/Borderline|327|211518041|Male|Meningioma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Meningioma|2018-2022
0-19|0.1|0.2|0.1|Benign/Borderline|60|42563170|Male|Meningioma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Meningioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|69|42391466|Male|Meningioma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Meningioma|2020
0-19|0.1|0.1|0.1|Benign/Borderline|47|42049566|Male|Meningioma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Meningioma|2021
0-19|0.1|0.2|0.2|Benign/Borderline|65|41897582|Male|Meningioma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Meningioma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Mixed glioma|2004
0-19|~|~|~|Malignant|~|41889233|Male|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Mixed glioma|2005
0-19|~|~|~|Malignant|~|42006384|Male|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Mixed glioma|2006
0-19|~|~|~|Malignant|~|42158997|Male|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|16|42367071|Male|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Mixed glioma|2008
0-19|~|~|~|Malignant|~|42541971|Male|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Mixed glioma|2009
0-19|~|~|~|Malignant|~|42609915|Male|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Mixed glioma|2010
0-19|0.0|0.1|0.0|Malignant|19|42572643|Male|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Mixed glioma|2011
0-19|~|~|~|Malignant|~|42484916|Male|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Mixed glioma|2012
0-19|~|~|~|Malignant|~|42387849|Male|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Mixed glioma|2013
0-19|~|~|~|Malignant|~|42339679|Male|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Mixed glioma|2014
0-19|~|~|~|Malignant|~|42351811|Male|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Mixed glioma|2015
0-19|~|~|~|Malignant|~|42425680|Male|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Mixed glioma|2016
0-19|~|~|~|Malignant|~|42534300|Male|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Mixed glioma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Mixed glioma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Mixed glioma|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Mixed glioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Mixed glioma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Mixed glioma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Mixed glioma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Mixed glioma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Mixed glioma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Mixed glioma|2022
0-19|0.1|0.1|0.1|Benign/Borderline|31|41889233|Male|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|60|42006384|Male|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|54|42158997|Male|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|23|42158997|Male|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|64|42367071|Male|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|21|42367071|Male|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.1|Benign/Borderline|50|42541971|Male|Neoplasm, unspecified|2008
0-19|0.0|0.1|0.0|Malignant|18|42541971|Male|Neoplasm, unspecified|2008
0-19|0.2|0.3|0.2|Benign/Borderline|90|42609915|Male|Neoplasm, unspecified|2009
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Neoplasm, unspecified|2009
0-19|0.1|0.2|0.2|Benign/Borderline|79|42572643|Male|Neoplasm, unspecified|2010
0-19|0.0|0.1|0.0|Malignant|17|42572643|Male|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|72|42484916|Male|Neoplasm, unspecified|2011
0-19|~|~|~|Malignant|~|42484916|Male|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.1|Benign/Borderline|62|42387849|Male|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|28|42387849|Male|Neoplasm, unspecified|2012
0-19|0.1|0.2|0.2|Benign/Borderline|72|42339679|Male|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.0|Malignant|19|42339679|Male|Neoplasm, unspecified|2013
0-19|0.1|0.2|0.2|Benign/Borderline|72|42351811|Male|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.1|Malignant|23|42351811|Male|Neoplasm, unspecified|2014
0-19|0.1|0.2|0.2|Benign/Borderline|64|42425680|Male|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|20|42425680|Male|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.2|Benign/Borderline|70|42534300|Male|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|22|42534300|Male|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|72|42605171|Male|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.1|Malignant|28|42605171|Male|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.2|Benign/Borderline|65|42616257|Male|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.0|Malignant|18|42616257|Male|Neoplasm, unspecified|2018
0-19|0.1|0.1|0.1|Benign/Borderline|268|211518041|Male|Neoplasm, unspecified|2018-2022
0-19|0.0|0.1|0.1|Malignant|115|211518041|Male|Neoplasm, unspecified|2018-2022
0-19|0.1|0.2|0.1|Benign/Borderline|54|42563170|Male|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.1|Malignant|21|42563170|Male|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|47|42391466|Male|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|27|42391466|Male|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.1|Benign/Borderline|48|42049566|Male|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|22|42049566|Male|Neoplasm, unspecified|2021
0-19|0.1|0.2|0.1|Benign/Borderline|54|41897582|Male|Neoplasm, unspecified|2022
0-19|0.0|0.1|0.1|Malignant|27|41897582|Male|Neoplasm, unspecified|2022
0-19|0.3|0.4|0.3|Benign/Borderline|127|41889233|Male|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|41889233|Male|Nerve sheath, benign and malignant|2004
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|42006384|Male|Nerve sheath, benign and malignant|2005
0-19|0.4|0.5|0.4|Benign/Borderline|176|42158997|Male|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|42158997|Male|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.4|Benign/Borderline|164|42367071|Male|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|42367071|Male|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|155|42541971|Male|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|42541971|Male|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|42609915|Male|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|145|42572643|Male|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|42572643|Male|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.4|Benign/Borderline|159|42484916|Male|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|42484916|Male|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|159|42387849|Male|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|42387849|Male|Nerve sheath, benign and malignant|2012
0-19|0.3|0.5|0.4|Benign/Borderline|166|42339679|Male|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|42339679|Male|Nerve sheath, benign and malignant|2013
0-19|0.3|0.4|0.4|Benign/Borderline|154|42351811|Male|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|42351811|Male|Nerve sheath, benign and malignant|2014
0-19|0.3|0.4|0.4|Benign/Borderline|157|42425680|Male|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|42425680|Male|Nerve sheath, benign and malignant|2015
0-19|0.4|0.5|0.4|Benign/Borderline|186|42534300|Male|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|42534300|Male|Nerve sheath, benign and malignant|2016
0-19|0.2|0.3|0.3|Benign/Borderline|120|42605171|Male|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|42605171|Male|Nerve sheath, benign and malignant|2017
0-19|0.2|0.3|0.2|Benign/Borderline|93|42616257|Male|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|42616257|Male|Nerve sheath, benign and malignant|2018
0-19|0.2|0.2|0.2|Benign/Borderline|400|211518041|Male|Nerve sheath, benign and malignant|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Nerve sheath, benign and malignant|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|101|42563170|Male|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|42563170|Male|Nerve sheath, benign and malignant|2019
0-19|0.1|0.2|0.2|Benign/Borderline|69|42391466|Male|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|42391466|Male|Nerve sheath, benign and malignant|2020
0-19|0.1|0.2|0.2|Benign/Borderline|68|42049566|Male|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|42049566|Male|Nerve sheath, benign and malignant|2021
0-19|0.1|0.2|0.2|Benign/Borderline|69|41897582|Male|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Malignant|~|41897582|Male|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|41889233|Male|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|42006384|Male|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|42158997|Male|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|42367071|Male|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|42541971|Male|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|42609915|Male|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|42572643|Male|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|42484916|Male|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|42387849|Male|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|42339679|Male|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|42351811|Male|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|42425680|Male|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|42534300|Male|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|42605171|Male|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|42616257|Male|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Neuroepithelial|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Neuroepithelial|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|42563170|Male|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|42391466|Male|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|42049566|Male|Neuroepithelial|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Neuroepithelial|2022
0-19|~|~|~|Malignant|~|41897582|Male|Neuroepithelial|2022
0-19|0.3|0.4|0.4|Benign/Borderline|151|41889233|Male|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|29|41889233|Male|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.4|Benign/Borderline|159|42006384|Male|Neuronal/glial, neuronal|2005
0-19|0.0|0.1|0.1|Malignant|30|42006384|Male|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.4|Benign/Borderline|159|42158997|Male|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|28|42158997|Male|Neuronal/glial, neuronal|2006
0-19|0.4|0.5|0.4|Benign/Borderline|174|42367071|Male|Neuronal/glial, neuronal|2007
0-19|0.0|0.1|0.1|Malignant|30|42367071|Male|Neuronal/glial, neuronal|2007
0-19|0.4|0.5|0.4|Benign/Borderline|182|42541971|Male|Neuronal/glial, neuronal|2008
0-19|0.0|0.1|0.1|Malignant|29|42541971|Male|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.4|Benign/Borderline|159|42609915|Male|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|18|42609915|Male|Neuronal/glial, neuronal|2009
0-19|0.4|0.5|0.4|Benign/Borderline|175|42572643|Male|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|16|42572643|Male|Neuronal/glial, neuronal|2010
0-19|0.4|0.5|0.4|Benign/Borderline|192|42484916|Male|Neuronal/glial, neuronal|2011
0-19|0.0|0.1|0.0|Malignant|21|42484916|Male|Neuronal/glial, neuronal|2011
0-19|0.4|0.6|0.5|Benign/Borderline|210|42387849|Male|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.1|Malignant|22|42387849|Male|Neuronal/glial, neuronal|2012
0-19|0.4|0.5|0.5|Benign/Borderline|193|42339679|Male|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|23|42339679|Male|Neuronal/glial, neuronal|2013
0-19|0.4|0.5|0.4|Benign/Borderline|178|42351811|Male|Neuronal/glial, neuronal|2014
0-19|0.0|0.1|0.1|Malignant|31|42351811|Male|Neuronal/glial, neuronal|2014
0-19|0.5|0.6|0.5|Benign/Borderline|226|42425680|Male|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.1|Malignant|26|42425680|Male|Neuronal/glial, neuronal|2015
0-19|0.5|0.6|0.5|Benign/Borderline|231|42534300|Male|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|26|42534300|Male|Neuronal/glial, neuronal|2016
0-19|0.5|0.6|0.6|Benign/Borderline|240|42605171|Male|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.0|Malignant|17|42605171|Male|Neuronal/glial, neuronal|2017
0-19|0.4|0.6|0.5|Benign/Borderline|216|42616257|Male|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.1|Malignant|22|42616257|Male|Neuronal/glial, neuronal|2018
0-19|0.5|0.5|0.5|Benign/Borderline|1024|211518041|Male|Neuronal/glial, neuronal|2018-2022
0-19|0.0|0.1|0.0|Malignant|100|211518041|Male|Neuronal/glial, neuronal|2018-2022
0-19|0.5|0.6|0.6|Benign/Borderline|239|42563170|Male|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|22|42563170|Male|Neuronal/glial, neuronal|2019
0-19|0.4|0.5|0.4|Benign/Borderline|179|42391466|Male|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.0|Malignant|18|42391466|Male|Neuronal/glial, neuronal|2020
0-19|0.4|0.5|0.4|Benign/Borderline|186|42049566|Male|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|17|42049566|Male|Neuronal/glial, neuronal|2021
0-19|0.4|0.6|0.5|Benign/Borderline|204|41897582|Male|Neuronal/glial, neuronal|2022
0-19|0.0|0.1|0.1|Malignant|21|41897582|Male|Neuronal/glial, neuronal|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Oligodendroglioma|2004
0-19|0.1|0.1|0.1|Malignant|38|41889233|Male|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|29|42006384|Male|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Oligodendroglioma|2006
0-19|0.0|0.1|0.1|Malignant|29|42158997|Male|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Oligodendroglioma|2008
0-19|0.0|0.1|0.1|Malignant|31|42541971|Male|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Oligodendroglioma|2009
0-19|0.0|0.1|0.1|Malignant|27|42609915|Male|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|22|42572643|Male|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|17|42484916|Male|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|26|42387849|Male|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|20|42339679|Male|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|19|42351811|Male|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|18|42425680|Male|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Oligodendroglioma|2016
0-19|0.0|0.1|0.0|Malignant|17|42534300|Male|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Oligodendroglioma|2017
0-19|~|~|~|Malignant|~|42605171|Male|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Oligodendroglioma|2018
0-19|~|~|~|Malignant|~|42616257|Male|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Oligodendroglioma|2018-2022
0-19|0.0|0.0|0.0|Malignant|46|211518041|Male|Oligodendroglioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Oligodendroglioma|2019
0-19|~|~|~|Malignant|~|42563170|Male|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Oligodendroglioma|2020
0-19|~|~|~|Malignant|~|42391466|Male|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Oligodendroglioma|2021
0-19|~|~|~|Malignant|~|42049566|Male|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Oligodendroglioma|2022
0-19|~|~|~|Malignant|~|41897582|Male|Oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|41889233|Male|Other mesenchymal|2004
0-19|0.0|0.1|0.1|Benign/Borderline|22|42006384|Male|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|42006384|Male|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|21|42158997|Male|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|42158997|Male|Other mesenchymal|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|42367071|Male|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|21|42541971|Male|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|42541971|Male|Other mesenchymal|2008
0-19|0.0|0.1|0.0|Benign/Borderline|20|42609915|Male|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|42609915|Male|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|27|42572643|Male|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|42572643|Male|Other mesenchymal|2010
0-19|0.1|0.1|0.1|Benign/Borderline|36|42484916|Male|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|42484916|Male|Other mesenchymal|2011
0-19|0.1|0.1|0.1|Benign/Borderline|46|42387849|Male|Other mesenchymal|2012
0-19|~|~|~|Malignant|~|42387849|Male|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|36|42339679|Male|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|42339679|Male|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|36|42351811|Male|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|42351811|Male|Other mesenchymal|2014
0-19|0.1|0.1|0.1|Benign/Borderline|36|42425680|Male|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|42425680|Male|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|51|42534300|Male|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|42534300|Male|Other mesenchymal|2016
0-19|0.1|0.2|0.1|Benign/Borderline|49|42605171|Male|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|42605171|Male|Other mesenchymal|2017
0-19|0.1|0.2|0.1|Benign/Borderline|52|42616257|Male|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|42616257|Male|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|199|211518041|Male|Other mesenchymal|2018-2022
0-19|0.0|0.0|0.0|Malignant|51|211518041|Male|Other mesenchymal|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|28|42563170|Male|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|42563170|Male|Other mesenchymal|2019
0-19|0.0|0.1|0.1|Benign/Borderline|25|42391466|Male|Other mesenchymal|2020
0-19|0.0|0.1|0.0|Malignant|16|42391466|Male|Other mesenchymal|2020
0-19|0.1|0.1|0.1|Benign/Borderline|45|42049566|Male|Other mesenchymal|2021
0-19|~|~|~|Malignant|~|42049566|Male|Other mesenchymal|2021
0-19|0.1|0.2|0.1|Benign/Borderline|49|41897582|Male|Other mesenchymal|2022
0-19|~|~|~|Malignant|~|41897582|Male|Other mesenchymal|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pilocytic astrocytoma|2004
0-19|0.8|1.0|0.9|Malignant|371|41889233|Male|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pilocytic astrocytoma|2005
0-19|0.8|0.9|0.9|Malignant|355|42006384|Male|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pilocytic astrocytoma|2006
0-19|0.8|0.9|0.9|Malignant|357|42158997|Male|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pilocytic astrocytoma|2007
0-19|0.8|0.9|0.8|Malignant|353|42367071|Male|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pilocytic astrocytoma|2008
0-19|0.9|1.0|1.0|Malignant|401|42541971|Male|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pilocytic astrocytoma|2009
0-19|0.8|1.0|0.9|Malignant|371|42609915|Male|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Pilocytic astrocytoma|2010
0-19|0.8|1.0|0.9|Malignant|386|42572643|Male|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Pilocytic astrocytoma|2011
0-19|0.9|1.1|1.0|Malignant|411|42484916|Male|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|434|42387849|Male|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Pilocytic astrocytoma|2013
0-19|0.9|1.1|1.0|Malignant|434|42339679|Male|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Pilocytic astrocytoma|2014
0-19|0.8|1.0|0.9|Malignant|385|42351811|Male|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|386|42425680|Male|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Pilocytic astrocytoma|2016
0-19|0.8|1.0|0.9|Malignant|387|42534300|Male|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Pilocytic astrocytoma|2017
0-19|1.0|1.2|1.1|Malignant|452|42605171|Male|Pilocytic astrocytoma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|78|42616257|Male|Pilocytic astrocytoma|2018
0-19|0.7|0.9|0.8|Malignant|355|42616257|Male|Pilocytic astrocytoma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|380|211518041|Male|Pilocytic astrocytoma|2018-2022
0-19|0.8|0.9|0.8|Malignant|1747|211518041|Male|Pilocytic astrocytoma|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|85|42563170|Male|Pilocytic astrocytoma|2019
0-19|0.7|0.9|0.8|Malignant|348|42563170|Male|Pilocytic astrocytoma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|69|42391466|Male|Pilocytic astrocytoma|2020
0-19|0.8|0.9|0.9|Malignant|362|42391466|Male|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|67|42049566|Male|Pilocytic astrocytoma|2021
0-19|0.8|1.0|0.9|Malignant|362|42049566|Male|Pilocytic astrocytoma|2021
0-19|0.2|0.2|0.2|Benign/Borderline|81|41897582|Male|Pilocytic astrocytoma|2022
0-19|0.7|0.9|0.8|Malignant|320|41897582|Male|Pilocytic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|41889233|Male|Pineal parenchymal|2004
0-19|0.0|0.1|0.0|Malignant|19|41889233|Male|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|42006384|Male|Pineal parenchymal|2005
0-19|~|~|~|Malignant|~|42006384|Male|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|42158997|Male|Pineal parenchymal|2006
0-19|~|~|~|Malignant|~|42158997|Male|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|42367071|Male|Pineal parenchymal|2007
0-19|0.0|0.1|0.0|Malignant|18|42367071|Male|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|42541971|Male|Pineal parenchymal|2008
0-19|~|~|~|Malignant|~|42541971|Male|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|42609915|Male|Pineal parenchymal|2009
0-19|~|~|~|Malignant|~|42609915|Male|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|42572643|Male|Pineal parenchymal|2010
0-19|~|~|~|Malignant|~|42572643|Male|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|42484916|Male|Pineal parenchymal|2011
0-19|0.0|0.1|0.0|Malignant|20|42484916|Male|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|42387849|Male|Pineal parenchymal|2012
0-19|0.0|0.1|0.0|Malignant|19|42387849|Male|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|42339679|Male|Pineal parenchymal|2013
0-19|0.0|0.1|0.0|Malignant|17|42339679|Male|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|42351811|Male|Pineal parenchymal|2014
0-19|0.0|0.1|0.1|Malignant|23|42351811|Male|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|42425680|Male|Pineal parenchymal|2015
0-19|0.0|0.1|0.0|Malignant|20|42425680|Male|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|42534300|Male|Pineal parenchymal|2016
0-19|0.0|0.1|0.1|Malignant|25|42534300|Male|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|42605171|Male|Pineal parenchymal|2017
0-19|~|~|~|Malignant|~|42605171|Male|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|42616257|Male|Pineal parenchymal|2018
0-19|~|~|~|Malignant|~|42616257|Male|Pineal parenchymal|2018
0-19|~|~|~|Benign/Borderline|~|211518041|Male|Pineal parenchymal|2018-2022
0-19|0.0|0.0|0.0|Malignant|83|211518041|Male|Pineal parenchymal|2018-2022
0-19|~|~|~|Benign/Borderline|~|42563170|Male|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|16|42563170|Male|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|42391466|Male|Pineal parenchymal|2020
0-19|0.0|0.1|0.0|Malignant|20|42391466|Male|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|42049566|Male|Pineal parenchymal|2021
0-19|~|~|~|Malignant|~|42049566|Male|Pineal parenchymal|2021
0-19|~|~|~|Benign/Borderline|~|41897582|Male|Pineal parenchymal|2022
0-19|0.0|0.1|0.0|Malignant|18|41897582|Male|Pineal parenchymal|2022
0-19|0.2|0.2|0.2|Benign/Borderline|86|41889233|Male|Pituitary|2004
0-19|~|~|~|Malignant|~|41889233|Male|Pituitary|2004
0-19|0.2|0.4|0.3|Benign/Borderline|127|42006384|Male|Pituitary|2005
0-19|~|~|~|Malignant|~|42006384|Male|Pituitary|2005
0-19|0.2|0.3|0.2|Benign/Borderline|103|42158997|Male|Pituitary|2006
0-19|~|~|~|Malignant|~|42158997|Male|Pituitary|2006
0-19|0.2|0.3|0.3|Benign/Borderline|116|42367071|Male|Pituitary|2007
0-19|~|~|~|Malignant|~|42367071|Male|Pituitary|2007
0-19|0.3|0.4|0.3|Benign/Borderline|139|42541971|Male|Pituitary|2008
0-19|~|~|~|Malignant|~|42541971|Male|Pituitary|2008
0-19|0.3|0.4|0.4|Benign/Borderline|161|42609915|Male|Pituitary|2009
0-19|~|~|~|Malignant|~|42609915|Male|Pituitary|2009
0-19|0.3|0.4|0.3|Benign/Borderline|145|42572643|Male|Pituitary|2010
0-19|~|~|~|Malignant|~|42572643|Male|Pituitary|2010
0-19|0.3|0.4|0.4|Benign/Borderline|154|42484916|Male|Pituitary|2011
0-19|~|~|~|Malignant|~|42484916|Male|Pituitary|2011
0-19|0.4|0.5|0.4|Benign/Borderline|183|42387849|Male|Pituitary|2012
0-19|~|~|~|Malignant|~|42387849|Male|Pituitary|2012
0-19|0.4|0.5|0.4|Benign/Borderline|186|42339679|Male|Pituitary|2013
0-19|~|~|~|Malignant|~|42339679|Male|Pituitary|2013
0-19|0.4|0.6|0.5|Benign/Borderline|206|42351811|Male|Pituitary|2014
0-19|~|~|~|Malignant|~|42351811|Male|Pituitary|2014
0-19|0.4|0.5|0.4|Benign/Borderline|178|42425680|Male|Pituitary|2015
0-19|~|~|~|Malignant|~|42425680|Male|Pituitary|2015
0-19|0.4|0.6|0.5|Benign/Borderline|212|42534300|Male|Pituitary|2016
0-19|~|~|~|Malignant|~|42534300|Male|Pituitary|2016
0-19|0.5|0.6|0.5|Benign/Borderline|235|42605171|Male|Pituitary|2017
0-19|~|~|~|Malignant|~|42605171|Male|Pituitary|2017
0-19|0.4|0.6|0.5|Benign/Borderline|211|42616257|Male|Pituitary|2018
0-19|~|~|~|Malignant|~|42616257|Male|Pituitary|2018
0-19|0.4|0.5|0.5|Benign/Borderline|989|211518041|Male|Pituitary|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Pituitary|2018-2022
0-19|0.4|0.6|0.5|Benign/Borderline|215|42563170|Male|Pituitary|2019
0-19|~|~|~|Malignant|~|42563170|Male|Pituitary|2019
0-19|0.4|0.5|0.5|Benign/Borderline|200|42391466|Male|Pituitary|2020
0-19|~|~|~|Malignant|~|42391466|Male|Pituitary|2020
0-19|0.4|0.5|0.4|Benign/Borderline|187|42049566|Male|Pituitary|2021
0-19|~|~|~|Malignant|~|42049566|Male|Pituitary|2021
0-19|0.3|0.5|0.4|Benign/Borderline|176|41897582|Male|Pituitary|2022
0-19|~|~|~|Malignant|~|41897582|Male|Pituitary|2022
0-19|1.5|1.8|1.7|Benign/Borderline|698|41889233|Male|Total|2004
0-19|3.4|3.8|3.6|Malignant|1504|41889233|Male|Total|2004
0-19|1.8|2.0|1.9|Benign/Borderline|799|42006384|Male|Total|2005
0-19|3.2|3.6|3.4|Malignant|1429|42006384|Male|Total|2005
0-19|1.8|2.1|2.0|Benign/Borderline|832|42158997|Male|Total|2006
0-19|3.4|3.8|3.6|Malignant|1509|42158997|Male|Total|2006
0-19|1.9|2.2|2.0|Benign/Borderline|868|42367071|Male|Total|2007
0-19|3.4|3.8|3.6|Malignant|1528|42367071|Male|Total|2007
0-19|1.9|2.2|2.1|Benign/Borderline|891|42541971|Male|Total|2008
0-19|3.6|4.0|3.8|Malignant|1606|42541971|Male|Total|2008
0-19|2.1|2.4|2.2|Benign/Borderline|963|42609915|Male|Total|2009
0-19|3.5|3.9|3.7|Malignant|1564|42609915|Male|Total|2009
0-19|2.0|2.3|2.2|Benign/Borderline|929|42572643|Male|Total|2010
0-19|3.6|4.0|3.8|Malignant|1615|42572643|Male|Total|2010
0-19|2.2|2.5|2.3|Benign/Borderline|986|42484916|Male|Total|2011
0-19|3.6|4.0|3.8|Malignant|1611|42484916|Male|Total|2011
0-19|2.3|2.6|2.4|Benign/Borderline|1038|42387849|Male|Total|2012
0-19|3.7|4.1|3.9|Malignant|1637|42387849|Male|Total|2012
0-19|2.3|2.6|2.4|Benign/Borderline|1033|42339679|Male|Total|2013
0-19|3.6|4.0|3.8|Malignant|1606|42339679|Male|Total|2013
0-19|2.3|2.6|2.5|Benign/Borderline|1054|42351811|Male|Total|2014
0-19|3.5|3.9|3.7|Malignant|1573|42351811|Male|Total|2014
0-19|2.3|2.6|2.4|Benign/Borderline|1037|42425680|Male|Total|2015
0-19|3.6|4.0|3.8|Malignant|1614|42425680|Male|Total|2015
0-19|2.6|2.9|2.7|Benign/Borderline|1155|42534300|Male|Total|2016
0-19|3.5|3.9|3.7|Malignant|1578|42534300|Male|Total|2016
0-19|2.5|2.8|2.6|Benign/Borderline|1114|42605171|Male|Total|2017
0-19|3.8|4.2|4.0|Malignant|1690|42605171|Male|Total|2017
0-19|2.6|2.9|2.7|Benign/Borderline|1168|42616257|Male|Total|2018
0-19|2.9|3.3|3.1|Malignant|1311|42616257|Male|Total|2018
0-19|2.3|2.5|2.4|Benign/Borderline|5094|211518041|Male|Total|2018-2022
0-19|2.9|3.0|3.0|Malignant|6238|211518041|Male|Total|2018-2022
0-19|2.4|2.7|2.5|Benign/Borderline|1084|42563170|Male|Total|2019
0-19|2.9|3.2|3.0|Malignant|1280|42563170|Male|Total|2019
0-19|2.0|2.3|2.1|Benign/Borderline|903|42391466|Male|Total|2020
0-19|2.8|3.1|3.0|Malignant|1254|42391466|Male|Total|2020
0-19|2.1|2.4|2.3|Benign/Borderline|961|42049566|Male|Total|2021
0-19|2.8|3.2|3.0|Malignant|1254|42049566|Male|Total|2021
0-19|2.2|2.5|2.3|Benign/Borderline|978|41897582|Male|Total|2022
0-19|2.6|2.9|2.7|Malignant|1139|41897582|Male|Total|2022
0-19|0.3|0.4|0.3|Benign/Borderline|127|41889233|Male|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Cranial and Spinal Nerves|2004
0-19|0.2|0.4|0.3|Benign/Borderline|124|42006384|Male|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Cranial and Spinal Nerves|2005
0-19|0.4|0.5|0.4|Benign/Borderline|176|42158997|Male|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.4|Benign/Borderline|164|42367071|Male|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|155|42541971|Male|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|157|42609915|Male|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|145|42572643|Male|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|42572643|Male|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.4|Benign/Borderline|159|42484916|Male|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|42484916|Male|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|159|42387849|Male|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|42387849|Male|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.5|0.4|Benign/Borderline|167|42339679|Male|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|42339679|Male|Tumors of Cranial and Spinal Nerves|2013
0-19|0.3|0.4|0.4|Benign/Borderline|156|42351811|Male|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|42351811|Male|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.4|0.4|Benign/Borderline|157|42425680|Male|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|42425680|Male|Tumors of Cranial and Spinal Nerves|2015
0-19|0.4|0.5|0.4|Benign/Borderline|186|42534300|Male|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|42534300|Male|Tumors of Cranial and Spinal Nerves|2016
0-19|0.2|0.3|0.3|Benign/Borderline|120|42605171|Male|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|42605171|Male|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.3|0.2|Benign/Borderline|93|42616257|Male|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|42616257|Male|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.2|0.2|Benign/Borderline|400|211518041|Male|Tumors of Cranial and Spinal Nerves|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Tumors of Cranial and Spinal Nerves|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|101|42563170|Male|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|42563170|Male|Tumors of Cranial and Spinal Nerves|2019
0-19|0.1|0.2|0.2|Benign/Borderline|69|42391466|Male|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|42391466|Male|Tumors of Cranial and Spinal Nerves|2020
0-19|0.1|0.2|0.2|Benign/Borderline|68|42049566|Male|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|42049566|Male|Tumors of Cranial and Spinal Nerves|2021
0-19|0.1|0.2|0.2|Benign/Borderline|69|41897582|Male|Tumors of Cranial and Spinal Nerves|2022
0-19|~|~|~|Malignant|~|41897582|Male|Tumors of Cranial and Spinal Nerves|2022
0-19|0.5|0.6|0.6|Benign/Borderline|237|41889233|Male|Tumors of Neuroepthelial Tissue|2004
0-19|3.1|3.4|3.3|Malignant|1361|41889233|Male|Tumors of Neuroepthelial Tissue|2004
0-19|0.5|0.7|0.6|Benign/Borderline|263|42006384|Male|Tumors of Neuroepthelial Tissue|2005
0-19|2.9|3.3|3.1|Malignant|1296|42006384|Male|Tumors of Neuroepthelial Tissue|2005
0-19|0.5|0.7|0.6|Benign/Borderline|262|42158997|Male|Tumors of Neuroepthelial Tissue|2006
0-19|3.1|3.4|3.2|Malignant|1362|42158997|Male|Tumors of Neuroepthelial Tissue|2006
0-19|0.6|0.7|0.6|Benign/Borderline|272|42367071|Male|Tumors of Neuroepthelial Tissue|2007
0-19|3.1|3.5|3.3|Malignant|1384|42367071|Male|Tumors of Neuroepthelial Tissue|2007
0-19|0.6|0.8|0.7|Benign/Borderline|289|42541971|Male|Tumors of Neuroepthelial Tissue|2008
0-19|3.2|3.6|3.4|Malignant|1443|42541971|Male|Tumors of Neuroepthelial Tissue|2008
0-19|0.6|0.7|0.7|Benign/Borderline|278|42609915|Male|Tumors of Neuroepthelial Tissue|2009
0-19|3.2|3.5|3.3|Malignant|1420|42609915|Male|Tumors of Neuroepthelial Tissue|2009
0-19|0.6|0.8|0.7|Benign/Borderline|296|42572643|Male|Tumors of Neuroepthelial Tissue|2010
0-19|3.3|3.6|3.4|Malignant|1459|42572643|Male|Tumors of Neuroepthelial Tissue|2010
0-19|0.7|0.8|0.7|Benign/Borderline|317|42484916|Male|Tumors of Neuroepthelial Tissue|2011
0-19|3.3|3.7|3.5|Malignant|1473|42484916|Male|Tumors of Neuroepthelial Tissue|2011
0-19|0.7|0.9|0.8|Benign/Borderline|330|42387849|Male|Tumors of Neuroepthelial Tissue|2012
0-19|3.3|3.7|3.5|Malignant|1472|42387849|Male|Tumors of Neuroepthelial Tissue|2012
0-19|0.7|0.8|0.7|Benign/Borderline|312|42339679|Male|Tumors of Neuroepthelial Tissue|2013
0-19|3.3|3.6|3.4|Malignant|1446|42339679|Male|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.8|0.7|Benign/Borderline|304|42351811|Male|Tumors of Neuroepthelial Tissue|2014
0-19|3.2|3.5|3.4|Malignant|1424|42351811|Male|Tumors of Neuroepthelial Tissue|2014
0-19|0.7|0.9|0.8|Benign/Borderline|337|42425680|Male|Tumors of Neuroepthelial Tissue|2015
0-19|3.3|3.6|3.4|Malignant|1459|42425680|Male|Tumors of Neuroepthelial Tissue|2015
0-19|0.8|1.0|0.9|Benign/Borderline|368|42534300|Male|Tumors of Neuroepthelial Tissue|2016
0-19|3.2|3.5|3.3|Malignant|1417|42534300|Male|Tumors of Neuroepthelial Tissue|2016
0-19|0.8|0.9|0.8|Benign/Borderline|358|42605171|Male|Tumors of Neuroepthelial Tissue|2017
0-19|3.4|3.7|3.6|Malignant|1510|42605171|Male|Tumors of Neuroepthelial Tissue|2017
0-19|0.9|1.1|1.0|Benign/Borderline|437|42616257|Male|Tumors of Neuroepthelial Tissue|2018
0-19|2.6|3.0|2.8|Malignant|1188|42616257|Male|Tumors of Neuroepthelial Tissue|2018
0-19|0.9|1.0|0.9|Benign/Borderline|1994|211518041|Male|Tumors of Neuroepthelial Tissue|2018-2022
0-19|2.6|2.7|2.6|Malignant|5508|211518041|Male|Tumors of Neuroepthelial Tissue|2018-2022
0-19|0.9|1.1|1.0|Benign/Borderline|445|42563170|Male|Tumors of Neuroepthelial Tissue|2019
0-19|2.5|2.8|2.7|Malignant|1131|42563170|Male|Tumors of Neuroepthelial Tissue|2019
0-19|0.7|0.9|0.8|Benign/Borderline|349|42391466|Male|Tumors of Neuroepthelial Tissue|2020
0-19|2.5|2.8|2.6|Malignant|1099|42391466|Male|Tumors of Neuroepthelial Tissue|2020
0-19|0.8|0.9|0.8|Benign/Borderline|353|42049566|Male|Tumors of Neuroepthelial Tissue|2021
0-19|2.5|2.8|2.6|Malignant|1092|42049566|Male|Tumors of Neuroepthelial Tissue|2021
0-19|0.9|1.1|1.0|Benign/Borderline|410|41897582|Male|Tumors of Neuroepthelial Tissue|2022
0-19|2.3|2.6|2.4|Malignant|998|41897582|Male|Tumors of Neuroepthelial Tissue|2022
0-19|0.4|0.5|0.4|Benign/Borderline|172|41889233|Male|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of Sellar Region|2004
0-19|0.5|0.6|0.5|Benign/Borderline|221|42006384|Male|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of Sellar Region|2005
0-19|0.4|0.5|0.4|Benign/Borderline|184|42158997|Male|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of Sellar Region|2006
0-19|0.4|0.5|0.5|Benign/Borderline|205|42367071|Male|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of Sellar Region|2007
0-19|0.5|0.6|0.5|Benign/Borderline|235|42541971|Male|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of Sellar Region|2008
0-19|0.5|0.6|0.6|Benign/Borderline|244|42609915|Male|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of Sellar Region|2009
0-19|0.5|0.6|0.5|Benign/Borderline|229|42572643|Male|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|42572643|Male|Tumors of Sellar Region|2010
0-19|0.5|0.6|0.5|Benign/Borderline|224|42484916|Male|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|42484916|Male|Tumors of Sellar Region|2011
0-19|0.5|0.7|0.6|Benign/Borderline|264|42387849|Male|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|42387849|Male|Tumors of Sellar Region|2012
0-19|0.6|0.7|0.7|Benign/Borderline|280|42339679|Male|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|42339679|Male|Tumors of Sellar Region|2013
0-19|0.7|0.8|0.7|Benign/Borderline|314|42351811|Male|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|42351811|Male|Tumors of Sellar Region|2014
0-19|0.6|0.7|0.6|Benign/Borderline|276|42425680|Male|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|42425680|Male|Tumors of Sellar Region|2015
0-19|0.6|0.8|0.7|Benign/Borderline|293|42534300|Male|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|42534300|Male|Tumors of Sellar Region|2016
0-19|0.7|0.9|0.8|Benign/Borderline|337|42605171|Male|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|42605171|Male|Tumors of Sellar Region|2017
0-19|0.6|0.8|0.7|Benign/Borderline|314|42616257|Male|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|42616257|Male|Tumors of Sellar Region|2018
0-19|0.6|0.7|0.7|Benign/Borderline|1416|211518041|Male|Tumors of Sellar Region|2018-2022
0-19|~|~|~|Malignant|~|211518041|Male|Tumors of Sellar Region|2018-2022
0-19|0.6|0.8|0.7|Benign/Borderline|296|42563170|Male|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|42563170|Male|Tumors of Sellar Region|2019
0-19|0.5|0.7|0.6|Benign/Borderline|255|42391466|Male|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|42391466|Male|Tumors of Sellar Region|2020
0-19|0.6|0.8|0.7|Benign/Borderline|290|42049566|Male|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|42049566|Male|Tumors of Sellar Region|2021
0-19|0.5|0.7|0.6|Benign/Borderline|261|41897582|Male|Tumors of Sellar Region|2022
0-19|~|~|~|Malignant|~|41897582|Male|Tumors of Sellar Region|2022
0-19|0.1|0.2|0.2|Benign/Borderline|79|41889233|Male|Tumors of the Meninges|2004
0-19|~|~|~|Malignant|~|41889233|Male|Tumors of the Meninges|2004
0-19|0.2|0.2|0.2|Benign/Borderline|86|42006384|Male|Tumors of the Meninges|2005
0-19|~|~|~|Malignant|~|42006384|Male|Tumors of the Meninges|2005
0-19|0.2|0.3|0.2|Benign/Borderline|88|42158997|Male|Tumors of the Meninges|2006
0-19|~|~|~|Malignant|~|42158997|Male|Tumors of the Meninges|2006
0-19|0.2|0.2|0.2|Benign/Borderline|85|42367071|Male|Tumors of the Meninges|2007
0-19|~|~|~|Malignant|~|42367071|Male|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|91|42541971|Male|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|42541971|Male|Tumors of the Meninges|2008
0-19|0.2|0.3|0.2|Benign/Borderline|101|42609915|Male|Tumors of the Meninges|2009
0-19|~|~|~|Malignant|~|42609915|Male|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|95|42572643|Male|Tumors of the Meninges|2010
0-19|~|~|~|Malignant|~|42572643|Male|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|122|42484916|Male|Tumors of the Meninges|2011
0-19|~|~|~|Malignant|~|42484916|Male|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|132|42387849|Male|Tumors of the Meninges|2012
0-19|~|~|~|Malignant|~|42387849|Male|Tumors of the Meninges|2012
0-19|0.2|0.3|0.3|Benign/Borderline|111|42339679|Male|Tumors of the Meninges|2013
0-19|~|~|~|Malignant|~|42339679|Male|Tumors of the Meninges|2013
0-19|0.2|0.3|0.3|Benign/Borderline|119|42351811|Male|Tumors of the Meninges|2014
0-19|~|~|~|Malignant|~|42351811|Male|Tumors of the Meninges|2014
0-19|0.2|0.3|0.3|Benign/Borderline|123|42425680|Male|Tumors of the Meninges|2015
0-19|~|~|~|Malignant|~|42425680|Male|Tumors of the Meninges|2015
0-19|0.2|0.3|0.3|Benign/Borderline|118|42534300|Male|Tumors of the Meninges|2016
0-19|~|~|~|Malignant|~|42534300|Male|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|135|42605171|Male|Tumors of the Meninges|2017
0-19|~|~|~|Malignant|~|42605171|Male|Tumors of the Meninges|2017
0-19|0.3|0.4|0.4|Benign/Borderline|157|42616257|Male|Tumors of the Meninges|2018
0-19|~|~|~|Malignant|~|42616257|Male|Tumors of the Meninges|2018
0-19|0.3|0.3|0.3|Benign/Borderline|622|211518041|Male|Tumors of the Meninges|2018-2022
0-19|0.0|0.0|0.0|Malignant|56|211518041|Male|Tumors of the Meninges|2018-2022
0-19|0.2|0.3|0.3|Benign/Borderline|110|42563170|Male|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|42563170|Male|Tumors of the Meninges|2019
0-19|0.2|0.3|0.3|Benign/Borderline|114|42391466|Male|Tumors of the Meninges|2020
0-19|0.0|0.1|0.0|Malignant|19|42391466|Male|Tumors of the Meninges|2020
0-19|0.2|0.3|0.3|Benign/Borderline|112|42049566|Male|Tumors of the Meninges|2021
0-19|0.0|0.1|0.0|Malignant|16|42049566|Male|Tumors of the Meninges|2021
0-19|0.3|0.4|0.3|Benign/Borderline|129|41897582|Male|Tumors of the Meninges|2022
0-19|~|~|~|Malignant|~|41897582|Male|Tumors of the Meninges|2022
0-19|0.1|0.2|0.2|Benign/Borderline|65|41889233|Male|Unclassified Tumors|2004
0-19|0.0|0.1|0.0|Malignant|16|41889233|Male|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|82|42006384|Male|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|19|42006384|Male|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|94|42158997|Male|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|23|42158997|Male|Unclassified Tumors|2006
0-19|0.2|0.3|0.3|Benign/Borderline|122|42367071|Male|Unclassified Tumors|2007
0-19|0.0|0.1|0.1|Malignant|25|42367071|Male|Unclassified Tumors|2007
0-19|0.2|0.3|0.2|Benign/Borderline|100|42541971|Male|Unclassified Tumors|2008
0-19|0.0|0.1|0.0|Malignant|21|42541971|Male|Unclassified Tumors|2008
0-19|0.3|0.4|0.4|Benign/Borderline|153|42609915|Male|Unclassified Tumors|2009
0-19|0.0|0.1|0.1|Malignant|22|42609915|Male|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|141|42572643|Male|Unclassified Tumors|2010
0-19|0.0|0.1|0.0|Malignant|18|42572643|Male|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|150|42484916|Male|Unclassified Tumors|2011
0-19|~|~|~|Malignant|~|42484916|Male|Unclassified Tumors|2011
0-19|0.3|0.4|0.3|Benign/Borderline|128|42387849|Male|Unclassified Tumors|2012
0-19|0.0|0.1|0.1|Malignant|31|42387849|Male|Unclassified Tumors|2012
0-19|0.3|0.4|0.3|Benign/Borderline|136|42339679|Male|Unclassified Tumors|2013
0-19|0.0|0.1|0.0|Malignant|21|42339679|Male|Unclassified Tumors|2013
0-19|0.3|0.4|0.3|Benign/Borderline|134|42351811|Male|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|24|42351811|Male|Unclassified Tumors|2014
0-19|0.2|0.3|0.3|Benign/Borderline|124|42425680|Male|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|21|42425680|Male|Unclassified Tumors|2015
0-19|0.3|0.4|0.4|Benign/Borderline|156|42534300|Male|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|22|42534300|Male|Unclassified Tumors|2016
0-19|0.3|0.4|0.3|Benign/Borderline|139|42605171|Male|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|29|42605171|Male|Unclassified Tumors|2017
0-19|0.3|0.4|0.3|Benign/Borderline|133|42616257|Male|Unclassified Tumors|2018
0-19|0.0|0.1|0.0|Malignant|20|42616257|Male|Unclassified Tumors|2018
0-19|0.2|0.3|0.3|Benign/Borderline|546|211518041|Male|Unclassified Tumors|2018-2022
0-19|0.0|0.1|0.1|Malignant|118|211518041|Male|Unclassified Tumors|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|107|42563170|Male|Unclassified Tumors|2019
0-19|0.0|0.1|0.1|Malignant|21|42563170|Male|Unclassified Tumors|2019
0-19|0.2|0.3|0.2|Benign/Borderline|101|42391466|Male|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|27|42391466|Male|Unclassified Tumors|2020
0-19|0.2|0.3|0.3|Benign/Borderline|111|42049566|Male|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|22|42049566|Male|Unclassified Tumors|2021
0-19|0.2|0.3|0.2|Benign/Borderline|94|41897582|Male|Unclassified Tumors|2022
0-19|0.0|0.1|0.1|Malignant|28|41897582|Male|Unclassified Tumors|2022
0-19|0.1|0.1|0.1|Benign/Borderline|35|41889233|Male|Unique astrocytoma variants|2004
0-19|~|~|~|Malignant|~|41889233|Male|Unique astrocytoma variants|2004
0-19|0.1|0.1|0.1|Benign/Borderline|38|42006384|Male|Unique astrocytoma variants|2005
0-19|~|~|~|Malignant|~|42006384|Male|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|26|42158997|Male|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|18|42158997|Male|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|32|42367071|Male|Unique astrocytoma variants|2007
0-19|0.0|0.1|0.1|Malignant|23|42367071|Male|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Benign/Borderline|43|42541971|Male|Unique astrocytoma variants|2008
0-19|0.0|0.1|0.0|Malignant|19|42541971|Male|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|46|42609915|Male|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|24|42609915|Male|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|35|42572643|Male|Unique astrocytoma variants|2010
0-19|0.0|0.1|0.0|Malignant|16|42572643|Male|Unique astrocytoma variants|2010
0-19|0.1|0.2|0.1|Benign/Borderline|50|42484916|Male|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|29|42484916|Male|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|46|42387849|Male|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.1|Malignant|26|42387849|Male|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|39|42339679|Male|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.1|Malignant|26|42339679|Male|Unique astrocytoma variants|2013
0-19|0.1|0.2|0.1|Benign/Borderline|52|42351811|Male|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Malignant|26|42351811|Male|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|31|42425680|Male|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|27|42425680|Male|Unique astrocytoma variants|2015
0-19|0.1|0.1|0.1|Benign/Borderline|39|42534300|Male|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|29|42534300|Male|Unique astrocytoma variants|2016
0-19|0.1|0.1|0.1|Benign/Borderline|37|42605171|Male|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.0|Malignant|17|42605171|Male|Unique astrocytoma variants|2017
0-19|0.1|0.1|0.1|Benign/Borderline|40|42616257|Male|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|22|42616257|Male|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|174|211518041|Male|Unique astrocytoma variants|2018-2022
0-19|0.0|0.1|0.0|Malignant|99|211518041|Male|Unique astrocytoma variants|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|37|42563170|Male|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|23|42563170|Male|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Benign/Borderline|23|42391466|Male|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Malignant|17|42391466|Male|Unique astrocytoma variants|2020
0-19|0.1|0.1|0.1|Benign/Borderline|35|42049566|Male|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.0|Malignant|21|42049566|Male|Unique astrocytoma variants|2021
0-19|0.1|0.1|0.1|Benign/Borderline|39|41897582|Male|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.0|Malignant|16|41897582|Male|Unique astrocytoma variants|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|All other|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|All other|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|All other|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|All other|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|All other|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|All other|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|All other|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|All other|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|All other|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|All other|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|All other|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|All other|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|All other|2010
0-19|0.0|0.0|0.0|Malignant|24|83224734|Male and Female|All other|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|All other|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|All other|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|All other|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|All other|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|All other|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|All other|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|All other|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|All other|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|All other|2015
0-19|0.0|0.0|0.0|Malignant|19|82974459|Male and Female|All other|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|All other|2016
0-19|0.0|0.0|0.0|Malignant|18|83184415|Male and Female|All other|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|All other|2017
0-19|0.0|0.0|0.0|Malignant|16|83308218|Male and Female|All other|2017
0-19|0.0|0.1|0.1|Benign/Borderline|46|83321994|Male and Female|All other|2018
0-19|0.3|0.4|0.3|Malignant|258|83321994|Male and Female|All other|2018
0-19|0.1|0.1|0.1|Benign/Borderline|338|413514777|Male and Female|All other|2018-2022
0-19|0.4|0.4|0.4|Malignant|1698|413514777|Male and Female|All other|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|77|83213818|Male and Female|All other|2019
0-19|0.3|0.4|0.4|Malignant|319|83213818|Male and Female|All other|2019
0-19|0.1|0.1|0.1|Benign/Borderline|68|82873432|Male and Female|All other|2020
0-19|0.3|0.4|0.4|Malignant|308|82873432|Male and Female|All other|2020
0-19|0.1|0.1|0.1|Benign/Borderline|76|82201873|Male and Female|All other|2021
0-19|0.4|0.5|0.4|Malignant|361|82201873|Male and Female|All other|2021
0-19|0.1|0.1|0.1|Benign/Borderline|71|81903660|Male and Female|All other|2022
0-19|0.5|0.6|0.6|Malignant|452|81903660|Male and Female|All other|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic astrocytoma|2004
0-19|0.1|0.1|0.1|Malignant|70|81754354|Male and Female|Anaplastic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic astrocytoma|2005
0-19|0.1|0.1|0.1|Malignant|61|82005260|Male and Female|Anaplastic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic astrocytoma|2006
0-19|0.1|0.1|0.1|Malignant|67|82324418|Male and Female|Anaplastic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic astrocytoma|2007
0-19|0.1|0.1|0.1|Malignant|88|82749431|Male and Female|Anaplastic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic astrocytoma|2008
0-19|0.1|0.1|0.1|Malignant|74|83118264|Male and Female|Anaplastic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic astrocytoma|2009
0-19|0.1|0.1|0.1|Malignant|71|83280391|Male and Female|Anaplastic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Anaplastic astrocytoma|2010
0-19|0.1|0.1|0.1|Malignant|84|83224734|Male and Female|Anaplastic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Anaplastic astrocytoma|2011
0-19|0.1|0.1|0.1|Malignant|72|83041095|Male and Female|Anaplastic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Anaplastic astrocytoma|2012
0-19|0.1|0.1|0.1|Malignant|68|82866386|Male and Female|Anaplastic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Anaplastic astrocytoma|2013
0-19|0.1|0.1|0.1|Malignant|96|82797930|Male and Female|Anaplastic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Anaplastic astrocytoma|2014
0-19|0.1|0.1|0.1|Malignant|96|82828260|Male and Female|Anaplastic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Anaplastic astrocytoma|2015
0-19|0.1|0.1|0.1|Malignant|81|82974459|Male and Female|Anaplastic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Anaplastic astrocytoma|2016
0-19|0.1|0.1|0.1|Malignant|75|83184415|Male and Female|Anaplastic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Anaplastic astrocytoma|2017
0-19|0.1|0.1|0.1|Malignant|60|83308218|Male and Female|Anaplastic astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Anaplastic astrocytoma|2018
0-19|0.1|0.1|0.1|Malignant|62|83321994|Male and Female|Anaplastic astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Anaplastic astrocytoma|2018-2022
0-19|0.0|0.1|0.1|Malignant|222|413514777|Male and Female|Anaplastic astrocytoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Anaplastic astrocytoma|2019
0-19|0.1|0.1|0.1|Malignant|66|83213818|Male and Female|Anaplastic astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Anaplastic astrocytoma|2020
0-19|0.0|0.1|0.1|Malignant|50|82873432|Male and Female|Anaplastic astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Anaplastic astrocytoma|2021
0-19|0.0|0.0|0.0|Malignant|28|82201873|Male and Female|Anaplastic astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Anaplastic astrocytoma|2022
0-19|0.0|0.0|0.0|Malignant|16|81903660|Male and Female|Anaplastic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Anaplastic oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Anaplastic oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Anaplastic oligodendroglioma|2006
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Anaplastic oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Anaplastic oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Anaplastic oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Anaplastic oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Anaplastic oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Anaplastic oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Anaplastic oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Anaplastic oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Anaplastic oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Anaplastic oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Anaplastic oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Anaplastic oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Anaplastic oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Anaplastic oligodendroglioma|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Anaplastic oligodendroglioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Anaplastic oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Anaplastic oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Anaplastic oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Anaplastic oligodendroglioma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Astrocytoma, NOS|2004
0-19|0.2|0.3|0.2|Malignant|200|81754354|Male and Female|Astrocytoma, NOS|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Astrocytoma, NOS|2005
0-19|0.2|0.3|0.2|Malignant|189|82005260|Male and Female|Astrocytoma, NOS|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Astrocytoma, NOS|2006
0-19|0.2|0.3|0.2|Malignant|197|82324418|Male and Female|Astrocytoma, NOS|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Astrocytoma, NOS|2007
0-19|0.2|0.3|0.2|Malignant|182|82749431|Male and Female|Astrocytoma, NOS|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Astrocytoma, NOS|2008
0-19|0.2|0.3|0.2|Malignant|182|83118264|Male and Female|Astrocytoma, NOS|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Astrocytoma, NOS|2009
0-19|0.2|0.3|0.2|Malignant|203|83280391|Male and Female|Astrocytoma, NOS|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Astrocytoma, NOS|2010
0-19|0.2|0.3|0.3|Malignant|212|83224734|Male and Female|Astrocytoma, NOS|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Astrocytoma, NOS|2011
0-19|0.2|0.3|0.2|Malignant|183|83041095|Male and Female|Astrocytoma, NOS|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Astrocytoma, NOS|2012
0-19|0.2|0.2|0.2|Malignant|165|82866386|Male and Female|Astrocytoma, NOS|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Astrocytoma, NOS|2013
0-19|0.2|0.3|0.2|Malignant|192|82797930|Male and Female|Astrocytoma, NOS|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Astrocytoma, NOS|2014
0-19|0.2|0.3|0.3|Malignant|218|82828260|Male and Female|Astrocytoma, NOS|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Astrocytoma, NOS|2015
0-19|0.2|0.2|0.2|Malignant|171|82974459|Male and Female|Astrocytoma, NOS|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Astrocytoma, NOS|2016
0-19|0.2|0.2|0.2|Malignant|176|83184415|Male and Female|Astrocytoma, NOS|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Astrocytoma, NOS|2017
0-19|0.2|0.3|0.2|Malignant|187|83308218|Male and Female|Astrocytoma, NOS|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Astrocytoma, NOS|2018
0-19|0.2|0.2|0.2|Malignant|180|83321994|Male and Female|Astrocytoma, NOS|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Astrocytoma, NOS|2018-2022
0-19|0.2|0.2|0.2|Malignant|686|413514777|Male and Female|Astrocytoma, NOS|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Astrocytoma, NOS|2019
0-19|0.2|0.2|0.2|Malignant|153|83213818|Male and Female|Astrocytoma, NOS|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Astrocytoma, NOS|2020
0-19|0.1|0.1|0.1|Malignant|102|82873432|Male and Female|Astrocytoma, NOS|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Astrocytoma, NOS|2021
0-19|0.1|0.2|0.2|Malignant|139|82201873|Male and Female|Astrocytoma, NOS|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Astrocytoma, NOS|2022
0-19|0.1|0.2|0.1|Malignant|112|81903660|Male and Female|Astrocytoma, NOS|2022
0-19|0.1|0.1|0.1|Benign/Borderline|57|81754354|Male and Female|Choroid plexus|2004
0-19|0.0|0.0|0.0|Malignant|21|81754354|Male and Female|Choroid plexus|2004
0-19|0.1|0.1|0.1|Benign/Borderline|56|82005260|Male and Female|Choroid plexus|2005
0-19|0.0|0.0|0.0|Malignant|24|82005260|Male and Female|Choroid plexus|2005
0-19|0.1|0.1|0.1|Benign/Borderline|68|82324418|Male and Female|Choroid plexus|2006
0-19|0.0|0.0|0.0|Malignant|21|82324418|Male and Female|Choroid plexus|2006
0-19|0.1|0.1|0.1|Benign/Borderline|66|82749431|Male and Female|Choroid plexus|2007
0-19|0.0|0.0|0.0|Malignant|21|82749431|Male and Female|Choroid plexus|2007
0-19|0.1|0.1|0.1|Benign/Borderline|79|83118264|Male and Female|Choroid plexus|2008
0-19|0.0|0.0|0.0|Malignant|21|83118264|Male and Female|Choroid plexus|2008
0-19|0.1|0.1|0.1|Benign/Borderline|62|83280391|Male and Female|Choroid plexus|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Choroid plexus|2009
0-19|0.1|0.1|0.1|Benign/Borderline|69|83224734|Male and Female|Choroid plexus|2010
0-19|0.0|0.0|0.0|Malignant|23|83224734|Male and Female|Choroid plexus|2010
0-19|0.1|0.1|0.1|Benign/Borderline|61|83041095|Male and Female|Choroid plexus|2011
0-19|0.0|0.0|0.0|Malignant|21|83041095|Male and Female|Choroid plexus|2011
0-19|0.1|0.1|0.1|Benign/Borderline|63|82866386|Male and Female|Choroid plexus|2012
0-19|0.0|0.0|0.0|Malignant|19|82866386|Male and Female|Choroid plexus|2012
0-19|0.1|0.1|0.1|Benign/Borderline|68|82797930|Male and Female|Choroid plexus|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Choroid plexus|2013
0-19|0.1|0.1|0.1|Benign/Borderline|56|82828260|Male and Female|Choroid plexus|2014
0-19|0.0|0.0|0.0|Malignant|28|82828260|Male and Female|Choroid plexus|2014
0-19|0.1|0.1|0.1|Benign/Borderline|67|82974459|Male and Female|Choroid plexus|2015
0-19|0.0|0.0|0.0|Malignant|22|82974459|Male and Female|Choroid plexus|2015
0-19|0.1|0.1|0.1|Benign/Borderline|61|83184415|Male and Female|Choroid plexus|2016
0-19|0.0|0.0|0.0|Malignant|21|83184415|Male and Female|Choroid plexus|2016
0-19|0.1|0.1|0.1|Benign/Borderline|65|83308218|Male and Female|Choroid plexus|2017
0-19|0.0|0.0|0.0|Malignant|16|83308218|Male and Female|Choroid plexus|2017
0-19|0.1|0.1|0.1|Benign/Borderline|69|83321994|Male and Female|Choroid plexus|2018
0-19|0.0|0.0|0.0|Malignant|17|83321994|Male and Female|Choroid plexus|2018
0-19|0.1|0.1|0.1|Benign/Borderline|296|413514777|Male and Female|Choroid plexus|2018-2022
0-19|0.0|0.0|0.0|Malignant|98|413514777|Male and Female|Choroid plexus|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|58|83213818|Male and Female|Choroid plexus|2019
0-19|0.0|0.0|0.0|Malignant|26|83213818|Male and Female|Choroid plexus|2019
0-19|0.1|0.1|0.1|Benign/Borderline|61|82873432|Male and Female|Choroid plexus|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Choroid plexus|2020
0-19|0.0|0.1|0.1|Benign/Borderline|47|82201873|Male and Female|Choroid plexus|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Choroid plexus|2021
0-19|0.1|0.1|0.1|Benign/Borderline|61|81903660|Male and Female|Choroid plexus|2022
0-19|0.0|0.1|0.0|Malignant|27|81903660|Male and Female|Choroid plexus|2022
0-19|0.2|0.2|0.2|Benign/Borderline|171|81754354|Male and Female|Craniopharyngioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Craniopharyngioma|2004
0-19|0.2|0.2|0.2|Benign/Borderline|172|82005260|Male and Female|Craniopharyngioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Craniopharyngioma|2005
0-19|0.2|0.2|0.2|Benign/Borderline|158|82324418|Male and Female|Craniopharyngioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Craniopharyngioma|2006
0-19|0.2|0.3|0.2|Benign/Borderline|185|82749431|Male and Female|Craniopharyngioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Craniopharyngioma|2007
0-19|0.2|0.2|0.2|Benign/Borderline|163|83118264|Male and Female|Craniopharyngioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Craniopharyngioma|2008
0-19|0.2|0.2|0.2|Benign/Borderline|174|83280391|Male and Female|Craniopharyngioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Craniopharyngioma|2009
0-19|0.2|0.2|0.2|Benign/Borderline|178|83224734|Male and Female|Craniopharyngioma|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Craniopharyngioma|2010
0-19|0.2|0.2|0.2|Benign/Borderline|157|83041095|Male and Female|Craniopharyngioma|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Craniopharyngioma|2011
0-19|0.2|0.2|0.2|Benign/Borderline|159|82866386|Male and Female|Craniopharyngioma|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Craniopharyngioma|2012
0-19|0.2|0.3|0.2|Benign/Borderline|183|82797930|Male and Female|Craniopharyngioma|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Craniopharyngioma|2013
0-19|0.2|0.3|0.2|Benign/Borderline|202|82828260|Male and Female|Craniopharyngioma|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Craniopharyngioma|2014
0-19|0.2|0.3|0.2|Benign/Borderline|180|82974459|Male and Female|Craniopharyngioma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Craniopharyngioma|2015
0-19|0.2|0.2|0.2|Benign/Borderline|149|83184415|Male and Female|Craniopharyngioma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Craniopharyngioma|2016
0-19|0.2|0.3|0.2|Benign/Borderline|182|83308218|Male and Female|Craniopharyngioma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Craniopharyngioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|158|83321994|Male and Female|Craniopharyngioma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Craniopharyngioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|783|413514777|Male and Female|Craniopharyngioma|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Craniopharyngioma|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|167|83213818|Male and Female|Craniopharyngioma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Craniopharyngioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|127|82873432|Male and Female|Craniopharyngioma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Craniopharyngioma|2020
0-19|0.2|0.3|0.2|Benign/Borderline|181|82201873|Male and Female|Craniopharyngioma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Craniopharyngioma|2021
0-19|0.2|0.2|0.2|Benign/Borderline|150|81903660|Male and Female|Craniopharyngioma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Craniopharyngioma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Diffuse astrocytoma|2004
0-19|0.0|0.1|0.1|Malignant|44|81754354|Male and Female|Diffuse astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Diffuse astrocytoma|2005
0-19|0.0|0.1|0.1|Malignant|43|82005260|Male and Female|Diffuse astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Diffuse astrocytoma|2006
0-19|0.0|0.1|0.0|Malignant|32|82324418|Male and Female|Diffuse astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Diffuse astrocytoma|2007
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Diffuse astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Diffuse astrocytoma|2008
0-19|0.0|0.1|0.1|Malignant|44|83118264|Male and Female|Diffuse astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Diffuse astrocytoma|2009
0-19|0.0|0.1|0.0|Malignant|39|83280391|Male and Female|Diffuse astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Diffuse astrocytoma|2010
0-19|0.0|0.1|0.0|Malignant|32|83224734|Male and Female|Diffuse astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Diffuse astrocytoma|2011
0-19|0.0|0.1|0.0|Malignant|35|83041095|Male and Female|Diffuse astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Diffuse astrocytoma|2012
0-19|0.0|0.0|0.0|Malignant|28|82866386|Male and Female|Diffuse astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Diffuse astrocytoma|2013
0-19|0.0|0.0|0.0|Malignant|16|82797930|Male and Female|Diffuse astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Diffuse astrocytoma|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Diffuse astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Diffuse astrocytoma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Diffuse astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Diffuse astrocytoma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Diffuse astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Diffuse astrocytoma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Diffuse astrocytoma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Diffuse astrocytoma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Diffuse astrocytoma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Diffuse astrocytoma|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Diffuse astrocytoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Diffuse astrocytoma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Diffuse astrocytoma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Diffuse astrocytoma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Diffuse astrocytoma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Diffuse astrocytoma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Diffuse astrocytoma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Diffuse astrocytoma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Diffuse astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004
0-19|0.6|0.7|0.6|Malignant|507|81754354|Male and Female|Embryonal/primitive/medulloblastoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005
0-19|0.5|0.6|0.6|Malignant|462|82005260|Male and Female|Embryonal/primitive/medulloblastoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006
0-19|0.6|0.7|0.6|Malignant|501|82324418|Male and Female|Embryonal/primitive/medulloblastoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007
0-19|0.6|0.7|0.6|Malignant|514|82749431|Male and Female|Embryonal/primitive/medulloblastoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008
0-19|0.6|0.7|0.7|Malignant|549|83118264|Male and Female|Embryonal/primitive/medulloblastoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009
0-19|0.6|0.7|0.6|Malignant|515|83280391|Male and Female|Embryonal/primitive/medulloblastoma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Embryonal/primitive/medulloblastoma|2010
0-19|0.5|0.6|0.6|Malignant|489|83224734|Male and Female|Embryonal/primitive/medulloblastoma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Embryonal/primitive/medulloblastoma|2011
0-19|0.5|0.7|0.6|Malignant|498|83041095|Male and Female|Embryonal/primitive/medulloblastoma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Embryonal/primitive/medulloblastoma|2012
0-19|0.5|0.6|0.6|Malignant|467|82866386|Male and Female|Embryonal/primitive/medulloblastoma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Embryonal/primitive/medulloblastoma|2013
0-19|0.5|0.6|0.6|Malignant|462|82797930|Male and Female|Embryonal/primitive/medulloblastoma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Embryonal/primitive/medulloblastoma|2014
0-19|0.5|0.7|0.6|Malignant|494|82828260|Male and Female|Embryonal/primitive/medulloblastoma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Embryonal/primitive/medulloblastoma|2015
0-19|0.5|0.7|0.6|Malignant|492|82974459|Male and Female|Embryonal/primitive/medulloblastoma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Embryonal/primitive/medulloblastoma|2016
0-19|0.5|0.6|0.6|Malignant|462|83184415|Male and Female|Embryonal/primitive/medulloblastoma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Embryonal/primitive/medulloblastoma|2017
0-19|0.5|0.6|0.6|Malignant|471|83308218|Male and Female|Embryonal/primitive/medulloblastoma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Embryonal/primitive/medulloblastoma|2018
0-19|0.4|0.5|0.4|Malignant|360|83321994|Male and Female|Embryonal/primitive/medulloblastoma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Embryonal/primitive/medulloblastoma|2018-2022
0-19|0.4|0.4|0.4|Malignant|1540|413514777|Male and Female|Embryonal/primitive/medulloblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Embryonal/primitive/medulloblastoma|2019
0-19|0.3|0.4|0.4|Malignant|296|83213818|Male and Female|Embryonal/primitive/medulloblastoma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Embryonal/primitive/medulloblastoma|2020
0-19|0.4|0.5|0.4|Malignant|335|82873432|Male and Female|Embryonal/primitive/medulloblastoma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Embryonal/primitive/medulloblastoma|2021
0-19|0.3|0.4|0.4|Malignant|298|82201873|Male and Female|Embryonal/primitive/medulloblastoma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Embryonal/primitive/medulloblastoma|2022
0-19|0.3|0.4|0.3|Malignant|251|81903660|Male and Female|Embryonal/primitive/medulloblastoma|2022
0-19|0.0|0.0|0.0|Benign/Borderline|25|81754354|Male and Female|Ependymoma variants|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Ependymoma variants|2004
0-19|0.0|0.0|0.0|Benign/Borderline|26|82005260|Male and Female|Ependymoma variants|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Ependymoma variants|2005
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Ependymoma variants|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Ependymoma variants|2006
0-19|0.0|0.1|0.0|Benign/Borderline|30|82749431|Male and Female|Ependymoma variants|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Ependymoma variants|2007
0-19|0.0|0.0|0.0|Benign/Borderline|29|83118264|Male and Female|Ependymoma variants|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Ependymoma variants|2008
0-19|0.0|0.0|0.0|Benign/Borderline|29|83280391|Male and Female|Ependymoma variants|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Ependymoma variants|2009
0-19|0.0|0.1|0.0|Benign/Borderline|41|83224734|Male and Female|Ependymoma variants|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Ependymoma variants|2010
0-19|0.0|0.1|0.1|Benign/Borderline|43|83041095|Male and Female|Ependymoma variants|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Ependymoma variants|2011
0-19|0.0|0.1|0.0|Benign/Borderline|33|82866386|Male and Female|Ependymoma variants|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Ependymoma variants|2012
0-19|0.0|0.1|0.0|Benign/Borderline|38|82797930|Male and Female|Ependymoma variants|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Ependymoma variants|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Ependymoma variants|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Ependymoma variants|2014
0-19|0.0|0.1|0.0|Benign/Borderline|31|82974459|Male and Female|Ependymoma variants|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Ependymoma variants|2015
0-19|0.0|0.1|0.0|Benign/Borderline|38|83184415|Male and Female|Ependymoma variants|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Ependymoma variants|2016
0-19|0.0|0.1|0.0|Benign/Borderline|36|83308218|Male and Female|Ependymoma variants|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Ependymoma variants|2017
0-19|0.0|0.1|0.0|Benign/Borderline|37|83321994|Male and Female|Ependymoma variants|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Ependymoma variants|2018
0-19|0.0|0.1|0.0|Benign/Borderline|188|413514777|Male and Female|Ependymoma variants|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Ependymoma variants|2018-2022
0-19|0.0|0.1|0.0|Benign/Borderline|39|83213818|Male and Female|Ependymoma variants|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Ependymoma variants|2019
0-19|0.0|0.1|0.0|Benign/Borderline|34|82873432|Male and Female|Ependymoma variants|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Ependymoma variants|2020
0-19|0.0|0.1|0.0|Benign/Borderline|39|82201873|Male and Female|Ependymoma variants|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Ependymoma variants|2021
0-19|0.0|0.1|0.0|Benign/Borderline|39|81903660|Male and Female|Ependymoma variants|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Ependymoma variants|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004
0-19|0.2|0.3|0.2|Malignant|199|81754354|Male and Female|Ependymoma/anaplastic ependymoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005
0-19|0.2|0.3|0.3|Malignant|218|82005260|Male and Female|Ependymoma/anaplastic ependymoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006
0-19|0.2|0.3|0.3|Malignant|208|82324418|Male and Female|Ependymoma/anaplastic ependymoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007
0-19|0.2|0.3|0.2|Malignant|187|82749431|Male and Female|Ependymoma/anaplastic ependymoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008
0-19|0.2|0.2|0.2|Malignant|172|83118264|Male and Female|Ependymoma/anaplastic ependymoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009
0-19|0.2|0.3|0.2|Malignant|194|83280391|Male and Female|Ependymoma/anaplastic ependymoma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Ependymoma/anaplastic ependymoma|2010
0-19|0.2|0.3|0.3|Malignant|213|83224734|Male and Female|Ependymoma/anaplastic ependymoma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Ependymoma/anaplastic ependymoma|2011
0-19|0.2|0.3|0.3|Malignant|210|83041095|Male and Female|Ependymoma/anaplastic ependymoma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Ependymoma/anaplastic ependymoma|2012
0-19|0.2|0.3|0.2|Malignant|204|82866386|Male and Female|Ependymoma/anaplastic ependymoma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Ependymoma/anaplastic ependymoma|2013
0-19|0.2|0.3|0.2|Malignant|204|82797930|Male and Female|Ependymoma/anaplastic ependymoma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Ependymoma/anaplastic ependymoma|2014
0-19|0.2|0.3|0.2|Malignant|202|82828260|Male and Female|Ependymoma/anaplastic ependymoma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Ependymoma/anaplastic ependymoma|2015
0-19|0.2|0.3|0.2|Malignant|201|82974459|Male and Female|Ependymoma/anaplastic ependymoma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Ependymoma/anaplastic ependymoma|2016
0-19|0.2|0.3|0.2|Malignant|182|83184415|Male and Female|Ependymoma/anaplastic ependymoma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Ependymoma/anaplastic ependymoma|2017
0-19|0.2|0.3|0.3|Malignant|222|83308218|Male and Female|Ependymoma/anaplastic ependymoma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Ependymoma/anaplastic ependymoma|2018
0-19|0.2|0.2|0.2|Malignant|171|83321994|Male and Female|Ependymoma/anaplastic ependymoma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Ependymoma/anaplastic ependymoma|2018-2022
0-19|0.2|0.2|0.2|Malignant|787|413514777|Male and Female|Ependymoma/anaplastic ependymoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Ependymoma/anaplastic ependymoma|2019
0-19|0.2|0.2|0.2|Malignant|173|83213818|Male and Female|Ependymoma/anaplastic ependymoma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Ependymoma/anaplastic ependymoma|2020
0-19|0.2|0.2|0.2|Malignant|164|82873432|Male and Female|Ependymoma/anaplastic ependymoma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Ependymoma/anaplastic ependymoma|2021
0-19|0.2|0.2|0.2|Malignant|147|82201873|Male and Female|Ependymoma/anaplastic ependymoma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Ependymoma/anaplastic ependymoma|2022
0-19|0.1|0.2|0.2|Malignant|132|81903660|Male and Female|Ependymoma/anaplastic ependymoma|2022
0-19|0.0|0.1|0.0|Benign/Borderline|32|81754354|Male and Female|Germ Cell Tumors|2004
0-19|0.2|0.2|0.2|Malignant|148|81754354|Male and Female|Germ Cell Tumors|2004
0-19|0.0|0.1|0.0|Benign/Borderline|37|82005260|Male and Female|Germ Cell Tumors|2005
0-19|0.1|0.2|0.2|Malignant|133|82005260|Male and Female|Germ Cell Tumors|2005
0-19|0.0|0.1|0.1|Benign/Borderline|46|82324418|Male and Female|Germ Cell Tumors|2006
0-19|0.1|0.2|0.2|Malignant|126|82324418|Male and Female|Germ Cell Tumors|2006
0-19|0.0|0.1|0.0|Benign/Borderline|35|82749431|Male and Female|Germ Cell Tumors|2007
0-19|0.1|0.2|0.2|Malignant|129|82749431|Male and Female|Germ Cell Tumors|2007
0-19|0.0|0.1|0.0|Benign/Borderline|38|83118264|Male and Female|Germ Cell Tumors|2008
0-19|0.1|0.2|0.2|Malignant|145|83118264|Male and Female|Germ Cell Tumors|2008
0-19|0.0|0.1|0.1|Benign/Borderline|50|83280391|Male and Female|Germ Cell Tumors|2009
0-19|0.1|0.2|0.2|Malignant|141|83280391|Male and Female|Germ Cell Tumors|2009
0-19|0.0|0.1|0.1|Benign/Borderline|44|83224734|Male and Female|Germ Cell Tumors|2010
0-19|0.2|0.2|0.2|Malignant|165|83224734|Male and Female|Germ Cell Tumors|2010
0-19|0.0|0.1|0.0|Benign/Borderline|37|83041095|Male and Female|Germ Cell Tumors|2011
0-19|0.1|0.2|0.2|Malignant|137|83041095|Male and Female|Germ Cell Tumors|2011
0-19|0.0|0.1|0.1|Benign/Borderline|42|82866386|Male and Female|Germ Cell Tumors|2012
0-19|0.1|0.2|0.2|Malignant|130|82866386|Male and Female|Germ Cell Tumors|2012
0-19|0.0|0.1|0.1|Benign/Borderline|48|82797930|Male and Female|Germ Cell Tumors|2013
0-19|0.2|0.2|0.2|Malignant|159|82797930|Male and Female|Germ Cell Tumors|2013
0-19|0.0|0.1|0.1|Benign/Borderline|50|82828260|Male and Female|Germ Cell Tumors|2014
0-19|0.1|0.2|0.2|Malignant|137|82828260|Male and Female|Germ Cell Tumors|2014
0-19|0.0|0.1|0.0|Benign/Borderline|38|82974459|Male and Female|Germ Cell Tumors|2015
0-19|0.2|0.2|0.2|Malignant|152|82974459|Male and Female|Germ Cell Tumors|2015
0-19|0.1|0.1|0.1|Benign/Borderline|61|83184415|Male and Female|Germ Cell Tumors|2016
0-19|0.2|0.2|0.2|Malignant|169|83184415|Male and Female|Germ Cell Tumors|2016
0-19|0.0|0.1|0.0|Benign/Borderline|40|83308218|Male and Female|Germ Cell Tumors|2017
0-19|0.2|0.2|0.2|Malignant|177|83308218|Male and Female|Germ Cell Tumors|2017
0-19|0.1|0.1|0.1|Benign/Borderline|59|83321994|Male and Female|Germ Cell Tumors|2018
0-19|0.1|0.2|0.2|Malignant|130|83321994|Male and Female|Germ Cell Tumors|2018
0-19|0.0|0.1|0.0|Benign/Borderline|193|413514777|Male and Female|Germ Cell Tumors|2018-2022
0-19|0.2|0.2|0.2|Malignant|712|413514777|Male and Female|Germ Cell Tumors|2018-2022
0-19|0.0|0.1|0.1|Benign/Borderline|42|83213818|Male and Female|Germ Cell Tumors|2019
0-19|0.2|0.2|0.2|Malignant|157|83213818|Male and Female|Germ Cell Tumors|2019
0-19|0.0|0.1|0.0|Benign/Borderline|29|82873432|Male and Female|Germ Cell Tumors|2020
0-19|0.2|0.2|0.2|Malignant|150|82873432|Male and Female|Germ Cell Tumors|2020
0-19|0.0|0.1|0.0|Benign/Borderline|36|82201873|Male and Female|Germ Cell Tumors|2021
0-19|0.2|0.2|0.2|Malignant|150|82201873|Male and Female|Germ Cell Tumors|2021
0-19|0.0|0.0|0.0|Benign/Borderline|27|81903660|Male and Female|Germ Cell Tumors|2022
0-19|0.1|0.2|0.1|Malignant|125|81903660|Male and Female|Germ Cell Tumors|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioblastoma|2004
0-19|0.1|0.2|0.2|Malignant|127|81754354|Male and Female|Glioblastoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioblastoma|2005
0-19|0.1|0.1|0.1|Malignant|100|82005260|Male and Female|Glioblastoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioblastoma|2006
0-19|0.1|0.2|0.1|Malignant|111|82324418|Male and Female|Glioblastoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioblastoma|2007
0-19|0.1|0.2|0.2|Malignant|126|82749431|Male and Female|Glioblastoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioblastoma|2008
0-19|0.1|0.2|0.2|Malignant|130|83118264|Male and Female|Glioblastoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioblastoma|2009
0-19|0.1|0.2|0.1|Malignant|121|83280391|Male and Female|Glioblastoma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Glioblastoma|2010
0-19|0.1|0.2|0.1|Malignant|119|83224734|Male and Female|Glioblastoma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Glioblastoma|2011
0-19|0.2|0.2|0.2|Malignant|160|83041095|Male and Female|Glioblastoma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Glioblastoma|2012
0-19|0.2|0.2|0.2|Malignant|155|82866386|Male and Female|Glioblastoma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Glioblastoma|2013
0-19|0.2|0.2|0.2|Malignant|162|82797930|Male and Female|Glioblastoma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Glioblastoma|2014
0-19|0.1|0.2|0.2|Malignant|145|82828260|Male and Female|Glioblastoma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Glioblastoma|2015
0-19|0.2|0.2|0.2|Malignant|149|82974459|Male and Female|Glioblastoma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Glioblastoma|2016
0-19|0.1|0.2|0.2|Malignant|132|83184415|Male and Female|Glioblastoma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Glioblastoma|2017
0-19|0.1|0.2|0.2|Malignant|142|83308218|Male and Female|Glioblastoma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Glioblastoma|2018
0-19|0.1|0.2|0.2|Malignant|140|83321994|Male and Female|Glioblastoma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Glioblastoma|2018-2022
0-19|0.1|0.1|0.1|Malignant|517|413514777|Male and Female|Glioblastoma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Glioblastoma|2019
0-19|0.1|0.2|0.1|Malignant|124|83213818|Male and Female|Glioblastoma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Glioblastoma|2020
0-19|0.1|0.1|0.1|Malignant|102|82873432|Male and Female|Glioblastoma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Glioblastoma|2021
0-19|0.1|0.1|0.1|Malignant|93|82201873|Male and Female|Glioblastoma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Glioblastoma|2022
0-19|0.1|0.1|0.1|Malignant|58|81903660|Male and Female|Glioblastoma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Glioma malignant, NOS|2004
0-19|0.5|0.6|0.6|Malignant|464|81754354|Male and Female|Glioma malignant, NOS|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Glioma malignant, NOS|2005
0-19|0.5|0.6|0.6|Malignant|457|82005260|Male and Female|Glioma malignant, NOS|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Glioma malignant, NOS|2006
0-19|0.6|0.7|0.6|Malignant|491|82324418|Male and Female|Glioma malignant, NOS|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Glioma malignant, NOS|2007
0-19|0.6|0.7|0.6|Malignant|518|82749431|Male and Female|Glioma malignant, NOS|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Glioma malignant, NOS|2008
0-19|0.6|0.7|0.7|Malignant|549|83118264|Male and Female|Glioma malignant, NOS|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Glioma malignant, NOS|2009
0-19|0.6|0.8|0.7|Malignant|573|83280391|Male and Female|Glioma malignant, NOS|2009
0-19|0.0|0.0|0.0|Benign/Borderline|23|83224734|Male and Female|Glioma malignant, NOS|2010
0-19|0.6|0.7|0.7|Malignant|547|83224734|Male and Female|Glioma malignant, NOS|2010
0-19|0.0|0.1|0.0|Benign/Borderline|34|83041095|Male and Female|Glioma malignant, NOS|2011
0-19|0.7|0.8|0.7|Malignant|602|83041095|Male and Female|Glioma malignant, NOS|2011
0-19|0.0|0.1|0.0|Benign/Borderline|36|82866386|Male and Female|Glioma malignant, NOS|2012
0-19|0.6|0.7|0.6|Malignant|520|82866386|Male and Female|Glioma malignant, NOS|2012
0-19|0.0|0.1|0.0|Benign/Borderline|34|82797930|Male and Female|Glioma malignant, NOS|2013
0-19|0.7|0.8|0.7|Malignant|584|82797930|Male and Female|Glioma malignant, NOS|2013
0-19|0.0|0.1|0.1|Benign/Borderline|44|82828260|Male and Female|Glioma malignant, NOS|2014
0-19|0.6|0.7|0.7|Malignant|544|82828260|Male and Female|Glioma malignant, NOS|2014
0-19|0.0|0.1|0.0|Benign/Borderline|38|82974459|Male and Female|Glioma malignant, NOS|2015
0-19|0.7|0.8|0.7|Malignant|596|82974459|Male and Female|Glioma malignant, NOS|2015
0-19|0.0|0.1|0.1|Benign/Borderline|54|83184415|Male and Female|Glioma malignant, NOS|2016
0-19|0.7|0.8|0.8|Malignant|628|83184415|Male and Female|Glioma malignant, NOS|2016
0-19|0.0|0.1|0.1|Benign/Borderline|49|83308218|Male and Female|Glioma malignant, NOS|2017
0-19|0.7|0.9|0.8|Malignant|669|83308218|Male and Female|Glioma malignant, NOS|2017
0-19|0.0|0.1|0.1|Benign/Borderline|52|83321994|Male and Female|Glioma malignant, NOS|2018
0-19|0.5|0.6|0.6|Malignant|487|83321994|Male and Female|Glioma malignant, NOS|2018
0-19|0.0|0.1|0.0|Benign/Borderline|191|413514777|Male and Female|Glioma malignant, NOS|2018-2022
0-19|0.6|0.6|0.6|Malignant|2443|413514777|Male and Female|Glioma malignant, NOS|2018-2022
0-19|0.0|0.1|0.0|Benign/Borderline|36|83213818|Male and Female|Glioma malignant, NOS|2019
0-19|0.5|0.6|0.6|Malignant|467|83213818|Male and Female|Glioma malignant, NOS|2019
0-19|0.0|0.1|0.0|Benign/Borderline|31|82873432|Male and Female|Glioma malignant, NOS|2020
0-19|0.5|0.6|0.6|Malignant|466|82873432|Male and Female|Glioma malignant, NOS|2020
0-19|0.0|0.1|0.0|Benign/Borderline|30|82201873|Male and Female|Glioma malignant, NOS|2021
0-19|0.6|0.7|0.6|Malignant|530|82201873|Male and Female|Glioma malignant, NOS|2021
0-19|0.0|0.1|0.1|Benign/Borderline|42|81903660|Male and Female|Glioma malignant, NOS|2022
0-19|0.6|0.7|0.6|Malignant|493|81903660|Male and Female|Glioma malignant, NOS|2022
0-19|0.0|0.1|0.0|Benign/Borderline|30|81754354|Male and Female|Hemangioblastoma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioblastoma|2004
0-19|0.0|0.1|0.0|Benign/Borderline|30|82005260|Male and Female|Hemangioblastoma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioblastoma|2005
0-19|0.0|0.0|0.0|Benign/Borderline|25|82324418|Male and Female|Hemangioblastoma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioblastoma|2006
0-19|0.0|0.1|0.0|Benign/Borderline|41|82749431|Male and Female|Hemangioblastoma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioblastoma|2007
0-19|0.0|0.0|0.0|Benign/Borderline|24|83118264|Male and Female|Hemangioblastoma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioblastoma|2008
0-19|0.0|0.1|0.0|Benign/Borderline|33|83280391|Male and Female|Hemangioblastoma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioblastoma|2009
0-19|0.0|0.0|0.0|Benign/Borderline|27|83224734|Male and Female|Hemangioblastoma|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Hemangioblastoma|2010
0-19|0.0|0.1|0.0|Benign/Borderline|40|83041095|Male and Female|Hemangioblastoma|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Hemangioblastoma|2011
0-19|0.0|0.1|0.0|Benign/Borderline|41|82866386|Male and Female|Hemangioblastoma|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Hemangioblastoma|2012
0-19|0.0|0.1|0.0|Benign/Borderline|39|82797930|Male and Female|Hemangioblastoma|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Hemangioblastoma|2013
0-19|0.0|0.1|0.1|Benign/Borderline|54|82828260|Male and Female|Hemangioblastoma|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Hemangioblastoma|2014
0-19|0.0|0.1|0.0|Benign/Borderline|35|82974459|Male and Female|Hemangioblastoma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Hemangioblastoma|2015
0-19|0.0|0.1|0.1|Benign/Borderline|43|83184415|Male and Female|Hemangioblastoma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Hemangioblastoma|2016
0-19|0.0|0.1|0.0|Benign/Borderline|35|83308218|Male and Female|Hemangioblastoma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Hemangioblastoma|2017
0-19|0.0|0.1|0.0|Benign/Borderline|39|83321994|Male and Female|Hemangioblastoma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Hemangioblastoma|2018
0-19|0.0|0.0|0.0|Benign/Borderline|175|413514777|Male and Female|Hemangioblastoma|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Hemangioblastoma|2018-2022
0-19|0.0|0.1|0.0|Benign/Borderline|36|83213818|Male and Female|Hemangioblastoma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Hemangioblastoma|2019
0-19|0.0|0.1|0.0|Benign/Borderline|39|82873432|Male and Female|Hemangioblastoma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Hemangioblastoma|2020
0-19|0.0|0.1|0.0|Benign/Borderline|34|82201873|Male and Female|Hemangioblastoma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Hemangioblastoma|2021
0-19|0.0|0.0|0.0|Benign/Borderline|27|81903660|Male and Female|Hemangioblastoma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Hemangioblastoma|2022
0-19|0.0|0.1|0.1|Benign/Borderline|53|81754354|Male and Female|Hemangioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Hemangioma|2004
0-19|0.0|0.1|0.1|Benign/Borderline|47|82005260|Male and Female|Hemangioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Hemangioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|74|82324418|Male and Female|Hemangioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Hemangioma|2006
0-19|0.1|0.1|0.1|Benign/Borderline|90|82749431|Male and Female|Hemangioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Hemangioma|2007
0-19|0.1|0.1|0.1|Benign/Borderline|100|83118264|Male and Female|Hemangioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Hemangioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|117|83280391|Male and Female|Hemangioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Hemangioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|106|83224734|Male and Female|Hemangioma|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Hemangioma|2010
0-19|0.2|0.2|0.2|Benign/Borderline|151|83041095|Male and Female|Hemangioma|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Hemangioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|134|82866386|Male and Female|Hemangioma|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Hemangioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|129|82797930|Male and Female|Hemangioma|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Hemangioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|127|82828260|Male and Female|Hemangioma|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Hemangioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|134|82974459|Male and Female|Hemangioma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Hemangioma|2015
0-19|0.1|0.2|0.2|Benign/Borderline|144|83184415|Male and Female|Hemangioma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Hemangioma|2016
0-19|0.1|0.2|0.1|Benign/Borderline|123|83308218|Male and Female|Hemangioma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Hemangioma|2017
0-19|0.1|0.2|0.2|Benign/Borderline|127|83321994|Male and Female|Hemangioma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Hemangioma|2018
0-19|0.1|0.1|0.1|Benign/Borderline|562|413514777|Male and Female|Hemangioma|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Hemangioma|2018-2022
0-19|0.1|0.2|0.1|Benign/Borderline|104|83213818|Male and Female|Hemangioma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Hemangioma|2019
0-19|0.1|0.2|0.1|Benign/Borderline|118|82873432|Male and Female|Hemangioma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Hemangioma|2020
0-19|0.1|0.2|0.1|Benign/Borderline|120|82201873|Male and Female|Hemangioma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Hemangioma|2021
0-19|0.1|0.1|0.1|Benign/Borderline|93|81903660|Male and Female|Hemangioma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Hemangioma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Local Extensions from Regional Tumors|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Local Extensions from Regional Tumors|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Local Extensions from Regional Tumors|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Local Extensions from Regional Tumors|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Local Extensions from Regional Tumors|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Local Extensions from Regional Tumors|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Local Extensions from Regional Tumors|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Local Extensions from Regional Tumors|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Local Extensions from Regional Tumors|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Local Extensions from Regional Tumors|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Local Extensions from Regional Tumors|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Local Extensions from Regional Tumors|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Local Extensions from Regional Tumors|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Local Extensions from Regional Tumors|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Local Extensions from Regional Tumors|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Local Extensions from Regional Tumors|2018-2022
0-19|0.0|0.0|0.0|Malignant|20|413514777|Male and Female|Local Extensions from Regional Tumors|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Local Extensions from Regional Tumors|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Local Extensions from Regional Tumors|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Local Extensions from Regional Tumors|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Local Extensions from Regional Tumors|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|0.0|0.0|0.0|Malignant|16|81754354|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|0.0|0.0|0.0|Malignant|19|82005260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|0.0|0.0|0.0|Malignant|16|83280391|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|0.0|0.0|0.0|Malignant|17|82974459|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
0-19|0.0|0.0|0.0|Malignant|49|413514777|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
0-19|0.1|0.1|0.1|Benign/Borderline|95|81754354|Male and Female|Meningioma|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Meningioma|2004
0-19|0.1|0.2|0.2|Benign/Borderline|127|82005260|Male and Female|Meningioma|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Meningioma|2005
0-19|0.1|0.1|0.1|Benign/Borderline|100|82324418|Male and Female|Meningioma|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Meningioma|2006
0-19|0.1|0.2|0.1|Benign/Borderline|108|82749431|Male and Female|Meningioma|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Meningioma|2007
0-19|0.1|0.2|0.1|Benign/Borderline|120|83118264|Male and Female|Meningioma|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Meningioma|2008
0-19|0.1|0.2|0.1|Benign/Borderline|125|83280391|Male and Female|Meningioma|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Meningioma|2009
0-19|0.1|0.2|0.1|Benign/Borderline|115|83224734|Male and Female|Meningioma|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Meningioma|2010
0-19|0.1|0.2|0.2|Benign/Borderline|132|83041095|Male and Female|Meningioma|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Meningioma|2011
0-19|0.1|0.2|0.2|Benign/Borderline|128|82866386|Male and Female|Meningioma|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Meningioma|2012
0-19|0.1|0.2|0.2|Benign/Borderline|134|82797930|Male and Female|Meningioma|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Meningioma|2013
0-19|0.1|0.2|0.2|Benign/Borderline|136|82828260|Male and Female|Meningioma|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Meningioma|2014
0-19|0.1|0.2|0.2|Benign/Borderline|142|82974459|Male and Female|Meningioma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Meningioma|2015
0-19|0.1|0.2|0.1|Benign/Borderline|122|83184415|Male and Female|Meningioma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Meningioma|2016
0-19|0.1|0.2|0.2|Benign/Borderline|132|83308218|Male and Female|Meningioma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Meningioma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|158|83321994|Male and Female|Meningioma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Meningioma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|687|413514777|Male and Female|Meningioma|2018-2022
0-19|0.0|0.0|0.0|Malignant|21|413514777|Male and Female|Meningioma|2018-2022
0-19|0.1|0.2|0.2|Benign/Borderline|139|83213818|Male and Female|Meningioma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Meningioma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|132|82873432|Male and Female|Meningioma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Meningioma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|133|82201873|Male and Female|Meningioma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Meningioma|2021
0-19|0.1|0.2|0.1|Benign/Borderline|125|81903660|Male and Female|Meningioma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Meningioma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Mixed glioma|2004
0-19|0.0|0.1|0.0|Malignant|34|81754354|Male and Female|Mixed glioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Mixed glioma|2005
0-19|0.0|0.1|0.0|Malignant|32|82005260|Male and Female|Mixed glioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Mixed glioma|2006
0-19|0.0|0.0|0.0|Malignant|22|82324418|Male and Female|Mixed glioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Mixed glioma|2007
0-19|0.0|0.1|0.0|Malignant|33|82749431|Male and Female|Mixed glioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Mixed glioma|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Mixed glioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Mixed glioma|2009
0-19|0.0|0.0|0.0|Malignant|27|83280391|Male and Female|Mixed glioma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Mixed glioma|2010
0-19|0.0|0.1|0.0|Malignant|33|83224734|Male and Female|Mixed glioma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Mixed glioma|2011
0-19|0.0|0.0|0.0|Malignant|28|83041095|Male and Female|Mixed glioma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Mixed glioma|2012
0-19|0.0|0.0|0.0|Malignant|25|82866386|Male and Female|Mixed glioma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Mixed glioma|2013
0-19|0.0|0.0|0.0|Malignant|18|82797930|Male and Female|Mixed glioma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Mixed glioma|2014
0-19|0.0|0.0|0.0|Malignant|19|82828260|Male and Female|Mixed glioma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Mixed glioma|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Mixed glioma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Mixed glioma|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Mixed glioma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Mixed glioma|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Mixed glioma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Mixed glioma|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Mixed glioma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Mixed glioma|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Mixed glioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Mixed glioma|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Mixed glioma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Mixed glioma|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Mixed glioma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Mixed glioma|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Mixed glioma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Mixed glioma|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Mixed glioma|2022
0-19|0.1|0.1|0.1|Benign/Borderline|62|81754354|Male and Female|Neoplasm, unspecified|2004
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Neoplasm, unspecified|2004
0-19|0.1|0.2|0.1|Benign/Borderline|118|82005260|Male and Female|Neoplasm, unspecified|2005
0-19|0.0|0.1|0.0|Malignant|37|82005260|Male and Female|Neoplasm, unspecified|2005
0-19|0.1|0.2|0.1|Benign/Borderline|105|82324418|Male and Female|Neoplasm, unspecified|2006
0-19|0.0|0.1|0.1|Malignant|51|82324418|Male and Female|Neoplasm, unspecified|2006
0-19|0.1|0.2|0.1|Benign/Borderline|117|82749431|Male and Female|Neoplasm, unspecified|2007
0-19|0.0|0.1|0.0|Malignant|37|82749431|Male and Female|Neoplasm, unspecified|2007
0-19|0.1|0.2|0.2|Benign/Borderline|128|83118264|Male and Female|Neoplasm, unspecified|2008
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Neoplasm, unspecified|2008
0-19|0.2|0.2|0.2|Benign/Borderline|152|83280391|Male and Female|Neoplasm, unspecified|2009
0-19|0.0|0.1|0.0|Malignant|36|83280391|Male and Female|Neoplasm, unspecified|2009
0-19|0.2|0.2|0.2|Benign/Borderline|170|83224734|Male and Female|Neoplasm, unspecified|2010
0-19|0.0|0.0|0.0|Malignant|26|83224734|Male and Female|Neoplasm, unspecified|2010
0-19|0.1|0.2|0.2|Benign/Borderline|141|83041095|Male and Female|Neoplasm, unspecified|2011
0-19|0.0|0.1|0.0|Malignant|33|83041095|Male and Female|Neoplasm, unspecified|2011
0-19|0.1|0.2|0.2|Benign/Borderline|141|82866386|Male and Female|Neoplasm, unspecified|2012
0-19|0.0|0.1|0.1|Malignant|52|82866386|Male and Female|Neoplasm, unspecified|2012
0-19|0.2|0.2|0.2|Benign/Borderline|148|82797930|Male and Female|Neoplasm, unspecified|2013
0-19|0.0|0.1|0.1|Malignant|42|82797930|Male and Female|Neoplasm, unspecified|2013
0-19|0.2|0.2|0.2|Benign/Borderline|154|82828260|Male and Female|Neoplasm, unspecified|2014
0-19|0.0|0.1|0.1|Malignant|42|82828260|Male and Female|Neoplasm, unspecified|2014
0-19|0.1|0.2|0.2|Benign/Borderline|146|82974459|Male and Female|Neoplasm, unspecified|2015
0-19|0.0|0.1|0.0|Malignant|36|82974459|Male and Female|Neoplasm, unspecified|2015
0-19|0.1|0.2|0.2|Benign/Borderline|128|83184415|Male and Female|Neoplasm, unspecified|2016
0-19|0.0|0.1|0.1|Malignant|45|83184415|Male and Female|Neoplasm, unspecified|2016
0-19|0.1|0.2|0.2|Benign/Borderline|131|83308218|Male and Female|Neoplasm, unspecified|2017
0-19|0.0|0.1|0.1|Malignant|48|83308218|Male and Female|Neoplasm, unspecified|2017
0-19|0.1|0.2|0.2|Benign/Borderline|138|83321994|Male and Female|Neoplasm, unspecified|2018
0-19|0.0|0.1|0.1|Malignant|45|83321994|Male and Female|Neoplasm, unspecified|2018
0-19|0.1|0.1|0.1|Benign/Borderline|549|413514777|Male and Female|Neoplasm, unspecified|2018-2022
0-19|0.0|0.1|0.1|Malignant|234|413514777|Male and Female|Neoplasm, unspecified|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|103|83213818|Male and Female|Neoplasm, unspecified|2019
0-19|0.0|0.1|0.0|Malignant|37|83213818|Male and Female|Neoplasm, unspecified|2019
0-19|0.1|0.1|0.1|Benign/Borderline|101|82873432|Male and Female|Neoplasm, unspecified|2020
0-19|0.0|0.1|0.1|Malignant|52|82873432|Male and Female|Neoplasm, unspecified|2020
0-19|0.1|0.2|0.1|Benign/Borderline|105|82201873|Male and Female|Neoplasm, unspecified|2021
0-19|0.0|0.1|0.1|Malignant|48|82201873|Male and Female|Neoplasm, unspecified|2021
0-19|0.1|0.1|0.1|Benign/Borderline|102|81903660|Male and Female|Neoplasm, unspecified|2022
0-19|0.0|0.1|0.1|Malignant|52|81903660|Male and Female|Neoplasm, unspecified|2022
0-19|0.3|0.3|0.3|Benign/Borderline|243|81754354|Male and Female|Nerve sheath, benign and malignant|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Nerve sheath, benign and malignant|2004
0-19|0.3|0.4|0.4|Benign/Borderline|290|82005260|Male and Female|Nerve sheath, benign and malignant|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Nerve sheath, benign and malignant|2005
0-19|0.4|0.5|0.4|Benign/Borderline|340|82324418|Male and Female|Nerve sheath, benign and malignant|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Nerve sheath, benign and malignant|2006
0-19|0.3|0.4|0.4|Benign/Borderline|301|82749431|Male and Female|Nerve sheath, benign and malignant|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Nerve sheath, benign and malignant|2007
0-19|0.3|0.4|0.4|Benign/Borderline|305|83118264|Male and Female|Nerve sheath, benign and malignant|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Nerve sheath, benign and malignant|2008
0-19|0.3|0.4|0.4|Benign/Borderline|313|83280391|Male and Female|Nerve sheath, benign and malignant|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Nerve sheath, benign and malignant|2009
0-19|0.3|0.4|0.3|Benign/Borderline|283|83224734|Male and Female|Nerve sheath, benign and malignant|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Nerve sheath, benign and malignant|2010
0-19|0.3|0.4|0.4|Benign/Borderline|293|83041095|Male and Female|Nerve sheath, benign and malignant|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Nerve sheath, benign and malignant|2011
0-19|0.3|0.4|0.4|Benign/Borderline|306|82866386|Male and Female|Nerve sheath, benign and malignant|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Nerve sheath, benign and malignant|2012
0-19|0.3|0.4|0.4|Benign/Borderline|323|82797930|Male and Female|Nerve sheath, benign and malignant|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Nerve sheath, benign and malignant|2013
0-19|0.3|0.4|0.3|Benign/Borderline|265|82828260|Male and Female|Nerve sheath, benign and malignant|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Nerve sheath, benign and malignant|2014
0-19|0.3|0.4|0.4|Benign/Borderline|317|82974459|Male and Female|Nerve sheath, benign and malignant|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Nerve sheath, benign and malignant|2015
0-19|0.3|0.4|0.4|Benign/Borderline|316|83184415|Male and Female|Nerve sheath, benign and malignant|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Nerve sheath, benign and malignant|2016
0-19|0.3|0.3|0.3|Benign/Borderline|254|83308218|Male and Female|Nerve sheath, benign and malignant|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Nerve sheath, benign and malignant|2017
0-19|0.2|0.2|0.2|Benign/Borderline|174|83321994|Male and Female|Nerve sheath, benign and malignant|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Nerve sheath, benign and malignant|2018
0-19|0.2|0.2|0.2|Benign/Borderline|788|413514777|Male and Female|Nerve sheath, benign and malignant|2018-2022
0-19|0.0|0.0|0.0|Malignant|19|413514777|Male and Female|Nerve sheath, benign and malignant|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|181|83213818|Male and Female|Nerve sheath, benign and malignant|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Nerve sheath, benign and malignant|2019
0-19|0.1|0.2|0.2|Benign/Borderline|147|82873432|Male and Female|Nerve sheath, benign and malignant|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Nerve sheath, benign and malignant|2020
0-19|0.2|0.2|0.2|Benign/Borderline|150|82201873|Male and Female|Nerve sheath, benign and malignant|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Nerve sheath, benign and malignant|2021
0-19|0.1|0.2|0.2|Benign/Borderline|136|81903660|Male and Female|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Nerve sheath, benign and malignant|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Neuroepithelial|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Neuroepithelial|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Neuroepithelial|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Neuroepithelial|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Neuroepithelial|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Neuroepithelial|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Neuroepithelial|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Neuroepithelial|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Neuroepithelial|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Neuroepithelial|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Neuroepithelial|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Neuroepithelial|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Neuroepithelial|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Neuroepithelial|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Neuroepithelial|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Neuroepithelial|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Neuroepithelial|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Neuroepithelial|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Neuroepithelial|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Neuroepithelial|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Neuroepithelial|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Neuroepithelial|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Neuroepithelial|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Neuroepithelial|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Neuroepithelial|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Neuroepithelial|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Neuroepithelial|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Neuroepithelial|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Neuroepithelial|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Neuroepithelial|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Neuroepithelial|2018-2022
0-19|0.0|0.0|0.0|Malignant|32|413514777|Male and Female|Neuroepithelial|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Neuroepithelial|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Neuroepithelial|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Neuroepithelial|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Neuroepithelial|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Neuroepithelial|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Neuroepithelial|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Neuroepithelial|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Neuroepithelial|2022
0-19|0.3|0.4|0.3|Benign/Borderline|266|81754354|Male and Female|Neuronal/glial, neuronal|2004
0-19|0.0|0.1|0.1|Malignant|51|81754354|Male and Female|Neuronal/glial, neuronal|2004
0-19|0.3|0.4|0.4|Benign/Borderline|296|82005260|Male and Female|Neuronal/glial, neuronal|2005
0-19|0.1|0.1|0.1|Malignant|56|82005260|Male and Female|Neuronal/glial, neuronal|2005
0-19|0.3|0.4|0.3|Benign/Borderline|285|82324418|Male and Female|Neuronal/glial, neuronal|2006
0-19|0.0|0.1|0.1|Malignant|53|82324418|Male and Female|Neuronal/glial, neuronal|2006
0-19|0.3|0.4|0.4|Benign/Borderline|314|82749431|Male and Female|Neuronal/glial, neuronal|2007
0-19|0.1|0.1|0.1|Malignant|62|82749431|Male and Female|Neuronal/glial, neuronal|2007
0-19|0.3|0.4|0.4|Benign/Borderline|316|83118264|Male and Female|Neuronal/glial, neuronal|2008
0-19|0.1|0.1|0.1|Malignant|57|83118264|Male and Female|Neuronal/glial, neuronal|2008
0-19|0.3|0.4|0.4|Benign/Borderline|296|83280391|Male and Female|Neuronal/glial, neuronal|2009
0-19|0.0|0.1|0.0|Malignant|35|83280391|Male and Female|Neuronal/glial, neuronal|2009
0-19|0.3|0.4|0.4|Benign/Borderline|318|83224734|Male and Female|Neuronal/glial, neuronal|2010
0-19|0.0|0.1|0.0|Malignant|35|83224734|Male and Female|Neuronal/glial, neuronal|2010
0-19|0.4|0.5|0.4|Benign/Borderline|346|83041095|Male and Female|Neuronal/glial, neuronal|2011
0-19|0.0|0.1|0.0|Malignant|36|83041095|Male and Female|Neuronal/glial, neuronal|2011
0-19|0.4|0.5|0.4|Benign/Borderline|365|82866386|Male and Female|Neuronal/glial, neuronal|2012
0-19|0.0|0.1|0.0|Malignant|41|82866386|Male and Female|Neuronal/glial, neuronal|2012
0-19|0.4|0.5|0.4|Benign/Borderline|359|82797930|Male and Female|Neuronal/glial, neuronal|2013
0-19|0.0|0.1|0.1|Malignant|45|82797930|Male and Female|Neuronal/glial, neuronal|2013
0-19|0.4|0.5|0.4|Benign/Borderline|342|82828260|Male and Female|Neuronal/glial, neuronal|2014
0-19|0.1|0.1|0.1|Malignant|57|82828260|Male and Female|Neuronal/glial, neuronal|2014
0-19|0.4|0.5|0.5|Benign/Borderline|401|82974459|Male and Female|Neuronal/glial, neuronal|2015
0-19|0.0|0.1|0.1|Malignant|43|82974459|Male and Female|Neuronal/glial, neuronal|2015
0-19|0.5|0.6|0.5|Benign/Borderline|422|83184415|Male and Female|Neuronal/glial, neuronal|2016
0-19|0.0|0.1|0.1|Malignant|55|83184415|Male and Female|Neuronal/glial, neuronal|2016
0-19|0.5|0.6|0.5|Benign/Borderline|420|83308218|Male and Female|Neuronal/glial, neuronal|2017
0-19|0.0|0.1|0.0|Malignant|41|83308218|Male and Female|Neuronal/glial, neuronal|2017
0-19|0.4|0.5|0.4|Benign/Borderline|376|83321994|Male and Female|Neuronal/glial, neuronal|2018
0-19|0.0|0.1|0.1|Malignant|52|83321994|Male and Female|Neuronal/glial, neuronal|2018
0-19|0.4|0.4|0.4|Benign/Borderline|1787|413514777|Male and Female|Neuronal/glial, neuronal|2018-2022
0-19|0.0|0.1|0.1|Malignant|213|413514777|Male and Female|Neuronal/glial, neuronal|2018-2022
0-19|0.4|0.5|0.5|Benign/Borderline|390|83213818|Male and Female|Neuronal/glial, neuronal|2019
0-19|0.0|0.1|0.1|Malignant|44|83213818|Male and Female|Neuronal/glial, neuronal|2019
0-19|0.4|0.4|0.4|Benign/Borderline|332|82873432|Male and Female|Neuronal/glial, neuronal|2020
0-19|0.0|0.1|0.1|Malignant|46|82873432|Male and Female|Neuronal/glial, neuronal|2020
0-19|0.4|0.4|0.4|Benign/Borderline|325|82201873|Male and Female|Neuronal/glial, neuronal|2021
0-19|0.0|0.1|0.0|Malignant|33|82201873|Male and Female|Neuronal/glial, neuronal|2021
0-19|0.4|0.5|0.4|Benign/Borderline|364|81903660|Male and Female|Neuronal/glial, neuronal|2022
0-19|0.0|0.1|0.0|Malignant|38|81903660|Male and Female|Neuronal/glial, neuronal|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Oligodendroglioma|2004
0-19|0.1|0.1|0.1|Malignant|62|81754354|Male and Female|Oligodendroglioma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Oligodendroglioma|2005
0-19|0.0|0.1|0.1|Malignant|52|82005260|Male and Female|Oligodendroglioma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Oligodendroglioma|2006
0-19|0.1|0.1|0.1|Malignant|56|82324418|Male and Female|Oligodendroglioma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Oligodendroglioma|2007
0-19|0.0|0.1|0.1|Malignant|53|82749431|Male and Female|Oligodendroglioma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Oligodendroglioma|2008
0-19|0.0|0.1|0.1|Malignant|48|83118264|Male and Female|Oligodendroglioma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Oligodendroglioma|2009
0-19|0.0|0.1|0.1|Malignant|44|83280391|Male and Female|Oligodendroglioma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Oligodendroglioma|2010
0-19|0.0|0.1|0.1|Malignant|46|83224734|Male and Female|Oligodendroglioma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Oligodendroglioma|2011
0-19|0.0|0.1|0.0|Malignant|37|83041095|Male and Female|Oligodendroglioma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Oligodendroglioma|2012
0-19|0.0|0.1|0.1|Malignant|48|82866386|Male and Female|Oligodendroglioma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Oligodendroglioma|2013
0-19|0.0|0.1|0.0|Malignant|36|82797930|Male and Female|Oligodendroglioma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Oligodendroglioma|2014
0-19|0.0|0.1|0.0|Malignant|38|82828260|Male and Female|Oligodendroglioma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Oligodendroglioma|2015
0-19|0.0|0.1|0.0|Malignant|36|82974459|Male and Female|Oligodendroglioma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Oligodendroglioma|2016
0-19|0.0|0.1|0.0|Malignant|38|83184415|Male and Female|Oligodendroglioma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Oligodendroglioma|2017
0-19|0.0|0.0|0.0|Malignant|27|83308218|Male and Female|Oligodendroglioma|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Oligodendroglioma|2018
0-19|0.0|0.0|0.0|Malignant|25|83321994|Male and Female|Oligodendroglioma|2018
0-19|~|~|~|Benign/Borderline|~|413514777|Male and Female|Oligodendroglioma|2018-2022
0-19|0.0|0.0|0.0|Malignant|104|413514777|Male and Female|Oligodendroglioma|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Oligodendroglioma|2019
0-19|0.0|0.0|0.0|Malignant|21|83213818|Male and Female|Oligodendroglioma|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Oligodendroglioma|2020
0-19|0.0|0.0|0.0|Malignant|18|82873432|Male and Female|Oligodendroglioma|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Oligodendroglioma|2021
0-19|0.0|0.0|0.0|Malignant|23|82201873|Male and Female|Oligodendroglioma|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Oligodendroglioma|2022
0-19|0.0|0.0|0.0|Malignant|17|81903660|Male and Female|Oligodendroglioma|2022
0-19|0.0|0.0|0.0|Benign/Borderline|28|81754354|Male and Female|Other mesenchymal|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Other mesenchymal|2004
0-19|0.0|0.1|0.0|Benign/Borderline|40|82005260|Male and Female|Other mesenchymal|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Other mesenchymal|2005
0-19|0.0|0.1|0.0|Benign/Borderline|40|82324418|Male and Female|Other mesenchymal|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Other mesenchymal|2006
0-19|0.0|0.1|0.0|Benign/Borderline|33|82749431|Male and Female|Other mesenchymal|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Other mesenchymal|2007
0-19|0.0|0.1|0.0|Benign/Borderline|40|83118264|Male and Female|Other mesenchymal|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Other mesenchymal|2008
0-19|0.0|0.1|0.1|Benign/Borderline|51|83280391|Male and Female|Other mesenchymal|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Other mesenchymal|2009
0-19|0.0|0.1|0.1|Benign/Borderline|54|83224734|Male and Female|Other mesenchymal|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Other mesenchymal|2010
0-19|0.1|0.1|0.1|Benign/Borderline|65|83041095|Male and Female|Other mesenchymal|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Other mesenchymal|2011
0-19|0.1|0.1|0.1|Benign/Borderline|100|82866386|Male and Female|Other mesenchymal|2012
0-19|0.0|0.0|0.0|Malignant|16|82866386|Male and Female|Other mesenchymal|2012
0-19|0.1|0.1|0.1|Benign/Borderline|79|82797930|Male and Female|Other mesenchymal|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Other mesenchymal|2013
0-19|0.1|0.1|0.1|Benign/Borderline|81|82828260|Male and Female|Other mesenchymal|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Other mesenchymal|2014
0-19|0.1|0.1|0.1|Benign/Borderline|86|82974459|Male and Female|Other mesenchymal|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Other mesenchymal|2015
0-19|0.1|0.2|0.1|Benign/Borderline|104|83184415|Male and Female|Other mesenchymal|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Other mesenchymal|2016
0-19|0.1|0.1|0.1|Benign/Borderline|100|83308218|Male and Female|Other mesenchymal|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Other mesenchymal|2017
0-19|0.1|0.2|0.1|Benign/Borderline|102|83321994|Male and Female|Other mesenchymal|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Other mesenchymal|2018
0-19|0.1|0.1|0.1|Benign/Borderline|426|413514777|Male and Female|Other mesenchymal|2018-2022
0-19|0.0|0.0|0.0|Malignant|81|413514777|Male and Female|Other mesenchymal|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|64|83213818|Male and Female|Other mesenchymal|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Other mesenchymal|2019
0-19|0.1|0.1|0.1|Benign/Borderline|72|82873432|Male and Female|Other mesenchymal|2020
0-19|0.0|0.0|0.0|Malignant|23|82873432|Male and Female|Other mesenchymal|2020
0-19|0.1|0.2|0.1|Benign/Borderline|103|82201873|Male and Female|Other mesenchymal|2021
0-19|0.0|0.0|0.0|Malignant|20|82201873|Male and Female|Other mesenchymal|2021
0-19|0.1|0.1|0.1|Benign/Borderline|85|81903660|Male and Female|Other mesenchymal|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Other mesenchymal|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pilocytic astrocytoma|2004
0-19|0.8|0.9|0.9|Malignant|702|81754354|Male and Female|Pilocytic astrocytoma|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pilocytic astrocytoma|2005
0-19|0.8|0.9|0.8|Malignant|682|82005260|Male and Female|Pilocytic astrocytoma|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pilocytic astrocytoma|2006
0-19|0.8|0.9|0.8|Malignant|678|82324418|Male and Female|Pilocytic astrocytoma|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pilocytic astrocytoma|2007
0-19|0.8|0.9|0.9|Malignant|701|82749431|Male and Female|Pilocytic astrocytoma|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pilocytic astrocytoma|2008
0-19|0.8|1.0|0.9|Malignant|742|83118264|Male and Female|Pilocytic astrocytoma|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pilocytic astrocytoma|2009
0-19|0.8|0.9|0.9|Malignant|731|83280391|Male and Female|Pilocytic astrocytoma|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Pilocytic astrocytoma|2010
0-19|0.9|1.0|1.0|Malignant|788|83224734|Male and Female|Pilocytic astrocytoma|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Pilocytic astrocytoma|2011
0-19|0.9|1.0|0.9|Malignant|769|83041095|Male and Female|Pilocytic astrocytoma|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Pilocytic astrocytoma|2012
0-19|0.9|1.1|1.0|Malignant|816|82866386|Male and Female|Pilocytic astrocytoma|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Pilocytic astrocytoma|2013
0-19|0.9|1.0|1.0|Malignant|799|82797930|Male and Female|Pilocytic astrocytoma|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Pilocytic astrocytoma|2014
0-19|0.9|1.0|1.0|Malignant|796|82828260|Male and Female|Pilocytic astrocytoma|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Pilocytic astrocytoma|2015
0-19|0.8|1.0|0.9|Malignant|748|82974459|Male and Female|Pilocytic astrocytoma|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Pilocytic astrocytoma|2016
0-19|0.8|0.9|0.9|Malignant|726|83184415|Male and Female|Pilocytic astrocytoma|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Pilocytic astrocytoma|2017
0-19|1.0|1.1|1.0|Malignant|861|83308218|Male and Female|Pilocytic astrocytoma|2017
0-19|0.2|0.2|0.2|Benign/Borderline|168|83321994|Male and Female|Pilocytic astrocytoma|2018
0-19|0.8|0.9|0.8|Malignant|688|83321994|Male and Female|Pilocytic astrocytoma|2018
0-19|0.2|0.2|0.2|Benign/Borderline|747|413514777|Male and Female|Pilocytic astrocytoma|2018-2022
0-19|0.7|0.8|0.8|Malignant|3191|413514777|Male and Female|Pilocytic astrocytoma|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|150|83213818|Male and Female|Pilocytic astrocytoma|2019
0-19|0.7|0.8|0.8|Malignant|648|83213818|Male and Female|Pilocytic astrocytoma|2019
0-19|0.1|0.2|0.2|Benign/Borderline|140|82873432|Male and Female|Pilocytic astrocytoma|2020
0-19|0.7|0.8|0.8|Malignant|630|82873432|Male and Female|Pilocytic astrocytoma|2020
0-19|0.1|0.2|0.2|Benign/Borderline|134|82201873|Male and Female|Pilocytic astrocytoma|2021
0-19|0.7|0.8|0.8|Malignant|626|82201873|Male and Female|Pilocytic astrocytoma|2021
0-19|0.2|0.2|0.2|Benign/Borderline|155|81903660|Male and Female|Pilocytic astrocytoma|2022
0-19|0.7|0.8|0.7|Malignant|599|81903660|Male and Female|Pilocytic astrocytoma|2022
0-19|~|~|~|Benign/Borderline|~|81754354|Male and Female|Pineal parenchymal|2004
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Pineal parenchymal|2004
0-19|~|~|~|Benign/Borderline|~|82005260|Male and Female|Pineal parenchymal|2005
0-19|0.0|0.0|0.0|Malignant|22|82005260|Male and Female|Pineal parenchymal|2005
0-19|~|~|~|Benign/Borderline|~|82324418|Male and Female|Pineal parenchymal|2006
0-19|0.0|0.0|0.0|Malignant|24|82324418|Male and Female|Pineal parenchymal|2006
0-19|~|~|~|Benign/Borderline|~|82749431|Male and Female|Pineal parenchymal|2007
0-19|0.0|0.0|0.0|Malignant|28|82749431|Male and Female|Pineal parenchymal|2007
0-19|~|~|~|Benign/Borderline|~|83118264|Male and Female|Pineal parenchymal|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Pineal parenchymal|2008
0-19|~|~|~|Benign/Borderline|~|83280391|Male and Female|Pineal parenchymal|2009
0-19|0.0|0.0|0.0|Malignant|26|83280391|Male and Female|Pineal parenchymal|2009
0-19|~|~|~|Benign/Borderline|~|83224734|Male and Female|Pineal parenchymal|2010
0-19|0.0|0.0|0.0|Malignant|26|83224734|Male and Female|Pineal parenchymal|2010
0-19|~|~|~|Benign/Borderline|~|83041095|Male and Female|Pineal parenchymal|2011
0-19|0.0|0.1|0.0|Malignant|35|83041095|Male and Female|Pineal parenchymal|2011
0-19|~|~|~|Benign/Borderline|~|82866386|Male and Female|Pineal parenchymal|2012
0-19|0.0|0.1|0.0|Malignant|33|82866386|Male and Female|Pineal parenchymal|2012
0-19|~|~|~|Benign/Borderline|~|82797930|Male and Female|Pineal parenchymal|2013
0-19|0.0|0.1|0.0|Malignant|32|82797930|Male and Female|Pineal parenchymal|2013
0-19|~|~|~|Benign/Borderline|~|82828260|Male and Female|Pineal parenchymal|2014
0-19|0.0|0.1|0.0|Malignant|39|82828260|Male and Female|Pineal parenchymal|2014
0-19|~|~|~|Benign/Borderline|~|82974459|Male and Female|Pineal parenchymal|2015
0-19|0.0|0.1|0.1|Malignant|45|82974459|Male and Female|Pineal parenchymal|2015
0-19|~|~|~|Benign/Borderline|~|83184415|Male and Female|Pineal parenchymal|2016
0-19|0.0|0.1|0.0|Malignant|41|83184415|Male and Female|Pineal parenchymal|2016
0-19|~|~|~|Benign/Borderline|~|83308218|Male and Female|Pineal parenchymal|2017
0-19|0.0|0.0|0.0|Malignant|27|83308218|Male and Female|Pineal parenchymal|2017
0-19|~|~|~|Benign/Borderline|~|83321994|Male and Female|Pineal parenchymal|2018
0-19|0.0|0.1|0.0|Malignant|33|83321994|Male and Female|Pineal parenchymal|2018
0-19|0.0|0.0|0.0|Benign/Borderline|29|413514777|Male and Female|Pineal parenchymal|2018-2022
0-19|0.0|0.0|0.0|Malignant|162|413514777|Male and Female|Pineal parenchymal|2018-2022
0-19|~|~|~|Benign/Borderline|~|83213818|Male and Female|Pineal parenchymal|2019
0-19|0.0|0.1|0.0|Malignant|35|83213818|Male and Female|Pineal parenchymal|2019
0-19|~|~|~|Benign/Borderline|~|82873432|Male and Female|Pineal parenchymal|2020
0-19|0.0|0.1|0.0|Malignant|33|82873432|Male and Female|Pineal parenchymal|2020
0-19|~|~|~|Benign/Borderline|~|82201873|Male and Female|Pineal parenchymal|2021
0-19|0.0|0.0|0.0|Malignant|28|82201873|Male and Female|Pineal parenchymal|2021
0-19|~|~|~|Benign/Borderline|~|81903660|Male and Female|Pineal parenchymal|2022
0-19|0.0|0.1|0.0|Malignant|33|81903660|Male and Female|Pineal parenchymal|2022
0-19|0.4|0.5|0.5|Benign/Borderline|378|81754354|Male and Female|Pituitary|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Pituitary|2004
0-19|0.5|0.6|0.5|Benign/Borderline|463|82005260|Male and Female|Pituitary|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Pituitary|2005
0-19|0.5|0.6|0.6|Benign/Borderline|483|82324418|Male and Female|Pituitary|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Pituitary|2006
0-19|0.5|0.6|0.6|Benign/Borderline|478|82749431|Male and Female|Pituitary|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Pituitary|2007
0-19|0.6|0.7|0.7|Benign/Borderline|572|83118264|Male and Female|Pituitary|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Pituitary|2008
0-19|0.6|0.7|0.7|Benign/Borderline|595|83280391|Male and Female|Pituitary|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Pituitary|2009
0-19|0.7|0.8|0.7|Benign/Borderline|634|83224734|Male and Female|Pituitary|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Pituitary|2010
0-19|0.7|0.8|0.8|Benign/Borderline|644|83041095|Male and Female|Pituitary|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Pituitary|2011
0-19|0.8|0.9|0.8|Benign/Borderline|715|82866386|Male and Female|Pituitary|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Pituitary|2012
0-19|0.8|0.9|0.9|Benign/Borderline|715|82797930|Male and Female|Pituitary|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Pituitary|2013
0-19|0.9|1.0|0.9|Benign/Borderline|780|82828260|Male and Female|Pituitary|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Pituitary|2014
0-19|0.8|1.0|0.9|Benign/Borderline|752|82974459|Male and Female|Pituitary|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Pituitary|2015
0-19|0.9|1.1|1.0|Benign/Borderline|844|83184415|Male and Female|Pituitary|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Pituitary|2016
0-19|1.0|1.1|1.1|Benign/Borderline|910|83308218|Male and Female|Pituitary|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Pituitary|2017
0-19|0.9|1.1|1.0|Benign/Borderline|859|83321994|Male and Female|Pituitary|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Pituitary|2018
0-19|0.9|1.0|1.0|Benign/Borderline|4060|413514777|Male and Female|Pituitary|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Pituitary|2018-2022
0-19|0.9|1.1|1.0|Benign/Borderline|851|83213818|Male and Female|Pituitary|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Pituitary|2019
0-19|0.9|1.0|0.9|Benign/Borderline|805|82873432|Male and Female|Pituitary|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Pituitary|2020
0-19|0.9|1.0|1.0|Benign/Borderline|829|82201873|Male and Female|Pituitary|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Pituitary|2021
0-19|0.8|0.9|0.8|Benign/Borderline|716|81903660|Male and Female|Pituitary|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Pituitary|2022
0-19|1.8|1.9|1.9|Benign/Borderline|1522|81754354|Male and Female|Total|2004
0-19|3.3|3.6|3.5|Malignant|2811|81754354|Male and Female|Total|2004
0-19|2.1|2.3|2.2|Benign/Borderline|1788|82005260|Male and Female|Total|2005
0-19|3.1|3.4|3.3|Malignant|2668|82005260|Male and Female|Total|2005
0-19|2.1|2.3|2.2|Benign/Borderline|1841|82324418|Male and Female|Total|2006
0-19|3.2|3.5|3.4|Malignant|2749|82324418|Male and Female|Total|2006
0-19|2.2|2.4|2.3|Benign/Borderline|1894|82749431|Male and Female|Total|2007
0-19|3.3|3.6|3.4|Malignant|2835|82749431|Male and Female|Total|2007
0-19|2.3|2.5|2.4|Benign/Borderline|2012|83118264|Male and Female|Total|2008
0-19|3.4|3.6|3.5|Malignant|2901|83118264|Male and Female|Total|2008
0-19|2.4|2.6|2.5|Benign/Borderline|2106|83280391|Male and Female|Total|2009
0-19|3.3|3.6|3.5|Malignant|2869|83280391|Male and Female|Total|2009
0-19|2.4|2.7|2.5|Benign/Borderline|2143|83224734|Male and Female|Total|2010
0-19|3.4|3.7|3.5|Malignant|2925|83224734|Male and Female|Total|2010
0-19|2.5|2.8|2.7|Benign/Borderline|2228|83041095|Male and Female|Total|2011
0-19|3.5|3.7|3.6|Malignant|2969|83041095|Male and Female|Total|2011
0-19|2.7|2.9|2.8|Benign/Borderline|2354|82866386|Male and Female|Total|2012
0-19|3.4|3.6|3.5|Malignant|2882|82866386|Male and Female|Total|2012
0-19|2.8|3.0|2.9|Benign/Borderline|2387|82797930|Male and Female|Total|2013
0-19|3.5|3.7|3.6|Malignant|2970|82797930|Male and Female|Total|2013
0-19|2.8|3.0|2.9|Benign/Borderline|2417|82828260|Male and Female|Total|2014
0-19|3.5|3.7|3.6|Malignant|2970|82828260|Male and Female|Total|2014
0-19|2.8|3.0|2.9|Benign/Borderline|2434|82974459|Male and Female|Total|2015
0-19|3.4|3.6|3.5|Malignant|2914|82974459|Male and Female|Total|2015
0-19|2.9|3.2|3.1|Benign/Borderline|2567|83184415|Male and Female|Total|2016
0-19|3.3|3.6|3.5|Malignant|2875|83184415|Male and Female|Total|2016
0-19|2.9|3.2|3.0|Benign/Borderline|2553|83308218|Male and Female|Total|2017
0-19|3.5|3.8|3.7|Malignant|3048|83308218|Male and Female|Total|2017
0-19|3.0|3.2|3.1|Benign/Borderline|2594|83321994|Male and Female|Total|2018
0-19|2.9|3.1|3.0|Malignant|2486|83321994|Male and Female|Total|2018
0-19|2.8|2.9|2.8|Benign/Borderline|11783|413514777|Male and Female|Total|2018-2022
0-19|2.7|2.8|2.8|Malignant|11384|413514777|Male and Female|Total|2018-2022
0-19|2.8|3.0|2.9|Benign/Borderline|2436|83213818|Male and Female|Total|2019
0-19|2.7|2.9|2.8|Malignant|2331|83213818|Male and Female|Total|2019
0-19|2.5|2.8|2.7|Benign/Borderline|2225|82873432|Male and Female|Total|2020
0-19|2.6|2.8|2.7|Malignant|2253|82873432|Male and Female|Total|2020
0-19|2.7|2.9|2.8|Benign/Borderline|2331|82201873|Male and Female|Total|2021
0-19|2.7|2.9|2.8|Malignant|2266|82201873|Male and Female|Total|2021
0-19|2.5|2.8|2.6|Benign/Borderline|2197|81903660|Male and Female|Total|2022
0-19|2.4|2.6|2.5|Malignant|2048|81903660|Male and Female|Total|2022
0-19|0.3|0.3|0.3|Benign/Borderline|243|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Cranial and Spinal Nerves|2004
0-19|0.3|0.4|0.4|Benign/Borderline|290|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Cranial and Spinal Nerves|2005
0-19|0.4|0.5|0.4|Benign/Borderline|340|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Cranial and Spinal Nerves|2006
0-19|0.3|0.4|0.4|Benign/Borderline|301|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Cranial and Spinal Nerves|2007
0-19|0.3|0.4|0.4|Benign/Borderline|305|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Cranial and Spinal Nerves|2008
0-19|0.3|0.4|0.4|Benign/Borderline|313|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Cranial and Spinal Nerves|2009
0-19|0.3|0.4|0.3|Benign/Borderline|283|83224734|Male and Female|Tumors of Cranial and Spinal Nerves|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Tumors of Cranial and Spinal Nerves|2010
0-19|0.3|0.4|0.4|Benign/Borderline|293|83041095|Male and Female|Tumors of Cranial and Spinal Nerves|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Tumors of Cranial and Spinal Nerves|2011
0-19|0.3|0.4|0.4|Benign/Borderline|306|82866386|Male and Female|Tumors of Cranial and Spinal Nerves|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Tumors of Cranial and Spinal Nerves|2012
0-19|0.3|0.4|0.4|Benign/Borderline|324|82797930|Male and Female|Tumors of Cranial and Spinal Nerves|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Tumors of Cranial and Spinal Nerves|2013
0-19|0.3|0.4|0.3|Benign/Borderline|267|82828260|Male and Female|Tumors of Cranial and Spinal Nerves|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Tumors of Cranial and Spinal Nerves|2014
0-19|0.3|0.4|0.4|Benign/Borderline|317|82974459|Male and Female|Tumors of Cranial and Spinal Nerves|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Tumors of Cranial and Spinal Nerves|2015
0-19|0.3|0.4|0.4|Benign/Borderline|316|83184415|Male and Female|Tumors of Cranial and Spinal Nerves|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Tumors of Cranial and Spinal Nerves|2016
0-19|0.3|0.3|0.3|Benign/Borderline|255|83308218|Male and Female|Tumors of Cranial and Spinal Nerves|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Tumors of Cranial and Spinal Nerves|2017
0-19|0.2|0.2|0.2|Benign/Borderline|174|83321994|Male and Female|Tumors of Cranial and Spinal Nerves|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Tumors of Cranial and Spinal Nerves|2018
0-19|0.2|0.2|0.2|Benign/Borderline|788|413514777|Male and Female|Tumors of Cranial and Spinal Nerves|2018-2022
0-19|0.0|0.0|0.0|Malignant|19|413514777|Male and Female|Tumors of Cranial and Spinal Nerves|2018-2022
0-19|0.2|0.2|0.2|Benign/Borderline|181|83213818|Male and Female|Tumors of Cranial and Spinal Nerves|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Tumors of Cranial and Spinal Nerves|2019
0-19|0.1|0.2|0.2|Benign/Borderline|147|82873432|Male and Female|Tumors of Cranial and Spinal Nerves|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Tumors of Cranial and Spinal Nerves|2020
0-19|0.2|0.2|0.2|Benign/Borderline|150|82201873|Male and Female|Tumors of Cranial and Spinal Nerves|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Tumors of Cranial and Spinal Nerves|2021
0-19|0.1|0.2|0.2|Benign/Borderline|136|81903660|Male and Female|Tumors of Cranial and Spinal Nerves|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Tumors of Cranial and Spinal Nerves|2022
0-19|0.5|0.6|0.5|Benign/Borderline|430|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004
0-19|3.0|3.3|3.2|Malignant|2571|81754354|Male and Female|Tumors of Neuroepthelial Tissue|2004
0-19|0.5|0.6|0.6|Benign/Borderline|464|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005
0-19|2.9|3.1|3.0|Malignant|2445|82005260|Male and Female|Tumors of Neuroepthelial Tissue|2005
0-19|0.5|0.6|0.6|Benign/Borderline|470|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006
0-19|3.0|3.2|3.1|Malignant|2529|82324418|Male and Female|Tumors of Neuroepthelial Tissue|2006
0-19|0.6|0.7|0.6|Benign/Borderline|505|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007
0-19|3.1|3.3|3.2|Malignant|2629|82749431|Male and Female|Tumors of Neuroepthelial Tissue|2007
0-19|0.6|0.7|0.6|Benign/Borderline|519|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008
0-19|3.1|3.4|3.2|Malignant|2684|83118264|Male and Female|Tumors of Neuroepthelial Tissue|2008
0-19|0.5|0.6|0.6|Benign/Borderline|496|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009
0-19|3.1|3.3|3.2|Malignant|2646|83280391|Male and Female|Tumors of Neuroepthelial Tissue|2009
0-19|0.6|0.7|0.6|Benign/Borderline|531|83224734|Male and Female|Tumors of Neuroepthelial Tissue|2010
0-19|3.1|3.4|3.2|Malignant|2689|83224734|Male and Female|Tumors of Neuroepthelial Tissue|2010
0-19|0.6|0.7|0.7|Benign/Borderline|568|83041095|Male and Female|Tumors of Neuroepthelial Tissue|2011
0-19|3.2|3.4|3.3|Malignant|2754|83041095|Male and Female|Tumors of Neuroepthelial Tissue|2011
0-19|0.7|0.8|0.7|Benign/Borderline|588|82866386|Male and Female|Tumors of Neuroepthelial Tissue|2012
0-19|3.1|3.3|3.2|Malignant|2655|82866386|Male and Female|Tumors of Neuroepthelial Tissue|2012
0-19|0.7|0.8|0.7|Benign/Borderline|586|82797930|Male and Female|Tumors of Neuroepthelial Tissue|2013
0-19|3.2|3.4|3.3|Malignant|2721|82797930|Male and Female|Tumors of Neuroepthelial Tissue|2013
0-19|0.6|0.7|0.7|Benign/Borderline|566|82828260|Male and Female|Tumors of Neuroepthelial Tissue|2014
0-19|3.2|3.5|3.3|Malignant|2749|82828260|Male and Female|Tumors of Neuroepthelial Tissue|2014
0-19|0.7|0.8|0.7|Benign/Borderline|602|82974459|Male and Female|Tumors of Neuroepthelial Tissue|2015
0-19|3.1|3.4|3.2|Malignant|2676|82974459|Male and Female|Tumors of Neuroepthelial Tissue|2015
0-19|0.7|0.8|0.8|Benign/Borderline|655|83184415|Male and Female|Tumors of Neuroepthelial Tissue|2016
0-19|3.0|3.3|3.2|Malignant|2612|83184415|Male and Female|Tumors of Neuroepthelial Tissue|2016
0-19|0.7|0.8|0.8|Benign/Borderline|645|83308218|Male and Female|Tumors of Neuroepthelial Tissue|2017
0-19|3.2|3.5|3.4|Malignant|2788|83308218|Male and Female|Tumors of Neuroepthelial Tissue|2017
0-19|0.9|1.0|0.9|Benign/Borderline|780|83321994|Male and Female|Tumors of Neuroepthelial Tissue|2018
0-19|2.6|2.9|2.7|Malignant|2275|83321994|Male and Female|Tumors of Neuroepthelial Tissue|2018
0-19|0.8|0.9|0.9|Benign/Borderline|3557|413514777|Male and Female|Tumors of Neuroepthelial Tissue|2018-2022
0-19|2.4|2.5|2.5|Malignant|10232|413514777|Male and Female|Tumors of Neuroepthelial Tissue|2018-2022
0-19|0.8|1.0|0.9|Benign/Borderline|748|83213818|Male and Female|Tumors of Neuroepthelial Tissue|2019
0-19|2.4|2.7|2.5|Malignant|2104|83213818|Male and Female|Tumors of Neuroepthelial Tissue|2019
0-19|0.7|0.9|0.8|Benign/Borderline|655|82873432|Male and Female|Tumors of Neuroepthelial Tissue|2020
0-19|2.3|2.5|2.4|Malignant|2006|82873432|Male and Female|Tumors of Neuroepthelial Tissue|2020
0-19|0.7|0.8|0.8|Benign/Borderline|639|82201873|Male and Female|Tumors of Neuroepthelial Tissue|2021
0-19|2.4|2.6|2.5|Malignant|2014|82201873|Male and Female|Tumors of Neuroepthelial Tissue|2021
0-19|0.8|1.0|0.9|Benign/Borderline|735|81903660|Male and Female|Tumors of Neuroepthelial Tissue|2022
0-19|2.2|2.4|2.3|Malignant|1833|81903660|Male and Female|Tumors of Neuroepthelial Tissue|2022
0-19|0.6|0.7|0.7|Benign/Borderline|549|81754354|Male and Female|Tumors of Sellar Region|2004
0-19|~|~|~|Malignant|~|81754354|Male and Female|Tumors of Sellar Region|2004
0-19|0.7|0.8|0.8|Benign/Borderline|635|82005260|Male and Female|Tumors of Sellar Region|2005
0-19|~|~|~|Malignant|~|82005260|Male and Female|Tumors of Sellar Region|2005
0-19|0.7|0.8|0.8|Benign/Borderline|641|82324418|Male and Female|Tumors of Sellar Region|2006
0-19|~|~|~|Malignant|~|82324418|Male and Female|Tumors of Sellar Region|2006
0-19|0.7|0.8|0.8|Benign/Borderline|663|82749431|Male and Female|Tumors of Sellar Region|2007
0-19|~|~|~|Malignant|~|82749431|Male and Female|Tumors of Sellar Region|2007
0-19|0.8|0.9|0.9|Benign/Borderline|735|83118264|Male and Female|Tumors of Sellar Region|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of Sellar Region|2008
0-19|0.8|1.0|0.9|Benign/Borderline|769|83280391|Male and Female|Tumors of Sellar Region|2009
0-19|~|~|~|Malignant|~|83280391|Male and Female|Tumors of Sellar Region|2009
0-19|0.9|1.0|1.0|Benign/Borderline|812|83224734|Male and Female|Tumors of Sellar Region|2010
0-19|~|~|~|Malignant|~|83224734|Male and Female|Tumors of Sellar Region|2010
0-19|0.9|1.0|0.9|Benign/Borderline|801|83041095|Male and Female|Tumors of Sellar Region|2011
0-19|~|~|~|Malignant|~|83041095|Male and Female|Tumors of Sellar Region|2011
0-19|1.0|1.1|1.0|Benign/Borderline|874|82866386|Male and Female|Tumors of Sellar Region|2012
0-19|~|~|~|Malignant|~|82866386|Male and Female|Tumors of Sellar Region|2012
0-19|1.0|1.1|1.1|Benign/Borderline|898|82797930|Male and Female|Tumors of Sellar Region|2013
0-19|~|~|~|Malignant|~|82797930|Male and Female|Tumors of Sellar Region|2013
0-19|1.1|1.2|1.2|Benign/Borderline|982|82828260|Male and Female|Tumors of Sellar Region|2014
0-19|~|~|~|Malignant|~|82828260|Male and Female|Tumors of Sellar Region|2014
0-19|1.0|1.2|1.1|Benign/Borderline|932|82974459|Male and Female|Tumors of Sellar Region|2015
0-19|~|~|~|Malignant|~|82974459|Male and Female|Tumors of Sellar Region|2015
0-19|1.1|1.3|1.2|Benign/Borderline|993|83184415|Male and Female|Tumors of Sellar Region|2016
0-19|~|~|~|Malignant|~|83184415|Male and Female|Tumors of Sellar Region|2016
0-19|1.2|1.4|1.3|Benign/Borderline|1092|83308218|Male and Female|Tumors of Sellar Region|2017
0-19|~|~|~|Malignant|~|83308218|Male and Female|Tumors of Sellar Region|2017
0-19|1.1|1.3|1.2|Benign/Borderline|1017|83321994|Male and Female|Tumors of Sellar Region|2018
0-19|~|~|~|Malignant|~|83321994|Male and Female|Tumors of Sellar Region|2018
0-19|1.1|1.2|1.1|Benign/Borderline|4843|413514777|Male and Female|Tumors of Sellar Region|2018-2022
0-19|~|~|~|Malignant|~|413514777|Male and Female|Tumors of Sellar Region|2018-2022
0-19|1.1|1.3|1.2|Benign/Borderline|1018|83213818|Male and Female|Tumors of Sellar Region|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Tumors of Sellar Region|2019
0-19|1.0|1.2|1.1|Benign/Borderline|932|82873432|Male and Female|Tumors of Sellar Region|2020
0-19|~|~|~|Malignant|~|82873432|Male and Female|Tumors of Sellar Region|2020
0-19|1.1|1.3|1.2|Benign/Borderline|1010|82201873|Male and Female|Tumors of Sellar Region|2021
0-19|~|~|~|Malignant|~|82201873|Male and Female|Tumors of Sellar Region|2021
0-19|1.0|1.1|1.0|Benign/Borderline|866|81903660|Male and Female|Tumors of Sellar Region|2022
0-19|~|~|~|Malignant|~|81903660|Male and Female|Tumors of Sellar Region|2022
0-19|0.2|0.2|0.2|Benign/Borderline|153|81754354|Male and Female|Tumors of the Meninges|2004
0-19|0.0|0.0|0.0|Malignant|20|81754354|Male and Female|Tumors of the Meninges|2004
0-19|0.2|0.3|0.2|Benign/Borderline|197|82005260|Male and Female|Tumors of the Meninges|2005
0-19|0.0|0.0|0.0|Malignant|20|82005260|Male and Female|Tumors of the Meninges|2005
0-19|0.2|0.2|0.2|Benign/Borderline|165|82324418|Male and Female|Tumors of the Meninges|2006
0-19|0.0|0.0|0.0|Malignant|17|82324418|Male and Female|Tumors of the Meninges|2006
0-19|0.2|0.2|0.2|Benign/Borderline|182|82749431|Male and Female|Tumors of the Meninges|2007
0-19|0.0|0.0|0.0|Malignant|17|82749431|Male and Female|Tumors of the Meninges|2007
0-19|0.2|0.3|0.2|Benign/Borderline|184|83118264|Male and Female|Tumors of the Meninges|2008
0-19|~|~|~|Malignant|~|83118264|Male and Female|Tumors of the Meninges|2008
0-19|0.2|0.3|0.2|Benign/Borderline|209|83280391|Male and Female|Tumors of the Meninges|2009
0-19|0.0|0.0|0.0|Malignant|21|83280391|Male and Female|Tumors of the Meninges|2009
0-19|0.2|0.3|0.2|Benign/Borderline|196|83224734|Male and Female|Tumors of the Meninges|2010
0-19|0.0|0.0|0.0|Malignant|21|83224734|Male and Female|Tumors of the Meninges|2010
0-19|0.2|0.3|0.3|Benign/Borderline|237|83041095|Male and Female|Tumors of the Meninges|2011
0-19|0.0|0.0|0.0|Malignant|16|83041095|Male and Female|Tumors of the Meninges|2011
0-19|0.3|0.4|0.3|Benign/Borderline|269|82866386|Male and Female|Tumors of the Meninges|2012
0-19|0.0|0.0|0.0|Malignant|20|82866386|Male and Female|Tumors of the Meninges|2012
0-19|0.3|0.3|0.3|Benign/Borderline|252|82797930|Male and Female|Tumors of the Meninges|2013
0-19|0.0|0.0|0.0|Malignant|22|82797930|Male and Female|Tumors of the Meninges|2013
0-19|0.3|0.4|0.3|Benign/Borderline|271|82828260|Male and Female|Tumors of the Meninges|2014
0-19|0.0|0.0|0.0|Malignant|18|82828260|Male and Female|Tumors of the Meninges|2014
0-19|0.3|0.4|0.3|Benign/Borderline|263|82974459|Male and Female|Tumors of the Meninges|2015
0-19|0.0|0.0|0.0|Malignant|22|82974459|Male and Female|Tumors of the Meninges|2015
0-19|0.3|0.4|0.3|Benign/Borderline|269|83184415|Male and Female|Tumors of the Meninges|2016
0-19|0.0|0.0|0.0|Malignant|22|83184415|Male and Female|Tumors of the Meninges|2016
0-19|0.3|0.4|0.3|Benign/Borderline|267|83308218|Male and Female|Tumors of the Meninges|2017
0-19|0.0|0.0|0.0|Malignant|17|83308218|Male and Female|Tumors of the Meninges|2017
0-19|0.3|0.4|0.4|Benign/Borderline|299|83321994|Male and Female|Tumors of the Meninges|2018
0-19|0.0|0.0|0.0|Malignant|16|83321994|Male and Female|Tumors of the Meninges|2018
0-19|0.3|0.3|0.3|Benign/Borderline|1288|413514777|Male and Female|Tumors of the Meninges|2018-2022
0-19|0.0|0.0|0.0|Malignant|104|413514777|Male and Female|Tumors of the Meninges|2018-2022
0-19|0.2|0.3|0.3|Benign/Borderline|239|83213818|Male and Female|Tumors of the Meninges|2019
0-19|~|~|~|Malignant|~|83213818|Male and Female|Tumors of the Meninges|2019
0-19|0.3|0.3|0.3|Benign/Borderline|243|82873432|Male and Female|Tumors of the Meninges|2020
0-19|0.0|0.1|0.0|Malignant|29|82873432|Male and Female|Tumors of the Meninges|2020
0-19|0.3|0.4|0.3|Benign/Borderline|270|82201873|Male and Female|Tumors of the Meninges|2021
0-19|0.0|0.0|0.0|Malignant|28|82201873|Male and Female|Tumors of the Meninges|2021
0-19|0.3|0.3|0.3|Benign/Borderline|237|81903660|Male and Female|Tumors of the Meninges|2022
0-19|0.0|0.0|0.0|Malignant|16|81903660|Male and Female|Tumors of the Meninges|2022
0-19|0.1|0.2|0.1|Benign/Borderline|115|81754354|Male and Female|Unclassified Tumors|2004
0-19|0.0|0.1|0.1|Malignant|43|81754354|Male and Female|Unclassified Tumors|2004
0-19|0.2|0.2|0.2|Benign/Borderline|165|82005260|Male and Female|Unclassified Tumors|2005
0-19|0.0|0.1|0.0|Malignant|38|82005260|Male and Female|Unclassified Tumors|2005
0-19|0.2|0.3|0.2|Benign/Borderline|179|82324418|Male and Female|Unclassified Tumors|2006
0-19|0.0|0.1|0.1|Malignant|52|82324418|Male and Female|Unclassified Tumors|2006
0-19|0.2|0.3|0.2|Benign/Borderline|208|82749431|Male and Female|Unclassified Tumors|2007
0-19|0.0|0.1|0.0|Malignant|41|82749431|Male and Female|Unclassified Tumors|2007
0-19|0.2|0.3|0.3|Benign/Borderline|228|83118264|Male and Female|Unclassified Tumors|2008
0-19|0.0|0.1|0.0|Malignant|35|83118264|Male and Female|Unclassified Tumors|2008
0-19|0.3|0.4|0.3|Benign/Borderline|269|83280391|Male and Female|Unclassified Tumors|2009
0-19|0.0|0.1|0.0|Malignant|38|83280391|Male and Female|Unclassified Tumors|2009
0-19|0.3|0.4|0.3|Benign/Borderline|277|83224734|Male and Female|Unclassified Tumors|2010
0-19|0.0|0.0|0.0|Malignant|27|83224734|Male and Female|Unclassified Tumors|2010
0-19|0.3|0.4|0.3|Benign/Borderline|292|83041095|Male and Female|Unclassified Tumors|2011
0-19|0.0|0.1|0.0|Malignant|34|83041095|Male and Female|Unclassified Tumors|2011
0-19|0.3|0.4|0.3|Benign/Borderline|275|82866386|Male and Female|Unclassified Tumors|2012
0-19|0.1|0.1|0.1|Malignant|55|82866386|Male and Female|Unclassified Tumors|2012
0-19|0.3|0.4|0.3|Benign/Borderline|278|82797930|Male and Female|Unclassified Tumors|2013
0-19|0.0|0.1|0.1|Malignant|45|82797930|Male and Female|Unclassified Tumors|2013
0-19|0.3|0.4|0.3|Benign/Borderline|281|82828260|Male and Female|Unclassified Tumors|2014
0-19|0.0|0.1|0.1|Malignant|45|82828260|Male and Female|Unclassified Tumors|2014
0-19|0.3|0.4|0.3|Benign/Borderline|282|82974459|Male and Female|Unclassified Tumors|2015
0-19|0.0|0.1|0.0|Malignant|38|82974459|Male and Female|Unclassified Tumors|2015
0-19|0.3|0.4|0.3|Benign/Borderline|272|83184415|Male and Female|Unclassified Tumors|2016
0-19|0.0|0.1|0.1|Malignant|46|83184415|Male and Female|Unclassified Tumors|2016
0-19|0.3|0.3|0.3|Benign/Borderline|254|83308218|Male and Female|Unclassified Tumors|2017
0-19|0.0|0.1|0.1|Malignant|50|83308218|Male and Female|Unclassified Tumors|2017
0-19|0.3|0.4|0.3|Benign/Borderline|265|83321994|Male and Female|Unclassified Tumors|2018
0-19|0.0|0.1|0.1|Malignant|48|83321994|Male and Female|Unclassified Tumors|2018
0-19|0.3|0.3|0.3|Benign/Borderline|1111|413514777|Male and Female|Unclassified Tumors|2018-2022
0-19|0.1|0.1|0.1|Malignant|240|413514777|Male and Female|Unclassified Tumors|2018-2022
0-19|0.2|0.3|0.2|Benign/Borderline|207|83213818|Male and Female|Unclassified Tumors|2019
0-19|0.0|0.1|0.0|Malignant|37|83213818|Male and Female|Unclassified Tumors|2019
0-19|0.2|0.3|0.3|Benign/Borderline|219|82873432|Male and Female|Unclassified Tumors|2020
0-19|0.0|0.1|0.1|Malignant|53|82873432|Male and Female|Unclassified Tumors|2020
0-19|0.2|0.3|0.3|Benign/Borderline|225|82201873|Male and Female|Unclassified Tumors|2021
0-19|0.0|0.1|0.1|Malignant|49|82201873|Male and Female|Unclassified Tumors|2021
0-19|0.2|0.3|0.2|Benign/Borderline|195|81903660|Male and Female|Unclassified Tumors|2022
0-19|0.0|0.1|0.1|Malignant|53|81903660|Male and Female|Unclassified Tumors|2022
0-19|0.1|0.1|0.1|Benign/Borderline|56|81754354|Male and Female|Unique astrocytoma variants|2004
0-19|0.0|0.1|0.0|Malignant|32|81754354|Male and Female|Unique astrocytoma variants|2004
0-19|0.1|0.1|0.1|Benign/Borderline|63|82005260|Male and Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.0|Malignant|31|82005260|Male and Female|Unique astrocytoma variants|2005
0-19|0.0|0.1|0.1|Benign/Borderline|50|82324418|Male and Female|Unique astrocytoma variants|2006
0-19|0.0|0.1|0.0|Malignant|37|82324418|Male and Female|Unique astrocytoma variants|2006
0-19|0.1|0.1|0.1|Benign/Borderline|68|82749431|Male and Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Malignant|58|82749431|Male and Female|Unique astrocytoma variants|2007
0-19|0.1|0.1|0.1|Benign/Borderline|70|83118264|Male and Female|Unique astrocytoma variants|2008
0-19|0.0|0.1|0.0|Malignant|32|83118264|Male and Female|Unique astrocytoma variants|2008
0-19|0.1|0.1|0.1|Benign/Borderline|82|83280391|Male and Female|Unique astrocytoma variants|2009
0-19|0.0|0.1|0.1|Malignant|45|83280391|Male and Female|Unique astrocytoma variants|2009
0-19|0.1|0.1|0.1|Benign/Borderline|67|83224734|Male and Female|Unique astrocytoma variants|2010
0-19|0.0|0.0|0.0|Malignant|27|83224734|Male and Female|Unique astrocytoma variants|2010
0-19|0.1|0.1|0.1|Benign/Borderline|71|83041095|Male and Female|Unique astrocytoma variants|2011
0-19|0.0|0.1|0.1|Malignant|53|83041095|Male and Female|Unique astrocytoma variants|2011
0-19|0.1|0.1|0.1|Benign/Borderline|80|82866386|Male and Female|Unique astrocytoma variants|2012
0-19|0.0|0.1|0.1|Malignant|45|82866386|Male and Female|Unique astrocytoma variants|2012
0-19|0.1|0.1|0.1|Benign/Borderline|78|82797930|Male and Female|Unique astrocytoma variants|2013
0-19|0.0|0.1|0.1|Malignant|44|82797930|Male and Female|Unique astrocytoma variants|2013
0-19|0.1|0.1|0.1|Benign/Borderline|97|82828260|Male and Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Malignant|42|82828260|Male and Female|Unique astrocytoma variants|2014
0-19|0.0|0.1|0.1|Benign/Borderline|54|82974459|Male and Female|Unique astrocytoma variants|2015
0-19|0.0|0.1|0.1|Malignant|53|82974459|Male and Female|Unique astrocytoma variants|2015
0-19|0.1|0.1|0.1|Benign/Borderline|63|83184415|Male and Female|Unique astrocytoma variants|2016
0-19|0.0|0.1|0.1|Malignant|50|83184415|Male and Female|Unique astrocytoma variants|2016
0-19|0.1|0.1|0.1|Benign/Borderline|63|83308218|Male and Female|Unique astrocytoma variants|2017
0-19|0.0|0.1|0.1|Malignant|43|83308218|Male and Female|Unique astrocytoma variants|2017
0-19|0.1|0.1|0.1|Benign/Borderline|66|83321994|Male and Female|Unique astrocytoma variants|2018
0-19|0.0|0.1|0.1|Malignant|46|83321994|Male and Female|Unique astrocytoma variants|2018
0-19|0.1|0.1|0.1|Benign/Borderline|299|413514777|Male and Female|Unique astrocytoma variants|2018-2022
0-19|0.0|0.1|0.1|Malignant|213|413514777|Male and Female|Unique astrocytoma variants|2018-2022
0-19|0.1|0.1|0.1|Benign/Borderline|67|83213818|Male and Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Malignant|43|83213818|Male and Female|Unique astrocytoma variants|2019
0-19|0.0|0.1|0.1|Benign/Borderline|49|82873432|Male and Female|Unique astrocytoma variants|2020
0-19|0.0|0.1|0.0|Malignant|38|82873432|Male and Female|Unique astrocytoma variants|2020
0-19|0.1|0.1|0.1|Benign/Borderline|55|82201873|Male and Female|Unique astrocytoma variants|2021
0-19|0.0|0.1|0.1|Malignant|45|82201873|Male and Female|Unique astrocytoma variants|2021
0-19|0.1|0.1|0.1|Benign/Borderline|62|81903660|Male and Female|Unique astrocytoma variants|2022
0-19|0.0|0.1|0.0|Malignant|41|81903660|Male and Female|Unique astrocytoma variants|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|All other|2004
20+|~|~|~|Malignant|~|109112165|Female|All other|2004
20+|0.0|0.0|0.0|Benign/Borderline|19|110320645|Female|All other|2005
20+|~|~|~|Malignant|~|110320645|Female|All other|2005
20+|0.0|0.0|0.0|Benign/Borderline|23|111567226|Female|All other|2006
20+|~|~|~|Malignant|~|111567226|Female|All other|2006
20+|0.0|0.0|0.0|Benign/Borderline|19|112783993|Female|All other|2007
20+|~|~|~|Malignant|~|112783993|Female|All other|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|All other|2008
20+|~|~|~|Malignant|~|114027722|Female|All other|2008
20+|0.0|0.0|0.0|Benign/Borderline|19|115293599|Female|All other|2009
20+|~|~|~|Malignant|~|115293599|Female|All other|2009
20+|0.0|0.0|0.0|Benign/Borderline|23|116601739|Female|All other|2010
20+|0.0|0.0|0.0|Malignant|19|116601739|Female|All other|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|All other|2011
20+|0.0|0.0|0.0|Malignant|21|117835225|Female|All other|2011
20+|0.0|0.0|0.0|Benign/Borderline|20|119037075|Female|All other|2012
20+|~|~|~|Malignant|~|119037075|Female|All other|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|All other|2013
20+|0.0|0.0|0.0|Malignant|23|120135849|Female|All other|2013
20+|0.0|0.0|0.0|Benign/Borderline|17|121272811|Female|All other|2014
20+|0.0|0.0|0.0|Malignant|21|121272811|Female|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|21|122354244|Female|All other|2015
20+|0.0|0.0|0.0|Malignant|27|122354244|Female|All other|2015
20+|0.0|0.0|0.0|Benign/Borderline|32|123412348|Female|All other|2016
20+|0.0|0.0|0.0|Malignant|26|123412348|Female|All other|2016
20+|0.0|0.0|0.0|Benign/Borderline|33|124381798|Female|All other|2017
20+|0.0|0.0|0.0|Malignant|32|124381798|Female|All other|2017
20+|0.0|0.1|0.0|Benign/Borderline|50|125251791|Female|All other|2018
20+|0.1|0.2|0.1|Malignant|175|125251791|Female|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|272|633928705|Female|All other|2018-2022
20+|0.2|0.2|0.2|Malignant|1014|633928705|Female|All other|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|47|126069751|Female|All other|2019
20+|0.2|0.2|0.2|Malignant|220|126069751|Female|All other|2019
20+|0.0|0.0|0.0|Benign/Borderline|43|126826793|Female|All other|2020
20+|0.1|0.2|0.2|Malignant|215|126826793|Female|All other|2020
20+|0.0|0.1|0.0|Benign/Borderline|56|127478443|Female|All other|2021
20+|0.1|0.2|0.1|Malignant|195|127478443|Female|All other|2021
20+|0.0|0.1|0.1|Benign/Borderline|76|128301927|Female|All other|2022
20+|0.1|0.2|0.2|Malignant|209|128301927|Female|All other|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic astrocytoma|2004
20+|0.5|0.6|0.5|Malignant|566|109112165|Female|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic astrocytoma|2005
20+|0.4|0.5|0.5|Malignant|514|110320645|Female|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic astrocytoma|2006
20+|0.4|0.5|0.4|Malignant|512|111567226|Female|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic astrocytoma|2007
20+|0.4|0.5|0.5|Malignant|532|112783993|Female|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic astrocytoma|2008
20+|0.4|0.5|0.4|Malignant|506|114027722|Female|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic astrocytoma|2009
20+|0.4|0.5|0.4|Malignant|500|115293599|Female|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Anaplastic astrocytoma|2010
20+|0.4|0.5|0.5|Malignant|573|116601739|Female|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Anaplastic astrocytoma|2011
20+|0.4|0.5|0.5|Malignant|572|117835225|Female|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Anaplastic astrocytoma|2012
20+|0.4|0.5|0.5|Malignant|592|119037075|Female|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Anaplastic astrocytoma|2013
20+|0.5|0.6|0.5|Malignant|639|120135849|Female|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Anaplastic astrocytoma|2014
20+|0.5|0.5|0.5|Malignant|618|121272811|Female|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Anaplastic astrocytoma|2015
20+|0.5|0.6|0.6|Malignant|706|122354244|Female|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Anaplastic astrocytoma|2016
20+|0.5|0.5|0.5|Malignant|642|123412348|Female|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Anaplastic astrocytoma|2017
20+|0.5|0.6|0.5|Malignant|674|124381798|Female|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Anaplastic astrocytoma|2018
20+|0.4|0.5|0.5|Malignant|631|125251791|Female|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Anaplastic astrocytoma|2018-2022
20+|0.3|0.4|0.4|Malignant|2323|633928705|Female|Anaplastic astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Anaplastic astrocytoma|2019
20+|0.4|0.5|0.4|Malignant|575|126069751|Female|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Anaplastic astrocytoma|2020
20+|0.4|0.4|0.4|Malignant|520|126826793|Female|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Anaplastic astrocytoma|2021
20+|0.3|0.3|0.3|Malignant|360|127478443|Female|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Anaplastic astrocytoma|2022
20+|0.2|0.2|0.2|Malignant|237|128301927|Female|Anaplastic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Anaplastic oligodendroglioma|2004
20+|0.1|0.2|0.2|Malignant|186|109112165|Female|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Anaplastic oligodendroglioma|2005
20+|0.1|0.2|0.1|Malignant|165|110320645|Female|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Anaplastic oligodendroglioma|2006
20+|0.1|0.1|0.1|Malignant|140|111567226|Female|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Anaplastic oligodendroglioma|2007
20+|0.1|0.2|0.1|Malignant|162|112783993|Female|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Anaplastic oligodendroglioma|2008
20+|0.1|0.2|0.1|Malignant|170|114027722|Female|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Anaplastic oligodendroglioma|2009
20+|0.1|0.1|0.1|Malignant|148|115293599|Female|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Anaplastic oligodendroglioma|2010
20+|0.1|0.1|0.1|Malignant|136|116601739|Female|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.1|Malignant|153|117835225|Female|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.1|Malignant|170|119037075|Female|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Anaplastic oligodendroglioma|2013
20+|0.1|0.2|0.1|Malignant|154|120135849|Female|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Anaplastic oligodendroglioma|2014
20+|0.1|0.2|0.1|Malignant|153|121272811|Female|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.1|Malignant|163|122354244|Female|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Anaplastic oligodendroglioma|2016
20+|0.1|0.2|0.1|Malignant|171|123412348|Female|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Anaplastic oligodendroglioma|2017
20+|0.1|0.2|0.1|Malignant|185|124381798|Female|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Anaplastic oligodendroglioma|2018
20+|0.1|0.1|0.1|Malignant|157|125251791|Female|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Anaplastic oligodendroglioma|2018-2022
20+|0.1|0.1|0.1|Malignant|628|633928705|Female|Anaplastic oligodendroglioma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Anaplastic oligodendroglioma|2019
20+|0.1|0.2|0.1|Malignant|165|126069751|Female|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Anaplastic oligodendroglioma|2020
20+|0.1|0.1|0.1|Malignant|128|126826793|Female|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Anaplastic oligodendroglioma|2021
20+|0.1|0.1|0.1|Malignant|117|127478443|Female|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Anaplastic oligodendroglioma|2022
20+|0.0|0.1|0.0|Malignant|61|128301927|Female|Anaplastic oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Astrocytoma, NOS|2004
20+|0.5|0.6|0.5|Malignant|575|109112165|Female|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Astrocytoma, NOS|2005
20+|0.5|0.5|0.5|Malignant|564|110320645|Female|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Astrocytoma, NOS|2006
20+|0.4|0.5|0.5|Malignant|546|111567226|Female|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Astrocytoma, NOS|2007
20+|0.4|0.5|0.5|Malignant|536|112783993|Female|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Astrocytoma, NOS|2008
20+|0.4|0.5|0.4|Malignant|494|114027722|Female|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Astrocytoma, NOS|2009
20+|0.4|0.5|0.4|Malignant|483|115293599|Female|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Astrocytoma, NOS|2010
20+|0.4|0.4|0.4|Malignant|481|116601739|Female|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Astrocytoma, NOS|2011
20+|0.4|0.4|0.4|Malignant|469|117835225|Female|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Astrocytoma, NOS|2012
20+|0.4|0.5|0.4|Malignant|492|119037075|Female|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Astrocytoma, NOS|2013
20+|0.3|0.4|0.4|Malignant|460|120135849|Female|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Astrocytoma, NOS|2014
20+|0.4|0.4|0.4|Malignant|504|121272811|Female|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Astrocytoma, NOS|2015
20+|0.4|0.5|0.4|Malignant|527|122354244|Female|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Astrocytoma, NOS|2016
20+|0.4|0.5|0.5|Malignant|571|123412348|Female|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Astrocytoma, NOS|2017
20+|0.4|0.5|0.4|Malignant|525|124381798|Female|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Astrocytoma, NOS|2018
20+|0.4|0.5|0.5|Malignant|603|125251791|Female|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Astrocytoma, NOS|2018-2022
20+|0.5|0.5|0.5|Malignant|3032|633928705|Female|Astrocytoma, NOS|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Astrocytoma, NOS|2019
20+|0.4|0.5|0.4|Malignant|556|126069751|Female|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Astrocytoma, NOS|2020
20+|0.4|0.5|0.4|Malignant|531|126826793|Female|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Astrocytoma, NOS|2021
20+|0.5|0.6|0.5|Malignant|647|127478443|Female|Astrocytoma, NOS|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Astrocytoma, NOS|2022
20+|0.5|0.6|0.6|Malignant|695|128301927|Female|Astrocytoma, NOS|2022
20+|0.0|0.0|0.0|Benign/Borderline|39|109112165|Female|Choroid plexus|2004
20+|~|~|~|Malignant|~|109112165|Female|Choroid plexus|2004
20+|0.0|0.0|0.0|Benign/Borderline|39|110320645|Female|Choroid plexus|2005
20+|~|~|~|Malignant|~|110320645|Female|Choroid plexus|2005
20+|0.0|0.1|0.0|Benign/Borderline|43|111567226|Female|Choroid plexus|2006
20+|~|~|~|Malignant|~|111567226|Female|Choroid plexus|2006
20+|0.0|0.1|0.1|Benign/Borderline|56|112783993|Female|Choroid plexus|2007
20+|~|~|~|Malignant|~|112783993|Female|Choroid plexus|2007
20+|0.0|0.1|0.0|Benign/Borderline|50|114027722|Female|Choroid plexus|2008
20+|~|~|~|Malignant|~|114027722|Female|Choroid plexus|2008
20+|0.0|0.1|0.0|Benign/Borderline|45|115293599|Female|Choroid plexus|2009
20+|~|~|~|Malignant|~|115293599|Female|Choroid plexus|2009
20+|0.0|0.1|0.0|Benign/Borderline|49|116601739|Female|Choroid plexus|2010
20+|~|~|~|Malignant|~|116601739|Female|Choroid plexus|2010
20+|0.0|0.1|0.0|Benign/Borderline|54|117835225|Female|Choroid plexus|2011
20+|~|~|~|Malignant|~|117835225|Female|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|42|119037075|Female|Choroid plexus|2012
20+|~|~|~|Malignant|~|119037075|Female|Choroid plexus|2012
20+|0.0|0.1|0.0|Benign/Borderline|51|120135849|Female|Choroid plexus|2013
20+|~|~|~|Malignant|~|120135849|Female|Choroid plexus|2013
20+|0.0|0.1|0.0|Benign/Borderline|48|121272811|Female|Choroid plexus|2014
20+|~|~|~|Malignant|~|121272811|Female|Choroid plexus|2014
20+|0.0|0.1|0.0|Benign/Borderline|47|122354244|Female|Choroid plexus|2015
20+|~|~|~|Malignant|~|122354244|Female|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|43|123412348|Female|Choroid plexus|2016
20+|~|~|~|Malignant|~|123412348|Female|Choroid plexus|2016
20+|0.0|0.0|0.0|Benign/Borderline|43|124381798|Female|Choroid plexus|2017
20+|~|~|~|Malignant|~|124381798|Female|Choroid plexus|2017
20+|0.0|0.1|0.0|Benign/Borderline|60|125251791|Female|Choroid plexus|2018
20+|~|~|~|Malignant|~|125251791|Female|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|252|633928705|Female|Choroid plexus|2018-2022
20+|~|~|~|Malignant|~|633928705|Female|Choroid plexus|2018-2022
20+|0.0|0.1|0.0|Benign/Borderline|53|126069751|Female|Choroid plexus|2019
20+|~|~|~|Malignant|~|126069751|Female|Choroid plexus|2019
20+|0.0|0.1|0.0|Benign/Borderline|46|126826793|Female|Choroid plexus|2020
20+|~|~|~|Malignant|~|126826793|Female|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|44|127478443|Female|Choroid plexus|2021
20+|~|~|~|Malignant|~|127478443|Female|Choroid plexus|2021
20+|0.0|0.1|0.0|Benign/Borderline|49|128301927|Female|Choroid plexus|2022
20+|~|~|~|Malignant|~|128301927|Female|Choroid plexus|2022
20+|0.2|0.2|0.2|Benign/Borderline|208|109112165|Female|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|109112165|Female|Craniopharyngioma|2004
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|110320645|Female|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|208|111567226|Female|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|111567226|Female|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|222|112783993|Female|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|112783993|Female|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|228|114027722|Female|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|114027722|Female|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|233|115293599|Female|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|115293599|Female|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|243|116601739|Female|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|116601739|Female|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|222|117835225|Female|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|117835225|Female|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|229|119037075|Female|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|119037075|Female|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|247|120135849|Female|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|120135849|Female|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|228|121272811|Female|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|121272811|Female|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|243|122354244|Female|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|122354244|Female|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|233|123412348|Female|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|123412348|Female|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|251|124381798|Female|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|124381798|Female|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|247|125251791|Female|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|125251791|Female|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|1154|633928705|Female|Craniopharyngioma|2018-2022
20+|~|~|~|Malignant|~|633928705|Female|Craniopharyngioma|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|239|126069751|Female|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|126069751|Female|Craniopharyngioma|2019
20+|0.1|0.2|0.2|Benign/Borderline|222|126826793|Female|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|126826793|Female|Craniopharyngioma|2020
20+|0.1|0.2|0.2|Benign/Borderline|214|127478443|Female|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|127478443|Female|Craniopharyngioma|2021
20+|0.1|0.2|0.2|Benign/Borderline|232|128301927|Female|Craniopharyngioma|2022
20+|~|~|~|Malignant|~|128301927|Female|Craniopharyngioma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Diffuse astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|114|109112165|Female|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Diffuse astrocytoma|2005
20+|0.1|0.1|0.1|Malignant|132|110320645|Female|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Diffuse astrocytoma|2006
20+|0.1|0.1|0.1|Malignant|94|111567226|Female|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Diffuse astrocytoma|2007
20+|0.1|0.1|0.1|Malignant|133|112783993|Female|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Diffuse astrocytoma|2008
20+|0.1|0.1|0.1|Malignant|130|114027722|Female|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Diffuse astrocytoma|2009
20+|0.1|0.2|0.1|Malignant|161|115293599|Female|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Diffuse astrocytoma|2010
20+|0.1|0.2|0.1|Malignant|164|116601739|Female|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|114|117835225|Female|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|94|119037075|Female|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Diffuse astrocytoma|2013
20+|0.0|0.1|0.1|Malignant|71|120135849|Female|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Diffuse astrocytoma|2014
20+|0.0|0.1|0.0|Malignant|63|121272811|Female|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Diffuse astrocytoma|2015
20+|0.0|0.0|0.0|Malignant|35|122354244|Female|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Diffuse astrocytoma|2016
20+|~|~|~|Malignant|~|123412348|Female|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Diffuse astrocytoma|2017
20+|~|~|~|Malignant|~|124381798|Female|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Diffuse astrocytoma|2018
20+|~|~|~|Malignant|~|125251791|Female|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Diffuse astrocytoma|2018-2022
20+|0.0|0.0|0.0|Malignant|23|633928705|Female|Diffuse astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|126069751|Female|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|126826793|Female|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|127478443|Female|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Diffuse astrocytoma|2022
20+|~|~|~|Malignant|~|128301927|Female|Diffuse astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|69|109112165|Female|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|83|110320645|Female|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|74|111567226|Female|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|93|112783993|Female|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|90|114027722|Female|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|102|115293599|Female|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|73|116601739|Female|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Embryonal/primitive/medulloblastoma|2011
20+|0.0|0.1|0.1|Malignant|70|117835225|Female|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|80|119037075|Female|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|91|120135849|Female|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|75|121272811|Female|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Embryonal/primitive/medulloblastoma|2015
20+|0.0|0.1|0.1|Malignant|68|122354244|Female|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Embryonal/primitive/medulloblastoma|2016
20+|0.0|0.1|0.1|Malignant|63|123412348|Female|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Embryonal/primitive/medulloblastoma|2017
20+|0.0|0.1|0.1|Malignant|62|124381798|Female|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Embryonal/primitive/medulloblastoma|2018
20+|0.0|0.1|0.0|Malignant|57|125251791|Female|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Embryonal/primitive/medulloblastoma|2018-2022
20+|0.0|0.1|0.1|Malignant|288|633928705|Female|Embryonal/primitive/medulloblastoma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Embryonal/primitive/medulloblastoma|2019
20+|0.0|0.1|0.1|Malignant|61|126069751|Female|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|58|126826793|Female|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Embryonal/primitive/medulloblastoma|2021
20+|0.0|0.1|0.1|Malignant|62|127478443|Female|Embryonal/primitive/medulloblastoma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Embryonal/primitive/medulloblastoma|2022
20+|0.0|0.1|0.0|Malignant|50|128301927|Female|Embryonal/primitive/medulloblastoma|2022
20+|0.1|0.1|0.1|Benign/Borderline|107|109112165|Female|Ependymoma variants|2004
20+|~|~|~|Malignant|~|109112165|Female|Ependymoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|117|110320645|Female|Ependymoma variants|2005
20+|~|~|~|Malignant|~|110320645|Female|Ependymoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|149|111567226|Female|Ependymoma variants|2006
20+|~|~|~|Malignant|~|111567226|Female|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|114|112783993|Female|Ependymoma variants|2007
20+|~|~|~|Malignant|~|112783993|Female|Ependymoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|110|114027722|Female|Ependymoma variants|2008
20+|~|~|~|Malignant|~|114027722|Female|Ependymoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|113|115293599|Female|Ependymoma variants|2009
20+|~|~|~|Malignant|~|115293599|Female|Ependymoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|124|116601739|Female|Ependymoma variants|2010
20+|~|~|~|Malignant|~|116601739|Female|Ependymoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|122|117835225|Female|Ependymoma variants|2011
20+|~|~|~|Malignant|~|117835225|Female|Ependymoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|130|119037075|Female|Ependymoma variants|2012
20+|~|~|~|Malignant|~|119037075|Female|Ependymoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|117|120135849|Female|Ependymoma variants|2013
20+|~|~|~|Malignant|~|120135849|Female|Ependymoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|132|121272811|Female|Ependymoma variants|2014
20+|~|~|~|Malignant|~|121272811|Female|Ependymoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|136|122354244|Female|Ependymoma variants|2015
20+|~|~|~|Malignant|~|122354244|Female|Ependymoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|126|123412348|Female|Ependymoma variants|2016
20+|~|~|~|Malignant|~|123412348|Female|Ependymoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|119|124381798|Female|Ependymoma variants|2017
20+|~|~|~|Malignant|~|124381798|Female|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|116|125251791|Female|Ependymoma variants|2018
20+|~|~|~|Malignant|~|125251791|Female|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|589|633928705|Female|Ependymoma variants|2018-2022
20+|~|~|~|Malignant|~|633928705|Female|Ependymoma variants|2018-2022
20+|0.1|0.1|0.1|Benign/Borderline|108|126069751|Female|Ependymoma variants|2019
20+|~|~|~|Malignant|~|126069751|Female|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|124|126826793|Female|Ependymoma variants|2020
20+|~|~|~|Malignant|~|126826793|Female|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|133|127478443|Female|Ependymoma variants|2021
20+|~|~|~|Malignant|~|127478443|Female|Ependymoma variants|2021
20+|0.1|0.1|0.1|Benign/Borderline|108|128301927|Female|Ependymoma variants|2022
20+|~|~|~|Malignant|~|128301927|Female|Ependymoma variants|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Ependymoma/anaplastic ependymoma|2004
20+|0.2|0.3|0.3|Malignant|294|109112165|Female|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Ependymoma/anaplastic ependymoma|2005
20+|0.2|0.3|0.3|Malignant|305|110320645|Female|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|294|111567226|Female|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|299|112783993|Female|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Ependymoma/anaplastic ependymoma|2008
20+|0.2|0.3|0.3|Malignant|316|114027722|Female|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|346|115293599|Female|Ependymoma/anaplastic ependymoma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Ependymoma/anaplastic ependymoma|2010
20+|0.2|0.3|0.3|Malignant|297|116601739|Female|Ependymoma/anaplastic ependymoma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|302|117835225|Female|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Ependymoma/anaplastic ependymoma|2012
20+|0.2|0.3|0.3|Malignant|305|119037075|Female|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.2|Malignant|279|120135849|Female|Ependymoma/anaplastic ependymoma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.2|0.2|Malignant|249|121272811|Female|Ependymoma/anaplastic ependymoma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.2|Malignant|277|122354244|Female|Ependymoma/anaplastic ependymoma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.2|Malignant|278|123412348|Female|Ependymoma/anaplastic ependymoma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|295|124381798|Female|Ependymoma/anaplastic ependymoma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.2|0.2|Malignant|244|125251791|Female|Ependymoma/anaplastic ependymoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|60|633928705|Female|Ependymoma/anaplastic ependymoma|2018-2022
20+|0.2|0.2|0.2|Malignant|1213|633928705|Female|Ependymoma/anaplastic ependymoma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.2|0.2|Malignant|255|126069751|Female|Ependymoma/anaplastic ependymoma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|252|126826793|Female|Ependymoma/anaplastic ependymoma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|258|127478443|Female|Ependymoma/anaplastic ependymoma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Ependymoma/anaplastic ependymoma|2022
20+|0.1|0.2|0.2|Malignant|204|128301927|Female|Ependymoma/anaplastic ependymoma|2022
20+|0.0|0.0|0.0|Benign/Borderline|18|109112165|Female|Germ Cell Tumors|2004
20+|~|~|~|Malignant|~|109112165|Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|36|110320645|Female|Germ Cell Tumors|2005
20+|~|~|~|Malignant|~|110320645|Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|37|111567226|Female|Germ Cell Tumors|2006
20+|~|~|~|Malignant|~|111567226|Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|37|112783993|Female|Germ Cell Tumors|2007
20+|~|~|~|Malignant|~|112783993|Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|33|114027722|Female|Germ Cell Tumors|2008
20+|~|~|~|Malignant|~|114027722|Female|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Benign/Borderline|43|115293599|Female|Germ Cell Tumors|2009
20+|~|~|~|Malignant|~|115293599|Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|32|116601739|Female|Germ Cell Tumors|2010
20+|~|~|~|Malignant|~|116601739|Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|40|117835225|Female|Germ Cell Tumors|2011
20+|~|~|~|Malignant|~|117835225|Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|32|119037075|Female|Germ Cell Tumors|2012
20+|~|~|~|Malignant|~|119037075|Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|27|120135849|Female|Germ Cell Tumors|2013
20+|~|~|~|Malignant|~|120135849|Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|32|121272811|Female|Germ Cell Tumors|2014
20+|~|~|~|Malignant|~|121272811|Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|33|122354244|Female|Germ Cell Tumors|2015
20+|~|~|~|Malignant|~|122354244|Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|33|123412348|Female|Germ Cell Tumors|2016
20+|~|~|~|Malignant|~|123412348|Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|25|124381798|Female|Germ Cell Tumors|2017
20+|~|~|~|Malignant|~|124381798|Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|20|125251791|Female|Germ Cell Tumors|2018
20+|~|~|~|Malignant|~|125251791|Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|134|633928705|Female|Germ Cell Tumors|2018-2022
20+|0.0|0.0|0.0|Malignant|37|633928705|Female|Germ Cell Tumors|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|43|126069751|Female|Germ Cell Tumors|2019
20+|~|~|~|Malignant|~|126069751|Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|23|126826793|Female|Germ Cell Tumors|2020
20+|~|~|~|Malignant|~|126826793|Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|27|127478443|Female|Germ Cell Tumors|2021
20+|~|~|~|Malignant|~|127478443|Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Benign/Borderline|21|128301927|Female|Germ Cell Tumors|2022
20+|~|~|~|Malignant|~|128301927|Female|Germ Cell Tumors|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioblastoma|2004
20+|3.4|3.6|3.5|Malignant|4107|109112165|Female|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioblastoma|2005
20+|3.4|3.6|3.5|Malignant|4160|110320645|Female|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioblastoma|2006
20+|3.4|3.7|3.6|Malignant|4285|111567226|Female|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioblastoma|2007
20+|3.5|3.7|3.6|Malignant|4375|112783993|Female|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioblastoma|2008
20+|3.4|3.6|3.5|Malignant|4403|114027722|Female|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioblastoma|2009
20+|3.4|3.6|3.5|Malignant|4493|115293599|Female|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Glioblastoma|2010
20+|3.4|3.6|3.5|Malignant|4612|116601739|Female|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Glioblastoma|2011
20+|3.4|3.6|3.5|Malignant|4578|117835225|Female|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Glioblastoma|2012
20+|3.5|3.7|3.6|Malignant|4856|119037075|Female|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Glioblastoma|2013
20+|3.5|3.7|3.6|Malignant|4907|120135849|Female|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Glioblastoma|2014
20+|3.3|3.5|3.4|Malignant|4802|121272811|Female|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Glioblastoma|2015
20+|3.5|3.7|3.6|Malignant|5136|122354244|Female|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Glioblastoma|2016
20+|3.5|3.7|3.6|Malignant|5219|123412348|Female|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Glioblastoma|2017
20+|3.5|3.7|3.6|Malignant|5254|124381798|Female|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Glioblastoma|2018
20+|3.4|3.6|3.5|Malignant|5289|125251791|Female|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Glioblastoma|2018-2022
20+|3.5|3.6|3.5|Malignant|27465|633928705|Female|Glioblastoma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Glioblastoma|2019
20+|3.4|3.6|3.5|Malignant|5337|126069751|Female|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Glioblastoma|2020
20+|3.5|3.7|3.6|Malignant|5614|126826793|Female|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Glioblastoma|2021
20+|3.4|3.6|3.5|Malignant|5541|127478443|Female|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Glioblastoma|2022
20+|3.4|3.6|3.5|Malignant|5684|128301927|Female|Glioblastoma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Glioma malignant, NOS|2004
20+|0.3|0.4|0.4|Malignant|427|109112165|Female|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Glioma malignant, NOS|2005
20+|0.3|0.4|0.3|Malignant|402|110320645|Female|Glioma malignant, NOS|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Glioma malignant, NOS|2006
20+|0.3|0.4|0.3|Malignant|398|111567226|Female|Glioma malignant, NOS|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Glioma malignant, NOS|2007
20+|0.3|0.4|0.3|Malignant|415|112783993|Female|Glioma malignant, NOS|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Glioma malignant, NOS|2008
20+|0.3|0.4|0.4|Malignant|451|114027722|Female|Glioma malignant, NOS|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|521|115293599|Female|Glioma malignant, NOS|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Glioma malignant, NOS|2010
20+|0.3|0.4|0.3|Malignant|412|116601739|Female|Glioma malignant, NOS|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Glioma malignant, NOS|2011
20+|0.3|0.4|0.4|Malignant|449|117835225|Female|Glioma malignant, NOS|2011
20+|0.0|0.0|0.0|Benign/Borderline|17|119037075|Female|Glioma malignant, NOS|2012
20+|0.3|0.4|0.3|Malignant|441|119037075|Female|Glioma malignant, NOS|2012
20+|0.0|0.0|0.0|Benign/Borderline|18|120135849|Female|Glioma malignant, NOS|2013
20+|0.3|0.4|0.4|Malignant|477|120135849|Female|Glioma malignant, NOS|2013
20+|0.0|0.0|0.0|Benign/Borderline|26|121272811|Female|Glioma malignant, NOS|2014
20+|0.3|0.4|0.4|Malignant|456|121272811|Female|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|30|122354244|Female|Glioma malignant, NOS|2015
20+|0.4|0.4|0.4|Malignant|526|122354244|Female|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|24|123412348|Female|Glioma malignant, NOS|2016
20+|0.4|0.4|0.4|Malignant|535|123412348|Female|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|34|124381798|Female|Glioma malignant, NOS|2017
20+|0.4|0.5|0.4|Malignant|561|124381798|Female|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|18|125251791|Female|Glioma malignant, NOS|2018
20+|0.3|0.4|0.4|Malignant|509|125251791|Female|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|100|633928705|Female|Glioma malignant, NOS|2018-2022
20+|0.4|0.4|0.4|Malignant|2595|633928705|Female|Glioma malignant, NOS|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|22|126069751|Female|Glioma malignant, NOS|2019
20+|0.3|0.4|0.4|Malignant|500|126069751|Female|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|18|126826793|Female|Glioma malignant, NOS|2020
20+|0.3|0.4|0.4|Malignant|502|126826793|Female|Glioma malignant, NOS|2020
20+|0.0|0.0|0.0|Benign/Borderline|19|127478443|Female|Glioma malignant, NOS|2021
20+|0.3|0.4|0.4|Malignant|513|127478443|Female|Glioma malignant, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|23|128301927|Female|Glioma malignant, NOS|2022
20+|0.4|0.4|0.4|Malignant|571|128301927|Female|Glioma malignant, NOS|2022
20+|0.2|0.2|0.2|Benign/Borderline|208|109112165|Female|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|109112165|Female|Hemangioblastoma|2004
20+|0.2|0.2|0.2|Benign/Borderline|235|110320645|Female|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|110320645|Female|Hemangioblastoma|2005
20+|0.2|0.2|0.2|Benign/Borderline|224|111567226|Female|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|111567226|Female|Hemangioblastoma|2006
20+|0.2|0.2|0.2|Benign/Borderline|218|112783993|Female|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|112783993|Female|Hemangioblastoma|2007
20+|0.2|0.2|0.2|Benign/Borderline|243|114027722|Female|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|114027722|Female|Hemangioblastoma|2008
20+|0.2|0.2|0.2|Benign/Borderline|239|115293599|Female|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|115293599|Female|Hemangioblastoma|2009
20+|0.2|0.2|0.2|Benign/Borderline|239|116601739|Female|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|116601739|Female|Hemangioblastoma|2010
20+|0.2|0.2|0.2|Benign/Borderline|252|117835225|Female|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|117835225|Female|Hemangioblastoma|2011
20+|0.2|0.3|0.2|Benign/Borderline|265|119037075|Female|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|119037075|Female|Hemangioblastoma|2012
20+|0.2|0.2|0.2|Benign/Borderline|235|120135849|Female|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|120135849|Female|Hemangioblastoma|2013
20+|0.2|0.2|0.2|Benign/Borderline|221|121272811|Female|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|121272811|Female|Hemangioblastoma|2014
20+|0.2|0.2|0.2|Benign/Borderline|251|122354244|Female|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|122354244|Female|Hemangioblastoma|2015
20+|0.2|0.2|0.2|Benign/Borderline|279|123412348|Female|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|123412348|Female|Hemangioblastoma|2016
20+|0.2|0.2|0.2|Benign/Borderline|237|124381798|Female|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|124381798|Female|Hemangioblastoma|2017
20+|0.2|0.2|0.2|Benign/Borderline|224|125251791|Female|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|125251791|Female|Hemangioblastoma|2018
20+|0.2|0.2|0.2|Benign/Borderline|1242|633928705|Female|Hemangioblastoma|2018-2022
20+|~|~|~|Malignant|~|633928705|Female|Hemangioblastoma|2018-2022
20+|0.2|0.3|0.2|Benign/Borderline|289|126069751|Female|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|126069751|Female|Hemangioblastoma|2019
20+|0.2|0.2|0.2|Benign/Borderline|243|126826793|Female|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|126826793|Female|Hemangioblastoma|2020
20+|0.2|0.2|0.2|Benign/Borderline|245|127478443|Female|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|127478443|Female|Hemangioblastoma|2021
20+|0.2|0.2|0.2|Benign/Borderline|241|128301927|Female|Hemangioblastoma|2022
20+|~|~|~|Malignant|~|128301927|Female|Hemangioblastoma|2022
20+|0.2|0.3|0.2|Benign/Borderline|248|109112165|Female|Hemangioma|2004
20+|~|~|~|Malignant|~|109112165|Female|Hemangioma|2004
20+|0.2|0.3|0.3|Benign/Borderline|292|110320645|Female|Hemangioma|2005
20+|~|~|~|Malignant|~|110320645|Female|Hemangioma|2005
20+|0.3|0.3|0.3|Benign/Borderline|324|111567226|Female|Hemangioma|2006
20+|~|~|~|Malignant|~|111567226|Female|Hemangioma|2006
20+|0.3|0.4|0.3|Benign/Borderline|382|112783993|Female|Hemangioma|2007
20+|~|~|~|Malignant|~|112783993|Female|Hemangioma|2007
20+|0.4|0.5|0.4|Benign/Borderline|490|114027722|Female|Hemangioma|2008
20+|~|~|~|Malignant|~|114027722|Female|Hemangioma|2008
20+|0.4|0.5|0.5|Benign/Borderline|544|115293599|Female|Hemangioma|2009
20+|~|~|~|Malignant|~|115293599|Female|Hemangioma|2009
20+|0.5|0.6|0.6|Benign/Borderline|679|116601739|Female|Hemangioma|2010
20+|~|~|~|Malignant|~|116601739|Female|Hemangioma|2010
20+|0.6|0.7|0.6|Benign/Borderline|729|117835225|Female|Hemangioma|2011
20+|~|~|~|Malignant|~|117835225|Female|Hemangioma|2011
20+|0.6|0.7|0.6|Benign/Borderline|742|119037075|Female|Hemangioma|2012
20+|~|~|~|Malignant|~|119037075|Female|Hemangioma|2012
20+|0.6|0.7|0.6|Benign/Borderline|759|120135849|Female|Hemangioma|2013
20+|~|~|~|Malignant|~|120135849|Female|Hemangioma|2013
20+|0.5|0.6|0.6|Benign/Borderline|706|121272811|Female|Hemangioma|2014
20+|~|~|~|Malignant|~|121272811|Female|Hemangioma|2014
20+|0.5|0.5|0.5|Benign/Borderline|616|122354244|Female|Hemangioma|2015
20+|~|~|~|Malignant|~|122354244|Female|Hemangioma|2015
20+|0.4|0.5|0.5|Benign/Borderline|606|123412348|Female|Hemangioma|2016
20+|~|~|~|Malignant|~|123412348|Female|Hemangioma|2016
20+|0.4|0.5|0.4|Benign/Borderline|568|124381798|Female|Hemangioma|2017
20+|~|~|~|Malignant|~|124381798|Female|Hemangioma|2017
20+|0.4|0.5|0.5|Benign/Borderline|591|125251791|Female|Hemangioma|2018
20+|~|~|~|Malignant|~|125251791|Female|Hemangioma|2018
20+|0.4|0.5|0.4|Benign/Borderline|2878|633928705|Female|Hemangioma|2018-2022
20+|~|~|~|Malignant|~|633928705|Female|Hemangioma|2018-2022
20+|0.4|0.5|0.4|Benign/Borderline|578|126069751|Female|Hemangioma|2019
20+|~|~|~|Malignant|~|126069751|Female|Hemangioma|2019
20+|0.4|0.5|0.5|Benign/Borderline|630|126826793|Female|Hemangioma|2020
20+|~|~|~|Malignant|~|126826793|Female|Hemangioma|2020
20+|0.4|0.4|0.4|Benign/Borderline|543|127478443|Female|Hemangioma|2021
20+|~|~|~|Malignant|~|127478443|Female|Hemangioma|2021
20+|0.4|0.4|0.4|Benign/Borderline|536|128301927|Female|Hemangioma|2022
20+|~|~|~|Malignant|~|128301927|Female|Hemangioma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|24|109112165|Female|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|24|112783993|Female|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|25|115293599|Female|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|22|116601739|Female|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|21|117835225|Female|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|20|119037075|Female|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|16|120135849|Female|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|26|121272811|Female|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|18|122354244|Female|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Malignant|~|123412348|Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Malignant|~|124381798|Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Malignant|~|125251791|Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Local Extensions from Regional Tumors|2018-2022
20+|0.0|0.0|0.0|Malignant|65|633928705|Female|Local Extensions from Regional Tumors|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Malignant|~|126069751|Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Malignant|~|126826793|Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Malignant|~|127478443|Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Local Extensions from Regional Tumors|2022
20+|~|~|~|Malignant|~|128301927|Female|Local Extensions from Regional Tumors|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.5|0.6|0.5|Malignant|591|109112165|Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.5|0.6|0.6|Malignant|665|110320645|Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.5|0.6|0.6|Malignant|675|111567226|Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.5|0.6|0.5|Malignant|639|112783993|Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.5|0.6|0.6|Malignant|703|114027722|Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.5|0.6|0.5|Malignant|665|115293599|Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.5|0.6|0.6|Malignant|740|116601739|Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.5|0.6|0.5|Malignant|713|117835225|Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.5|0.6|0.5|Malignant|702|119037075|Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.5|0.6|0.6|Malignant|741|120135849|Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.6|0.6|Malignant|814|121272811|Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.5|0.6|0.5|Malignant|763|122354244|Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.6|0.6|Malignant|841|123412348|Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.5|0.6|0.6|Malignant|835|124381798|Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.5|0.6|0.6|Malignant|822|125251791|Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
20+|0.5|0.5|0.5|Malignant|4027|633928705|Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.5|0.6|0.5|Malignant|799|126069751|Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.5|0.6|0.5|Malignant|853|126826793|Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.5|0.6|0.5|Malignant|813|127478443|Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|0.4|0.5|0.5|Malignant|740|128301927|Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|12.2|12.7|12.5|Benign/Borderline|14460|109112165|Female|Meningioma|2004
20+|0.2|0.3|0.2|Malignant|275|109112165|Female|Meningioma|2004
20+|13.8|14.2|14.0|Benign/Borderline|16507|110320645|Female|Meningioma|2005
20+|0.2|0.3|0.2|Malignant|281|110320645|Female|Meningioma|2005
20+|14.4|14.9|14.7|Benign/Borderline|17618|111567226|Female|Meningioma|2006
20+|0.2|0.2|0.2|Malignant|251|111567226|Female|Meningioma|2006
20+|15.1|15.5|15.3|Benign/Borderline|18659|112783993|Female|Meningioma|2007
20+|0.2|0.2|0.2|Malignant|267|112783993|Female|Meningioma|2007
20+|15.9|16.3|16.1|Benign/Borderline|19996|114027722|Female|Meningioma|2008
20+|0.2|0.2|0.2|Malignant|218|114027722|Female|Meningioma|2008
20+|17.0|17.4|17.2|Benign/Borderline|21746|115293599|Female|Meningioma|2009
20+|0.1|0.2|0.2|Malignant|208|115293599|Female|Meningioma|2009
20+|16.5|16.9|16.7|Benign/Borderline|21437|116601739|Female|Meningioma|2010
20+|0.1|0.2|0.2|Malignant|211|116601739|Female|Meningioma|2010
20+|16.7|17.1|16.9|Benign/Borderline|21971|117835225|Female|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|188|117835225|Female|Meningioma|2011
20+|17.1|17.5|17.3|Benign/Borderline|22850|119037075|Female|Meningioma|2012
20+|0.1|0.2|0.2|Malignant|205|119037075|Female|Meningioma|2012
20+|17.3|17.8|17.6|Benign/Borderline|23490|120135849|Female|Meningioma|2013
20+|0.1|0.2|0.2|Malignant|229|120135849|Female|Meningioma|2013
20+|17.8|18.3|18.0|Benign/Borderline|24585|121272811|Female|Meningioma|2014
20+|0.1|0.2|0.2|Malignant|221|121272811|Female|Meningioma|2014
20+|18.5|19.0|18.7|Benign/Borderline|25881|122354244|Female|Meningioma|2015
20+|0.1|0.2|0.1|Malignant|202|122354244|Female|Meningioma|2015
20+|19.0|19.5|19.3|Benign/Borderline|26929|123412348|Female|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|177|123412348|Female|Meningioma|2016
20+|19.6|20.1|19.8|Benign/Borderline|28237|124381798|Female|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|181|124381798|Female|Meningioma|2017
20+|19.9|20.3|20.1|Benign/Borderline|29046|125251791|Female|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|178|125251791|Female|Meningioma|2018
20+|20.2|20.4|20.3|Benign/Borderline|150566|633928705|Female|Meningioma|2018-2022
20+|0.1|0.1|0.1|Malignant|924|633928705|Female|Meningioma|2018-2022
20+|20.8|21.3|21.1|Benign/Borderline|30884|126069751|Female|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|163|126069751|Female|Meningioma|2019
20+|18.7|19.2|18.9|Benign/Borderline|28073|126826793|Female|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|168|126826793|Female|Meningioma|2020
20+|20.6|21.0|20.8|Benign/Borderline|31296|127478443|Female|Meningioma|2021
20+|0.1|0.2|0.1|Malignant|203|127478443|Female|Meningioma|2021
20+|20.2|20.7|20.5|Benign/Borderline|31267|128301927|Female|Meningioma|2022
20+|0.1|0.2|0.1|Malignant|212|128301927|Female|Meningioma|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Mixed glioma|2004
20+|0.2|0.2|0.2|Malignant|198|109112165|Female|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Mixed glioma|2005
20+|0.2|0.2|0.2|Malignant|236|110320645|Female|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Mixed glioma|2006
20+|0.2|0.3|0.2|Malignant|272|111567226|Female|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Mixed glioma|2007
20+|0.2|0.3|0.2|Malignant|241|112783993|Female|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Mixed glioma|2008
20+|0.2|0.3|0.2|Malignant|263|114027722|Female|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Mixed glioma|2009
20+|0.2|0.3|0.3|Malignant|288|115293599|Female|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Mixed glioma|2010
20+|0.2|0.3|0.2|Malignant|274|116601739|Female|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Mixed glioma|2011
20+|0.2|0.3|0.2|Malignant|274|117835225|Female|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Mixed glioma|2012
20+|0.2|0.2|0.2|Malignant|243|119037075|Female|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Mixed glioma|2013
20+|0.2|0.2|0.2|Malignant|248|120135849|Female|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Mixed glioma|2014
20+|0.1|0.2|0.2|Malignant|200|121272811|Female|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|131|122354244|Female|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Mixed glioma|2016
20+|0.0|0.0|0.0|Malignant|43|123412348|Female|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|31|124381798|Female|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Mixed glioma|2018
20+|~|~|~|Malignant|~|125251791|Female|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Mixed glioma|2018-2022
20+|0.0|0.0|0.0|Malignant|34|633928705|Female|Mixed glioma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Mixed glioma|2019
20+|~|~|~|Malignant|~|126069751|Female|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Mixed glioma|2020
20+|~|~|~|Malignant|~|126826793|Female|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Mixed glioma|2021
20+|~|~|~|Malignant|~|127478443|Female|Mixed glioma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Mixed glioma|2022
20+|~|~|~|Malignant|~|128301927|Female|Mixed glioma|2022
20+|0.5|0.6|0.6|Benign/Borderline|693|109112165|Female|Neoplasm, unspecified|2004
20+|0.5|0.6|0.5|Malignant|683|109112165|Female|Neoplasm, unspecified|2004
20+|0.7|0.8|0.7|Benign/Borderline|863|110320645|Female|Neoplasm, unspecified|2005
20+|0.5|0.6|0.6|Malignant|715|110320645|Female|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|805|111567226|Female|Neoplasm, unspecified|2006
20+|0.5|0.6|0.6|Malignant|723|111567226|Female|Neoplasm, unspecified|2006
20+|0.6|0.7|0.7|Benign/Borderline|849|112783993|Female|Neoplasm, unspecified|2007
20+|0.5|0.5|0.5|Malignant|648|112783993|Female|Neoplasm, unspecified|2007
20+|0.6|0.7|0.7|Benign/Borderline|834|114027722|Female|Neoplasm, unspecified|2008
20+|0.5|0.6|0.6|Malignant|754|114027722|Female|Neoplasm, unspecified|2008
20+|0.7|0.8|0.7|Benign/Borderline|927|115293599|Female|Neoplasm, unspecified|2009
20+|0.5|0.6|0.6|Malignant|783|115293599|Female|Neoplasm, unspecified|2009
20+|0.6|0.7|0.6|Benign/Borderline|829|116601739|Female|Neoplasm, unspecified|2010
20+|0.4|0.5|0.5|Malignant|642|116601739|Female|Neoplasm, unspecified|2010
20+|0.6|0.7|0.7|Benign/Borderline|856|117835225|Female|Neoplasm, unspecified|2011
20+|0.4|0.5|0.5|Malignant|650|117835225|Female|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|887|119037075|Female|Neoplasm, unspecified|2012
20+|0.4|0.5|0.5|Malignant|655|119037075|Female|Neoplasm, unspecified|2012
20+|0.6|0.6|0.6|Benign/Borderline|802|120135849|Female|Neoplasm, unspecified|2013
20+|0.4|0.5|0.5|Malignant|666|120135849|Female|Neoplasm, unspecified|2013
20+|0.6|0.7|0.7|Benign/Borderline|904|121272811|Female|Neoplasm, unspecified|2014
20+|0.5|0.5|0.5|Malignant|745|121272811|Female|Neoplasm, unspecified|2014
20+|0.6|0.7|0.7|Benign/Borderline|880|122354244|Female|Neoplasm, unspecified|2015
20+|0.5|0.5|0.5|Malignant|741|122354244|Female|Neoplasm, unspecified|2015
20+|0.6|0.6|0.6|Benign/Borderline|820|123412348|Female|Neoplasm, unspecified|2016
20+|0.4|0.5|0.4|Malignant|626|123412348|Female|Neoplasm, unspecified|2016
20+|0.5|0.6|0.6|Benign/Borderline|788|124381798|Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Malignant|686|124381798|Female|Neoplasm, unspecified|2017
20+|0.5|0.6|0.5|Benign/Borderline|756|125251791|Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.5|Malignant|686|125251791|Female|Neoplasm, unspecified|2018
20+|0.5|0.5|0.5|Benign/Borderline|3420|633928705|Female|Neoplasm, unspecified|2018-2022
20+|0.4|0.5|0.5|Malignant|3531|633928705|Female|Neoplasm, unspecified|2018-2022
20+|0.4|0.5|0.5|Benign/Borderline|643|126069751|Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Malignant|716|126069751|Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Benign/Borderline|666|126826793|Female|Neoplasm, unspecified|2020
20+|0.5|0.5|0.5|Malignant|781|126826793|Female|Neoplasm, unspecified|2020
20+|0.4|0.5|0.4|Benign/Borderline|630|127478443|Female|Neoplasm, unspecified|2021
20+|0.4|0.5|0.4|Malignant|692|127478443|Female|Neoplasm, unspecified|2021
20+|0.5|0.5|0.5|Benign/Borderline|725|128301927|Female|Neoplasm, unspecified|2022
20+|0.4|0.4|0.4|Malignant|656|128301927|Female|Neoplasm, unspecified|2022
20+|2.2|2.4|2.3|Benign/Borderline|2615|109112165|Female|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Nerve sheath, benign and malignant|2004
20+|2.4|2.6|2.5|Benign/Borderline|2880|110320645|Female|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Nerve sheath, benign and malignant|2005
20+|2.5|2.7|2.6|Benign/Borderline|3008|111567226|Female|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|3039|112783993|Female|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Nerve sheath, benign and malignant|2007
20+|2.6|2.8|2.7|Benign/Borderline|3183|114027722|Female|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Nerve sheath, benign and malignant|2008
20+|2.6|2.8|2.7|Benign/Borderline|3299|115293599|Female|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Nerve sheath, benign and malignant|2009
20+|2.4|2.6|2.5|Benign/Borderline|3129|116601739|Female|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|23|116601739|Female|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|3387|117835225|Female|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|21|117835225|Female|Nerve sheath, benign and malignant|2011
20+|2.7|2.9|2.8|Benign/Borderline|3616|119037075|Female|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|27|119037075|Female|Nerve sheath, benign and malignant|2012
20+|2.9|3.1|3.0|Benign/Borderline|3812|120135849|Female|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|23|120135849|Female|Nerve sheath, benign and malignant|2013
20+|2.9|3.1|3.0|Benign/Borderline|3951|121272811|Female|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|16|121272811|Female|Nerve sheath, benign and malignant|2014
20+|3.0|3.2|3.1|Benign/Borderline|4112|122354244|Female|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|24|122354244|Female|Nerve sheath, benign and malignant|2015
20+|3.0|3.2|3.1|Benign/Borderline|4102|123412348|Female|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|28|123412348|Female|Nerve sheath, benign and malignant|2016
20+|2.9|3.1|3.0|Benign/Borderline|4062|124381798|Female|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|19|124381798|Female|Nerve sheath, benign and malignant|2017
20+|2.9|3.1|3.0|Benign/Borderline|4117|125251791|Female|Nerve sheath, benign and malignant|2018
20+|~|~|~|Malignant|~|125251791|Female|Nerve sheath, benign and malignant|2018
20+|2.8|2.9|2.9|Benign/Borderline|20081|633928705|Female|Nerve sheath, benign and malignant|2018-2022
20+|0.0|0.0|0.0|Malignant|101|633928705|Female|Nerve sheath, benign and malignant|2018-2022
20+|2.9|3.1|3.0|Benign/Borderline|4195|126069751|Female|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|18|126069751|Female|Nerve sheath, benign and malignant|2019
20+|2.5|2.7|2.6|Benign/Borderline|3571|126826793|Female|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|16|126826793|Female|Nerve sheath, benign and malignant|2020
20+|3.0|3.2|3.1|Benign/Borderline|4324|127478443|Female|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|29|127478443|Female|Nerve sheath, benign and malignant|2021
20+|2.6|2.8|2.7|Benign/Borderline|3874|128301927|Female|Nerve sheath, benign and malignant|2022
20+|0.0|0.0|0.0|Malignant|23|128301927|Female|Nerve sheath, benign and malignant|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|17|111567226|Female|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|27|114027722|Female|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|27|116601739|Female|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|23|117835225|Female|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|28|119037075|Female|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|21|120135849|Female|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|22|121272811|Female|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|39|122354244|Female|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|22|123412348|Female|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|16|124381798|Female|Neuroepithelial|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Neuroepithelial|2018
20+|~|~|~|Malignant|~|125251791|Female|Neuroepithelial|2018
20+|0.0|0.0|0.0|Benign/Borderline|26|633928705|Female|Neuroepithelial|2018-2022
20+|0.0|0.0|0.0|Malignant|57|633928705|Female|Neuroepithelial|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Malignant|17|126069751|Female|Neuroepithelial|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Neuroepithelial|2020
20+|~|~|~|Malignant|~|126826793|Female|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Neuroepithelial|2021
20+|~|~|~|Malignant|~|127478443|Female|Neuroepithelial|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Neuroepithelial|2022
20+|~|~|~|Malignant|~|128301927|Female|Neuroepithelial|2022
20+|0.1|0.2|0.1|Benign/Borderline|154|109112165|Female|Neuronal/glial, neuronal|2004
20+|~|~|~|Malignant|~|109112165|Female|Neuronal/glial, neuronal|2004
20+|0.1|0.2|0.2|Benign/Borderline|186|110320645|Female|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|18|110320645|Female|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|188|111567226|Female|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|18|111567226|Female|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|208|112783993|Female|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|22|112783993|Female|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|204|114027722|Female|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|224|115293599|Female|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|21|115293599|Female|Neuronal/glial, neuronal|2009
20+|0.2|0.3|0.2|Benign/Borderline|249|116601739|Female|Neuronal/glial, neuronal|2010
20+|0.0|0.0|0.0|Malignant|18|116601739|Female|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|248|117835225|Female|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|18|117835225|Female|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|217|119037075|Female|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|22|119037075|Female|Neuronal/glial, neuronal|2012
20+|0.1|0.2|0.2|Benign/Borderline|183|120135849|Female|Neuronal/glial, neuronal|2013
20+|~|~|~|Malignant|~|120135849|Female|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|243|121272811|Female|Neuronal/glial, neuronal|2014
20+|~|~|~|Malignant|~|121272811|Female|Neuronal/glial, neuronal|2014
20+|0.2|0.2|0.2|Benign/Borderline|237|122354244|Female|Neuronal/glial, neuronal|2015
20+|~|~|~|Malignant|~|122354244|Female|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|249|123412348|Female|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|28|123412348|Female|Neuronal/glial, neuronal|2016
20+|0.2|0.3|0.2|Benign/Borderline|275|124381798|Female|Neuronal/glial, neuronal|2017
20+|0.0|0.0|0.0|Malignant|22|124381798|Female|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|218|125251791|Female|Neuronal/glial, neuronal|2018
20+|~|~|~|Malignant|~|125251791|Female|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|1164|633928705|Female|Neuronal/glial, neuronal|2018-2022
20+|0.0|0.0|0.0|Malignant|85|633928705|Female|Neuronal/glial, neuronal|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|245|126069751|Female|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|17|126069751|Female|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|233|126826793|Female|Neuronal/glial, neuronal|2020
20+|~|~|~|Malignant|~|126826793|Female|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|236|127478443|Female|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|16|127478443|Female|Neuronal/glial, neuronal|2021
20+|0.2|0.2|0.2|Benign/Borderline|232|128301927|Female|Neuronal/glial, neuronal|2022
20+|0.0|0.0|0.0|Malignant|27|128301927|Female|Neuronal/glial, neuronal|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Oligodendroglioma|2004
20+|0.3|0.4|0.3|Malignant|356|109112165|Female|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Oligodendroglioma|2005
20+|0.3|0.4|0.3|Malignant|366|110320645|Female|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Oligodendroglioma|2006
20+|0.3|0.4|0.4|Malignant|387|111567226|Female|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Oligodendroglioma|2007
20+|0.3|0.4|0.3|Malignant|373|112783993|Female|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Oligodendroglioma|2008
20+|0.3|0.4|0.3|Malignant|373|114027722|Female|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Oligodendroglioma|2009
20+|0.3|0.4|0.3|Malignant|372|115293599|Female|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Oligodendroglioma|2010
20+|0.3|0.3|0.3|Malignant|341|116601739|Female|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Oligodendroglioma|2011
20+|0.3|0.3|0.3|Malignant|323|117835225|Female|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Oligodendroglioma|2012
20+|0.2|0.3|0.3|Malignant|308|119037075|Female|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Oligodendroglioma|2013
20+|0.3|0.3|0.3|Malignant|358|120135849|Female|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Oligodendroglioma|2014
20+|0.2|0.3|0.3|Malignant|310|121272811|Female|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Oligodendroglioma|2015
20+|0.2|0.3|0.3|Malignant|317|122354244|Female|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Oligodendroglioma|2016
20+|0.3|0.3|0.3|Malignant|346|123412348|Female|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Oligodendroglioma|2017
20+|0.3|0.3|0.3|Malignant|326|124381798|Female|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Oligodendroglioma|2018
20+|0.2|0.3|0.3|Malignant|311|125251791|Female|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|633928705|Female|Oligodendroglioma|2018-2022
20+|0.3|0.3|0.3|Malignant|1610|633928705|Female|Oligodendroglioma|2018-2022
20+|~|~|~|Benign/Borderline|~|126069751|Female|Oligodendroglioma|2019
20+|0.2|0.3|0.3|Malignant|322|126069751|Female|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Oligodendroglioma|2020
20+|0.2|0.3|0.2|Malignant|263|126826793|Female|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|127478443|Female|Oligodendroglioma|2021
20+|0.2|0.3|0.3|Malignant|329|127478443|Female|Oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Oligodendroglioma|2022
20+|0.3|0.4|0.3|Malignant|385|128301927|Female|Oligodendroglioma|2022
20+|0.0|0.1|0.1|Benign/Borderline|70|109112165|Female|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|27|109112165|Female|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|83|110320645|Female|Other mesenchymal|2005
20+|0.0|0.0|0.0|Malignant|28|110320645|Female|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|89|111567226|Female|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|28|111567226|Female|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|84|112783993|Female|Other mesenchymal|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|106|114027722|Female|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|53|114027722|Female|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|98|115293599|Female|Other mesenchymal|2009
20+|0.0|0.0|0.0|Malignant|30|115293599|Female|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|99|116601739|Female|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|37|116601739|Female|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|96|117835225|Female|Other mesenchymal|2011
20+|0.0|0.0|0.0|Malignant|32|117835225|Female|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|110|119037075|Female|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|40|119037075|Female|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|110|120135849|Female|Other mesenchymal|2013
20+|0.0|0.0|0.0|Malignant|40|120135849|Female|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|100|121272811|Female|Other mesenchymal|2014
20+|0.0|0.0|0.0|Malignant|36|121272811|Female|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|96|122354244|Female|Other mesenchymal|2015
20+|0.0|0.0|0.0|Malignant|43|122354244|Female|Other mesenchymal|2015
20+|0.0|0.1|0.1|Benign/Borderline|83|123412348|Female|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|42|123412348|Female|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|116|124381798|Female|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|67|124381798|Female|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|99|125251791|Female|Other mesenchymal|2018
20+|0.0|0.0|0.0|Malignant|50|125251791|Female|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|446|633928705|Female|Other mesenchymal|2018-2022
20+|0.0|0.0|0.0|Malignant|253|633928705|Female|Other mesenchymal|2018-2022
20+|0.1|0.1|0.1|Benign/Borderline|88|126069751|Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Malignant|53|126069751|Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Benign/Borderline|66|126826793|Female|Other mesenchymal|2020
20+|0.0|0.1|0.1|Malignant|64|126826793|Female|Other mesenchymal|2020
20+|0.0|0.1|0.1|Benign/Borderline|87|127478443|Female|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|57|127478443|Female|Other mesenchymal|2021
20+|0.1|0.1|0.1|Benign/Borderline|106|128301927|Female|Other mesenchymal|2022
20+|0.0|0.0|0.0|Malignant|29|128301927|Female|Other mesenchymal|2022
20+|~|~|~|Benign/Borderline|~|109112165|Female|Pilocytic astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|128|109112165|Female|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|110320645|Female|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|152|110320645|Female|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|111567226|Female|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|150|111567226|Female|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|112783993|Female|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.2|Malignant|166|112783993|Female|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|114027722|Female|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|147|114027722|Female|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|115293599|Female|Pilocytic astrocytoma|2009
20+|0.1|0.1|0.1|Malignant|135|115293599|Female|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|116601739|Female|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|170|116601739|Female|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|117835225|Female|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.1|Malignant|163|117835225|Female|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|119037075|Female|Pilocytic astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|127|119037075|Female|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|120135849|Female|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|161|120135849|Female|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|121272811|Female|Pilocytic astrocytoma|2014
20+|0.1|0.1|0.1|Malignant|148|121272811|Female|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|122354244|Female|Pilocytic astrocytoma|2015
20+|0.1|0.2|0.1|Malignant|153|122354244|Female|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|123412348|Female|Pilocytic astrocytoma|2016
20+|0.1|0.1|0.1|Malignant|138|123412348|Female|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|124381798|Female|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|134|124381798|Female|Pilocytic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|125251791|Female|Pilocytic astrocytoma|2018
20+|0.1|0.1|0.1|Malignant|128|125251791|Female|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|68|633928705|Female|Pilocytic astrocytoma|2018-2022
20+|0.1|0.1|0.1|Malignant|627|633928705|Female|Pilocytic astrocytoma|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|16|126069751|Female|Pilocytic astrocytoma|2019
20+|0.1|0.1|0.1|Malignant|129|126069751|Female|Pilocytic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|126826793|Female|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|125|126826793|Female|Pilocytic astrocytoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|16|127478443|Female|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|131|127478443|Female|Pilocytic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|128301927|Female|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Malignant|114|128301927|Female|Pilocytic astrocytoma|2022
20+|0.0|0.0|0.0|Benign/Borderline|20|109112165|Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Malignant|16|109112165|Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Benign/Borderline|35|110320645|Female|Pineal parenchymal|2005
20+|~|~|~|Malignant|~|110320645|Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|30|111567226|Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Benign/Borderline|32|112783993|Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|28|112783993|Female|Pineal parenchymal|2007
20+|0.0|0.1|0.0|Benign/Borderline|46|114027722|Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|21|114027722|Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Benign/Borderline|32|115293599|Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|30|115293599|Female|Pineal parenchymal|2009
20+|0.0|0.1|0.0|Benign/Borderline|43|116601739|Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|23|116601739|Female|Pineal parenchymal|2010
20+|0.0|0.1|0.0|Benign/Borderline|48|117835225|Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|26|117835225|Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|38|119037075|Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|21|119037075|Female|Pineal parenchymal|2012
20+|0.0|0.1|0.0|Benign/Borderline|54|120135849|Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|35|120135849|Female|Pineal parenchymal|2013
20+|0.0|0.1|0.0|Benign/Borderline|44|121272811|Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|19|121272811|Female|Pineal parenchymal|2014
20+|0.0|0.1|0.0|Benign/Borderline|53|122354244|Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|31|122354244|Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|39|123412348|Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|30|123412348|Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|39|124381798|Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|26|124381798|Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|37|125251791|Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|22|125251791|Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|150|633928705|Female|Pineal parenchymal|2018-2022
20+|0.0|0.0|0.0|Malignant|116|633928705|Female|Pineal parenchymal|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|31|126069751|Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|31|126069751|Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|27|126826793|Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|22|126826793|Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Benign/Borderline|27|127478443|Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|25|127478443|Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Benign/Borderline|28|128301927|Female|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Malignant|16|128301927|Female|Pineal parenchymal|2022
20+|3.8|4.1|4.0|Benign/Borderline|4287|109112165|Female|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Pituitary|2004
20+|4.4|4.7|4.6|Benign/Borderline|4994|110320645|Female|Pituitary|2005
20+|0.0|0.0|0.0|Malignant|24|110320645|Female|Pituitary|2005
20+|4.8|5.1|5.0|Benign/Borderline|5502|111567226|Female|Pituitary|2006
20+|~|~|~|Malignant|~|111567226|Female|Pituitary|2006
20+|5.0|5.3|5.1|Benign/Borderline|5715|112783993|Female|Pituitary|2007
20+|~|~|~|Malignant|~|112783993|Female|Pituitary|2007
20+|5.4|5.7|5.5|Benign/Borderline|6204|114027722|Female|Pituitary|2008
20+|~|~|~|Malignant|~|114027722|Female|Pituitary|2008
20+|5.9|6.2|6.0|Benign/Borderline|6826|115293599|Female|Pituitary|2009
20+|0.0|0.0|0.0|Malignant|17|115293599|Female|Pituitary|2009
20+|5.9|6.2|6.0|Benign/Borderline|6899|116601739|Female|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|18|116601739|Female|Pituitary|2010
20+|6.0|6.3|6.2|Benign/Borderline|7128|117835225|Female|Pituitary|2011
20+|~|~|~|Malignant|~|117835225|Female|Pituitary|2011
20+|6.5|6.8|6.6|Benign/Borderline|7686|119037075|Female|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|16|119037075|Female|Pituitary|2012
20+|6.3|6.6|6.5|Benign/Borderline|7634|120135849|Female|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|16|120135849|Female|Pituitary|2013
20+|6.6|6.9|6.7|Benign/Borderline|7914|121272811|Female|Pituitary|2014
20+|~|~|~|Malignant|~|121272811|Female|Pituitary|2014
20+|6.9|7.2|7.0|Benign/Borderline|8384|122354244|Female|Pituitary|2015
20+|~|~|~|Malignant|~|122354244|Female|Pituitary|2015
20+|7.0|7.3|7.1|Benign/Borderline|8607|123412348|Female|Pituitary|2016
20+|~|~|~|Malignant|~|123412348|Female|Pituitary|2016
20+|7.3|7.7|7.5|Benign/Borderline|9106|124381798|Female|Pituitary|2017
20+|~|~|~|Malignant|~|124381798|Female|Pituitary|2017
20+|7.4|7.7|7.5|Benign/Borderline|9233|125251791|Female|Pituitary|2018
20+|~|~|~|Malignant|~|125251791|Female|Pituitary|2018
20+|7.1|7.3|7.2|Benign/Borderline|44654|633928705|Female|Pituitary|2018-2022
20+|0.0|0.0|0.0|Malignant|222|633928705|Female|Pituitary|2018-2022
20+|7.4|7.8|7.6|Benign/Borderline|9384|126069751|Female|Pituitary|2019
20+|~|~|~|Malignant|~|126069751|Female|Pituitary|2019
20+|6.5|6.8|6.7|Benign/Borderline|8241|126826793|Female|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|16|126826793|Female|Pituitary|2020
20+|7.2|7.5|7.4|Benign/Borderline|9163|127478443|Female|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|31|127478443|Female|Pituitary|2021
20+|6.7|7.0|6.9|Benign/Borderline|8633|128301927|Female|Pituitary|2022
20+|0.1|0.1|0.1|Malignant|156|128301927|Female|Pituitary|2022
20+|20.1|20.6|20.4|Benign/Borderline|23197|109112165|Female|Total|2004
20+|7.5|7.8|7.6|Malignant|8755|109112165|Female|Total|2004
20+|22.7|23.2|23.0|Benign/Borderline|26527|110320645|Female|Total|2005
20+|7.5|7.8|7.7|Malignant|8938|110320645|Female|Total|2005
20+|23.9|24.4|24.2|Benign/Borderline|28314|111567226|Female|Total|2006
20+|7.5|7.8|7.6|Malignant|8999|111567226|Female|Total|2006
20+|24.7|25.2|25.0|Benign/Borderline|29702|112783993|Female|Total|2007
20+|7.4|7.8|7.6|Malignant|9092|112783993|Female|Total|2007
20+|26.0|26.6|26.3|Benign/Borderline|31820|114027722|Female|Total|2008
20+|7.5|7.8|7.6|Malignant|9260|114027722|Female|Total|2008
20+|27.8|28.4|28.1|Benign/Borderline|34478|115293599|Female|Total|2009
20+|7.4|7.8|7.6|Malignant|9420|115293599|Female|Total|2009
20+|27.2|27.8|27.5|Benign/Borderline|34148|116601739|Female|Total|2010
20+|7.2|7.5|7.4|Malignant|9335|116601739|Female|Total|2010
20+|27.8|28.4|28.1|Benign/Borderline|35270|117835225|Female|Total|2011
20+|7.1|7.4|7.2|Malignant|9222|117835225|Female|Total|2011
20+|28.8|29.4|29.1|Benign/Borderline|36977|119037075|Female|Total|2012
20+|7.2|7.5|7.3|Malignant|9498|119037075|Female|Total|2012
20+|28.9|29.5|29.2|Benign/Borderline|37653|120135849|Female|Total|2013
20+|7.2|7.5|7.3|Malignant|9694|120135849|Female|Total|2013
20+|29.7|30.3|30.0|Benign/Borderline|39258|121272811|Female|Total|2014
20+|7.0|7.3|7.1|Malignant|9572|121272811|Female|Total|2014
20+|30.8|31.4|31.1|Benign/Borderline|41135|122354244|Female|Total|2015
20+|7.2|7.5|7.4|Malignant|9975|122354244|Female|Total|2015
20+|31.3|31.9|31.6|Benign/Borderline|42319|123412348|Female|Total|2016
20+|7.0|7.3|7.2|Malignant|9900|123412348|Female|Total|2016
20+|32.1|32.7|32.4|Benign/Borderline|44031|124381798|Female|Total|2017
20+|7.0|7.3|7.1|Malignant|9986|124381798|Female|Total|2017
20+|32.3|32.9|32.6|Benign/Borderline|44936|125251791|Female|Total|2018
20+|6.7|7.0|6.9|Malignant|9823|125251791|Female|Total|2018
20+|32.1|32.3|32.2|Benign/Borderline|227625|633928705|Female|Total|2018-2022
20+|6.7|6.8|6.7|Malignant|49454|633928705|Female|Total|2018-2022
20+|33.3|33.9|33.6|Benign/Borderline|46975|126069751|Female|Total|2019
20+|6.7|6.9|6.8|Malignant|9808|126069751|Female|Total|2019
20+|29.7|30.3|30.0|Benign/Borderline|42333|126826793|Female|Total|2020
20+|6.6|6.9|6.8|Malignant|10000|126826793|Female|Total|2020
20+|32.7|33.4|33.0|Benign/Borderline|47159|127478443|Female|Total|2021
20+|6.5|6.8|6.7|Malignant|9897|127478443|Female|Total|2021
20+|31.5|32.1|31.8|Benign/Borderline|46222|128301927|Female|Total|2022
20+|6.5|6.8|6.6|Malignant|9926|128301927|Female|Total|2022
20+|2.2|2.4|2.3|Benign/Borderline|2615|109112165|Female|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|19|109112165|Female|Tumors of Cranial and Spinal Nerves|2004
20+|2.4|2.6|2.5|Benign/Borderline|2883|110320645|Female|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|22|110320645|Female|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.7|2.6|Benign/Borderline|3009|111567226|Female|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|22|111567226|Female|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|3040|112783993|Female|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|39|112783993|Female|Tumors of Cranial and Spinal Nerves|2007
20+|2.6|2.8|2.7|Benign/Borderline|3185|114027722|Female|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|26|114027722|Female|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|3302|115293599|Female|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|16|115293599|Female|Tumors of Cranial and Spinal Nerves|2009
20+|2.4|2.6|2.5|Benign/Borderline|3132|116601739|Female|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|23|116601739|Female|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|3390|117835225|Female|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|21|117835225|Female|Tumors of Cranial and Spinal Nerves|2011
20+|2.7|2.9|2.8|Benign/Borderline|3616|119037075|Female|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|27|119037075|Female|Tumors of Cranial and Spinal Nerves|2012
20+|2.9|3.1|3.0|Benign/Borderline|3813|120135849|Female|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|23|120135849|Female|Tumors of Cranial and Spinal Nerves|2013
20+|2.9|3.1|3.0|Benign/Borderline|3957|121272811|Female|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|16|121272811|Female|Tumors of Cranial and Spinal Nerves|2014
20+|3.0|3.2|3.1|Benign/Borderline|4115|122354244|Female|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|24|122354244|Female|Tumors of Cranial and Spinal Nerves|2015
20+|3.0|3.2|3.1|Benign/Borderline|4109|123412348|Female|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|28|123412348|Female|Tumors of Cranial and Spinal Nerves|2016
20+|2.9|3.1|3.0|Benign/Borderline|4063|124381798|Female|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|19|124381798|Female|Tumors of Cranial and Spinal Nerves|2017
20+|2.9|3.1|3.0|Benign/Borderline|4120|125251791|Female|Tumors of Cranial and Spinal Nerves|2018
20+|~|~|~|Malignant|~|125251791|Female|Tumors of Cranial and Spinal Nerves|2018
20+|2.8|2.9|2.9|Benign/Borderline|20089|633928705|Female|Tumors of Cranial and Spinal Nerves|2018-2022
20+|0.0|0.0|0.0|Malignant|101|633928705|Female|Tumors of Cranial and Spinal Nerves|2018-2022
20+|2.9|3.1|3.0|Benign/Borderline|4195|126069751|Female|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|18|126069751|Female|Tumors of Cranial and Spinal Nerves|2019
20+|2.5|2.7|2.6|Benign/Borderline|3573|126826793|Female|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|16|126826793|Female|Tumors of Cranial and Spinal Nerves|2020
20+|3.0|3.2|3.1|Benign/Borderline|4325|127478443|Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|29|127478443|Female|Tumors of Cranial and Spinal Nerves|2021
20+|2.6|2.8|2.7|Benign/Borderline|3876|128301927|Female|Tumors of Cranial and Spinal Nerves|2022
20+|0.0|0.0|0.0|Malignant|23|128301927|Female|Tumors of Cranial and Spinal Nerves|2022
20+|0.3|0.4|0.4|Benign/Borderline|385|109112165|Female|Tumors of Neuroepthelial Tissue|2004
20+|6.1|6.4|6.2|Malignant|7090|109112165|Female|Tumors of Neuroepthelial Tissue|2004
20+|0.4|0.4|0.4|Benign/Borderline|442|110320645|Female|Tumors of Neuroepthelial Tissue|2005
20+|6.1|6.3|6.2|Malignant|7164|110320645|Female|Tumors of Neuroepthelial Tissue|2005
20+|0.4|0.5|0.5|Benign/Borderline|490|111567226|Female|Tumors of Neuroepthelial Tissue|2006
20+|6.1|6.3|6.2|Malignant|7244|111567226|Female|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.4|Benign/Borderline|491|112783993|Female|Tumors of Neuroepthelial Tissue|2007
20+|6.1|6.4|6.3|Malignant|7418|112783993|Female|Tumors of Neuroepthelial Tissue|2007
20+|0.4|0.5|0.4|Benign/Borderline|495|114027722|Female|Tumors of Neuroepthelial Tissue|2008
20+|6.0|6.3|6.2|Malignant|7446|114027722|Female|Tumors of Neuroepthelial Tissue|2008
20+|0.4|0.5|0.5|Benign/Borderline|516|115293599|Female|Tumors of Neuroepthelial Tissue|2009
20+|6.1|6.4|6.2|Malignant|7658|115293599|Female|Tumors of Neuroepthelial Tissue|2009
20+|0.4|0.5|0.5|Benign/Borderline|555|116601739|Female|Tumors of Neuroepthelial Tissue|2010
20+|6.0|6.2|6.1|Malignant|7626|116601739|Female|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.5|0.5|Benign/Borderline|582|117835225|Female|Tumors of Neuroepthelial Tissue|2011
20+|5.8|6.1|6.0|Malignant|7569|117835225|Female|Tumors of Neuroepthelial Tissue|2011
20+|0.4|0.5|0.5|Benign/Borderline|555|119037075|Female|Tumors of Neuroepthelial Tissue|2012
20+|5.9|6.2|6.1|Malignant|7818|119037075|Female|Tumors of Neuroepthelial Tissue|2012
20+|0.4|0.5|0.5|Benign/Borderline|532|120135849|Female|Tumors of Neuroepthelial Tissue|2013
20+|5.9|6.2|6.1|Malignant|7948|120135849|Female|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.5|Benign/Borderline|610|121272811|Female|Tumors of Neuroepthelial Tissue|2014
20+|5.6|5.9|5.8|Malignant|7679|121272811|Female|Tumors of Neuroepthelial Tissue|2014
20+|0.5|0.6|0.5|Benign/Borderline|632|122354244|Female|Tumors of Neuroepthelial Tissue|2015
20+|5.9|6.2|6.1|Malignant|8151|122354244|Female|Tumors of Neuroepthelial Tissue|2015
20+|0.5|0.6|0.5|Benign/Borderline|617|123412348|Female|Tumors of Neuroepthelial Tissue|2016
20+|5.8|6.1|5.9|Malignant|8139|123412348|Female|Tumors of Neuroepthelial Tissue|2016
20+|0.5|0.6|0.5|Benign/Borderline|636|124381798|Female|Tumors of Neuroepthelial Tissue|2017
20+|5.8|6.0|5.9|Malignant|8161|124381798|Female|Tumors of Neuroepthelial Tissue|2017
20+|0.4|0.5|0.5|Benign/Borderline|593|125251791|Female|Tumors of Neuroepthelial Tissue|2018
20+|5.5|5.8|5.7|Malignant|8033|125251791|Female|Tumors of Neuroepthelial Tissue|2018
20+|0.5|0.5|0.5|Benign/Borderline|3025|633928705|Female|Tumors of Neuroepthelial Tissue|2018-2022
20+|5.5|5.6|5.5|Malignant|40253|633928705|Female|Tumors of Neuroepthelial Tissue|2018-2022
20+|0.5|0.6|0.5|Benign/Borderline|630|126069751|Female|Tumors of Neuroepthelial Tissue|2019
20+|5.5|5.7|5.6|Malignant|8011|126069751|Female|Tumors of Neuroepthelial Tissue|2019
20+|0.4|0.5|0.5|Benign/Borderline|595|126826793|Female|Tumors of Neuroepthelial Tissue|2020
20+|5.4|5.7|5.5|Malignant|8080|126826793|Female|Tumors of Neuroepthelial Tissue|2020
20+|0.5|0.6|0.5|Benign/Borderline|624|127478443|Female|Tumors of Neuroepthelial Tissue|2021
20+|5.3|5.6|5.5|Malignant|8042|127478443|Female|Tumors of Neuroepthelial Tissue|2021
20+|0.4|0.5|0.5|Benign/Borderline|583|128301927|Female|Tumors of Neuroepthelial Tissue|2022
20+|5.3|5.6|5.4|Malignant|8087|128301927|Female|Tumors of Neuroepthelial Tissue|2022
20+|4.0|4.3|4.1|Benign/Borderline|4495|109112165|Female|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|26|109112165|Female|Tumors of Sellar Region|2004
20+|4.6|4.9|4.7|Benign/Borderline|5180|110320645|Female|Tumors of Sellar Region|2005
20+|0.0|0.0|0.0|Malignant|25|110320645|Female|Tumors of Sellar Region|2005
20+|5.0|5.3|5.2|Benign/Borderline|5710|111567226|Female|Tumors of Sellar Region|2006
20+|~|~|~|Malignant|~|111567226|Female|Tumors of Sellar Region|2006
20+|5.2|5.5|5.3|Benign/Borderline|5937|112783993|Female|Tumors of Sellar Region|2007
20+|~|~|~|Malignant|~|112783993|Female|Tumors of Sellar Region|2007
20+|5.6|5.9|5.7|Benign/Borderline|6432|114027722|Female|Tumors of Sellar Region|2008
20+|~|~|~|Malignant|~|114027722|Female|Tumors of Sellar Region|2008
20+|6.1|6.4|6.2|Benign/Borderline|7059|115293599|Female|Tumors of Sellar Region|2009
20+|0.0|0.0|0.0|Malignant|18|115293599|Female|Tumors of Sellar Region|2009
20+|6.1|6.4|6.2|Benign/Borderline|7142|116601739|Female|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|18|116601739|Female|Tumors of Sellar Region|2010
20+|6.2|6.5|6.4|Benign/Borderline|7350|117835225|Female|Tumors of Sellar Region|2011
20+|~|~|~|Malignant|~|117835225|Female|Tumors of Sellar Region|2011
20+|6.7|7.0|6.8|Benign/Borderline|7915|119037075|Female|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|16|119037075|Female|Tumors of Sellar Region|2012
20+|6.5|6.8|6.7|Benign/Borderline|7881|120135849|Female|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|17|120135849|Female|Tumors of Sellar Region|2013
20+|6.7|7.0|6.9|Benign/Borderline|8142|121272811|Female|Tumors of Sellar Region|2014
20+|~|~|~|Malignant|~|121272811|Female|Tumors of Sellar Region|2014
20+|7.1|7.4|7.2|Benign/Borderline|8627|122354244|Female|Tumors of Sellar Region|2015
20+|~|~|~|Malignant|~|122354244|Female|Tumors of Sellar Region|2015
20+|7.2|7.5|7.3|Benign/Borderline|8840|123412348|Female|Tumors of Sellar Region|2016
20+|~|~|~|Malignant|~|123412348|Female|Tumors of Sellar Region|2016
20+|7.5|7.8|7.7|Benign/Borderline|9357|124381798|Female|Tumors of Sellar Region|2017
20+|~|~|~|Malignant|~|124381798|Female|Tumors of Sellar Region|2017
20+|7.6|7.9|7.7|Benign/Borderline|9480|125251791|Female|Tumors of Sellar Region|2018
20+|~|~|~|Malignant|~|125251791|Female|Tumors of Sellar Region|2018
20+|7.3|7.4|7.4|Benign/Borderline|45808|633928705|Female|Tumors of Sellar Region|2018-2022
20+|0.0|0.0|0.0|Malignant|223|633928705|Female|Tumors of Sellar Region|2018-2022
20+|7.6|7.9|7.8|Benign/Borderline|9623|126069751|Female|Tumors of Sellar Region|2019
20+|~|~|~|Malignant|~|126069751|Female|Tumors of Sellar Region|2019
20+|6.7|7.0|6.8|Benign/Borderline|8463|126826793|Female|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|16|126826793|Female|Tumors of Sellar Region|2020
20+|7.4|7.7|7.5|Benign/Borderline|9377|127478443|Female|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|32|127478443|Female|Tumors of Sellar Region|2021
20+|6.9|7.2|7.0|Benign/Borderline|8865|128301927|Female|Tumors of Sellar Region|2022
20+|0.1|0.1|0.1|Malignant|156|128301927|Female|Tumors of Sellar Region|2022
20+|12.5|12.9|12.7|Benign/Borderline|14738|109112165|Female|Tumors of the Meninges|2004
20+|0.2|0.3|0.3|Malignant|302|109112165|Female|Tumors of the Meninges|2004
20+|14.0|14.5|14.3|Benign/Borderline|16825|110320645|Female|Tumors of the Meninges|2005
20+|0.2|0.3|0.3|Malignant|309|110320645|Female|Tumors of the Meninges|2005
20+|14.7|15.2|14.9|Benign/Borderline|17931|111567226|Female|Tumors of the Meninges|2006
20+|0.2|0.3|0.2|Malignant|282|111567226|Female|Tumors of the Meninges|2006
20+|15.3|15.8|15.6|Benign/Borderline|18961|112783993|Female|Tumors of the Meninges|2007
20+|0.2|0.3|0.3|Malignant|308|112783993|Female|Tumors of the Meninges|2007
20+|16.2|16.6|16.4|Benign/Borderline|20345|114027722|Female|Tumors of the Meninges|2008
20+|0.2|0.3|0.2|Malignant|272|114027722|Female|Tumors of the Meninges|2008
20+|17.3|17.7|17.5|Benign/Borderline|22083|115293599|Female|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|240|115293599|Female|Tumors of the Meninges|2009
20+|16.7|17.2|17.0|Benign/Borderline|21775|116601739|Female|Tumors of the Meninges|2010
20+|0.2|0.2|0.2|Malignant|248|116601739|Female|Tumors of the Meninges|2010
20+|17.0|17.4|17.2|Benign/Borderline|22319|117835225|Female|Tumors of the Meninges|2011
20+|0.2|0.2|0.2|Malignant|220|117835225|Female|Tumors of the Meninges|2011
20+|17.4|17.8|17.6|Benign/Borderline|23225|119037075|Female|Tumors of the Meninges|2012
20+|0.2|0.2|0.2|Malignant|245|119037075|Female|Tumors of the Meninges|2012
20+|17.6|18.1|17.8|Benign/Borderline|23835|120135849|Female|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|273|120135849|Female|Tumors of the Meninges|2013
20+|18.1|18.5|18.3|Benign/Borderline|24906|121272811|Female|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|262|121272811|Female|Tumors of the Meninges|2014
20+|18.8|19.2|19.0|Benign/Borderline|26228|122354244|Female|Tumors of the Meninges|2015
20+|0.2|0.2|0.2|Malignant|249|122354244|Female|Tumors of the Meninges|2015
20+|19.3|19.8|19.6|Benign/Borderline|27291|123412348|Female|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|222|123412348|Female|Tumors of the Meninges|2016
20+|19.9|20.4|20.1|Benign/Borderline|28590|124381798|Female|Tumors of the Meninges|2017
20+|0.2|0.2|0.2|Malignant|250|124381798|Female|Tumors of the Meninges|2017
20+|20.1|20.6|20.4|Benign/Borderline|29369|125251791|Female|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|231|125251791|Female|Tumors of the Meninges|2018
20+|20.4|20.6|20.5|Benign/Borderline|152254|633928705|Female|Tumors of the Meninges|2018-2022
20+|0.2|0.2|0.2|Malignant|1183|633928705|Female|Tumors of the Meninges|2018-2022
20+|21.1|21.6|21.4|Benign/Borderline|31261|126069751|Female|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|218|126069751|Female|Tumors of the Meninges|2019
20+|18.9|19.4|19.2|Benign/Borderline|28382|126826793|Female|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|232|126826793|Female|Tumors of the Meninges|2020
20+|20.8|21.3|21.1|Benign/Borderline|31628|127478443|Female|Tumors of the Meninges|2021
20+|0.2|0.2|0.2|Malignant|261|127478443|Female|Tumors of the Meninges|2021
20+|20.5|20.9|20.7|Benign/Borderline|31614|128301927|Female|Tumors of the Meninges|2022
20+|0.1|0.2|0.2|Malignant|241|128301927|Female|Tumors of the Meninges|2022
20+|0.8|0.9|0.8|Benign/Borderline|945|109112165|Female|Unclassified Tumors|2004
20+|0.5|0.6|0.6|Malignant|689|109112165|Female|Unclassified Tumors|2004
20+|0.9|1.1|1.0|Benign/Borderline|1159|110320645|Female|Unclassified Tumors|2005
20+|0.5|0.6|0.6|Malignant|719|110320645|Female|Unclassified Tumors|2005
20+|0.9|1.0|1.0|Benign/Borderline|1137|111567226|Female|Unclassified Tumors|2006
20+|0.5|0.6|0.6|Malignant|728|111567226|Female|Unclassified Tumors|2006
20+|1.0|1.1|1.0|Benign/Borderline|1235|112783993|Female|Unclassified Tumors|2007
20+|0.5|0.5|0.5|Malignant|650|112783993|Female|Unclassified Tumors|2007
20+|1.0|1.2|1.1|Benign/Borderline|1329|114027722|Female|Unclassified Tumors|2008
20+|0.5|0.6|0.6|Malignant|769|114027722|Female|Unclassified Tumors|2008
20+|1.1|1.3|1.2|Benign/Borderline|1472|115293599|Female|Unclassified Tumors|2009
20+|0.5|0.6|0.6|Malignant|790|115293599|Female|Unclassified Tumors|2009
20+|1.2|1.3|1.2|Benign/Borderline|1511|116601739|Female|Unclassified Tumors|2010
20+|0.4|0.5|0.5|Malignant|650|116601739|Female|Unclassified Tumors|2010
20+|1.2|1.4|1.3|Benign/Borderline|1589|117835225|Female|Unclassified Tumors|2011
20+|0.4|0.5|0.5|Malignant|656|117835225|Female|Unclassified Tumors|2011
20+|1.2|1.4|1.3|Benign/Borderline|1630|119037075|Female|Unclassified Tumors|2012
20+|0.4|0.5|0.5|Malignant|660|119037075|Female|Unclassified Tumors|2012
20+|1.2|1.3|1.2|Benign/Borderline|1565|120135849|Female|Unclassified Tumors|2013
20+|0.4|0.5|0.5|Malignant|670|120135849|Female|Unclassified Tumors|2013
20+|1.2|1.3|1.3|Benign/Borderline|1611|121272811|Female|Unclassified Tumors|2014
20+|0.5|0.6|0.5|Malignant|753|121272811|Female|Unclassified Tumors|2014
20+|1.1|1.2|1.1|Benign/Borderline|1499|122354244|Female|Unclassified Tumors|2015
20+|0.5|0.5|0.5|Malignant|750|122354244|Female|Unclassified Tumors|2015
20+|1.0|1.1|1.1|Benign/Borderline|1428|123412348|Female|Unclassified Tumors|2016
20+|0.4|0.5|0.4|Malignant|632|123412348|Female|Unclassified Tumors|2016
20+|1.0|1.1|1.0|Benign/Borderline|1358|124381798|Female|Unclassified Tumors|2017
20+|0.4|0.5|0.5|Malignant|694|124381798|Female|Unclassified Tumors|2017
20+|0.9|1.1|1.0|Benign/Borderline|1352|125251791|Female|Unclassified Tumors|2018
20+|0.4|0.5|0.5|Malignant|696|125251791|Female|Unclassified Tumors|2018
20+|0.9|0.9|0.9|Benign/Borderline|6306|633928705|Female|Unclassified Tumors|2018-2022
20+|0.4|0.5|0.5|Malignant|3565|633928705|Female|Unclassified Tumors|2018-2022
20+|0.9|1.0|0.9|Benign/Borderline|1223|126069751|Female|Unclassified Tumors|2019
20+|0.4|0.5|0.5|Malignant|722|126069751|Female|Unclassified Tumors|2019
20+|0.9|1.0|0.9|Benign/Borderline|1296|126826793|Female|Unclassified Tumors|2020
20+|0.5|0.5|0.5|Malignant|785|126826793|Female|Unclassified Tumors|2020
20+|0.8|0.9|0.8|Benign/Borderline|1174|127478443|Female|Unclassified Tumors|2021
20+|0.4|0.5|0.4|Malignant|698|127478443|Female|Unclassified Tumors|2021
20+|0.8|0.9|0.9|Benign/Borderline|1261|128301927|Female|Unclassified Tumors|2022
20+|0.4|0.4|0.4|Malignant|664|128301927|Female|Unclassified Tumors|2022
20+|0.0|0.1|0.0|Benign/Borderline|54|109112165|Female|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|18|109112165|Female|Unique astrocytoma variants|2004
20+|0.0|0.1|0.0|Benign/Borderline|43|110320645|Female|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|23|110320645|Female|Unique astrocytoma variants|2005
20+|0.0|0.1|0.0|Benign/Borderline|50|111567226|Female|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|25|111567226|Female|Unique astrocytoma variants|2006
20+|0.0|0.1|0.1|Benign/Borderline|63|112783993|Female|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|20|112783993|Female|Unique astrocytoma variants|2007
20+|0.0|0.1|0.1|Benign/Borderline|62|114027722|Female|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|22|114027722|Female|Unique astrocytoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|78|115293599|Female|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|29|115293599|Female|Unique astrocytoma variants|2009
20+|0.0|0.1|0.1|Benign/Borderline|74|116601739|Female|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|20|116601739|Female|Unique astrocytoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|82|117835225|Female|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|31|117835225|Female|Unique astrocytoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|104|119037075|Female|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|32|119037075|Female|Unique astrocytoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|100|120135849|Female|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|30|120135849|Female|Unique astrocytoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|103|121272811|Female|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|39|121272811|Female|Unique astrocytoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|112|122354244|Female|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|24|122354244|Female|Unique astrocytoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|122|123412348|Female|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|37|123412348|Female|Unique astrocytoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|106|124381798|Female|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|31|124381798|Female|Unique astrocytoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|113|125251791|Female|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|34|125251791|Female|Unique astrocytoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|598|633928705|Female|Unique astrocytoma variants|2018-2022
20+|0.0|0.0|0.0|Malignant|142|633928705|Female|Unique astrocytoma variants|2018-2022
20+|0.1|0.1|0.1|Benign/Borderline|133|126069751|Female|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|29|126069751|Female|Unique astrocytoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|109|126826793|Female|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|26|126826793|Female|Unique astrocytoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|131|127478443|Female|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|21|127478443|Female|Unique astrocytoma variants|2021
20+|0.1|0.1|0.1|Benign/Borderline|112|128301927|Female|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Malignant|32|128301927|Female|Unique astrocytoma variants|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|All other|2004
20+|~|~|~|Malignant|~|101938779|Male|All other|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|All other|2005
20+|~|~|~|Malignant|~|103190694|Male|All other|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|All other|2006
20+|~|~|~|Malignant|~|104488268|Male|All other|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|All other|2007
20+|~|~|~|Malignant|~|105697783|Male|All other|2007
20+|0.0|0.0|0.0|Benign/Borderline|22|106947980|Male|All other|2008
20+|~|~|~|Malignant|~|106947980|Male|All other|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|All other|2009
20+|~|~|~|Malignant|~|108197539|Male|All other|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|All other|2010
20+|0.0|0.0|0.0|Malignant|16|109552956|Male|All other|2010
20+|0.0|0.0|0.0|Benign/Borderline|18|110970760|Male|All other|2011
20+|0.0|0.0|0.0|Malignant|23|110970760|Male|All other|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|All other|2012
20+|0.0|0.0|0.0|Malignant|20|112446425|Male|All other|2012
20+|0.0|0.0|0.0|Benign/Borderline|19|113806970|Male|All other|2013
20+|0.0|0.0|0.0|Malignant|29|113806970|Male|All other|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|All other|2014
20+|0.0|0.0|0.0|Malignant|27|115171685|Male|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|26|116507411|Male|All other|2015
20+|0.0|0.0|0.0|Malignant|26|116507411|Male|All other|2015
20+|0.0|0.1|0.0|Benign/Borderline|49|117775787|Male|All other|2016
20+|0.0|0.0|0.0|Malignant|27|117775787|Male|All other|2016
20+|0.0|0.1|0.0|Benign/Borderline|42|118925006|Male|All other|2017
20+|0.0|0.0|0.0|Malignant|25|118925006|Male|All other|2017
20+|0.0|0.1|0.0|Benign/Borderline|46|119961472|Male|All other|2018
20+|0.2|0.2|0.2|Malignant|225|119961472|Male|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|236|608171213|Male|All other|2018-2022
20+|0.2|0.2|0.2|Malignant|1386|608171213|Male|All other|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|40|120948548|Male|All other|2019
20+|0.2|0.3|0.2|Malignant|297|120948548|Male|All other|2019
20+|0.0|0.0|0.0|Benign/Borderline|40|121826708|Male|All other|2020
20+|0.2|0.3|0.3|Malignant|309|121826708|Male|All other|2020
20+|0.0|0.1|0.0|Benign/Borderline|56|122368661|Male|All other|2021
20+|0.2|0.3|0.2|Malignant|270|122368661|Male|All other|2021
20+|0.0|0.1|0.0|Benign/Borderline|54|123065824|Male|All other|2022
20+|0.2|0.3|0.2|Malignant|285|123065824|Male|All other|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic astrocytoma|2004
20+|0.6|0.7|0.7|Malignant|677|101938779|Male|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic astrocytoma|2005
20+|0.6|0.7|0.7|Malignant|701|103190694|Male|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic astrocytoma|2006
20+|0.6|0.7|0.7|Malignant|702|104488268|Male|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic astrocytoma|2007
20+|0.6|0.7|0.6|Malignant|674|105697783|Male|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic astrocytoma|2008
20+|0.6|0.7|0.7|Malignant|709|106947980|Male|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic astrocytoma|2009
20+|0.6|0.7|0.7|Malignant|717|108197539|Male|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Anaplastic astrocytoma|2010
20+|0.6|0.7|0.7|Malignant|713|109552956|Male|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Anaplastic astrocytoma|2011
20+|0.6|0.7|0.6|Malignant|711|110970760|Male|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Anaplastic astrocytoma|2012
20+|0.6|0.7|0.7|Malignant|746|112446425|Male|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Anaplastic astrocytoma|2013
20+|0.7|0.8|0.7|Malignant|802|113806970|Male|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Anaplastic astrocytoma|2014
20+|0.6|0.7|0.7|Malignant|798|115171685|Male|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Anaplastic astrocytoma|2015
20+|0.6|0.7|0.7|Malignant|784|116507411|Male|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Anaplastic astrocytoma|2016
20+|0.6|0.7|0.7|Malignant|843|117775787|Male|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Anaplastic astrocytoma|2017
20+|0.6|0.7|0.7|Malignant|789|118925006|Male|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Anaplastic astrocytoma|2018
20+|0.6|0.7|0.7|Malignant|816|119961472|Male|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Anaplastic astrocytoma|2018-2022
20+|0.5|0.5|0.5|Malignant|2960|608171213|Male|Anaplastic astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Anaplastic astrocytoma|2019
20+|0.5|0.6|0.6|Malignant|725|120948548|Male|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Anaplastic astrocytoma|2020
20+|0.5|0.6|0.5|Malignant|658|121826708|Male|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Anaplastic astrocytoma|2021
20+|0.4|0.4|0.4|Malignant|467|122368661|Male|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Anaplastic astrocytoma|2022
20+|0.2|0.3|0.3|Malignant|294|123065824|Male|Anaplastic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Anaplastic oligodendroglioma|2004
20+|0.2|0.2|0.2|Malignant|213|101938779|Male|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Anaplastic oligodendroglioma|2005
20+|0.2|0.2|0.2|Malignant|214|103190694|Male|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Anaplastic oligodendroglioma|2006
20+|0.2|0.2|0.2|Malignant|217|104488268|Male|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Anaplastic oligodendroglioma|2007
20+|0.2|0.2|0.2|Malignant|191|105697783|Male|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Anaplastic oligodendroglioma|2008
20+|0.2|0.2|0.2|Malignant|192|106947980|Male|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Anaplastic oligodendroglioma|2009
20+|0.2|0.2|0.2|Malignant|192|108197539|Male|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Anaplastic oligodendroglioma|2010
20+|0.2|0.2|0.2|Malignant|193|109552956|Male|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.2|Malignant|188|110970760|Male|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.2|Malignant|190|112446425|Male|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Anaplastic oligodendroglioma|2013
20+|0.2|0.2|0.2|Malignant|223|113806970|Male|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Anaplastic oligodendroglioma|2014
20+|0.2|0.2|0.2|Malignant|209|115171685|Male|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.2|Malignant|194|116507411|Male|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Anaplastic oligodendroglioma|2016
20+|0.2|0.2|0.2|Malignant|204|117775787|Male|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Anaplastic oligodendroglioma|2017
20+|0.2|0.2|0.2|Malignant|237|118925006|Male|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.2|Malignant|188|119961472|Male|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Anaplastic oligodendroglioma|2018-2022
20+|0.1|0.2|0.1|Malignant|863|608171213|Male|Anaplastic oligodendroglioma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Anaplastic oligodendroglioma|2019
20+|0.2|0.2|0.2|Malignant|222|120948548|Male|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Anaplastic oligodendroglioma|2020
20+|0.1|0.2|0.2|Malignant|196|121826708|Male|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Anaplastic oligodendroglioma|2021
20+|0.1|0.2|0.1|Malignant|163|122368661|Male|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Anaplastic oligodendroglioma|2022
20+|0.1|0.1|0.1|Malignant|94|123065824|Male|Anaplastic oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Astrocytoma, NOS|2004
20+|0.6|0.7|0.6|Malignant|635|101938779|Male|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Astrocytoma, NOS|2005
20+|0.6|0.7|0.6|Malignant|637|103190694|Male|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Astrocytoma, NOS|2006
20+|0.6|0.7|0.6|Malignant|644|104488268|Male|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Astrocytoma, NOS|2007
20+|0.6|0.7|0.6|Malignant|629|105697783|Male|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Astrocytoma, NOS|2008
20+|0.6|0.6|0.6|Malignant|632|106947980|Male|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Astrocytoma, NOS|2009
20+|0.5|0.6|0.5|Malignant|577|108197539|Male|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Astrocytoma, NOS|2010
20+|0.5|0.6|0.6|Malignant|624|109552956|Male|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Astrocytoma, NOS|2011
20+|0.5|0.6|0.5|Malignant|590|110970760|Male|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Astrocytoma, NOS|2012
20+|0.5|0.5|0.5|Malignant|563|112446425|Male|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Astrocytoma, NOS|2013
20+|0.5|0.5|0.5|Malignant|574|113806970|Male|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Astrocytoma, NOS|2014
20+|0.5|0.6|0.5|Malignant|608|115171685|Male|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Astrocytoma, NOS|2015
20+|0.6|0.6|0.6|Malignant|703|116507411|Male|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Astrocytoma, NOS|2016
20+|0.6|0.6|0.6|Malignant|708|117775787|Male|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Astrocytoma, NOS|2017
20+|0.5|0.6|0.6|Malignant|708|118925006|Male|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Astrocytoma, NOS|2018
20+|0.6|0.6|0.6|Malignant|716|119961472|Male|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Astrocytoma, NOS|2018-2022
20+|0.6|0.7|0.6|Malignant|3879|608171213|Male|Astrocytoma, NOS|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Astrocytoma, NOS|2019
20+|0.5|0.6|0.6|Malignant|718|120948548|Male|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Astrocytoma, NOS|2020
20+|0.5|0.6|0.6|Malignant|718|121826708|Male|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Astrocytoma, NOS|2021
20+|0.7|0.8|0.7|Malignant|867|122368661|Male|Astrocytoma, NOS|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Astrocytoma, NOS|2022
20+|0.7|0.8|0.7|Malignant|860|123065824|Male|Astrocytoma, NOS|2022
20+|0.0|0.0|0.0|Benign/Borderline|26|101938779|Male|Choroid plexus|2004
20+|~|~|~|Malignant|~|101938779|Male|Choroid plexus|2004
20+|0.0|0.1|0.0|Benign/Borderline|37|103190694|Male|Choroid plexus|2005
20+|~|~|~|Malignant|~|103190694|Male|Choroid plexus|2005
20+|0.0|0.0|0.0|Benign/Borderline|26|104488268|Male|Choroid plexus|2006
20+|~|~|~|Malignant|~|104488268|Male|Choroid plexus|2006
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Choroid plexus|2007
20+|~|~|~|Malignant|~|105697783|Male|Choroid plexus|2007
20+|0.0|0.0|0.0|Benign/Borderline|29|106947980|Male|Choroid plexus|2008
20+|~|~|~|Malignant|~|106947980|Male|Choroid plexus|2008
20+|0.0|0.0|0.0|Benign/Borderline|29|108197539|Male|Choroid plexus|2009
20+|~|~|~|Malignant|~|108197539|Male|Choroid plexus|2009
20+|0.0|0.0|0.0|Benign/Borderline|36|109552956|Male|Choroid plexus|2010
20+|~|~|~|Malignant|~|109552956|Male|Choroid plexus|2010
20+|0.0|0.0|0.0|Benign/Borderline|32|110970760|Male|Choroid plexus|2011
20+|~|~|~|Malignant|~|110970760|Male|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|36|112446425|Male|Choroid plexus|2012
20+|~|~|~|Malignant|~|112446425|Male|Choroid plexus|2012
20+|0.0|0.0|0.0|Benign/Borderline|31|113806970|Male|Choroid plexus|2013
20+|~|~|~|Malignant|~|113806970|Male|Choroid plexus|2013
20+|0.0|0.0|0.0|Benign/Borderline|42|115171685|Male|Choroid plexus|2014
20+|~|~|~|Malignant|~|115171685|Male|Choroid plexus|2014
20+|0.0|0.0|0.0|Benign/Borderline|38|116507411|Male|Choroid plexus|2015
20+|~|~|~|Malignant|~|116507411|Male|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|31|117775787|Male|Choroid plexus|2016
20+|~|~|~|Malignant|~|117775787|Male|Choroid plexus|2016
20+|0.0|0.1|0.0|Benign/Borderline|55|118925006|Male|Choroid plexus|2017
20+|~|~|~|Malignant|~|118925006|Male|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|25|119961472|Male|Choroid plexus|2018
20+|~|~|~|Malignant|~|119961472|Male|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|153|608171213|Male|Choroid plexus|2018-2022
20+|0.0|0.0|0.0|Malignant|21|608171213|Male|Choroid plexus|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|33|120948548|Male|Choroid plexus|2019
20+|~|~|~|Malignant|~|120948548|Male|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|27|121826708|Male|Choroid plexus|2020
20+|~|~|~|Malignant|~|121826708|Male|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|38|122368661|Male|Choroid plexus|2021
20+|~|~|~|Malignant|~|122368661|Male|Choroid plexus|2021
20+|0.0|0.0|0.0|Benign/Borderline|30|123065824|Male|Choroid plexus|2022
20+|~|~|~|Malignant|~|123065824|Male|Choroid plexus|2022
20+|0.2|0.2|0.2|Benign/Borderline|188|101938779|Male|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|101938779|Male|Craniopharyngioma|2004
20+|0.2|0.3|0.2|Benign/Borderline|234|103190694|Male|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|103190694|Male|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|194|104488268|Male|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|104488268|Male|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|202|105697783|Male|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|105697783|Male|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|201|106947980|Male|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|106947980|Male|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|201|108197539|Male|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|108197539|Male|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|203|109552956|Male|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|109552956|Male|Craniopharyngioma|2010
20+|0.1|0.2|0.2|Benign/Borderline|199|110970760|Male|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|110970760|Male|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|218|112446425|Male|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|112446425|Male|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|237|113806970|Male|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|113806970|Male|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|214|115171685|Male|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|115171685|Male|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|227|116507411|Male|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|116507411|Male|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|250|117775787|Male|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|117775787|Male|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|248|118925006|Male|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|118925006|Male|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|231|119961472|Male|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|119961472|Male|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|1199|608171213|Male|Craniopharyngioma|2018-2022
20+|~|~|~|Malignant|~|608171213|Male|Craniopharyngioma|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|251|120948548|Male|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|120948548|Male|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|239|121826708|Male|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|121826708|Male|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|235|122368661|Male|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|122368661|Male|Craniopharyngioma|2021
20+|0.2|0.2|0.2|Benign/Borderline|243|123065824|Male|Craniopharyngioma|2022
20+|~|~|~|Malignant|~|123065824|Male|Craniopharyngioma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Diffuse astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|146|101938779|Male|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Diffuse astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|149|103190694|Male|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Diffuse astrocytoma|2006
20+|0.2|0.2|0.2|Malignant|200|104488268|Male|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Diffuse astrocytoma|2007
20+|0.2|0.2|0.2|Malignant|185|105697783|Male|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Diffuse astrocytoma|2008
20+|0.2|0.2|0.2|Malignant|211|106947980|Male|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Diffuse astrocytoma|2009
20+|0.2|0.2|0.2|Malignant|207|108197539|Male|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Diffuse astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|186|109552956|Male|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|136|110970760|Male|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|113|112446425|Male|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Diffuse astrocytoma|2013
20+|0.1|0.1|0.1|Malignant|104|113806970|Male|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Diffuse astrocytoma|2014
20+|0.0|0.1|0.1|Malignant|69|115171685|Male|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Diffuse astrocytoma|2015
20+|0.0|0.1|0.0|Malignant|49|116507411|Male|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Diffuse astrocytoma|2016
20+|0.0|0.0|0.0|Malignant|23|117775787|Male|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Diffuse astrocytoma|2017
20+|~|~|~|Malignant|~|118925006|Male|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Diffuse astrocytoma|2018
20+|~|~|~|Malignant|~|119961472|Male|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Diffuse astrocytoma|2018-2022
20+|0.0|0.0|0.0|Malignant|31|608171213|Male|Diffuse astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|120948548|Male|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|121826708|Male|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|122368661|Male|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Diffuse astrocytoma|2022
20+|~|~|~|Malignant|~|123065824|Male|Diffuse astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|97|101938779|Male|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|105|103190694|Male|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|97|104488268|Male|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|124|105697783|Male|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|124|106947980|Male|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|132|108197539|Male|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|126|109552956|Male|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Embryonal/primitive/medulloblastoma|2011
20+|0.1|0.1|0.1|Malignant|115|110970760|Male|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|93|112446425|Male|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|98|113806970|Male|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|107|115171685|Male|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Embryonal/primitive/medulloblastoma|2015
20+|0.1|0.1|0.1|Malignant|102|116507411|Male|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Embryonal/primitive/medulloblastoma|2016
20+|0.1|0.1|0.1|Malignant|119|117775787|Male|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Embryonal/primitive/medulloblastoma|2017
20+|0.1|0.1|0.1|Malignant|99|118925006|Male|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Embryonal/primitive/medulloblastoma|2018
20+|0.1|0.1|0.1|Malignant|85|119961472|Male|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Embryonal/primitive/medulloblastoma|2018-2022
20+|0.1|0.1|0.1|Malignant|392|608171213|Male|Embryonal/primitive/medulloblastoma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Embryonal/primitive/medulloblastoma|2019
20+|0.1|0.1|0.1|Malignant|82|120948548|Male|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|67|121826708|Male|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Malignant|78|122368661|Male|Embryonal/primitive/medulloblastoma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Embryonal/primitive/medulloblastoma|2022
20+|0.1|0.1|0.1|Malignant|80|123065824|Male|Embryonal/primitive/medulloblastoma|2022
20+|0.1|0.2|0.1|Benign/Borderline|142|101938779|Male|Ependymoma variants|2004
20+|~|~|~|Malignant|~|101938779|Male|Ependymoma variants|2004
20+|0.1|0.2|0.1|Benign/Borderline|151|103190694|Male|Ependymoma variants|2005
20+|~|~|~|Malignant|~|103190694|Male|Ependymoma variants|2005
20+|0.1|0.2|0.2|Benign/Borderline|163|104488268|Male|Ependymoma variants|2006
20+|~|~|~|Malignant|~|104488268|Male|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|137|105697783|Male|Ependymoma variants|2007
20+|~|~|~|Malignant|~|105697783|Male|Ependymoma variants|2007
20+|0.1|0.2|0.1|Benign/Borderline|146|106947980|Male|Ependymoma variants|2008
20+|~|~|~|Malignant|~|106947980|Male|Ependymoma variants|2008
20+|0.1|0.2|0.1|Benign/Borderline|149|108197539|Male|Ependymoma variants|2009
20+|~|~|~|Malignant|~|108197539|Male|Ependymoma variants|2009
20+|0.1|0.2|0.1|Benign/Borderline|156|109552956|Male|Ependymoma variants|2010
20+|~|~|~|Malignant|~|109552956|Male|Ependymoma variants|2010
20+|0.1|0.2|0.1|Benign/Borderline|151|110970760|Male|Ependymoma variants|2011
20+|~|~|~|Malignant|~|110970760|Male|Ependymoma variants|2011
20+|0.1|0.2|0.1|Benign/Borderline|165|112446425|Male|Ependymoma variants|2012
20+|~|~|~|Malignant|~|112446425|Male|Ependymoma variants|2012
20+|0.1|0.2|0.1|Benign/Borderline|162|113806970|Male|Ependymoma variants|2013
20+|~|~|~|Malignant|~|113806970|Male|Ependymoma variants|2013
20+|0.1|0.2|0.1|Benign/Borderline|170|115171685|Male|Ependymoma variants|2014
20+|~|~|~|Malignant|~|115171685|Male|Ependymoma variants|2014
20+|0.1|0.2|0.1|Benign/Borderline|161|116507411|Male|Ependymoma variants|2015
20+|~|~|~|Malignant|~|116507411|Male|Ependymoma variants|2015
20+|0.1|0.2|0.2|Benign/Borderline|174|117775787|Male|Ependymoma variants|2016
20+|~|~|~|Malignant|~|117775787|Male|Ependymoma variants|2016
20+|0.1|0.2|0.1|Benign/Borderline|164|118925006|Male|Ependymoma variants|2017
20+|~|~|~|Malignant|~|118925006|Male|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|142|119961472|Male|Ependymoma variants|2018
20+|~|~|~|Malignant|~|119961472|Male|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|750|608171213|Male|Ependymoma variants|2018-2022
20+|~|~|~|Malignant|~|608171213|Male|Ependymoma variants|2018-2022
20+|0.1|0.1|0.1|Benign/Borderline|141|120948548|Male|Ependymoma variants|2019
20+|~|~|~|Malignant|~|120948548|Male|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|145|121826708|Male|Ependymoma variants|2020
20+|~|~|~|Malignant|~|121826708|Male|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|149|122368661|Male|Ependymoma variants|2021
20+|~|~|~|Malignant|~|122368661|Male|Ependymoma variants|2021
20+|0.1|0.2|0.1|Benign/Borderline|173|123065824|Male|Ependymoma variants|2022
20+|~|~|~|Malignant|~|123065824|Male|Ependymoma variants|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Ependymoma/anaplastic ependymoma|2004
20+|0.3|0.3|0.3|Malignant|305|101938779|Male|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Ependymoma/anaplastic ependymoma|2005
20+|0.3|0.3|0.3|Malignant|302|103190694|Male|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|292|104488268|Male|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|288|105697783|Male|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Ependymoma/anaplastic ependymoma|2008
20+|0.3|0.3|0.3|Malignant|325|106947980|Male|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|341|108197539|Male|Ependymoma/anaplastic ependymoma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Ependymoma/anaplastic ependymoma|2010
20+|0.3|0.3|0.3|Malignant|333|109552956|Male|Ependymoma/anaplastic ependymoma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|298|110970760|Male|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Ependymoma/anaplastic ependymoma|2012
20+|0.3|0.3|0.3|Malignant|329|112446425|Male|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.3|Malignant|308|113806970|Male|Ependymoma/anaplastic ependymoma|2013
20+|0.0|0.0|0.0|Benign/Borderline|22|115171685|Male|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.3|0.3|Malignant|322|115171685|Male|Ependymoma/anaplastic ependymoma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.3|Malignant|310|116507411|Male|Ependymoma/anaplastic ependymoma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.3|Malignant|331|117775787|Male|Ependymoma/anaplastic ependymoma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|307|118925006|Male|Ependymoma/anaplastic ependymoma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.3|0.3|Malignant|315|119961472|Male|Ependymoma/anaplastic ependymoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|48|608171213|Male|Ependymoma/anaplastic ependymoma|2018-2022
20+|0.2|0.2|0.2|Malignant|1392|608171213|Male|Ependymoma/anaplastic ependymoma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.3|0.2|Malignant|282|120948548|Male|Ependymoma/anaplastic ependymoma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|273|121826708|Male|Ependymoma/anaplastic ependymoma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|270|122368661|Male|Ependymoma/anaplastic ependymoma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Ependymoma/anaplastic ependymoma|2022
20+|0.2|0.2|0.2|Malignant|252|123065824|Male|Ependymoma/anaplastic ependymoma|2022
20+|0.0|0.0|0.0|Benign/Borderline|22|101938779|Male|Germ Cell Tumors|2004
20+|0.0|0.1|0.0|Malignant|40|101938779|Male|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|33|103190694|Male|Germ Cell Tumors|2005
20+|0.0|0.1|0.0|Malignant|54|103190694|Male|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|29|104488268|Male|Germ Cell Tumors|2006
20+|0.0|0.1|0.0|Malignant|47|104488268|Male|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|35|105697783|Male|Germ Cell Tumors|2007
20+|0.1|0.1|0.1|Malignant|76|105697783|Male|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|34|106947980|Male|Germ Cell Tumors|2008
20+|0.0|0.1|0.0|Malignant|53|106947980|Male|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Benign/Borderline|37|108197539|Male|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Malignant|36|108197539|Male|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|30|109552956|Male|Germ Cell Tumors|2010
20+|0.0|0.1|0.1|Malignant|56|109552956|Male|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|24|110970760|Male|Germ Cell Tumors|2011
20+|0.0|0.1|0.1|Malignant|60|110970760|Male|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|33|112446425|Male|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Malignant|42|112446425|Male|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|27|113806970|Male|Germ Cell Tumors|2013
20+|0.0|0.1|0.0|Malignant|45|113806970|Male|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|28|115171685|Male|Germ Cell Tumors|2014
20+|0.0|0.1|0.1|Malignant|62|115171685|Male|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|30|116507411|Male|Germ Cell Tumors|2015
20+|0.0|0.1|0.0|Malignant|55|116507411|Male|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|33|117775787|Male|Germ Cell Tumors|2016
20+|0.0|0.1|0.1|Malignant|67|117775787|Male|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|32|118925006|Male|Germ Cell Tumors|2017
20+|0.0|0.1|0.1|Malignant|62|118925006|Male|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|23|119961472|Male|Germ Cell Tumors|2018
20+|0.0|0.1|0.1|Malignant|60|119961472|Male|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|118|608171213|Male|Germ Cell Tumors|2018-2022
20+|0.0|0.1|0.0|Malignant|291|608171213|Male|Germ Cell Tumors|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|31|120948548|Male|Germ Cell Tumors|2019
20+|0.0|0.1|0.1|Malignant|64|120948548|Male|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|24|121826708|Male|Germ Cell Tumors|2020
20+|0.0|0.1|0.0|Malignant|46|121826708|Male|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|18|122368661|Male|Germ Cell Tumors|2021
20+|0.0|0.1|0.1|Malignant|68|122368661|Male|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Benign/Borderline|22|123065824|Male|Germ Cell Tumors|2022
20+|0.0|0.1|0.0|Malignant|53|123065824|Male|Germ Cell Tumors|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioblastoma|2004
20+|5.5|5.8|5.6|Malignant|5480|101938779|Male|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioblastoma|2005
20+|5.5|5.8|5.6|Malignant|5542|103190694|Male|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioblastoma|2006
20+|5.3|5.6|5.4|Malignant|5502|104488268|Male|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioblastoma|2007
20+|5.4|5.7|5.6|Malignant|5818|105697783|Male|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Glioblastoma|2008
20+|5.5|5.8|5.7|Malignant|6017|106947980|Male|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Glioblastoma|2009
20+|5.4|5.7|5.6|Malignant|6004|108197539|Male|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Glioblastoma|2010
20+|5.4|5.6|5.5|Malignant|6120|109552956|Male|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Glioblastoma|2011
20+|5.4|5.7|5.5|Malignant|6306|110970760|Male|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Glioblastoma|2012
20+|5.4|5.7|5.6|Malignant|6510|112446425|Male|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Glioblastoma|2013
20+|5.4|5.7|5.6|Malignant|6642|113806970|Male|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Glioblastoma|2014
20+|5.5|5.7|5.6|Malignant|6812|115171685|Male|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Glioblastoma|2015
20+|5.4|5.7|5.6|Malignant|6916|116507411|Male|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Glioblastoma|2016
20+|5.5|5.8|5.7|Malignant|7216|117775787|Male|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Glioblastoma|2017
20+|5.5|5.8|5.7|Malignant|7369|118925006|Male|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Glioblastoma|2018
20+|5.5|5.8|5.6|Malignant|7462|119961472|Male|Glioblastoma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Glioblastoma|2018-2022
20+|5.5|5.6|5.5|Malignant|37877|608171213|Male|Glioblastoma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Glioblastoma|2019
20+|5.5|5.8|5.6|Malignant|7581|120948548|Male|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Glioblastoma|2020
20+|5.4|5.7|5.6|Malignant|7652|121826708|Male|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Glioblastoma|2021
20+|5.3|5.6|5.4|Malignant|7615|122368661|Male|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Glioblastoma|2022
20+|5.2|5.4|5.3|Malignant|7567|123065824|Male|Glioblastoma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Glioma malignant, NOS|2004
20+|0.4|0.5|0.4|Malignant|426|101938779|Male|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Glioma malignant, NOS|2005
20+|0.4|0.5|0.5|Malignant|443|103190694|Male|Glioma malignant, NOS|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Glioma malignant, NOS|2006
20+|0.4|0.5|0.4|Malignant|443|104488268|Male|Glioma malignant, NOS|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Glioma malignant, NOS|2007
20+|0.4|0.5|0.5|Malignant|462|105697783|Male|Glioma malignant, NOS|2007
20+|0.0|0.0|0.0|Benign/Borderline|16|106947980|Male|Glioma malignant, NOS|2008
20+|0.4|0.5|0.5|Malignant|482|106947980|Male|Glioma malignant, NOS|2008
20+|0.0|0.0|0.0|Benign/Borderline|16|108197539|Male|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|464|108197539|Male|Glioma malignant, NOS|2009
20+|0.0|0.0|0.0|Benign/Borderline|16|109552956|Male|Glioma malignant, NOS|2010
20+|0.3|0.4|0.4|Malignant|405|109552956|Male|Glioma malignant, NOS|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|110970760|Male|Glioma malignant, NOS|2011
20+|0.4|0.5|0.5|Malignant|500|110970760|Male|Glioma malignant, NOS|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Glioma malignant, NOS|2012
20+|0.4|0.5|0.5|Malignant|487|112446425|Male|Glioma malignant, NOS|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Glioma malignant, NOS|2013
20+|0.4|0.5|0.4|Malignant|470|113806970|Male|Glioma malignant, NOS|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Glioma malignant, NOS|2014
20+|0.4|0.5|0.4|Malignant|503|115171685|Male|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|23|116507411|Male|Glioma malignant, NOS|2015
20+|0.4|0.5|0.4|Malignant|481|116507411|Male|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|30|117775787|Male|Glioma malignant, NOS|2016
20+|0.4|0.5|0.5|Malignant|545|117775787|Male|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|19|118925006|Male|Glioma malignant, NOS|2017
20+|0.5|0.6|0.5|Malignant|611|118925006|Male|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|23|119961472|Male|Glioma malignant, NOS|2018
20+|0.4|0.5|0.5|Malignant|580|119961472|Male|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|104|608171213|Male|Glioma malignant, NOS|2018-2022
20+|0.5|0.5|0.5|Malignant|2976|608171213|Male|Glioma malignant, NOS|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|23|120948548|Male|Glioma malignant, NOS|2019
20+|0.4|0.5|0.5|Malignant|553|120948548|Male|Glioma malignant, NOS|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Glioma malignant, NOS|2020
20+|0.4|0.5|0.5|Malignant|572|121826708|Male|Glioma malignant, NOS|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Glioma malignant, NOS|2021
20+|0.4|0.5|0.5|Malignant|586|122368661|Male|Glioma malignant, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|33|123065824|Male|Glioma malignant, NOS|2022
20+|0.5|0.6|0.5|Malignant|685|123065824|Male|Glioma malignant, NOS|2022
20+|0.2|0.3|0.2|Benign/Borderline|253|101938779|Male|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|101938779|Male|Hemangioblastoma|2004
20+|0.2|0.3|0.3|Benign/Borderline|289|103190694|Male|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|103190694|Male|Hemangioblastoma|2005
20+|0.2|0.3|0.3|Benign/Borderline|279|104488268|Male|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|104488268|Male|Hemangioblastoma|2006
20+|0.2|0.3|0.2|Benign/Borderline|256|105697783|Male|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|105697783|Male|Hemangioblastoma|2007
20+|0.2|0.3|0.3|Benign/Borderline|295|106947980|Male|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|106947980|Male|Hemangioblastoma|2008
20+|0.2|0.3|0.3|Benign/Borderline|279|108197539|Male|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|108197539|Male|Hemangioblastoma|2009
20+|0.2|0.3|0.3|Benign/Borderline|306|109552956|Male|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|109552956|Male|Hemangioblastoma|2010
20+|0.2|0.3|0.3|Benign/Borderline|282|110970760|Male|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|110970760|Male|Hemangioblastoma|2011
20+|0.2|0.3|0.3|Benign/Borderline|286|112446425|Male|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|112446425|Male|Hemangioblastoma|2012
20+|0.2|0.3|0.2|Benign/Borderline|279|113806970|Male|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|113806970|Male|Hemangioblastoma|2013
20+|0.2|0.3|0.2|Benign/Borderline|282|115171685|Male|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|115171685|Male|Hemangioblastoma|2014
20+|0.2|0.3|0.3|Benign/Borderline|302|116507411|Male|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|116507411|Male|Hemangioblastoma|2015
20+|0.2|0.3|0.2|Benign/Borderline|294|117775787|Male|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|117775787|Male|Hemangioblastoma|2016
20+|0.2|0.3|0.3|Benign/Borderline|338|118925006|Male|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|118925006|Male|Hemangioblastoma|2017
20+|0.2|0.3|0.2|Benign/Borderline|311|119961472|Male|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|119961472|Male|Hemangioblastoma|2018
20+|0.2|0.3|0.2|Benign/Borderline|1520|608171213|Male|Hemangioblastoma|2018-2022
20+|~|~|~|Malignant|~|608171213|Male|Hemangioblastoma|2018-2022
20+|0.2|0.3|0.2|Benign/Borderline|286|120948548|Male|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|120948548|Male|Hemangioblastoma|2019
20+|0.2|0.3|0.2|Benign/Borderline|316|121826708|Male|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|121826708|Male|Hemangioblastoma|2020
20+|0.2|0.3|0.2|Benign/Borderline|298|122368661|Male|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|122368661|Male|Hemangioblastoma|2021
20+|0.2|0.3|0.2|Benign/Borderline|309|123065824|Male|Hemangioblastoma|2022
20+|~|~|~|Malignant|~|123065824|Male|Hemangioblastoma|2022
20+|0.1|0.2|0.1|Benign/Borderline|141|101938779|Male|Hemangioma|2004
20+|~|~|~|Malignant|~|101938779|Male|Hemangioma|2004
20+|0.2|0.2|0.2|Benign/Borderline|205|103190694|Male|Hemangioma|2005
20+|~|~|~|Malignant|~|103190694|Male|Hemangioma|2005
20+|0.2|0.3|0.2|Benign/Borderline|240|104488268|Male|Hemangioma|2006
20+|~|~|~|Malignant|~|104488268|Male|Hemangioma|2006
20+|0.2|0.3|0.3|Benign/Borderline|272|105697783|Male|Hemangioma|2007
20+|~|~|~|Malignant|~|105697783|Male|Hemangioma|2007
20+|0.3|0.4|0.3|Benign/Borderline|332|106947980|Male|Hemangioma|2008
20+|~|~|~|Malignant|~|106947980|Male|Hemangioma|2008
20+|0.4|0.5|0.4|Benign/Borderline|445|108197539|Male|Hemangioma|2009
20+|~|~|~|Malignant|~|108197539|Male|Hemangioma|2009
20+|0.4|0.5|0.4|Benign/Borderline|457|109552956|Male|Hemangioma|2010
20+|~|~|~|Malignant|~|109552956|Male|Hemangioma|2010
20+|0.4|0.5|0.5|Benign/Borderline|520|110970760|Male|Hemangioma|2011
20+|~|~|~|Malignant|~|110970760|Male|Hemangioma|2011
20+|0.4|0.5|0.5|Benign/Borderline|517|112446425|Male|Hemangioma|2012
20+|~|~|~|Malignant|~|112446425|Male|Hemangioma|2012
20+|0.4|0.5|0.4|Benign/Borderline|519|113806970|Male|Hemangioma|2013
20+|~|~|~|Malignant|~|113806970|Male|Hemangioma|2013
20+|0.4|0.5|0.4|Benign/Borderline|522|115171685|Male|Hemangioma|2014
20+|~|~|~|Malignant|~|115171685|Male|Hemangioma|2014
20+|0.4|0.4|0.4|Benign/Borderline|476|116507411|Male|Hemangioma|2015
20+|~|~|~|Malignant|~|116507411|Male|Hemangioma|2015
20+|0.3|0.4|0.4|Benign/Borderline|433|117775787|Male|Hemangioma|2016
20+|~|~|~|Malignant|~|117775787|Male|Hemangioma|2016
20+|0.4|0.4|0.4|Benign/Borderline|460|118925006|Male|Hemangioma|2017
20+|~|~|~|Malignant|~|118925006|Male|Hemangioma|2017
20+|0.4|0.4|0.4|Benign/Borderline|477|119961472|Male|Hemangioma|2018
20+|~|~|~|Malignant|~|119961472|Male|Hemangioma|2018
20+|0.4|0.4|0.4|Benign/Borderline|2334|608171213|Male|Hemangioma|2018-2022
20+|~|~|~|Malignant|~|608171213|Male|Hemangioma|2018-2022
20+|0.4|0.4|0.4|Benign/Borderline|492|120948548|Male|Hemangioma|2019
20+|~|~|~|Malignant|~|120948548|Male|Hemangioma|2019
20+|0.3|0.4|0.4|Benign/Borderline|466|121826708|Male|Hemangioma|2020
20+|~|~|~|Malignant|~|121826708|Male|Hemangioma|2020
20+|0.3|0.4|0.4|Benign/Borderline|473|122368661|Male|Hemangioma|2021
20+|~|~|~|Malignant|~|122368661|Male|Hemangioma|2021
20+|0.3|0.4|0.3|Benign/Borderline|426|123065824|Male|Hemangioma|2022
20+|~|~|~|Malignant|~|123065824|Male|Hemangioma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|25|101938779|Male|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|23|103190694|Male|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|36|104488268|Male|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|31|106947980|Male|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|30|108197539|Male|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|30|109552956|Male|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|23|110970760|Male|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|27|112446425|Male|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|30|113806970|Male|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|24|115171685|Male|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|23|116507411|Male|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Local Extensions from Regional Tumors|2016
20+|0.0|0.0|0.0|Malignant|26|117775787|Male|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Malignant|25|118925006|Male|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Local Extensions from Regional Tumors|2018
20+|0.0|0.0|0.0|Malignant|18|119961472|Male|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Local Extensions from Regional Tumors|2018-2022
20+|0.0|0.0|0.0|Malignant|83|608171213|Male|Local Extensions from Regional Tumors|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Local Extensions from Regional Tumors|2019
20+|0.0|0.0|0.0|Malignant|20|120948548|Male|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Local Extensions from Regional Tumors|2020
20+|~|~|~|Malignant|~|121826708|Male|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Local Extensions from Regional Tumors|2021
20+|0.0|0.0|0.0|Malignant|21|122368661|Male|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Local Extensions from Regional Tumors|2022
20+|~|~|~|Malignant|~|123065824|Male|Local Extensions from Regional Tumors|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.7|0.8|0.8|Malignant|749|101938779|Male|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.7|0.8|0.8|Malignant|774|103190694|Male|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.7|0.8|0.8|Malignant|761|104488268|Male|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.7|0.8|0.7|Malignant|731|105697783|Male|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.7|0.8|0.7|Malignant|770|106947980|Male|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.7|0.8|0.7|Malignant|751|108197539|Male|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.6|0.7|0.7|Malignant|755|109552956|Male|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.7|0.8|0.7|Malignant|804|110970760|Male|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.6|0.7|0.7|Malignant|751|112446425|Male|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.6|0.7|0.6|Malignant|727|113806970|Male|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.7|0.7|Malignant|822|115171685|Male|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.6|0.7|0.7|Malignant|825|116507411|Male|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.7|0.7|Malignant|824|117775787|Male|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.7|0.8|0.7|Malignant|886|118925006|Male|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.6|0.7|0.7|Malignant|856|119961472|Male|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Lymphomas and Hematopoietic Neoplasms|2018-2022
20+|0.6|0.6|0.6|Malignant|4219|608171213|Male|Lymphomas and Hematopoietic Neoplasms|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.6|0.7|0.6|Malignant|845|120948548|Male|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.6|0.7|0.6|Malignant|841|121826708|Male|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.6|0.7|0.6|Malignant|846|122368661|Male|Lymphomas and Hematopoietic Neoplasms|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Lymphomas and Hematopoietic Neoplasms|2022
20+|0.6|0.6|0.6|Malignant|831|123065824|Male|Lymphomas and Hematopoietic Neoplasms|2022
20+|5.1|5.4|5.3|Benign/Borderline|4961|101938779|Male|Meningioma|2004
20+|0.2|0.2|0.2|Malignant|175|101938779|Male|Meningioma|2004
20+|5.6|6.0|5.8|Benign/Borderline|5528|103190694|Male|Meningioma|2005
20+|0.1|0.2|0.2|Malignant|153|103190694|Male|Meningioma|2005
20+|6.0|6.3|6.1|Benign/Borderline|5943|104488268|Male|Meningioma|2006
20+|0.1|0.2|0.2|Malignant|156|104488268|Male|Meningioma|2006
20+|6.1|6.4|6.3|Benign/Borderline|6209|105697783|Male|Meningioma|2007
20+|0.1|0.2|0.2|Malignant|176|105697783|Male|Meningioma|2007
20+|6.6|6.9|6.7|Benign/Borderline|6855|106947980|Male|Meningioma|2008
20+|0.1|0.2|0.1|Malignant|148|106947980|Male|Meningioma|2008
20+|7.0|7.3|7.2|Benign/Borderline|7368|108197539|Male|Meningioma|2009
20+|0.1|0.2|0.1|Malignant|152|108197539|Male|Meningioma|2009
20+|6.9|7.2|7.1|Benign/Borderline|7433|109552956|Male|Meningioma|2010
20+|0.1|0.1|0.1|Malignant|123|109552956|Male|Meningioma|2010
20+|6.9|7.3|7.1|Benign/Borderline|7671|110970760|Male|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|143|110970760|Male|Meningioma|2011
20+|7.0|7.4|7.2|Benign/Borderline|7926|112446425|Male|Meningioma|2012
20+|0.1|0.2|0.1|Malignant|155|112446425|Male|Meningioma|2012
20+|7.4|7.7|7.5|Benign/Borderline|8455|113806970|Male|Meningioma|2013
20+|0.1|0.2|0.1|Malignant|158|113806970|Male|Meningioma|2013
20+|7.4|7.7|7.5|Benign/Borderline|8661|115171685|Male|Meningioma|2014
20+|0.1|0.2|0.1|Malignant|170|115171685|Male|Meningioma|2014
20+|7.7|8.1|7.9|Benign/Borderline|9285|116507411|Male|Meningioma|2015
20+|0.1|0.1|0.1|Malignant|149|116507411|Male|Meningioma|2015
20+|7.9|8.2|8.0|Benign/Borderline|9598|117775787|Male|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|163|117775787|Male|Meningioma|2016
20+|8.2|8.6|8.4|Benign/Borderline|10241|118925006|Male|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|152|118925006|Male|Meningioma|2017
20+|8.3|8.6|8.5|Benign/Borderline|10554|119961472|Male|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|142|119961472|Male|Meningioma|2018
20+|8.6|8.7|8.7|Benign/Borderline|55795|608171213|Male|Meningioma|2018-2022
20+|0.1|0.1|0.1|Malignant|748|608171213|Male|Meningioma|2018-2022
20+|8.8|9.2|9.0|Benign/Borderline|11393|120948548|Male|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|151|120948548|Male|Meningioma|2019
20+|8.1|8.5|8.3|Benign/Borderline|10704|121826708|Male|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|143|121826708|Male|Meningioma|2020
20+|8.6|8.9|8.7|Benign/Borderline|11425|122368661|Male|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|162|122368661|Male|Meningioma|2021
20+|8.6|9.0|8.8|Benign/Borderline|11719|123065824|Male|Meningioma|2022
20+|0.1|0.1|0.1|Malignant|150|123065824|Male|Meningioma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Mixed glioma|2004
20+|0.3|0.3|0.3|Malignant|293|101938779|Male|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Mixed glioma|2005
20+|0.3|0.4|0.3|Malignant|329|103190694|Male|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Mixed glioma|2006
20+|0.3|0.4|0.4|Malignant|367|104488268|Male|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Mixed glioma|2007
20+|0.3|0.4|0.3|Malignant|353|105697783|Male|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Mixed glioma|2008
20+|0.3|0.4|0.3|Malignant|341|106947980|Male|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Mixed glioma|2009
20+|0.3|0.4|0.4|Malignant|390|108197539|Male|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Mixed glioma|2010
20+|0.3|0.4|0.3|Malignant|341|109552956|Male|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Mixed glioma|2011
20+|0.3|0.4|0.3|Malignant|366|110970760|Male|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Mixed glioma|2012
20+|0.3|0.3|0.3|Malignant|332|112446425|Male|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Mixed glioma|2013
20+|0.3|0.4|0.3|Malignant|373|113806970|Male|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Mixed glioma|2014
20+|0.2|0.3|0.2|Malignant|269|115171685|Male|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Mixed glioma|2015
20+|0.1|0.2|0.1|Malignant|147|116507411|Male|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Mixed glioma|2016
20+|0.0|0.1|0.1|Malignant|63|117775787|Male|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|30|118925006|Male|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Mixed glioma|2018
20+|~|~|~|Malignant|~|119961472|Male|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Mixed glioma|2018-2022
20+|0.0|0.0|0.0|Malignant|42|608171213|Male|Mixed glioma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Mixed glioma|2019
20+|~|~|~|Malignant|~|120948548|Male|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Mixed glioma|2020
20+|~|~|~|Malignant|~|121826708|Male|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Mixed glioma|2021
20+|~|~|~|Malignant|~|122368661|Male|Mixed glioma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Mixed glioma|2022
20+|~|~|~|Malignant|~|123065824|Male|Mixed glioma|2022
20+|0.5|0.6|0.6|Benign/Borderline|501|101938779|Male|Neoplasm, unspecified|2004
20+|0.6|0.7|0.7|Malignant|586|101938779|Male|Neoplasm, unspecified|2004
20+|0.6|0.7|0.7|Benign/Borderline|637|103190694|Male|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Malignant|603|103190694|Male|Neoplasm, unspecified|2005
20+|0.6|0.7|0.6|Benign/Borderline|626|104488268|Male|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Malignant|564|104488268|Male|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Benign/Borderline|589|105697783|Male|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Malignant|566|105697783|Male|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Benign/Borderline|621|106947980|Male|Neoplasm, unspecified|2008
20+|0.6|0.7|0.6|Malignant|614|106947980|Male|Neoplasm, unspecified|2008
20+|0.6|0.7|0.6|Benign/Borderline|617|108197539|Male|Neoplasm, unspecified|2009
20+|0.6|0.7|0.6|Malignant|633|108197539|Male|Neoplasm, unspecified|2009
20+|0.6|0.7|0.7|Benign/Borderline|679|109552956|Male|Neoplasm, unspecified|2010
20+|0.6|0.7|0.6|Malignant|601|109552956|Male|Neoplasm, unspecified|2010
20+|0.6|0.6|0.6|Benign/Borderline|639|110970760|Male|Neoplasm, unspecified|2011
20+|0.6|0.6|0.6|Malignant|613|110970760|Male|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|711|112446425|Male|Neoplasm, unspecified|2012
20+|0.5|0.6|0.6|Malignant|620|112446425|Male|Neoplasm, unspecified|2012
20+|0.6|0.7|0.6|Benign/Borderline|696|113806970|Male|Neoplasm, unspecified|2013
20+|0.5|0.6|0.6|Malignant|609|113806970|Male|Neoplasm, unspecified|2013
20+|0.5|0.6|0.6|Benign/Borderline|648|115171685|Male|Neoplasm, unspecified|2014
20+|0.6|0.7|0.6|Malignant|669|115171685|Male|Neoplasm, unspecified|2014
20+|0.5|0.6|0.6|Benign/Borderline|656|116507411|Male|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Malignant|630|116507411|Male|Neoplasm, unspecified|2015
20+|0.5|0.6|0.5|Benign/Borderline|606|117775787|Male|Neoplasm, unspecified|2016
20+|0.5|0.6|0.6|Malignant|637|117775787|Male|Neoplasm, unspecified|2016
20+|0.4|0.5|0.5|Benign/Borderline|574|118925006|Male|Neoplasm, unspecified|2017
20+|0.5|0.5|0.5|Malignant|584|118925006|Male|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Benign/Borderline|556|119961472|Male|Neoplasm, unspecified|2018
20+|0.5|0.6|0.6|Malignant|668|119961472|Male|Neoplasm, unspecified|2018
20+|0.4|0.5|0.4|Benign/Borderline|2700|608171213|Male|Neoplasm, unspecified|2018-2022
20+|0.5|0.6|0.6|Malignant|3478|608171213|Male|Neoplasm, unspecified|2018-2022
20+|0.4|0.5|0.4|Benign/Borderline|504|120948548|Male|Neoplasm, unspecified|2019
20+|0.6|0.6|0.6|Malignant|716|120948548|Male|Neoplasm, unspecified|2019
20+|0.4|0.5|0.4|Benign/Borderline|546|121826708|Male|Neoplasm, unspecified|2020
20+|0.6|0.7|0.6|Malignant|745|121826708|Male|Neoplasm, unspecified|2020
20+|0.4|0.5|0.4|Benign/Borderline|552|122368661|Male|Neoplasm, unspecified|2021
20+|0.5|0.6|0.6|Malignant|693|122368661|Male|Neoplasm, unspecified|2021
20+|0.4|0.5|0.4|Benign/Borderline|542|123065824|Male|Neoplasm, unspecified|2022
20+|0.5|0.6|0.5|Malignant|656|123065824|Male|Neoplasm, unspecified|2022
20+|2.2|2.4|2.3|Benign/Borderline|2369|101938779|Male|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Nerve sheath, benign and malignant|2004
20+|2.5|2.7|2.6|Benign/Borderline|2725|103190694|Male|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Nerve sheath, benign and malignant|2005
20+|2.4|2.6|2.5|Benign/Borderline|2699|104488268|Male|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Nerve sheath, benign and malignant|2006
20+|2.5|2.7|2.6|Benign/Borderline|2785|105697783|Male|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Nerve sheath, benign and malignant|2007
20+|2.4|2.6|2.5|Benign/Borderline|2769|106947980|Male|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Nerve sheath, benign and malignant|2008
20+|2.6|2.8|2.7|Benign/Borderline|2944|108197539|Male|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Nerve sheath, benign and malignant|2009
20+|2.6|2.8|2.7|Benign/Borderline|3002|109552956|Male|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|23|109552956|Male|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|3101|110970760|Male|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|17|110970760|Male|Nerve sheath, benign and malignant|2011
20+|2.7|2.9|2.8|Benign/Borderline|3302|112446425|Male|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|24|112446425|Male|Nerve sheath, benign and malignant|2012
20+|2.8|3.0|2.9|Benign/Borderline|3432|113806970|Male|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|22|113806970|Male|Nerve sheath, benign and malignant|2013
20+|3.0|3.2|3.1|Benign/Borderline|3700|115171685|Male|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|21|115171685|Male|Nerve sheath, benign and malignant|2014
20+|2.9|3.1|3.0|Benign/Borderline|3692|116507411|Male|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|17|116507411|Male|Nerve sheath, benign and malignant|2015
20+|2.9|3.1|3.0|Benign/Borderline|3672|117775787|Male|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|25|117775787|Male|Nerve sheath, benign and malignant|2016
20+|2.9|3.1|3.0|Benign/Borderline|3788|118925006|Male|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|26|118925006|Male|Nerve sheath, benign and malignant|2017
20+|2.9|3.1|3.0|Benign/Borderline|3823|119961472|Male|Nerve sheath, benign and malignant|2018
20+|~|~|~|Malignant|~|119961472|Male|Nerve sheath, benign and malignant|2018
20+|2.8|2.9|2.8|Benign/Borderline|18600|608171213|Male|Nerve sheath, benign and malignant|2018-2022
20+|0.0|0.0|0.0|Malignant|105|608171213|Male|Nerve sheath, benign and malignant|2018-2022
20+|2.9|3.1|3.0|Benign/Borderline|3857|120948548|Male|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|19|120948548|Male|Nerve sheath, benign and malignant|2019
20+|2.5|2.6|2.5|Benign/Borderline|3346|121826708|Male|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|23|121826708|Male|Nerve sheath, benign and malignant|2020
20+|2.8|3.0|2.9|Benign/Borderline|3763|122368661|Male|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|18|122368661|Male|Nerve sheath, benign and malignant|2021
20+|2.8|3.0|2.9|Benign/Borderline|3811|123065824|Male|Nerve sheath, benign and malignant|2022
20+|0.0|0.0|0.0|Malignant|30|123065824|Male|Nerve sheath, benign and malignant|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|29|101938779|Male|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|31|105697783|Male|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|18|106947980|Male|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|24|108197539|Male|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|25|109552956|Male|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|27|110970760|Male|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|27|112446425|Male|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|27|113806970|Male|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|35|115171685|Male|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|34|116507411|Male|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|25|117775787|Male|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|19|118925006|Male|Neuroepithelial|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Neuroepithelial|2018
20+|~|~|~|Malignant|~|119961472|Male|Neuroepithelial|2018
20+|0.0|0.0|0.0|Benign/Borderline|22|608171213|Male|Neuroepithelial|2018-2022
20+|0.0|0.0|0.0|Malignant|55|608171213|Male|Neuroepithelial|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Neuroepithelial|2019
20+|~|~|~|Malignant|~|120948548|Male|Neuroepithelial|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Neuroepithelial|2020
20+|~|~|~|Malignant|~|121826708|Male|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Neuroepithelial|2021
20+|~|~|~|Malignant|~|122368661|Male|Neuroepithelial|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Neuroepithelial|2022
20+|~|~|~|Malignant|~|123065824|Male|Neuroepithelial|2022
20+|0.1|0.2|0.2|Benign/Borderline|163|101938779|Male|Neuronal/glial, neuronal|2004
20+|0.0|0.0|0.0|Malignant|22|101938779|Male|Neuronal/glial, neuronal|2004
20+|0.2|0.2|0.2|Benign/Borderline|192|103190694|Male|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|35|103190694|Male|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|202|104488268|Male|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|26|104488268|Male|Neuronal/glial, neuronal|2006
20+|0.1|0.2|0.2|Benign/Borderline|186|105697783|Male|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|23|105697783|Male|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|217|106947980|Male|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|24|106947980|Male|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|219|108197539|Male|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Neuronal/glial, neuronal|2009
20+|0.2|0.2|0.2|Benign/Borderline|236|109552956|Male|Neuronal/glial, neuronal|2010
20+|~|~|~|Malignant|~|109552956|Male|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|193|110970760|Male|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|22|110970760|Male|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|210|112446425|Male|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|22|112446425|Male|Neuronal/glial, neuronal|2012
20+|0.2|0.2|0.2|Benign/Borderline|217|113806970|Male|Neuronal/glial, neuronal|2013
20+|0.0|0.0|0.0|Malignant|18|113806970|Male|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|227|115171685|Male|Neuronal/glial, neuronal|2014
20+|0.0|0.0|0.0|Malignant|20|115171685|Male|Neuronal/glial, neuronal|2014
20+|0.2|0.3|0.2|Benign/Borderline|269|116507411|Male|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|17|116507411|Male|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|248|117775787|Male|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|19|117775787|Male|Neuronal/glial, neuronal|2016
20+|0.2|0.2|0.2|Benign/Borderline|253|118925006|Male|Neuronal/glial, neuronal|2017
20+|~|~|~|Malignant|~|118925006|Male|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|256|119961472|Male|Neuronal/glial, neuronal|2018
20+|~|~|~|Malignant|~|119961472|Male|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|1193|608171213|Male|Neuronal/glial, neuronal|2018-2022
20+|0.0|0.0|0.0|Malignant|99|608171213|Male|Neuronal/glial, neuronal|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|258|120948548|Male|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|17|120948548|Male|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|222|121826708|Male|Neuronal/glial, neuronal|2020
20+|0.0|0.0|0.0|Malignant|19|121826708|Male|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|254|122368661|Male|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|27|122368661|Male|Neuronal/glial, neuronal|2021
20+|0.1|0.2|0.2|Benign/Borderline|203|123065824|Male|Neuronal/glial, neuronal|2022
20+|0.0|0.0|0.0|Malignant|25|123065824|Male|Neuronal/glial, neuronal|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Oligodendroglioma|2004
20+|0.4|0.5|0.5|Malignant|476|101938779|Male|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Oligodendroglioma|2005
20+|0.4|0.5|0.4|Malignant|446|103190694|Male|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Oligodendroglioma|2006
20+|0.4|0.5|0.5|Malignant|481|104488268|Male|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Oligodendroglioma|2007
20+|0.4|0.5|0.4|Malignant|444|105697783|Male|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Oligodendroglioma|2008
20+|0.4|0.4|0.4|Malignant|420|106947980|Male|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Oligodendroglioma|2009
20+|0.4|0.5|0.5|Malignant|481|108197539|Male|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Oligodendroglioma|2010
20+|0.4|0.5|0.4|Malignant|479|109552956|Male|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Oligodendroglioma|2011
20+|0.4|0.5|0.4|Malignant|450|110970760|Male|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Oligodendroglioma|2012
20+|0.3|0.4|0.3|Malignant|381|112446425|Male|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Oligodendroglioma|2013
20+|0.3|0.4|0.3|Malignant|370|113806970|Male|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Oligodendroglioma|2014
20+|0.3|0.4|0.4|Malignant|423|115171685|Male|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Oligodendroglioma|2015
20+|0.3|0.4|0.4|Malignant|409|116507411|Male|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Oligodendroglioma|2016
20+|0.3|0.4|0.4|Malignant|405|117775787|Male|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Oligodendroglioma|2017
20+|0.3|0.4|0.4|Malignant|410|118925006|Male|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Oligodendroglioma|2018
20+|0.3|0.4|0.3|Malignant|363|119961472|Male|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|608171213|Male|Oligodendroglioma|2018-2022
20+|0.3|0.4|0.4|Malignant|2033|608171213|Male|Oligodendroglioma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Oligodendroglioma|2019
20+|0.3|0.4|0.4|Malignant|429|120948548|Male|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Oligodendroglioma|2020
20+|0.3|0.4|0.3|Malignant|381|121826708|Male|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Oligodendroglioma|2021
20+|0.3|0.4|0.4|Malignant|412|122368661|Male|Oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Oligodendroglioma|2022
20+|0.3|0.4|0.4|Malignant|448|123065824|Male|Oligodendroglioma|2022
20+|0.1|0.1|0.1|Benign/Borderline|84|101938779|Male|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|32|101938779|Male|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|74|103190694|Male|Other mesenchymal|2005
20+|0.0|0.1|0.0|Malignant|37|103190694|Male|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|70|104488268|Male|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|30|104488268|Male|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|84|105697783|Male|Other mesenchymal|2007
20+|0.0|0.1|0.0|Malignant|41|105697783|Male|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|105|106947980|Male|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|48|106947980|Male|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|104|108197539|Male|Other mesenchymal|2009
20+|0.0|0.1|0.0|Malignant|50|108197539|Male|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|81|109552956|Male|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|35|109552956|Male|Other mesenchymal|2010
20+|0.0|0.1|0.1|Benign/Borderline|69|110970760|Male|Other mesenchymal|2011
20+|0.0|0.1|0.0|Malignant|46|110970760|Male|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|93|112446425|Male|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|31|112446425|Male|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|74|113806970|Male|Other mesenchymal|2013
20+|0.0|0.1|0.0|Malignant|45|113806970|Male|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|89|115171685|Male|Other mesenchymal|2014
20+|0.0|0.1|0.0|Malignant|48|115171685|Male|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|106|116507411|Male|Other mesenchymal|2015
20+|0.0|0.1|0.0|Malignant|51|116507411|Male|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|83|117775787|Male|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|44|117775787|Male|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|86|118925006|Male|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|53|118925006|Male|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|88|119961472|Male|Other mesenchymal|2018
20+|0.0|0.1|0.0|Malignant|61|119961472|Male|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|419|608171213|Male|Other mesenchymal|2018-2022
20+|0.0|0.0|0.0|Malignant|263|608171213|Male|Other mesenchymal|2018-2022
20+|0.0|0.1|0.1|Benign/Borderline|74|120948548|Male|Other mesenchymal|2019
20+|0.0|0.1|0.0|Malignant|47|120948548|Male|Other mesenchymal|2019
20+|0.0|0.1|0.0|Benign/Borderline|63|121826708|Male|Other mesenchymal|2020
20+|0.0|0.1|0.0|Malignant|56|121826708|Male|Other mesenchymal|2020
20+|0.1|0.1|0.1|Benign/Borderline|87|122368661|Male|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|54|122368661|Male|Other mesenchymal|2021
20+|0.1|0.1|0.1|Benign/Borderline|107|123065824|Male|Other mesenchymal|2022
20+|0.0|0.0|0.0|Malignant|45|123065824|Male|Other mesenchymal|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pilocytic astrocytoma|2004
20+|0.1|0.2|0.1|Malignant|151|101938779|Male|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.2|Malignant|158|103190694|Male|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|104488268|Male|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|158|104488268|Male|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|143|105697783|Male|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|106947980|Male|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|145|106947980|Male|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pilocytic astrocytoma|2009
20+|0.1|0.2|0.1|Malignant|139|108197539|Male|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.1|Malignant|165|109552956|Male|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|110970760|Male|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.2|Malignant|175|110970760|Male|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|112446425|Male|Pilocytic astrocytoma|2012
20+|0.1|0.2|0.1|Malignant|147|112446425|Male|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|148|113806970|Male|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|115171685|Male|Pilocytic astrocytoma|2014
20+|0.1|0.2|0.1|Malignant|154|115171685|Male|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Pilocytic astrocytoma|2015
20+|0.1|0.2|0.1|Malignant|149|116507411|Male|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|117775787|Male|Pilocytic astrocytoma|2016
20+|0.1|0.2|0.1|Malignant|165|117775787|Male|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|118925006|Male|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|143|118925006|Male|Pilocytic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|119961472|Male|Pilocytic astrocytoma|2018
20+|0.1|0.2|0.1|Malignant|155|119961472|Male|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|32|608171213|Male|Pilocytic astrocytoma|2018-2022
20+|0.1|0.1|0.1|Malignant|735|608171213|Male|Pilocytic astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Pilocytic astrocytoma|2019
20+|0.1|0.2|0.1|Malignant|164|120948548|Male|Pilocytic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|121826708|Male|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|144|121826708|Male|Pilocytic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|132|122368661|Male|Pilocytic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|123065824|Male|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Malignant|140|123065824|Male|Pilocytic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|101938779|Male|Pineal parenchymal|2004
20+|~|~|~|Malignant|~|101938779|Male|Pineal parenchymal|2004
20+|~|~|~|Benign/Borderline|~|103190694|Male|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Malignant|18|103190694|Male|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|18|104488268|Male|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Pineal parenchymal|2006
20+|~|~|~|Benign/Borderline|~|105697783|Male|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|16|105697783|Male|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Benign/Borderline|24|106947980|Male|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|22|106947980|Male|Pineal parenchymal|2008
20+|~|~|~|Benign/Borderline|~|108197539|Male|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|18|108197539|Male|Pineal parenchymal|2009
20+|~|~|~|Benign/Borderline|~|109552956|Male|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|18|109552956|Male|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Benign/Borderline|16|110970760|Male|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|18|110970760|Male|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|25|112446425|Male|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|20|112446425|Male|Pineal parenchymal|2012
20+|~|~|~|Benign/Borderline|~|113806970|Male|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|36|113806970|Male|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Benign/Borderline|22|115171685|Male|Pineal parenchymal|2014
20+|~|~|~|Malignant|~|115171685|Male|Pineal parenchymal|2014
20+|~|~|~|Benign/Borderline|~|116507411|Male|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|28|116507411|Male|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|26|117775787|Male|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|36|117775787|Male|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|18|118925006|Male|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|27|118925006|Male|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|24|119961472|Male|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|21|119961472|Male|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|93|608171213|Male|Pineal parenchymal|2018-2022
20+|0.0|0.0|0.0|Malignant|115|608171213|Male|Pineal parenchymal|2018-2022
20+|~|~|~|Benign/Borderline|~|120948548|Male|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|18|120948548|Male|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|19|121826708|Male|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|24|121826708|Male|Pineal parenchymal|2020
20+|~|~|~|Benign/Borderline|~|122368661|Male|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|32|122368661|Male|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Benign/Borderline|23|123065824|Male|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Malignant|20|123065824|Male|Pineal parenchymal|2022
20+|3.4|3.7|3.5|Benign/Borderline|3522|101938779|Male|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Pituitary|2004
20+|3.7|4.0|3.9|Benign/Borderline|3895|103190694|Male|Pituitary|2005
20+|~|~|~|Malignant|~|103190694|Male|Pituitary|2005
20+|3.9|4.2|4.1|Benign/Borderline|4170|104488268|Male|Pituitary|2006
20+|0.0|0.0|0.0|Malignant|17|104488268|Male|Pituitary|2006
20+|4.2|4.5|4.4|Benign/Borderline|4588|105697783|Male|Pituitary|2007
20+|0.0|0.0|0.0|Malignant|25|105697783|Male|Pituitary|2007
20+|4.6|4.8|4.7|Benign/Borderline|4999|106947980|Male|Pituitary|2008
20+|~|~|~|Malignant|~|106947980|Male|Pituitary|2008
20+|4.8|5.1|4.9|Benign/Borderline|5352|108197539|Male|Pituitary|2009
20+|~|~|~|Malignant|~|108197539|Male|Pituitary|2009
20+|4.9|5.2|5.1|Benign/Borderline|5602|109552956|Male|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|16|109552956|Male|Pituitary|2010
20+|5.0|5.3|5.2|Benign/Borderline|5763|110970760|Male|Pituitary|2011
20+|0.0|0.0|0.0|Malignant|21|110970760|Male|Pituitary|2011
20+|5.4|5.7|5.5|Benign/Borderline|6292|112446425|Male|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|18|112446425|Male|Pituitary|2012
20+|5.4|5.7|5.5|Benign/Borderline|6387|113806970|Male|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|27|113806970|Male|Pituitary|2013
20+|5.4|5.7|5.5|Benign/Borderline|6522|115171685|Male|Pituitary|2014
20+|0.0|0.0|0.0|Malignant|20|115171685|Male|Pituitary|2014
20+|5.6|5.8|5.7|Benign/Borderline|6834|116507411|Male|Pituitary|2015
20+|0.0|0.0|0.0|Malignant|17|116507411|Male|Pituitary|2015
20+|5.6|5.9|5.7|Benign/Borderline|6992|117775787|Male|Pituitary|2016
20+|0.0|0.0|0.0|Malignant|18|117775787|Male|Pituitary|2016
20+|5.8|6.0|5.9|Benign/Borderline|7286|118925006|Male|Pituitary|2017
20+|0.0|0.0|0.0|Malignant|19|118925006|Male|Pituitary|2017
20+|5.7|6.0|5.9|Benign/Borderline|7371|119961472|Male|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|21|119961472|Male|Pituitary|2018
20+|5.5|5.6|5.6|Benign/Borderline|35836|608171213|Male|Pituitary|2018-2022
20+|0.0|0.0|0.0|Malignant|232|608171213|Male|Pituitary|2018-2022
20+|5.8|6.1|5.9|Benign/Borderline|7534|120948548|Male|Pituitary|2019
20+|~|~|~|Malignant|~|120948548|Male|Pituitary|2019
20+|5.0|5.2|5.1|Benign/Borderline|6547|121826708|Male|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|22|121826708|Male|Pituitary|2020
20+|5.5|5.8|5.7|Benign/Borderline|7339|122368661|Male|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|20|122368661|Male|Pituitary|2021
20+|5.2|5.5|5.4|Benign/Borderline|7045|123065824|Male|Pituitary|2022
20+|0.1|0.1|0.1|Malignant|158|123065824|Male|Pituitary|2022
20+|12.6|13.0|12.8|Benign/Borderline|12499|101938779|Male|Total|2004
20+|10.7|11.1|10.9|Malignant|10653|101938779|Male|Total|2004
20+|14.1|14.5|14.3|Benign/Borderline|14152|103190694|Male|Total|2005
20+|10.7|11.1|10.9|Malignant|10821|103190694|Male|Total|2005
20+|14.4|14.9|14.7|Benign/Borderline|14820|104488268|Male|Total|2006
20+|10.5|10.9|10.7|Malignant|10847|104488268|Male|Total|2006
20+|14.9|15.4|15.1|Benign/Borderline|15552|105697783|Male|Total|2007
20+|10.5|10.9|10.7|Malignant|11088|105697783|Male|Total|2007
20+|15.8|16.3|16.1|Benign/Borderline|16811|106947980|Male|Total|2008
20+|10.6|11.1|10.8|Malignant|11410|106947980|Male|Total|2008
20+|16.7|17.2|16.9|Benign/Borderline|17957|108197539|Male|Total|2009
20+|10.5|10.9|10.7|Malignant|11439|108197539|Male|Total|2009
20+|16.8|17.3|17.0|Benign/Borderline|18453|109552956|Male|Total|2010
20+|10.2|10.6|10.4|Malignant|11427|109552956|Male|Total|2010
20+|16.8|17.3|17.1|Benign/Borderline|18890|110970760|Male|Total|2011
20+|10.3|10.6|10.5|Malignant|11685|110970760|Male|Total|2011
20+|17.5|18.0|17.8|Benign/Borderline|20024|112446425|Male|Total|2012
20+|10.0|10.4|10.2|Malignant|11675|112446425|Male|Total|2012
20+|17.8|18.3|18.1|Benign/Borderline|20738|113806970|Male|Total|2013
20+|10.0|10.4|10.2|Malignant|11914|113806970|Male|Total|2013
20+|18.1|18.6|18.3|Benign/Borderline|21362|115171685|Male|Total|2014
20+|10.2|10.5|10.4|Malignant|12243|115171685|Male|Total|2014
20+|18.5|19.0|18.8|Benign/Borderline|22326|116507411|Male|Total|2015
20+|9.9|10.2|10.0|Malignant|12135|116507411|Male|Total|2015
20+|18.6|19.1|18.8|Benign/Borderline|22705|117775787|Male|Total|2016
20+|10.0|10.4|10.2|Malignant|12559|117775787|Male|Total|2016
20+|19.1|19.6|19.4|Benign/Borderline|23808|118925006|Male|Total|2017
20+|9.9|10.3|10.1|Malignant|12641|118925006|Male|Total|2017
20+|19.1|19.6|19.3|Benign/Borderline|24168|119961472|Male|Total|2018
20+|9.7|10.1|9.9|Malignant|12648|119961472|Male|Total|2018
20+|18.9|19.1|19.0|Benign/Borderline|122196|608171213|Male|Total|2018-2022
20+|9.5|9.7|9.6|Malignant|63141|608171213|Male|Total|2018-2022
20+|19.6|20.1|19.8|Benign/Borderline|25167|120948548|Male|Total|2019
20+|9.7|10.0|9.8|Malignant|12738|120948548|Male|Total|2019
20+|17.6|18.1|17.8|Benign/Borderline|22954|121826708|Male|Total|2020
20+|9.4|9.8|9.6|Malignant|12687|121826708|Male|Total|2020
20+|18.9|19.4|19.2|Benign/Borderline|24934|122368661|Male|Total|2021
20+|9.3|9.6|9.5|Malignant|12599|122368661|Male|Total|2021
20+|18.7|19.2|18.9|Benign/Borderline|24973|123065824|Male|Total|2022
20+|9.0|9.4|9.2|Malignant|12469|123065824|Male|Total|2022
20+|2.2|2.4|2.3|Benign/Borderline|2369|101938779|Male|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|27|101938779|Male|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.7|2.6|Benign/Borderline|2725|103190694|Male|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|30|103190694|Male|Tumors of Cranial and Spinal Nerves|2005
20+|2.4|2.6|2.5|Benign/Borderline|2700|104488268|Male|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.7|2.6|Benign/Borderline|2786|105697783|Male|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|20|105697783|Male|Tumors of Cranial and Spinal Nerves|2007
20+|2.5|2.6|2.5|Benign/Borderline|2771|106947980|Male|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|25|106947980|Male|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|2948|108197539|Male|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|21|108197539|Male|Tumors of Cranial and Spinal Nerves|2009
20+|2.6|2.8|2.7|Benign/Borderline|3003|109552956|Male|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|23|109552956|Male|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|3104|110970760|Male|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|17|110970760|Male|Tumors of Cranial and Spinal Nerves|2011
20+|2.7|2.9|2.8|Benign/Borderline|3304|112446425|Male|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|24|112446425|Male|Tumors of Cranial and Spinal Nerves|2012
20+|2.8|3.0|2.9|Benign/Borderline|3436|113806970|Male|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|22|113806970|Male|Tumors of Cranial and Spinal Nerves|2013
20+|3.0|3.2|3.1|Benign/Borderline|3703|115171685|Male|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|21|115171685|Male|Tumors of Cranial and Spinal Nerves|2014
20+|2.9|3.1|3.0|Benign/Borderline|3699|116507411|Male|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|17|116507411|Male|Tumors of Cranial and Spinal Nerves|2015
20+|2.9|3.1|3.0|Benign/Borderline|3676|117775787|Male|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|25|117775787|Male|Tumors of Cranial and Spinal Nerves|2016
20+|2.9|3.1|3.0|Benign/Borderline|3792|118925006|Male|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|26|118925006|Male|Tumors of Cranial and Spinal Nerves|2017
20+|2.9|3.1|3.0|Benign/Borderline|3826|119961472|Male|Tumors of Cranial and Spinal Nerves|2018
20+|~|~|~|Malignant|~|119961472|Male|Tumors of Cranial and Spinal Nerves|2018
20+|2.8|2.9|2.8|Benign/Borderline|18616|608171213|Male|Tumors of Cranial and Spinal Nerves|2018-2022
20+|0.0|0.0|0.0|Malignant|105|608171213|Male|Tumors of Cranial and Spinal Nerves|2018-2022
20+|2.9|3.1|3.0|Benign/Borderline|3863|120948548|Male|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|19|120948548|Male|Tumors of Cranial and Spinal Nerves|2019
20+|2.5|2.6|2.5|Benign/Borderline|3348|121826708|Male|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|23|121826708|Male|Tumors of Cranial and Spinal Nerves|2020
20+|2.8|3.0|2.9|Benign/Borderline|3767|122368661|Male|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|18|122368661|Male|Tumors of Cranial and Spinal Nerves|2021
20+|2.8|3.0|2.9|Benign/Borderline|3812|123065824|Male|Tumors of Cranial and Spinal Nerves|2022
20+|0.0|0.0|0.0|Malignant|30|123065824|Male|Tumors of Cranial and Spinal Nerves|2022
20+|0.4|0.5|0.4|Benign/Borderline|454|101938779|Male|Tumors of Neuroepthelial Tissue|2004
20+|8.9|9.3|9.1|Malignant|8992|101938779|Male|Tumors of Neuroepthelial Tissue|2004
20+|0.5|0.6|0.5|Benign/Borderline|531|103190694|Male|Tumors of Neuroepthelial Tissue|2005
20+|8.9|9.3|9.1|Malignant|9120|103190694|Male|Tumors of Neuroepthelial Tissue|2005
20+|0.5|0.6|0.5|Benign/Borderline|565|104488268|Male|Tumors of Neuroepthelial Tissue|2006
20+|8.8|9.2|9.0|Malignant|9203|104488268|Male|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.5|Benign/Borderline|527|105697783|Male|Tumors of Neuroepthelial Tissue|2007
20+|8.8|9.2|9.0|Malignant|9416|105697783|Male|Tumors of Neuroepthelial Tissue|2007
20+|0.5|0.6|0.5|Benign/Borderline|593|106947980|Male|Tumors of Neuroepthelial Tissue|2008
20+|9.0|9.3|9.1|Malignant|9701|106947980|Male|Tumors of Neuroepthelial Tissue|2008
20+|0.5|0.6|0.6|Benign/Borderline|603|108197539|Male|Tumors of Neuroepthelial Tissue|2009
20+|8.9|9.2|9.0|Malignant|9748|108197539|Male|Tumors of Neuroepthelial Tissue|2009
20+|0.6|0.7|0.6|Benign/Borderline|656|109552956|Male|Tumors of Neuroepthelial Tissue|2010
20+|8.7|9.0|8.9|Malignant|9774|109552956|Male|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.6|0.6|Benign/Borderline|617|110970760|Male|Tumors of Neuroepthelial Tissue|2011
20+|8.7|9.0|8.8|Malignant|9941|110970760|Male|Tumors of Neuroepthelial Tissue|2011
20+|0.5|0.6|0.6|Benign/Borderline|644|112446425|Male|Tumors of Neuroepthelial Tissue|2012
20+|8.5|8.9|8.7|Malignant|9995|112446425|Male|Tumors of Neuroepthelial Tissue|2012
20+|0.5|0.6|0.5|Benign/Borderline|623|113806970|Male|Tumors of Neuroepthelial Tissue|2013
20+|8.6|8.9|8.7|Malignant|10241|113806970|Male|Tumors of Neuroepthelial Tissue|2013
20+|0.6|0.6|0.6|Benign/Borderline|690|115171685|Male|Tumors of Neuroepthelial Tissue|2014
20+|8.6|8.9|8.7|Malignant|10390|115171685|Male|Tumors of Neuroepthelial Tissue|2014
20+|0.6|0.7|0.6|Benign/Borderline|709|116507411|Male|Tumors of Neuroepthelial Tissue|2015
20+|8.4|8.7|8.5|Malignant|10358|116507411|Male|Tumors of Neuroepthelial Tissue|2015
20+|0.6|0.7|0.6|Benign/Borderline|738|117775787|Male|Tumors of Neuroepthelial Tissue|2016
20+|8.5|8.8|8.6|Malignant|10737|117775787|Male|Tumors of Neuroepthelial Tissue|2016
20+|0.6|0.7|0.6|Benign/Borderline|742|118925006|Male|Tumors of Neuroepthelial Tissue|2017
20+|8.4|8.8|8.6|Malignant|10822|118925006|Male|Tumors of Neuroepthelial Tissue|2017
20+|0.6|0.6|0.6|Benign/Borderline|724|119961472|Male|Tumors of Neuroepthelial Tissue|2018
20+|8.2|8.6|8.4|Malignant|10785|119961472|Male|Tumors of Neuroepthelial Tissue|2018
20+|0.6|0.6|0.6|Benign/Borderline|3640|608171213|Male|Tumors of Neuroepthelial Tissue|2018-2022
20+|8.0|8.2|8.1|Malignant|53645|608171213|Male|Tumors of Neuroepthelial Tissue|2018-2022
20+|0.6|0.7|0.6|Benign/Borderline|738|120948548|Male|Tumors of Neuroepthelial Tissue|2019
20+|8.2|8.5|8.3|Malignant|10851|120948548|Male|Tumors of Neuroepthelial Tissue|2019
20+|0.5|0.6|0.6|Benign/Borderline|697|121826708|Male|Tumors of Neuroepthelial Tissue|2020
20+|7.9|8.3|8.1|Malignant|10781|121826708|Male|Tumors of Neuroepthelial Tissue|2020
20+|0.6|0.7|0.6|Benign/Borderline|739|122368661|Male|Tumors of Neuroepthelial Tissue|2021
20+|7.8|8.2|8.0|Malignant|10704|122368661|Male|Tumors of Neuroepthelial Tissue|2021
20+|0.6|0.6|0.6|Benign/Borderline|742|123065824|Male|Tumors of Neuroepthelial Tissue|2022
20+|7.6|7.9|7.7|Malignant|10524|123065824|Male|Tumors of Neuroepthelial Tissue|2022
20+|3.6|3.8|3.7|Benign/Borderline|3710|101938779|Male|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Tumors of Sellar Region|2004
20+|4.0|4.2|4.1|Benign/Borderline|4129|103190694|Male|Tumors of Sellar Region|2005
20+|~|~|~|Malignant|~|103190694|Male|Tumors of Sellar Region|2005
20+|4.1|4.4|4.2|Benign/Borderline|4364|104488268|Male|Tumors of Sellar Region|2006
20+|0.0|0.0|0.0|Malignant|18|104488268|Male|Tumors of Sellar Region|2006
20+|4.4|4.7|4.6|Benign/Borderline|4790|105697783|Male|Tumors of Sellar Region|2007
20+|0.0|0.0|0.0|Malignant|25|105697783|Male|Tumors of Sellar Region|2007
20+|4.8|5.0|4.9|Benign/Borderline|5200|106947980|Male|Tumors of Sellar Region|2008
20+|~|~|~|Malignant|~|106947980|Male|Tumors of Sellar Region|2008
20+|5.0|5.3|5.1|Benign/Borderline|5553|108197539|Male|Tumors of Sellar Region|2009
20+|~|~|~|Malignant|~|108197539|Male|Tumors of Sellar Region|2009
20+|5.1|5.4|5.3|Benign/Borderline|5805|109552956|Male|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|16|109552956|Male|Tumors of Sellar Region|2010
20+|5.2|5.5|5.3|Benign/Borderline|5962|110970760|Male|Tumors of Sellar Region|2011
20+|0.0|0.0|0.0|Malignant|22|110970760|Male|Tumors of Sellar Region|2011
20+|5.6|5.9|5.7|Benign/Borderline|6510|112446425|Male|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|18|112446425|Male|Tumors of Sellar Region|2012
20+|5.6|5.9|5.7|Benign/Borderline|6624|113806970|Male|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|27|113806970|Male|Tumors of Sellar Region|2013
20+|5.6|5.9|5.7|Benign/Borderline|6736|115171685|Male|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|23|115171685|Male|Tumors of Sellar Region|2014
20+|5.8|6.0|5.9|Benign/Borderline|7061|116507411|Male|Tumors of Sellar Region|2015
20+|0.0|0.0|0.0|Malignant|17|116507411|Male|Tumors of Sellar Region|2015
20+|5.8|6.1|6.0|Benign/Borderline|7242|117775787|Male|Tumors of Sellar Region|2016
20+|0.0|0.0|0.0|Malignant|19|117775787|Male|Tumors of Sellar Region|2016
20+|6.0|6.2|6.1|Benign/Borderline|7534|118925006|Male|Tumors of Sellar Region|2017
20+|0.0|0.0|0.0|Malignant|19|118925006|Male|Tumors of Sellar Region|2017
20+|5.9|6.2|6.1|Benign/Borderline|7602|119961472|Male|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|21|119961472|Male|Tumors of Sellar Region|2018
20+|5.7|5.8|5.8|Benign/Borderline|37035|608171213|Male|Tumors of Sellar Region|2018-2022
20+|0.0|0.0|0.0|Malignant|233|608171213|Male|Tumors of Sellar Region|2018-2022
20+|6.0|6.3|6.1|Benign/Borderline|7785|120948548|Male|Tumors of Sellar Region|2019
20+|~|~|~|Malignant|~|120948548|Male|Tumors of Sellar Region|2019
20+|5.2|5.4|5.3|Benign/Borderline|6786|121826708|Male|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|23|121826708|Male|Tumors of Sellar Region|2020
20+|5.7|6.0|5.9|Benign/Borderline|7574|122368661|Male|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|20|122368661|Male|Tumors of Sellar Region|2021
20+|5.4|5.7|5.6|Benign/Borderline|7288|123065824|Male|Tumors of Sellar Region|2022
20+|0.1|0.1|0.1|Malignant|158|123065824|Male|Tumors of Sellar Region|2022
20+|5.5|5.8|5.6|Benign/Borderline|5298|101938779|Male|Tumors of the Meninges|2004
20+|0.2|0.2|0.2|Malignant|208|101938779|Male|Tumors of the Meninges|2004
20+|6.0|6.3|6.2|Benign/Borderline|5891|103190694|Male|Tumors of the Meninges|2005
20+|0.2|0.2|0.2|Malignant|193|103190694|Male|Tumors of the Meninges|2005
20+|6.3|6.6|6.4|Benign/Borderline|6292|104488268|Male|Tumors of the Meninges|2006
20+|0.2|0.2|0.2|Malignant|189|104488268|Male|Tumors of the Meninges|2006
20+|6.4|6.7|6.6|Benign/Borderline|6549|105697783|Male|Tumors of the Meninges|2007
20+|0.2|0.2|0.2|Malignant|222|105697783|Male|Tumors of the Meninges|2007
20+|6.9|7.3|7.1|Benign/Borderline|7255|106947980|Male|Tumors of the Meninges|2008
20+|0.2|0.2|0.2|Malignant|201|106947980|Male|Tumors of the Meninges|2008
20+|7.3|7.7|7.5|Benign/Borderline|7751|108197539|Male|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|203|108197539|Male|Tumors of the Meninges|2009
20+|7.2|7.6|7.4|Benign/Borderline|7820|109552956|Male|Tumors of the Meninges|2010
20+|0.1|0.2|0.1|Malignant|160|109552956|Male|Tumors of the Meninges|2010
20+|7.3|7.6|7.4|Benign/Borderline|8022|110970760|Male|Tumors of the Meninges|2011
20+|0.1|0.2|0.2|Malignant|190|110970760|Male|Tumors of the Meninges|2011
20+|7.4|7.7|7.5|Benign/Borderline|8305|112446425|Male|Tumors of the Meninges|2012
20+|0.1|0.2|0.2|Malignant|186|112446425|Male|Tumors of the Meninges|2012
20+|7.7|8.0|7.8|Benign/Borderline|8808|113806970|Male|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|203|113806970|Male|Tumors of the Meninges|2013
20+|7.7|8.0|7.9|Benign/Borderline|9032|115171685|Male|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|220|115171685|Male|Tumors of the Meninges|2014
20+|8.1|8.4|8.2|Benign/Borderline|9693|116507411|Male|Tumors of the Meninges|2015
20+|0.1|0.2|0.2|Malignant|202|116507411|Male|Tumors of the Meninges|2015
20+|8.2|8.5|8.4|Benign/Borderline|9975|117775787|Male|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|212|117775787|Male|Tumors of the Meninges|2016
20+|8.6|8.9|8.7|Benign/Borderline|10665|118925006|Male|Tumors of the Meninges|2017
20+|0.1|0.2|0.2|Malignant|209|118925006|Male|Tumors of the Meninges|2017
20+|8.6|9.0|8.8|Benign/Borderline|10953|119961472|Male|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|208|119961472|Male|Tumors of the Meninges|2018
20+|8.9|9.0|9.0|Benign/Borderline|57734|608171213|Male|Tumors of the Meninges|2018-2022
20+|0.1|0.2|0.2|Malignant|1022|608171213|Male|Tumors of the Meninges|2018-2022
20+|9.1|9.5|9.3|Benign/Borderline|11753|120948548|Male|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|199|120948548|Male|Tumors of the Meninges|2019
20+|8.4|8.8|8.6|Benign/Borderline|11083|121826708|Male|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|201|121826708|Male|Tumors of the Meninges|2020
20+|8.9|9.2|9.0|Benign/Borderline|11810|122368661|Male|Tumors of the Meninges|2021
20+|0.1|0.2|0.2|Malignant|217|122368661|Male|Tumors of the Meninges|2021
20+|8.9|9.3|9.1|Benign/Borderline|12135|123065824|Male|Tumors of the Meninges|2022
20+|0.1|0.2|0.1|Malignant|197|123065824|Male|Tumors of the Meninges|2022
20+|0.6|0.7|0.7|Benign/Borderline|644|101938779|Male|Unclassified Tumors|2004
20+|0.6|0.7|0.7|Malignant|594|101938779|Male|Unclassified Tumors|2004
20+|0.8|0.9|0.9|Benign/Borderline|843|103190694|Male|Unclassified Tumors|2005
20+|0.6|0.7|0.7|Malignant|612|103190694|Male|Unclassified Tumors|2005
20+|0.8|0.9|0.9|Benign/Borderline|868|104488268|Male|Unclassified Tumors|2006
20+|0.6|0.7|0.6|Malignant|575|104488268|Male|Unclassified Tumors|2006
20+|0.8|0.9|0.9|Benign/Borderline|863|105697783|Male|Unclassified Tumors|2007
20+|0.6|0.7|0.6|Malignant|575|105697783|Male|Unclassified Tumors|2007
20+|0.9|1.0|0.9|Benign/Borderline|957|106947980|Male|Unclassified Tumors|2008
20+|0.6|0.7|0.7|Malignant|624|106947980|Male|Unclassified Tumors|2008
20+|1.0|1.1|1.0|Benign/Borderline|1064|108197539|Male|Unclassified Tumors|2009
20+|0.6|0.7|0.7|Malignant|642|108197539|Male|Unclassified Tumors|2009
20+|1.0|1.1|1.1|Benign/Borderline|1138|109552956|Male|Unclassified Tumors|2010
20+|0.6|0.7|0.6|Malignant|613|109552956|Male|Unclassified Tumors|2010
20+|1.0|1.1|1.1|Benign/Borderline|1160|110970760|Male|Unclassified Tumors|2011
20+|0.6|0.7|0.6|Malignant|628|110970760|Male|Unclassified Tumors|2011
20+|1.1|1.2|1.1|Benign/Borderline|1228|112446425|Male|Unclassified Tumors|2012
20+|0.6|0.7|0.6|Malignant|632|112446425|Male|Unclassified Tumors|2012
20+|1.0|1.1|1.1|Benign/Borderline|1218|113806970|Male|Unclassified Tumors|2013
20+|0.5|0.6|0.6|Malignant|619|113806970|Male|Unclassified Tumors|2013
20+|1.0|1.1|1.0|Benign/Borderline|1172|115171685|Male|Unclassified Tumors|2014
20+|0.6|0.7|0.6|Malignant|681|115171685|Male|Unclassified Tumors|2014
20+|0.9|1.0|1.0|Benign/Borderline|1133|116507411|Male|Unclassified Tumors|2015
20+|0.5|0.6|0.6|Malignant|638|116507411|Male|Unclassified Tumors|2015
20+|0.8|1.0|0.9|Benign/Borderline|1040|117775787|Male|Unclassified Tumors|2016
20+|0.5|0.6|0.6|Malignant|649|117775787|Male|Unclassified Tumors|2016
20+|0.8|0.9|0.9|Benign/Borderline|1039|118925006|Male|Unclassified Tumors|2017
20+|0.5|0.5|0.5|Malignant|592|118925006|Male|Unclassified Tumors|2017
20+|0.8|0.9|0.9|Benign/Borderline|1036|119961472|Male|Unclassified Tumors|2018
20+|0.5|0.6|0.6|Malignant|685|119961472|Male|Unclassified Tumors|2018
20+|0.8|0.8|0.8|Benign/Borderline|5044|608171213|Male|Unclassified Tumors|2018-2022
20+|0.6|0.6|0.6|Malignant|3543|608171213|Male|Unclassified Tumors|2018-2022
20+|0.8|0.9|0.8|Benign/Borderline|997|120948548|Male|Unclassified Tumors|2019
20+|0.6|0.6|0.6|Malignant|729|120948548|Male|Unclassified Tumors|2019
20+|0.8|0.9|0.8|Benign/Borderline|1014|121826708|Male|Unclassified Tumors|2020
20+|0.6|0.7|0.6|Malignant|758|121826708|Male|Unclassified Tumors|2020
20+|0.8|0.9|0.8|Benign/Borderline|1026|122368661|Male|Unclassified Tumors|2021
20+|0.5|0.6|0.6|Malignant|705|122368661|Male|Unclassified Tumors|2021
20+|0.7|0.8|0.8|Benign/Borderline|971|123065824|Male|Unclassified Tumors|2022
20+|0.5|0.6|0.5|Malignant|666|123065824|Male|Unclassified Tumors|2022
20+|0.1|0.1|0.1|Benign/Borderline|100|101938779|Male|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|18|101938779|Male|Unique astrocytoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|116|103190694|Male|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|17|103190694|Male|Unique astrocytoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|140|104488268|Male|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|25|104488268|Male|Unique astrocytoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|125|105697783|Male|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|30|105697783|Male|Unique astrocytoma variants|2007
20+|0.1|0.2|0.1|Benign/Borderline|153|106947980|Male|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|35|106947980|Male|Unique astrocytoma variants|2008
20+|0.1|0.2|0.2|Benign/Borderline|165|108197539|Male|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|37|108197539|Male|Unique astrocytoma variants|2009
20+|0.1|0.2|0.2|Benign/Borderline|187|109552956|Male|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|26|109552956|Male|Unique astrocytoma variants|2010
20+|0.1|0.2|0.2|Benign/Borderline|193|110970760|Male|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|31|110970760|Male|Unique astrocytoma variants|2011
20+|0.1|0.2|0.2|Benign/Borderline|182|112446425|Male|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|27|112446425|Male|Unique astrocytoma variants|2012
20+|0.1|0.2|0.1|Benign/Borderline|176|113806970|Male|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|39|113806970|Male|Unique astrocytoma variants|2013
20+|0.1|0.2|0.2|Benign/Borderline|183|115171685|Male|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|40|115171685|Male|Unique astrocytoma variants|2014
20+|0.1|0.2|0.2|Benign/Borderline|183|116507411|Male|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|27|116507411|Male|Unique astrocytoma variants|2015
20+|0.1|0.2|0.2|Benign/Borderline|208|117775787|Male|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|32|117775787|Male|Unique astrocytoma variants|2016
20+|0.1|0.2|0.2|Benign/Borderline|215|118925006|Male|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|43|118925006|Male|Unique astrocytoma variants|2017
20+|0.2|0.2|0.2|Benign/Borderline|234|119961472|Male|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|33|119961472|Male|Unique astrocytoma variants|2018
20+|0.2|0.2|0.2|Benign/Borderline|1228|608171213|Male|Unique astrocytoma variants|2018-2022
20+|0.0|0.0|0.0|Malignant|166|608171213|Male|Unique astrocytoma variants|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|245|120948548|Male|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|29|120948548|Male|Unique astrocytoma variants|2019
20+|0.2|0.2|0.2|Benign/Borderline|245|121826708|Male|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|37|121826708|Male|Unique astrocytoma variants|2020
20+|0.2|0.2|0.2|Benign/Borderline|245|122368661|Male|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|31|122368661|Male|Unique astrocytoma variants|2021
20+|0.2|0.2|0.2|Benign/Borderline|259|123065824|Male|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Malignant|36|123065824|Male|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Benign/Borderline|25|211050944|Male and Female|All other|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|All other|2004
20+|0.0|0.0|0.0|Benign/Borderline|32|213511339|Male and Female|All other|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|All other|2005
20+|0.0|0.0|0.0|Benign/Borderline|38|216055494|Male and Female|All other|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|All other|2006
20+|0.0|0.0|0.0|Benign/Borderline|32|218481776|Male and Female|All other|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|All other|2007
20+|0.0|0.0|0.0|Benign/Borderline|36|220975702|Male and Female|All other|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|All other|2008
20+|0.0|0.0|0.0|Benign/Borderline|30|223491138|Male and Female|All other|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|All other|2009
20+|0.0|0.0|0.0|Benign/Borderline|34|226154695|Male and Female|All other|2010
20+|0.0|0.0|0.0|Malignant|35|226154695|Male and Female|All other|2010
20+|0.0|0.0|0.0|Benign/Borderline|32|228805985|Male and Female|All other|2011
20+|0.0|0.0|0.0|Malignant|44|228805985|Male and Female|All other|2011
20+|0.0|0.0|0.0|Benign/Borderline|33|231483500|Male and Female|All other|2012
20+|0.0|0.0|0.0|Malignant|35|231483500|Male and Female|All other|2012
20+|0.0|0.0|0.0|Benign/Borderline|34|233942819|Male and Female|All other|2013
20+|0.0|0.0|0.0|Malignant|52|233942819|Male and Female|All other|2013
20+|0.0|0.0|0.0|Benign/Borderline|30|236444496|Male and Female|All other|2014
20+|0.0|0.0|0.0|Malignant|48|236444496|Male and Female|All other|2014
20+|0.0|0.0|0.0|Benign/Borderline|47|238861655|Male and Female|All other|2015
20+|0.0|0.0|0.0|Malignant|53|238861655|Male and Female|All other|2015
20+|0.0|0.0|0.0|Benign/Borderline|81|241188135|Male and Female|All other|2016
20+|0.0|0.0|0.0|Malignant|53|241188135|Male and Female|All other|2016
20+|0.0|0.0|0.0|Benign/Borderline|75|243306804|Male and Female|All other|2017
20+|0.0|0.0|0.0|Malignant|57|243306804|Male and Female|All other|2017
20+|0.0|0.0|0.0|Benign/Borderline|96|245213263|Male and Female|All other|2018
20+|0.1|0.2|0.2|Malignant|400|245213263|Male and Female|All other|2018
20+|0.0|0.0|0.0|Benign/Borderline|508|1242099918|Male and Female|All other|2018-2022
20+|0.2|0.2|0.2|Malignant|2400|1242099918|Male and Female|All other|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|87|247018299|Male and Female|All other|2019
20+|0.2|0.2|0.2|Malignant|517|247018299|Male and Female|All other|2019
20+|0.0|0.0|0.0|Benign/Borderline|83|248653501|Male and Female|All other|2020
20+|0.2|0.2|0.2|Malignant|524|248653501|Male and Female|All other|2020
20+|0.0|0.1|0.0|Benign/Borderline|112|249847104|Male and Female|All other|2021
20+|0.2|0.2|0.2|Malignant|465|249847104|Male and Female|All other|2021
20+|0.0|0.1|0.1|Benign/Borderline|130|251367751|Male and Female|All other|2022
20+|0.2|0.2|0.2|Malignant|494|251367751|Male and Female|All other|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic astrocytoma|2004
20+|0.6|0.6|0.6|Malignant|1243|211050944|Male and Female|Anaplastic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic astrocytoma|2005
20+|0.5|0.6|0.6|Malignant|1215|213511339|Male and Female|Anaplastic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic astrocytoma|2006
20+|0.5|0.6|0.6|Malignant|1214|216055494|Male and Female|Anaplastic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic astrocytoma|2007
20+|0.5|0.6|0.5|Malignant|1206|218481776|Male and Female|Anaplastic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic astrocytoma|2008
20+|0.5|0.6|0.5|Malignant|1215|220975702|Male and Female|Anaplastic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic astrocytoma|2009
20+|0.5|0.6|0.5|Malignant|1217|223491138|Male and Female|Anaplastic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Anaplastic astrocytoma|2010
20+|0.5|0.6|0.6|Malignant|1286|226154695|Male and Female|Anaplastic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Anaplastic astrocytoma|2011
20+|0.5|0.6|0.5|Malignant|1283|228805985|Male and Female|Anaplastic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Anaplastic astrocytoma|2012
20+|0.5|0.6|0.6|Malignant|1338|231483500|Male and Female|Anaplastic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Anaplastic astrocytoma|2013
20+|0.6|0.6|0.6|Malignant|1441|233942819|Male and Female|Anaplastic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Anaplastic astrocytoma|2014
20+|0.6|0.6|0.6|Malignant|1416|236444496|Male and Female|Anaplastic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Anaplastic astrocytoma|2015
20+|0.6|0.6|0.6|Malignant|1490|238861655|Male and Female|Anaplastic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Anaplastic astrocytoma|2016
20+|0.6|0.6|0.6|Malignant|1485|241188135|Male and Female|Anaplastic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Anaplastic astrocytoma|2017
20+|0.6|0.6|0.6|Malignant|1463|243306804|Male and Female|Anaplastic astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Anaplastic astrocytoma|2018
20+|0.5|0.6|0.6|Malignant|1447|245213263|Male and Female|Anaplastic astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Anaplastic astrocytoma|2018-2022
20+|0.4|0.4|0.4|Malignant|5283|1242099918|Male and Female|Anaplastic astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Anaplastic astrocytoma|2019
20+|0.5|0.5|0.5|Malignant|1300|247018299|Male and Female|Anaplastic astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Anaplastic astrocytoma|2020
20+|0.4|0.5|0.5|Malignant|1178|248653501|Male and Female|Anaplastic astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Anaplastic astrocytoma|2021
20+|0.3|0.4|0.3|Malignant|827|249847104|Male and Female|Anaplastic astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Anaplastic astrocytoma|2022
20+|0.2|0.2|0.2|Malignant|531|251367751|Male and Female|Anaplastic astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Anaplastic oligodendroglioma|2004
20+|0.2|0.2|0.2|Malignant|399|211050944|Male and Female|Anaplastic oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Anaplastic oligodendroglioma|2005
20+|0.2|0.2|0.2|Malignant|379|213511339|Male and Female|Anaplastic oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Anaplastic oligodendroglioma|2006
20+|0.1|0.2|0.2|Malignant|357|216055494|Male and Female|Anaplastic oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Anaplastic oligodendroglioma|2007
20+|0.1|0.2|0.2|Malignant|353|218481776|Male and Female|Anaplastic oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Anaplastic oligodendroglioma|2008
20+|0.1|0.2|0.2|Malignant|362|220975702|Male and Female|Anaplastic oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Anaplastic oligodendroglioma|2009
20+|0.1|0.2|0.2|Malignant|340|223491138|Male and Female|Anaplastic oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Anaplastic oligodendroglioma|2010
20+|0.1|0.2|0.1|Malignant|329|226154695|Male and Female|Anaplastic oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Anaplastic oligodendroglioma|2011
20+|0.1|0.2|0.1|Malignant|341|228805985|Male and Female|Anaplastic oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Anaplastic oligodendroglioma|2012
20+|0.1|0.2|0.2|Malignant|360|231483500|Male and Female|Anaplastic oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Anaplastic oligodendroglioma|2013
20+|0.1|0.2|0.2|Malignant|377|233942819|Male and Female|Anaplastic oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Anaplastic oligodendroglioma|2014
20+|0.1|0.2|0.2|Malignant|362|236444496|Male and Female|Anaplastic oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Anaplastic oligodendroglioma|2015
20+|0.1|0.2|0.1|Malignant|357|238861655|Male and Female|Anaplastic oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Anaplastic oligodendroglioma|2016
20+|0.1|0.2|0.2|Malignant|375|241188135|Male and Female|Anaplastic oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Anaplastic oligodendroglioma|2017
20+|0.2|0.2|0.2|Malignant|422|243306804|Male and Female|Anaplastic oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Anaplastic oligodendroglioma|2018
20+|0.1|0.2|0.1|Malignant|345|245213263|Male and Female|Anaplastic oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Anaplastic oligodendroglioma|2018-2022
20+|0.1|0.1|0.1|Malignant|1491|1242099918|Male and Female|Anaplastic oligodendroglioma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Anaplastic oligodendroglioma|2019
20+|0.1|0.2|0.2|Malignant|387|247018299|Male and Female|Anaplastic oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Anaplastic oligodendroglioma|2020
20+|0.1|0.1|0.1|Malignant|324|248653501|Male and Female|Anaplastic oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Anaplastic oligodendroglioma|2021
20+|0.1|0.1|0.1|Malignant|280|249847104|Male and Female|Anaplastic oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Anaplastic oligodendroglioma|2022
20+|0.1|0.1|0.1|Malignant|155|251367751|Male and Female|Anaplastic oligodendroglioma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Astrocytoma, NOS|2004
20+|0.5|0.6|0.6|Malignant|1210|211050944|Male and Female|Astrocytoma, NOS|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Astrocytoma, NOS|2005
20+|0.5|0.6|0.6|Malignant|1201|213511339|Male and Female|Astrocytoma, NOS|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Astrocytoma, NOS|2006
20+|0.5|0.6|0.6|Malignant|1190|216055494|Male and Female|Astrocytoma, NOS|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Astrocytoma, NOS|2007
20+|0.5|0.6|0.5|Malignant|1165|218481776|Male and Female|Astrocytoma, NOS|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Astrocytoma, NOS|2008
20+|0.5|0.5|0.5|Malignant|1126|220975702|Male and Female|Astrocytoma, NOS|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Astrocytoma, NOS|2009
20+|0.4|0.5|0.5|Malignant|1060|223491138|Male and Female|Astrocytoma, NOS|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Astrocytoma, NOS|2010
20+|0.5|0.5|0.5|Malignant|1105|226154695|Male and Female|Astrocytoma, NOS|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Astrocytoma, NOS|2011
20+|0.4|0.5|0.5|Malignant|1059|228805985|Male and Female|Astrocytoma, NOS|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Astrocytoma, NOS|2012
20+|0.4|0.5|0.5|Malignant|1055|231483500|Male and Female|Astrocytoma, NOS|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Astrocytoma, NOS|2013
20+|0.4|0.5|0.4|Malignant|1034|233942819|Male and Female|Astrocytoma, NOS|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Astrocytoma, NOS|2014
20+|0.4|0.5|0.5|Malignant|1112|236444496|Male and Female|Astrocytoma, NOS|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Astrocytoma, NOS|2015
20+|0.5|0.5|0.5|Malignant|1230|238861655|Male and Female|Astrocytoma, NOS|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Astrocytoma, NOS|2016
20+|0.5|0.6|0.5|Malignant|1279|241188135|Male and Female|Astrocytoma, NOS|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Astrocytoma, NOS|2017
20+|0.5|0.5|0.5|Malignant|1233|243306804|Male and Female|Astrocytoma, NOS|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Astrocytoma, NOS|2018
20+|0.5|0.6|0.5|Malignant|1319|245213263|Male and Female|Astrocytoma, NOS|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Astrocytoma, NOS|2018-2022
20+|0.6|0.6|0.6|Malignant|6911|1242099918|Male and Female|Astrocytoma, NOS|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Astrocytoma, NOS|2019
20+|0.5|0.5|0.5|Malignant|1274|247018299|Male and Female|Astrocytoma, NOS|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Astrocytoma, NOS|2020
20+|0.5|0.5|0.5|Malignant|1249|248653501|Male and Female|Astrocytoma, NOS|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Astrocytoma, NOS|2021
20+|0.6|0.7|0.6|Malignant|1514|249847104|Male and Female|Astrocytoma, NOS|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Astrocytoma, NOS|2022
20+|0.6|0.7|0.6|Malignant|1555|251367751|Male and Female|Astrocytoma, NOS|2022
20+|0.0|0.0|0.0|Benign/Borderline|65|211050944|Male and Female|Choroid plexus|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Choroid plexus|2004
20+|0.0|0.0|0.0|Benign/Borderline|76|213511339|Male and Female|Choroid plexus|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Choroid plexus|2005
20+|0.0|0.0|0.0|Benign/Borderline|69|216055494|Male and Female|Choroid plexus|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Choroid plexus|2006
20+|0.0|0.1|0.0|Benign/Borderline|91|218481776|Male and Female|Choroid plexus|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Choroid plexus|2007
20+|0.0|0.0|0.0|Benign/Borderline|79|220975702|Male and Female|Choroid plexus|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Choroid plexus|2008
20+|0.0|0.0|0.0|Benign/Borderline|74|223491138|Male and Female|Choroid plexus|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Choroid plexus|2009
20+|0.0|0.0|0.0|Benign/Borderline|85|226154695|Male and Female|Choroid plexus|2010
20+|~|~|~|Malignant|~|226154695|Male and Female|Choroid plexus|2010
20+|0.0|0.0|0.0|Benign/Borderline|86|228805985|Male and Female|Choroid plexus|2011
20+|~|~|~|Malignant|~|228805985|Male and Female|Choroid plexus|2011
20+|0.0|0.0|0.0|Benign/Borderline|78|231483500|Male and Female|Choroid plexus|2012
20+|~|~|~|Malignant|~|231483500|Male and Female|Choroid plexus|2012
20+|0.0|0.0|0.0|Benign/Borderline|82|233942819|Male and Female|Choroid plexus|2013
20+|~|~|~|Malignant|~|233942819|Male and Female|Choroid plexus|2013
20+|0.0|0.0|0.0|Benign/Borderline|90|236444496|Male and Female|Choroid plexus|2014
20+|~|~|~|Malignant|~|236444496|Male and Female|Choroid plexus|2014
20+|0.0|0.0|0.0|Benign/Borderline|85|238861655|Male and Female|Choroid plexus|2015
20+|~|~|~|Malignant|~|238861655|Male and Female|Choroid plexus|2015
20+|0.0|0.0|0.0|Benign/Borderline|74|241188135|Male and Female|Choroid plexus|2016
20+|~|~|~|Malignant|~|241188135|Male and Female|Choroid plexus|2016
20+|0.0|0.0|0.0|Benign/Borderline|98|243306804|Male and Female|Choroid plexus|2017
20+|~|~|~|Malignant|~|243306804|Male and Female|Choroid plexus|2017
20+|0.0|0.0|0.0|Benign/Borderline|85|245213263|Male and Female|Choroid plexus|2018
20+|~|~|~|Malignant|~|245213263|Male and Female|Choroid plexus|2018
20+|0.0|0.0|0.0|Benign/Borderline|405|1242099918|Male and Female|Choroid plexus|2018-2022
20+|0.0|0.0|0.0|Malignant|31|1242099918|Male and Female|Choroid plexus|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|86|247018299|Male and Female|Choroid plexus|2019
20+|~|~|~|Malignant|~|247018299|Male and Female|Choroid plexus|2019
20+|0.0|0.0|0.0|Benign/Borderline|73|248653501|Male and Female|Choroid plexus|2020
20+|~|~|~|Malignant|~|248653501|Male and Female|Choroid plexus|2020
20+|0.0|0.0|0.0|Benign/Borderline|82|249847104|Male and Female|Choroid plexus|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Choroid plexus|2021
20+|0.0|0.0|0.0|Benign/Borderline|79|251367751|Male and Female|Choroid plexus|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Choroid plexus|2022
20+|0.2|0.2|0.2|Benign/Borderline|396|211050944|Male and Female|Craniopharyngioma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Craniopharyngioma|2004
20+|0.2|0.2|0.2|Benign/Borderline|420|213511339|Male and Female|Craniopharyngioma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Craniopharyngioma|2005
20+|0.2|0.2|0.2|Benign/Borderline|402|216055494|Male and Female|Craniopharyngioma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Craniopharyngioma|2006
20+|0.2|0.2|0.2|Benign/Borderline|424|218481776|Male and Female|Craniopharyngioma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Craniopharyngioma|2007
20+|0.2|0.2|0.2|Benign/Borderline|429|220975702|Male and Female|Craniopharyngioma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Craniopharyngioma|2008
20+|0.2|0.2|0.2|Benign/Borderline|434|223491138|Male and Female|Craniopharyngioma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Craniopharyngioma|2009
20+|0.2|0.2|0.2|Benign/Borderline|446|226154695|Male and Female|Craniopharyngioma|2010
20+|~|~|~|Malignant|~|226154695|Male and Female|Craniopharyngioma|2010
20+|0.2|0.2|0.2|Benign/Borderline|421|228805985|Male and Female|Craniopharyngioma|2011
20+|~|~|~|Malignant|~|228805985|Male and Female|Craniopharyngioma|2011
20+|0.2|0.2|0.2|Benign/Borderline|447|231483500|Male and Female|Craniopharyngioma|2012
20+|~|~|~|Malignant|~|231483500|Male and Female|Craniopharyngioma|2012
20+|0.2|0.2|0.2|Benign/Borderline|484|233942819|Male and Female|Craniopharyngioma|2013
20+|~|~|~|Malignant|~|233942819|Male and Female|Craniopharyngioma|2013
20+|0.2|0.2|0.2|Benign/Borderline|442|236444496|Male and Female|Craniopharyngioma|2014
20+|~|~|~|Malignant|~|236444496|Male and Female|Craniopharyngioma|2014
20+|0.2|0.2|0.2|Benign/Borderline|470|238861655|Male and Female|Craniopharyngioma|2015
20+|~|~|~|Malignant|~|238861655|Male and Female|Craniopharyngioma|2015
20+|0.2|0.2|0.2|Benign/Borderline|483|241188135|Male and Female|Craniopharyngioma|2016
20+|~|~|~|Malignant|~|241188135|Male and Female|Craniopharyngioma|2016
20+|0.2|0.2|0.2|Benign/Borderline|499|243306804|Male and Female|Craniopharyngioma|2017
20+|~|~|~|Malignant|~|243306804|Male and Female|Craniopharyngioma|2017
20+|0.2|0.2|0.2|Benign/Borderline|478|245213263|Male and Female|Craniopharyngioma|2018
20+|~|~|~|Malignant|~|245213263|Male and Female|Craniopharyngioma|2018
20+|0.2|0.2|0.2|Benign/Borderline|2353|1242099918|Male and Female|Craniopharyngioma|2018-2022
20+|~|~|~|Malignant|~|1242099918|Male and Female|Craniopharyngioma|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|490|247018299|Male and Female|Craniopharyngioma|2019
20+|~|~|~|Malignant|~|247018299|Male and Female|Craniopharyngioma|2019
20+|0.2|0.2|0.2|Benign/Borderline|461|248653501|Male and Female|Craniopharyngioma|2020
20+|~|~|~|Malignant|~|248653501|Male and Female|Craniopharyngioma|2020
20+|0.2|0.2|0.2|Benign/Borderline|449|249847104|Male and Female|Craniopharyngioma|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Craniopharyngioma|2021
20+|0.2|0.2|0.2|Benign/Borderline|475|251367751|Male and Female|Craniopharyngioma|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Craniopharyngioma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Diffuse astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|260|211050944|Male and Female|Diffuse astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Diffuse astrocytoma|2005
20+|0.1|0.1|0.1|Malignant|281|213511339|Male and Female|Diffuse astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Diffuse astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|294|216055494|Male and Female|Diffuse astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Diffuse astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|318|218481776|Male and Female|Diffuse astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Diffuse astrocytoma|2008
20+|0.1|0.2|0.2|Malignant|341|220975702|Male and Female|Diffuse astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Diffuse astrocytoma|2009
20+|0.1|0.2|0.2|Malignant|368|223491138|Male and Female|Diffuse astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Diffuse astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|350|226154695|Male and Female|Diffuse astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Diffuse astrocytoma|2011
20+|0.1|0.1|0.1|Malignant|250|228805985|Male and Female|Diffuse astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Diffuse astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|207|231483500|Male and Female|Diffuse astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Diffuse astrocytoma|2013
20+|0.1|0.1|0.1|Malignant|175|233942819|Male and Female|Diffuse astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Diffuse astrocytoma|2014
20+|0.0|0.1|0.1|Malignant|132|236444496|Male and Female|Diffuse astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Diffuse astrocytoma|2015
20+|0.0|0.0|0.0|Malignant|84|238861655|Male and Female|Diffuse astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Diffuse astrocytoma|2016
20+|0.0|0.0|0.0|Malignant|35|241188135|Male and Female|Diffuse astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Diffuse astrocytoma|2017
20+|0.0|0.0|0.0|Malignant|24|243306804|Male and Female|Diffuse astrocytoma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Diffuse astrocytoma|2018
20+|0.0|0.0|0.0|Malignant|23|245213263|Male and Female|Diffuse astrocytoma|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Diffuse astrocytoma|2018-2022
20+|0.0|0.0|0.0|Malignant|54|1242099918|Male and Female|Diffuse astrocytoma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Diffuse astrocytoma|2019
20+|~|~|~|Malignant|~|247018299|Male and Female|Diffuse astrocytoma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Diffuse astrocytoma|2020
20+|~|~|~|Malignant|~|248653501|Male and Female|Diffuse astrocytoma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Diffuse astrocytoma|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Diffuse astrocytoma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Diffuse astrocytoma|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Diffuse astrocytoma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004
20+|0.1|0.1|0.1|Malignant|166|211050944|Male and Female|Embryonal/primitive/medulloblastoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005
20+|0.1|0.1|0.1|Malignant|188|213511339|Male and Female|Embryonal/primitive/medulloblastoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006
20+|0.1|0.1|0.1|Malignant|171|216055494|Male and Female|Embryonal/primitive/medulloblastoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007
20+|0.1|0.1|0.1|Malignant|217|218481776|Male and Female|Embryonal/primitive/medulloblastoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008
20+|0.1|0.1|0.1|Malignant|214|220975702|Male and Female|Embryonal/primitive/medulloblastoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009
20+|0.1|0.1|0.1|Malignant|234|223491138|Male and Female|Embryonal/primitive/medulloblastoma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Embryonal/primitive/medulloblastoma|2010
20+|0.1|0.1|0.1|Malignant|199|226154695|Male and Female|Embryonal/primitive/medulloblastoma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Embryonal/primitive/medulloblastoma|2011
20+|0.1|0.1|0.1|Malignant|185|228805985|Male and Female|Embryonal/primitive/medulloblastoma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Embryonal/primitive/medulloblastoma|2012
20+|0.1|0.1|0.1|Malignant|173|231483500|Male and Female|Embryonal/primitive/medulloblastoma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Embryonal/primitive/medulloblastoma|2013
20+|0.1|0.1|0.1|Malignant|189|233942819|Male and Female|Embryonal/primitive/medulloblastoma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Embryonal/primitive/medulloblastoma|2014
20+|0.1|0.1|0.1|Malignant|182|236444496|Male and Female|Embryonal/primitive/medulloblastoma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Embryonal/primitive/medulloblastoma|2015
20+|0.1|0.1|0.1|Malignant|170|238861655|Male and Female|Embryonal/primitive/medulloblastoma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Embryonal/primitive/medulloblastoma|2016
20+|0.1|0.1|0.1|Malignant|182|241188135|Male and Female|Embryonal/primitive/medulloblastoma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Embryonal/primitive/medulloblastoma|2017
20+|0.1|0.1|0.1|Malignant|161|243306804|Male and Female|Embryonal/primitive/medulloblastoma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Embryonal/primitive/medulloblastoma|2018
20+|0.1|0.1|0.1|Malignant|142|245213263|Male and Female|Embryonal/primitive/medulloblastoma|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Embryonal/primitive/medulloblastoma|2018-2022
20+|0.1|0.1|0.1|Malignant|680|1242099918|Male and Female|Embryonal/primitive/medulloblastoma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Embryonal/primitive/medulloblastoma|2019
20+|0.1|0.1|0.1|Malignant|143|247018299|Male and Female|Embryonal/primitive/medulloblastoma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Embryonal/primitive/medulloblastoma|2020
20+|0.0|0.1|0.1|Malignant|125|248653501|Male and Female|Embryonal/primitive/medulloblastoma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Embryonal/primitive/medulloblastoma|2021
20+|0.1|0.1|0.1|Malignant|140|249847104|Male and Female|Embryonal/primitive/medulloblastoma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Embryonal/primitive/medulloblastoma|2022
20+|0.0|0.1|0.1|Malignant|130|251367751|Male and Female|Embryonal/primitive/medulloblastoma|2022
20+|0.1|0.1|0.1|Benign/Borderline|249|211050944|Male and Female|Ependymoma variants|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Ependymoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|268|213511339|Male and Female|Ependymoma variants|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Ependymoma variants|2005
20+|0.1|0.2|0.1|Benign/Borderline|312|216055494|Male and Female|Ependymoma variants|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Ependymoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|251|218481776|Male and Female|Ependymoma variants|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Ependymoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|256|220975702|Male and Female|Ependymoma variants|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Ependymoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|262|223491138|Male and Female|Ependymoma variants|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Ependymoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|280|226154695|Male and Female|Ependymoma variants|2010
20+|~|~|~|Malignant|~|226154695|Male and Female|Ependymoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|273|228805985|Male and Female|Ependymoma variants|2011
20+|~|~|~|Malignant|~|228805985|Male and Female|Ependymoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|295|231483500|Male and Female|Ependymoma variants|2012
20+|~|~|~|Malignant|~|231483500|Male and Female|Ependymoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|279|233942819|Male and Female|Ependymoma variants|2013
20+|~|~|~|Malignant|~|233942819|Male and Female|Ependymoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|302|236444496|Male and Female|Ependymoma variants|2014
20+|~|~|~|Malignant|~|236444496|Male and Female|Ependymoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|297|238861655|Male and Female|Ependymoma variants|2015
20+|~|~|~|Malignant|~|238861655|Male and Female|Ependymoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|300|241188135|Male and Female|Ependymoma variants|2016
20+|~|~|~|Malignant|~|241188135|Male and Female|Ependymoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|283|243306804|Male and Female|Ependymoma variants|2017
20+|~|~|~|Malignant|~|243306804|Male and Female|Ependymoma variants|2017
20+|0.1|0.1|0.1|Benign/Borderline|258|245213263|Male and Female|Ependymoma variants|2018
20+|~|~|~|Malignant|~|245213263|Male and Female|Ependymoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|1339|1242099918|Male and Female|Ependymoma variants|2018-2022
20+|~|~|~|Malignant|~|1242099918|Male and Female|Ependymoma variants|2018-2022
20+|0.1|0.1|0.1|Benign/Borderline|249|247018299|Male and Female|Ependymoma variants|2019
20+|~|~|~|Malignant|~|247018299|Male and Female|Ependymoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|269|248653501|Male and Female|Ependymoma variants|2020
20+|~|~|~|Malignant|~|248653501|Male and Female|Ependymoma variants|2020
20+|0.1|0.1|0.1|Benign/Borderline|282|249847104|Male and Female|Ependymoma variants|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Ependymoma variants|2021
20+|0.1|0.1|0.1|Benign/Borderline|281|251367751|Male and Female|Ependymoma variants|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Ependymoma variants|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004
20+|0.3|0.3|0.3|Malignant|599|211050944|Male and Female|Ependymoma/anaplastic ependymoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005
20+|0.3|0.3|0.3|Malignant|607|213511339|Male and Female|Ependymoma/anaplastic ependymoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006
20+|0.2|0.3|0.3|Malignant|586|216055494|Male and Female|Ependymoma/anaplastic ependymoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007
20+|0.2|0.3|0.3|Malignant|587|218481776|Male and Female|Ependymoma/anaplastic ependymoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008
20+|0.3|0.3|0.3|Malignant|641|220975702|Male and Female|Ependymoma/anaplastic ependymoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009
20+|0.3|0.3|0.3|Malignant|687|223491138|Male and Female|Ependymoma/anaplastic ependymoma|2009
20+|0.0|0.0|0.0|Benign/Borderline|17|226154695|Male and Female|Ependymoma/anaplastic ependymoma|2010
20+|0.3|0.3|0.3|Malignant|630|226154695|Male and Female|Ependymoma/anaplastic ependymoma|2010
20+|0.0|0.0|0.0|Benign/Borderline|17|228805985|Male and Female|Ependymoma/anaplastic ependymoma|2011
20+|0.2|0.3|0.3|Malignant|600|228805985|Male and Female|Ependymoma/anaplastic ependymoma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Ependymoma/anaplastic ependymoma|2012
20+|0.2|0.3|0.3|Malignant|634|231483500|Male and Female|Ependymoma/anaplastic ependymoma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Ependymoma/anaplastic ependymoma|2013
20+|0.2|0.3|0.2|Malignant|587|233942819|Male and Female|Ependymoma/anaplastic ependymoma|2013
20+|0.0|0.0|0.0|Benign/Borderline|29|236444496|Male and Female|Ependymoma/anaplastic ependymoma|2014
20+|0.2|0.3|0.2|Malignant|571|236444496|Male and Female|Ependymoma/anaplastic ependymoma|2014
20+|0.0|0.0|0.0|Benign/Borderline|27|238861655|Male and Female|Ependymoma/anaplastic ependymoma|2015
20+|0.2|0.3|0.2|Malignant|587|238861655|Male and Female|Ependymoma/anaplastic ependymoma|2015
20+|0.0|0.0|0.0|Benign/Borderline|21|241188135|Male and Female|Ependymoma/anaplastic ependymoma|2016
20+|0.2|0.3|0.3|Malignant|609|241188135|Male and Female|Ependymoma/anaplastic ependymoma|2016
20+|0.0|0.0|0.0|Benign/Borderline|26|243306804|Male and Female|Ependymoma/anaplastic ependymoma|2017
20+|0.2|0.3|0.2|Malignant|602|243306804|Male and Female|Ependymoma/anaplastic ependymoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|19|245213263|Male and Female|Ependymoma/anaplastic ependymoma|2018
20+|0.2|0.2|0.2|Malignant|559|245213263|Male and Female|Ependymoma/anaplastic ependymoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|108|1242099918|Male and Female|Ependymoma/anaplastic ependymoma|2018-2022
20+|0.2|0.2|0.2|Malignant|2605|1242099918|Male and Female|Ependymoma/anaplastic ependymoma|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|19|247018299|Male and Female|Ependymoma/anaplastic ependymoma|2019
20+|0.2|0.2|0.2|Malignant|537|247018299|Male and Female|Ependymoma/anaplastic ependymoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|27|248653501|Male and Female|Ependymoma/anaplastic ependymoma|2020
20+|0.2|0.2|0.2|Malignant|525|248653501|Male and Female|Ependymoma/anaplastic ependymoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|20|249847104|Male and Female|Ependymoma/anaplastic ependymoma|2021
20+|0.2|0.2|0.2|Malignant|528|249847104|Male and Female|Ependymoma/anaplastic ependymoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|23|251367751|Male and Female|Ependymoma/anaplastic ependymoma|2022
20+|0.2|0.2|0.2|Malignant|456|251367751|Male and Female|Ependymoma/anaplastic ependymoma|2022
20+|0.0|0.0|0.0|Benign/Borderline|40|211050944|Male and Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Malignant|54|211050944|Male and Female|Germ Cell Tumors|2004
20+|0.0|0.0|0.0|Benign/Borderline|69|213511339|Male and Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Germ Cell Tumors|2005
20+|0.0|0.0|0.0|Benign/Borderline|66|216055494|Male and Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Malignant|62|216055494|Male and Female|Germ Cell Tumors|2006
20+|0.0|0.0|0.0|Benign/Borderline|72|218481776|Male and Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Malignant|81|218481776|Male and Female|Germ Cell Tumors|2007
20+|0.0|0.0|0.0|Benign/Borderline|67|220975702|Male and Female|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Malignant|64|220975702|Male and Female|Germ Cell Tumors|2008
20+|0.0|0.0|0.0|Benign/Borderline|80|223491138|Male and Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Malignant|44|223491138|Male and Female|Germ Cell Tumors|2009
20+|0.0|0.0|0.0|Benign/Borderline|62|226154695|Male and Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Malignant|64|226154695|Male and Female|Germ Cell Tumors|2010
20+|0.0|0.0|0.0|Benign/Borderline|64|228805985|Male and Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Malignant|69|228805985|Male and Female|Germ Cell Tumors|2011
20+|0.0|0.0|0.0|Benign/Borderline|65|231483500|Male and Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Malignant|52|231483500|Male and Female|Germ Cell Tumors|2012
20+|0.0|0.0|0.0|Benign/Borderline|54|233942819|Male and Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Malignant|51|233942819|Male and Female|Germ Cell Tumors|2013
20+|0.0|0.0|0.0|Benign/Borderline|60|236444496|Male and Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Malignant|69|236444496|Male and Female|Germ Cell Tumors|2014
20+|0.0|0.0|0.0|Benign/Borderline|63|238861655|Male and Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Malignant|60|238861655|Male and Female|Germ Cell Tumors|2015
20+|0.0|0.0|0.0|Benign/Borderline|66|241188135|Male and Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Malignant|78|241188135|Male and Female|Germ Cell Tumors|2016
20+|0.0|0.0|0.0|Benign/Borderline|57|243306804|Male and Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Malignant|67|243306804|Male and Female|Germ Cell Tumors|2017
20+|0.0|0.0|0.0|Benign/Borderline|43|245213263|Male and Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Malignant|67|245213263|Male and Female|Germ Cell Tumors|2018
20+|0.0|0.0|0.0|Benign/Borderline|252|1242099918|Male and Female|Germ Cell Tumors|2018-2022
20+|0.0|0.0|0.0|Malignant|328|1242099918|Male and Female|Germ Cell Tumors|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|74|247018299|Male and Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Malignant|76|247018299|Male and Female|Germ Cell Tumors|2019
20+|0.0|0.0|0.0|Benign/Borderline|47|248653501|Male and Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Malignant|54|248653501|Male and Female|Germ Cell Tumors|2020
20+|0.0|0.0|0.0|Benign/Borderline|45|249847104|Male and Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Malignant|76|249847104|Male and Female|Germ Cell Tumors|2021
20+|0.0|0.0|0.0|Benign/Borderline|43|251367751|Male and Female|Germ Cell Tumors|2022
20+|0.0|0.0|0.0|Malignant|55|251367751|Male and Female|Germ Cell Tumors|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioblastoma|2004
20+|4.4|4.6|4.5|Malignant|9587|211050944|Male and Female|Glioblastoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioblastoma|2005
20+|4.4|4.5|4.5|Malignant|9702|213511339|Male and Female|Glioblastoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Glioblastoma|2006
20+|4.3|4.5|4.4|Malignant|9787|216055494|Male and Female|Glioblastoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Glioblastoma|2007
20+|4.4|4.6|4.5|Malignant|10193|218481776|Male and Female|Glioblastoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Glioblastoma|2008
20+|4.4|4.6|4.5|Malignant|10420|220975702|Male and Female|Glioblastoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Glioblastoma|2009
20+|4.4|4.5|4.4|Malignant|10497|223491138|Male and Female|Glioblastoma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Glioblastoma|2010
20+|4.3|4.5|4.4|Malignant|10732|226154695|Male and Female|Glioblastoma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Glioblastoma|2011
20+|4.3|4.5|4.4|Malignant|10884|228805985|Male and Female|Glioblastoma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Glioblastoma|2012
20+|4.4|4.6|4.5|Malignant|11366|231483500|Male and Female|Glioblastoma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Glioblastoma|2013
20+|4.4|4.6|4.5|Malignant|11549|233942819|Male and Female|Glioblastoma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Glioblastoma|2014
20+|4.3|4.5|4.4|Malignant|11614|236444496|Male and Female|Glioblastoma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Glioblastoma|2015
20+|4.4|4.6|4.5|Malignant|12052|238861655|Male and Female|Glioblastoma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Glioblastoma|2016
20+|4.5|4.6|4.6|Malignant|12435|241188135|Male and Female|Glioblastoma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Glioblastoma|2017
20+|4.5|4.6|4.5|Malignant|12623|243306804|Male and Female|Glioblastoma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Glioblastoma|2018
20+|4.4|4.6|4.5|Malignant|12751|245213263|Male and Female|Glioblastoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|18|1242099918|Male and Female|Glioblastoma|2018-2022
20+|4.4|4.5|4.4|Malignant|65342|1242099918|Male and Female|Glioblastoma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Glioblastoma|2019
20+|4.4|4.6|4.5|Malignant|12918|247018299|Male and Female|Glioblastoma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Glioblastoma|2020
20+|4.4|4.6|4.5|Malignant|13266|248653501|Male and Female|Glioblastoma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Glioblastoma|2021
20+|4.3|4.5|4.4|Malignant|13156|249847104|Male and Female|Glioblastoma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Glioblastoma|2022
20+|4.3|4.4|4.3|Malignant|13251|251367751|Male and Female|Glioblastoma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Glioma malignant, NOS|2004
20+|0.4|0.4|0.4|Malignant|853|211050944|Male and Female|Glioma malignant, NOS|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Glioma malignant, NOS|2005
20+|0.4|0.4|0.4|Malignant|845|213511339|Male and Female|Glioma malignant, NOS|2005
20+|0.0|0.0|0.0|Benign/Borderline|19|216055494|Male and Female|Glioma malignant, NOS|2006
20+|0.4|0.4|0.4|Malignant|841|216055494|Male and Female|Glioma malignant, NOS|2006
20+|0.0|0.0|0.0|Benign/Borderline|16|218481776|Male and Female|Glioma malignant, NOS|2007
20+|0.4|0.4|0.4|Malignant|877|218481776|Male and Female|Glioma malignant, NOS|2007
20+|0.0|0.0|0.0|Benign/Borderline|24|220975702|Male and Female|Glioma malignant, NOS|2008
20+|0.4|0.4|0.4|Malignant|933|220975702|Male and Female|Glioma malignant, NOS|2008
20+|0.0|0.0|0.0|Benign/Borderline|28|223491138|Male and Female|Glioma malignant, NOS|2009
20+|0.4|0.5|0.4|Malignant|985|223491138|Male and Female|Glioma malignant, NOS|2009
20+|0.0|0.0|0.0|Benign/Borderline|22|226154695|Male and Female|Glioma malignant, NOS|2010
20+|0.3|0.4|0.4|Malignant|817|226154695|Male and Female|Glioma malignant, NOS|2010
20+|0.0|0.0|0.0|Benign/Borderline|31|228805985|Male and Female|Glioma malignant, NOS|2011
20+|0.4|0.4|0.4|Malignant|949|228805985|Male and Female|Glioma malignant, NOS|2011
20+|0.0|0.0|0.0|Benign/Borderline|31|231483500|Male and Female|Glioma malignant, NOS|2012
20+|0.4|0.4|0.4|Malignant|928|231483500|Male and Female|Glioma malignant, NOS|2012
20+|0.0|0.0|0.0|Benign/Borderline|30|233942819|Male and Female|Glioma malignant, NOS|2013
20+|0.4|0.4|0.4|Malignant|947|233942819|Male and Female|Glioma malignant, NOS|2013
20+|0.0|0.0|0.0|Benign/Borderline|41|236444496|Male and Female|Glioma malignant, NOS|2014
20+|0.4|0.4|0.4|Malignant|959|236444496|Male and Female|Glioma malignant, NOS|2014
20+|0.0|0.0|0.0|Benign/Borderline|53|238861655|Male and Female|Glioma malignant, NOS|2015
20+|0.4|0.4|0.4|Malignant|1007|238861655|Male and Female|Glioma malignant, NOS|2015
20+|0.0|0.0|0.0|Benign/Borderline|54|241188135|Male and Female|Glioma malignant, NOS|2016
20+|0.4|0.5|0.4|Malignant|1080|241188135|Male and Female|Glioma malignant, NOS|2016
20+|0.0|0.0|0.0|Benign/Borderline|53|243306804|Male and Female|Glioma malignant, NOS|2017
20+|0.4|0.5|0.5|Malignant|1172|243306804|Male and Female|Glioma malignant, NOS|2017
20+|0.0|0.0|0.0|Benign/Borderline|41|245213263|Male and Female|Glioma malignant, NOS|2018
20+|0.4|0.5|0.4|Malignant|1089|245213263|Male and Female|Glioma malignant, NOS|2018
20+|0.0|0.0|0.0|Benign/Borderline|204|1242099918|Male and Female|Glioma malignant, NOS|2018-2022
20+|0.4|0.4|0.4|Malignant|5571|1242099918|Male and Female|Glioma malignant, NOS|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|45|247018299|Male and Female|Glioma malignant, NOS|2019
20+|0.4|0.4|0.4|Malignant|1053|247018299|Male and Female|Glioma malignant, NOS|2019
20+|0.0|0.0|0.0|Benign/Borderline|30|248653501|Male and Female|Glioma malignant, NOS|2020
20+|0.4|0.4|0.4|Malignant|1074|248653501|Male and Female|Glioma malignant, NOS|2020
20+|0.0|0.0|0.0|Benign/Borderline|32|249847104|Male and Female|Glioma malignant, NOS|2021
20+|0.4|0.4|0.4|Malignant|1099|249847104|Male and Female|Glioma malignant, NOS|2021
20+|0.0|0.0|0.0|Benign/Borderline|56|251367751|Male and Female|Glioma malignant, NOS|2022
20+|0.4|0.5|0.5|Malignant|1256|251367751|Male and Female|Glioma malignant, NOS|2022
20+|0.2|0.2|0.2|Benign/Borderline|461|211050944|Male and Female|Hemangioblastoma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioblastoma|2004
20+|0.2|0.3|0.2|Benign/Borderline|524|213511339|Male and Female|Hemangioblastoma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioblastoma|2005
20+|0.2|0.3|0.2|Benign/Borderline|503|216055494|Male and Female|Hemangioblastoma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioblastoma|2006
20+|0.2|0.2|0.2|Benign/Borderline|474|218481776|Male and Female|Hemangioblastoma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioblastoma|2007
20+|0.2|0.3|0.2|Benign/Borderline|538|220975702|Male and Female|Hemangioblastoma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioblastoma|2008
20+|0.2|0.3|0.2|Benign/Borderline|518|223491138|Male and Female|Hemangioblastoma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioblastoma|2009
20+|0.2|0.3|0.2|Benign/Borderline|545|226154695|Male and Female|Hemangioblastoma|2010
20+|~|~|~|Malignant|~|226154695|Male and Female|Hemangioblastoma|2010
20+|0.2|0.3|0.2|Benign/Borderline|534|228805985|Male and Female|Hemangioblastoma|2011
20+|~|~|~|Malignant|~|228805985|Male and Female|Hemangioblastoma|2011
20+|0.2|0.3|0.2|Benign/Borderline|551|231483500|Male and Female|Hemangioblastoma|2012
20+|~|~|~|Malignant|~|231483500|Male and Female|Hemangioblastoma|2012
20+|0.2|0.2|0.2|Benign/Borderline|514|233942819|Male and Female|Hemangioblastoma|2013
20+|~|~|~|Malignant|~|233942819|Male and Female|Hemangioblastoma|2013
20+|0.2|0.2|0.2|Benign/Borderline|503|236444496|Male and Female|Hemangioblastoma|2014
20+|~|~|~|Malignant|~|236444496|Male and Female|Hemangioblastoma|2014
20+|0.2|0.2|0.2|Benign/Borderline|553|238861655|Male and Female|Hemangioblastoma|2015
20+|~|~|~|Malignant|~|238861655|Male and Female|Hemangioblastoma|2015
20+|0.2|0.2|0.2|Benign/Borderline|573|241188135|Male and Female|Hemangioblastoma|2016
20+|~|~|~|Malignant|~|241188135|Male and Female|Hemangioblastoma|2016
20+|0.2|0.3|0.2|Benign/Borderline|575|243306804|Male and Female|Hemangioblastoma|2017
20+|~|~|~|Malignant|~|243306804|Male and Female|Hemangioblastoma|2017
20+|0.2|0.2|0.2|Benign/Borderline|535|245213263|Male and Female|Hemangioblastoma|2018
20+|~|~|~|Malignant|~|245213263|Male and Female|Hemangioblastoma|2018
20+|0.2|0.2|0.2|Benign/Borderline|2762|1242099918|Male and Female|Hemangioblastoma|2018-2022
20+|0.0|0.0|0.0|Malignant|17|1242099918|Male and Female|Hemangioblastoma|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|575|247018299|Male and Female|Hemangioblastoma|2019
20+|~|~|~|Malignant|~|247018299|Male and Female|Hemangioblastoma|2019
20+|0.2|0.2|0.2|Benign/Borderline|559|248653501|Male and Female|Hemangioblastoma|2020
20+|~|~|~|Malignant|~|248653501|Male and Female|Hemangioblastoma|2020
20+|0.2|0.2|0.2|Benign/Borderline|543|249847104|Male and Female|Hemangioblastoma|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Hemangioblastoma|2021
20+|0.2|0.2|0.2|Benign/Borderline|550|251367751|Male and Female|Hemangioblastoma|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Hemangioblastoma|2022
20+|0.2|0.2|0.2|Benign/Borderline|389|211050944|Male and Female|Hemangioma|2004
20+|~|~|~|Malignant|~|211050944|Male and Female|Hemangioma|2004
20+|0.2|0.3|0.2|Benign/Borderline|497|213511339|Male and Female|Hemangioma|2005
20+|~|~|~|Malignant|~|213511339|Male and Female|Hemangioma|2005
20+|0.2|0.3|0.3|Benign/Borderline|564|216055494|Male and Female|Hemangioma|2006
20+|~|~|~|Malignant|~|216055494|Male and Female|Hemangioma|2006
20+|0.3|0.3|0.3|Benign/Borderline|654|218481776|Male and Female|Hemangioma|2007
20+|~|~|~|Malignant|~|218481776|Male and Female|Hemangioma|2007
20+|0.3|0.4|0.4|Benign/Borderline|822|220975702|Male and Female|Hemangioma|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Hemangioma|2008
20+|0.4|0.5|0.4|Benign/Borderline|989|223491138|Male and Female|Hemangioma|2009
20+|~|~|~|Malignant|~|223491138|Male and Female|Hemangioma|2009
20+|0.5|0.5|0.5|Benign/Borderline|1136|226154695|Male and Female|Hemangioma|2010
20+|~|~|~|Malignant|~|226154695|Male and Female|Hemangioma|2010
20+|0.5|0.6|0.5|Benign/Borderline|1249|228805985|Male and Female|Hemangioma|2011
20+|~|~|~|Malignant|~|228805985|Male and Female|Hemangioma|2011
20+|0.5|0.6|0.5|Benign/Borderline|1259|231483500|Male and Female|Hemangioma|2012
20+|~|~|~|Malignant|~|231483500|Male and Female|Hemangioma|2012
20+|0.5|0.6|0.5|Benign/Borderline|1278|233942819|Male and Female|Hemangioma|2013
20+|~|~|~|Malignant|~|233942819|Male and Female|Hemangioma|2013
20+|0.5|0.5|0.5|Benign/Borderline|1228|236444496|Male and Female|Hemangioma|2014
20+|~|~|~|Malignant|~|236444496|Male and Female|Hemangioma|2014
20+|0.4|0.5|0.4|Benign/Borderline|1092|238861655|Male and Female|Hemangioma|2015
20+|~|~|~|Malignant|~|238861655|Male and Female|Hemangioma|2015
20+|0.4|0.4|0.4|Benign/Borderline|1039|241188135|Male and Female|Hemangioma|2016
20+|~|~|~|Malignant|~|241188135|Male and Female|Hemangioma|2016
20+|0.4|0.4|0.4|Benign/Borderline|1028|243306804|Male and Female|Hemangioma|2017
20+|~|~|~|Malignant|~|243306804|Male and Female|Hemangioma|2017
20+|0.4|0.4|0.4|Benign/Borderline|1068|245213263|Male and Female|Hemangioma|2018
20+|~|~|~|Malignant|~|245213263|Male and Female|Hemangioma|2018
20+|0.4|0.4|0.4|Benign/Borderline|5212|1242099918|Male and Female|Hemangioma|2018-2022
20+|0.0|0.0|0.0|Malignant|16|1242099918|Male and Female|Hemangioma|2018-2022
20+|0.4|0.4|0.4|Benign/Borderline|1070|247018299|Male and Female|Hemangioma|2019
20+|~|~|~|Malignant|~|247018299|Male and Female|Hemangioma|2019
20+|0.4|0.4|0.4|Benign/Borderline|1096|248653501|Male and Female|Hemangioma|2020
20+|~|~|~|Malignant|~|248653501|Male and Female|Hemangioma|2020
20+|0.4|0.4|0.4|Benign/Borderline|1016|249847104|Male and Female|Hemangioma|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Hemangioma|2021
20+|0.3|0.4|0.4|Benign/Borderline|962|251367751|Male and Female|Hemangioma|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Hemangioma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Local Extensions from Regional Tumors|2004
20+|0.0|0.0|0.0|Malignant|49|211050944|Male and Female|Local Extensions from Regional Tumors|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Local Extensions from Regional Tumors|2005
20+|0.0|0.0|0.0|Malignant|46|213511339|Male and Female|Local Extensions from Regional Tumors|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Local Extensions from Regional Tumors|2006
20+|0.0|0.0|0.0|Malignant|54|216055494|Male and Female|Local Extensions from Regional Tumors|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Local Extensions from Regional Tumors|2007
20+|0.0|0.0|0.0|Malignant|47|218481776|Male and Female|Local Extensions from Regional Tumors|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Local Extensions from Regional Tumors|2008
20+|0.0|0.0|0.0|Malignant|52|220975702|Male and Female|Local Extensions from Regional Tumors|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Local Extensions from Regional Tumors|2009
20+|0.0|0.0|0.0|Malignant|55|223491138|Male and Female|Local Extensions from Regional Tumors|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Local Extensions from Regional Tumors|2010
20+|0.0|0.0|0.0|Malignant|52|226154695|Male and Female|Local Extensions from Regional Tumors|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Local Extensions from Regional Tumors|2011
20+|0.0|0.0|0.0|Malignant|44|228805985|Male and Female|Local Extensions from Regional Tumors|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Local Extensions from Regional Tumors|2012
20+|0.0|0.0|0.0|Malignant|47|231483500|Male and Female|Local Extensions from Regional Tumors|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Local Extensions from Regional Tumors|2013
20+|0.0|0.0|0.0|Malignant|46|233942819|Male and Female|Local Extensions from Regional Tumors|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Local Extensions from Regional Tumors|2014
20+|0.0|0.0|0.0|Malignant|50|236444496|Male and Female|Local Extensions from Regional Tumors|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Local Extensions from Regional Tumors|2015
20+|0.0|0.0|0.0|Malignant|41|238861655|Male and Female|Local Extensions from Regional Tumors|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Local Extensions from Regional Tumors|2016
20+|0.0|0.0|0.0|Malignant|41|241188135|Male and Female|Local Extensions from Regional Tumors|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Local Extensions from Regional Tumors|2017
20+|0.0|0.0|0.0|Malignant|40|243306804|Male and Female|Local Extensions from Regional Tumors|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Local Extensions from Regional Tumors|2018
20+|0.0|0.0|0.0|Malignant|31|245213263|Male and Female|Local Extensions from Regional Tumors|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Local Extensions from Regional Tumors|2018-2022
20+|0.0|0.0|0.0|Malignant|148|1242099918|Male and Female|Local Extensions from Regional Tumors|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Local Extensions from Regional Tumors|2019
20+|0.0|0.0|0.0|Malignant|35|247018299|Male and Female|Local Extensions from Regional Tumors|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Local Extensions from Regional Tumors|2020
20+|0.0|0.0|0.0|Malignant|24|248653501|Male and Female|Local Extensions from Regional Tumors|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Local Extensions from Regional Tumors|2021
20+|0.0|0.0|0.0|Malignant|35|249847104|Male and Female|Local Extensions from Regional Tumors|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Local Extensions from Regional Tumors|2022
20+|0.0|0.0|0.0|Malignant|23|251367751|Male and Female|Local Extensions from Regional Tumors|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|0.6|0.7|0.6|Malignant|1340|211050944|Male and Female|Lymphomas and Hematopoietic Neoplasms|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|0.6|0.7|0.7|Malignant|1439|213511339|Male and Female|Lymphomas and Hematopoietic Neoplasms|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|0.6|0.7|0.7|Malignant|1436|216055494|Male and Female|Lymphomas and Hematopoietic Neoplasms|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|0.6|0.7|0.6|Malignant|1370|218481776|Male and Female|Lymphomas and Hematopoietic Neoplasms|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|0.6|0.7|0.7|Malignant|1473|220975702|Male and Female|Lymphomas and Hematopoietic Neoplasms|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|0.6|0.6|0.6|Malignant|1416|223491138|Male and Female|Lymphomas and Hematopoietic Neoplasms|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|0.6|0.7|0.6|Malignant|1495|226154695|Male and Female|Lymphomas and Hematopoietic Neoplasms|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|0.6|0.7|0.6|Malignant|1517|228805985|Male and Female|Lymphomas and Hematopoietic Neoplasms|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|0.6|0.6|0.6|Malignant|1453|231483500|Male and Female|Lymphomas and Hematopoietic Neoplasms|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|0.6|0.6|0.6|Malignant|1468|233942819|Male and Female|Lymphomas and Hematopoietic Neoplasms|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|0.6|0.7|0.6|Malignant|1636|236444496|Male and Female|Lymphomas and Hematopoietic Neoplasms|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|0.6|0.6|0.6|Malignant|1588|238861655|Male and Female|Lymphomas and Hematopoietic Neoplasms|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|0.6|0.7|0.6|Malignant|1665|241188135|Male and Female|Lymphomas and Hematopoietic Neoplasms|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|0.6|0.7|0.6|Malignant|1721|243306804|Male and Female|Lymphomas and Hematopoietic Neoplasms|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|0.6|0.6|0.6|Malignant|1678|245213263|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
20+|0.6|0.6|0.6|Malignant|8246|1242099918|Male and Female|Lymphomas and Hematopoietic Neoplasms|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|0.6|0.6|0.6|Malignant|1644|247018299|Male and Female|Lymphomas and Hematopoietic Neoplasms|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|0.6|0.6|0.6|Malignant|1694|248653501|Male and Female|Lymphomas and Hematopoietic Neoplasms|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|0.5|0.6|0.6|Malignant|1659|249847104|Male and Female|Lymphomas and Hematopoietic Neoplasms|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|0.5|0.6|0.5|Malignant|1571|251367751|Male and Female|Lymphomas and Hematopoietic Neoplasms|2022
20+|9.0|9.3|9.1|Benign/Borderline|19421|211050944|Male and Female|Meningioma|2004
20+|0.2|0.2|0.2|Malignant|450|211050944|Male and Female|Meningioma|2004
20+|10.1|10.3|10.2|Benign/Borderline|22035|213511339|Male and Female|Meningioma|2005
20+|0.2|0.2|0.2|Malignant|434|213511339|Male and Female|Meningioma|2005
20+|10.6|10.9|10.7|Benign/Borderline|23561|216055494|Male and Female|Meningioma|2006
20+|0.2|0.2|0.2|Malignant|407|216055494|Male and Female|Meningioma|2006
20+|11.0|11.3|11.1|Benign/Borderline|24868|218481776|Male and Female|Meningioma|2007
20+|0.2|0.2|0.2|Malignant|443|218481776|Male and Female|Meningioma|2007
20+|11.6|11.9|11.8|Benign/Borderline|26851|220975702|Male and Female|Meningioma|2008
20+|0.1|0.2|0.2|Malignant|366|220975702|Male and Female|Meningioma|2008
20+|12.4|12.7|12.5|Benign/Borderline|29114|223491138|Male and Female|Meningioma|2009
20+|0.1|0.2|0.2|Malignant|360|223491138|Male and Female|Meningioma|2009
20+|12.1|12.4|12.2|Benign/Borderline|28870|226154695|Male and Female|Meningioma|2010
20+|0.1|0.2|0.1|Malignant|334|226154695|Male and Female|Meningioma|2010
20+|12.2|12.5|12.3|Benign/Borderline|29642|228805985|Male and Female|Meningioma|2011
20+|0.1|0.2|0.1|Malignant|331|228805985|Male and Female|Meningioma|2011
20+|12.4|12.7|12.6|Benign/Borderline|30776|231483500|Male and Female|Meningioma|2012
20+|0.1|0.2|0.1|Malignant|360|231483500|Male and Female|Meningioma|2012
20+|12.7|13.0|12.8|Benign/Borderline|31945|233942819|Male and Female|Meningioma|2013
20+|0.1|0.2|0.2|Malignant|387|233942819|Male and Female|Meningioma|2013
20+|13.0|13.3|13.1|Benign/Borderline|33246|236444496|Male and Female|Meningioma|2014
20+|0.1|0.2|0.2|Malignant|391|236444496|Male and Female|Meningioma|2014
20+|13.5|13.8|13.6|Benign/Borderline|35166|238861655|Male and Female|Meningioma|2015
20+|0.1|0.2|0.1|Malignant|351|238861655|Male and Female|Meningioma|2015
20+|13.8|14.1|14.0|Benign/Borderline|36527|241188135|Male and Female|Meningioma|2016
20+|0.1|0.1|0.1|Malignant|340|241188135|Male and Female|Meningioma|2016
20+|14.3|14.6|14.4|Benign/Borderline|38478|243306804|Male and Female|Meningioma|2017
20+|0.1|0.1|0.1|Malignant|333|243306804|Male and Female|Meningioma|2017
20+|14.5|14.8|14.6|Benign/Borderline|39600|245213263|Male and Female|Meningioma|2018
20+|0.1|0.1|0.1|Malignant|320|245213263|Male and Female|Meningioma|2018
20+|14.7|14.8|14.8|Benign/Borderline|206361|1242099918|Male and Female|Meningioma|2018-2022
20+|0.1|0.1|0.1|Malignant|1672|1242099918|Male and Female|Meningioma|2018-2022
20+|15.2|15.5|15.3|Benign/Borderline|42277|247018299|Male and Female|Meningioma|2019
20+|0.1|0.1|0.1|Malignant|314|247018299|Male and Female|Meningioma|2019
20+|13.7|14.0|13.9|Benign/Borderline|38777|248653501|Male and Female|Meningioma|2020
20+|0.1|0.1|0.1|Malignant|311|248653501|Male and Female|Meningioma|2020
20+|14.9|15.2|15.1|Benign/Borderline|42721|249847104|Male and Female|Meningioma|2021
20+|0.1|0.1|0.1|Malignant|365|249847104|Male and Female|Meningioma|2021
20+|14.8|15.1|14.9|Benign/Borderline|42986|251367751|Male and Female|Meningioma|2022
20+|0.1|0.1|0.1|Malignant|362|251367751|Male and Female|Meningioma|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Mixed glioma|2004
20+|0.2|0.3|0.2|Malignant|491|211050944|Male and Female|Mixed glioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Mixed glioma|2005
20+|0.2|0.3|0.3|Malignant|565|213511339|Male and Female|Mixed glioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Mixed glioma|2006
20+|0.3|0.3|0.3|Malignant|639|216055494|Male and Female|Mixed glioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Mixed glioma|2007
20+|0.3|0.3|0.3|Malignant|594|218481776|Male and Female|Mixed glioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Mixed glioma|2008
20+|0.3|0.3|0.3|Malignant|604|220975702|Male and Female|Mixed glioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Mixed glioma|2009
20+|0.3|0.3|0.3|Malignant|678|223491138|Male and Female|Mixed glioma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Mixed glioma|2010
20+|0.3|0.3|0.3|Malignant|615|226154695|Male and Female|Mixed glioma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Mixed glioma|2011
20+|0.3|0.3|0.3|Malignant|640|228805985|Male and Female|Mixed glioma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Mixed glioma|2012
20+|0.2|0.3|0.3|Malignant|575|231483500|Male and Female|Mixed glioma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Mixed glioma|2013
20+|0.3|0.3|0.3|Malignant|621|233942819|Male and Female|Mixed glioma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Mixed glioma|2014
20+|0.2|0.2|0.2|Malignant|469|236444496|Male and Female|Mixed glioma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Mixed glioma|2015
20+|0.1|0.1|0.1|Malignant|278|238861655|Male and Female|Mixed glioma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Mixed glioma|2016
20+|0.0|0.1|0.0|Malignant|106|241188135|Male and Female|Mixed glioma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Mixed glioma|2017
20+|0.0|0.0|0.0|Malignant|61|243306804|Male and Female|Mixed glioma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Mixed glioma|2018
20+|0.0|0.0|0.0|Malignant|20|245213263|Male and Female|Mixed glioma|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Mixed glioma|2018-2022
20+|0.0|0.0|0.0|Malignant|76|1242099918|Male and Female|Mixed glioma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Mixed glioma|2019
20+|0.0|0.0|0.0|Malignant|20|247018299|Male and Female|Mixed glioma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Mixed glioma|2020
20+|0.0|0.0|0.0|Malignant|18|248653501|Male and Female|Mixed glioma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Mixed glioma|2021
20+|~|~|~|Malignant|~|249847104|Male and Female|Mixed glioma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Mixed glioma|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Mixed glioma|2022
20+|0.5|0.6|0.6|Benign/Borderline|1194|211050944|Male and Female|Neoplasm, unspecified|2004
20+|0.6|0.6|0.6|Malignant|1269|211050944|Male and Female|Neoplasm, unspecified|2004
20+|0.7|0.7|0.7|Benign/Borderline|1500|213511339|Male and Female|Neoplasm, unspecified|2005
20+|0.6|0.6|0.6|Malignant|1318|213511339|Male and Female|Neoplasm, unspecified|2005
20+|0.6|0.7|0.7|Benign/Borderline|1431|216055494|Male and Female|Neoplasm, unspecified|2006
20+|0.6|0.6|0.6|Malignant|1287|216055494|Male and Female|Neoplasm, unspecified|2006
20+|0.6|0.7|0.6|Benign/Borderline|1438|218481776|Male and Female|Neoplasm, unspecified|2007
20+|0.5|0.6|0.5|Malignant|1214|218481776|Male and Female|Neoplasm, unspecified|2007
20+|0.6|0.7|0.6|Benign/Borderline|1455|220975702|Male and Female|Neoplasm, unspecified|2008
20+|0.6|0.6|0.6|Malignant|1368|220975702|Male and Female|Neoplasm, unspecified|2008
20+|0.6|0.7|0.7|Benign/Borderline|1544|223491138|Male and Female|Neoplasm, unspecified|2009
20+|0.6|0.6|0.6|Malignant|1416|223491138|Male and Female|Neoplasm, unspecified|2009
20+|0.6|0.7|0.6|Benign/Borderline|1508|226154695|Male and Female|Neoplasm, unspecified|2010
20+|0.5|0.6|0.5|Malignant|1243|226154695|Male and Female|Neoplasm, unspecified|2010
20+|0.6|0.7|0.6|Benign/Borderline|1495|228805985|Male and Female|Neoplasm, unspecified|2011
20+|0.5|0.6|0.5|Malignant|1263|228805985|Male and Female|Neoplasm, unspecified|2011
20+|0.6|0.7|0.7|Benign/Borderline|1598|231483500|Male and Female|Neoplasm, unspecified|2012
20+|0.5|0.6|0.5|Malignant|1275|231483500|Male and Female|Neoplasm, unspecified|2012
20+|0.6|0.6|0.6|Benign/Borderline|1498|233942819|Male and Female|Neoplasm, unspecified|2013
20+|0.5|0.5|0.5|Malignant|1275|233942819|Male and Female|Neoplasm, unspecified|2013
20+|0.6|0.7|0.6|Benign/Borderline|1552|236444496|Male and Female|Neoplasm, unspecified|2014
20+|0.5|0.6|0.6|Malignant|1414|236444496|Male and Female|Neoplasm, unspecified|2014
20+|0.6|0.6|0.6|Benign/Borderline|1536|238861655|Male and Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.5|Malignant|1371|238861655|Male and Female|Neoplasm, unspecified|2015
20+|0.5|0.6|0.6|Benign/Borderline|1426|241188135|Male and Female|Neoplasm, unspecified|2016
20+|0.5|0.5|0.5|Malignant|1263|241188135|Male and Female|Neoplasm, unspecified|2016
20+|0.5|0.6|0.5|Benign/Borderline|1362|243306804|Male and Female|Neoplasm, unspecified|2017
20+|0.4|0.5|0.5|Malignant|1270|243306804|Male and Female|Neoplasm, unspecified|2017
20+|0.5|0.5|0.5|Benign/Borderline|1312|245213263|Male and Female|Neoplasm, unspecified|2018
20+|0.5|0.5|0.5|Malignant|1354|245213263|Male and Female|Neoplasm, unspecified|2018
20+|0.4|0.5|0.5|Benign/Borderline|6120|1242099918|Male and Female|Neoplasm, unspecified|2018-2022
20+|0.5|0.5|0.5|Malignant|7009|1242099918|Male and Female|Neoplasm, unspecified|2018-2022
20+|0.4|0.5|0.4|Benign/Borderline|1147|247018299|Male and Female|Neoplasm, unspecified|2019
20+|0.5|0.6|0.5|Malignant|1432|247018299|Male and Female|Neoplasm, unspecified|2019
20+|0.4|0.5|0.5|Benign/Borderline|1212|248653501|Male and Female|Neoplasm, unspecified|2020
20+|0.5|0.6|0.6|Malignant|1526|248653501|Male and Female|Neoplasm, unspecified|2020
20+|0.4|0.5|0.4|Benign/Borderline|1182|249847104|Male and Female|Neoplasm, unspecified|2021
20+|0.5|0.5|0.5|Malignant|1385|249847104|Male and Female|Neoplasm, unspecified|2021
20+|0.4|0.5|0.5|Benign/Borderline|1267|251367751|Male and Female|Neoplasm, unspecified|2022
20+|0.4|0.5|0.5|Malignant|1312|251367751|Male and Female|Neoplasm, unspecified|2022
20+|2.3|2.4|2.3|Benign/Borderline|4984|211050944|Male and Female|Nerve sheath, benign and malignant|2004
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Nerve sheath, benign and malignant|2004
20+|2.5|2.6|2.6|Benign/Borderline|5605|213511339|Male and Female|Nerve sheath, benign and malignant|2005
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Nerve sheath, benign and malignant|2005
20+|2.5|2.6|2.6|Benign/Borderline|5707|216055494|Male and Female|Nerve sheath, benign and malignant|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Nerve sheath, benign and malignant|2006
20+|2.5|2.6|2.6|Benign/Borderline|5824|218481776|Male and Female|Nerve sheath, benign and malignant|2007
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Nerve sheath, benign and malignant|2007
20+|2.5|2.7|2.6|Benign/Borderline|5952|220975702|Male and Female|Nerve sheath, benign and malignant|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Nerve sheath, benign and malignant|2008
20+|2.6|2.7|2.7|Benign/Borderline|6243|223491138|Male and Female|Nerve sheath, benign and malignant|2009
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Nerve sheath, benign and malignant|2009
20+|2.5|2.7|2.6|Benign/Borderline|6131|226154695|Male and Female|Nerve sheath, benign and malignant|2010
20+|0.0|0.0|0.0|Malignant|46|226154695|Male and Female|Nerve sheath, benign and malignant|2010
20+|2.6|2.8|2.7|Benign/Borderline|6488|228805985|Male and Female|Nerve sheath, benign and malignant|2011
20+|0.0|0.0|0.0|Malignant|38|228805985|Male and Female|Nerve sheath, benign and malignant|2011
20+|2.8|2.9|2.8|Benign/Borderline|6918|231483500|Male and Female|Nerve sheath, benign and malignant|2012
20+|0.0|0.0|0.0|Malignant|51|231483500|Male and Female|Nerve sheath, benign and malignant|2012
20+|2.9|3.0|2.9|Benign/Borderline|7244|233942819|Male and Female|Nerve sheath, benign and malignant|2013
20+|0.0|0.0|0.0|Malignant|45|233942819|Male and Female|Nerve sheath, benign and malignant|2013
20+|3.0|3.1|3.0|Benign/Borderline|7651|236444496|Male and Female|Nerve sheath, benign and malignant|2014
20+|0.0|0.0|0.0|Malignant|37|236444496|Male and Female|Nerve sheath, benign and malignant|2014
20+|3.0|3.1|3.1|Benign/Borderline|7804|238861655|Male and Female|Nerve sheath, benign and malignant|2015
20+|0.0|0.0|0.0|Malignant|41|238861655|Male and Female|Nerve sheath, benign and malignant|2015
20+|3.0|3.1|3.0|Benign/Borderline|7774|241188135|Male and Female|Nerve sheath, benign and malignant|2016
20+|0.0|0.0|0.0|Malignant|53|241188135|Male and Female|Nerve sheath, benign and malignant|2016
20+|2.9|3.1|3.0|Benign/Borderline|7850|243306804|Male and Female|Nerve sheath, benign and malignant|2017
20+|0.0|0.0|0.0|Malignant|45|243306804|Male and Female|Nerve sheath, benign and malignant|2017
20+|2.9|3.0|3.0|Benign/Borderline|7940|245213263|Male and Female|Nerve sheath, benign and malignant|2018
20+|0.0|0.0|0.0|Malignant|30|245213263|Male and Female|Nerve sheath, benign and malignant|2018
20+|2.8|2.9|2.9|Benign/Borderline|38681|1242099918|Male and Female|Nerve sheath, benign and malignant|2018-2022
20+|0.0|0.0|0.0|Malignant|206|1242099918|Male and Female|Nerve sheath, benign and malignant|2018-2022
20+|2.9|3.1|3.0|Benign/Borderline|8052|247018299|Male and Female|Nerve sheath, benign and malignant|2019
20+|0.0|0.0|0.0|Malignant|37|247018299|Male and Female|Nerve sheath, benign and malignant|2019
20+|2.5|2.6|2.6|Benign/Borderline|6917|248653501|Male and Female|Nerve sheath, benign and malignant|2020
20+|0.0|0.0|0.0|Malignant|39|248653501|Male and Female|Nerve sheath, benign and malignant|2020
20+|2.9|3.0|3.0|Benign/Borderline|8087|249847104|Male and Female|Nerve sheath, benign and malignant|2021
20+|0.0|0.0|0.0|Malignant|47|249847104|Male and Female|Nerve sheath, benign and malignant|2021
20+|2.7|2.8|2.8|Benign/Borderline|7685|251367751|Male and Female|Nerve sheath, benign and malignant|2022
20+|0.0|0.0|0.0|Malignant|53|251367751|Male and Female|Nerve sheath, benign and malignant|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Neuroepithelial|2004
20+|0.0|0.0|0.0|Malignant|48|211050944|Male and Female|Neuroepithelial|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Neuroepithelial|2005
20+|0.0|0.0|0.0|Malignant|41|213511339|Male and Female|Neuroepithelial|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Neuroepithelial|2006
20+|0.0|0.0|0.0|Malignant|42|216055494|Male and Female|Neuroepithelial|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Neuroepithelial|2007
20+|0.0|0.0|0.0|Malignant|51|218481776|Male and Female|Neuroepithelial|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Neuroepithelial|2008
20+|0.0|0.0|0.0|Malignant|45|220975702|Male and Female|Neuroepithelial|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Neuroepithelial|2009
20+|0.0|0.0|0.0|Malignant|45|223491138|Male and Female|Neuroepithelial|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Neuroepithelial|2010
20+|0.0|0.0|0.0|Malignant|52|226154695|Male and Female|Neuroepithelial|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Neuroepithelial|2011
20+|0.0|0.0|0.0|Malignant|50|228805985|Male and Female|Neuroepithelial|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Neuroepithelial|2012
20+|0.0|0.0|0.0|Malignant|55|231483500|Male and Female|Neuroepithelial|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Neuroepithelial|2013
20+|0.0|0.0|0.0|Malignant|48|233942819|Male and Female|Neuroepithelial|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Neuroepithelial|2014
20+|0.0|0.0|0.0|Malignant|57|236444496|Male and Female|Neuroepithelial|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Neuroepithelial|2015
20+|0.0|0.0|0.0|Malignant|73|238861655|Male and Female|Neuroepithelial|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Neuroepithelial|2016
20+|0.0|0.0|0.0|Malignant|47|241188135|Male and Female|Neuroepithelial|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Neuroepithelial|2017
20+|0.0|0.0|0.0|Malignant|35|243306804|Male and Female|Neuroepithelial|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Neuroepithelial|2018
20+|0.0|0.0|0.0|Malignant|24|245213263|Male and Female|Neuroepithelial|2018
20+|0.0|0.0|0.0|Benign/Borderline|48|1242099918|Male and Female|Neuroepithelial|2018-2022
20+|0.0|0.0|0.0|Malignant|112|1242099918|Male and Female|Neuroepithelial|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Neuroepithelial|2019
20+|0.0|0.0|0.0|Malignant|28|247018299|Male and Female|Neuroepithelial|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Neuroepithelial|2020
20+|0.0|0.0|0.0|Malignant|24|248653501|Male and Female|Neuroepithelial|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Neuroepithelial|2021
20+|0.0|0.0|0.0|Malignant|23|249847104|Male and Female|Neuroepithelial|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Neuroepithelial|2022
20+|~|~|~|Malignant|~|251367751|Male and Female|Neuroepithelial|2022
20+|0.1|0.2|0.1|Benign/Borderline|317|211050944|Male and Female|Neuronal/glial, neuronal|2004
20+|0.0|0.0|0.0|Malignant|37|211050944|Male and Female|Neuronal/glial, neuronal|2004
20+|0.2|0.2|0.2|Benign/Borderline|378|213511339|Male and Female|Neuronal/glial, neuronal|2005
20+|0.0|0.0|0.0|Malignant|53|213511339|Male and Female|Neuronal/glial, neuronal|2005
20+|0.2|0.2|0.2|Benign/Borderline|390|216055494|Male and Female|Neuronal/glial, neuronal|2006
20+|0.0|0.0|0.0|Malignant|44|216055494|Male and Female|Neuronal/glial, neuronal|2006
20+|0.2|0.2|0.2|Benign/Borderline|394|218481776|Male and Female|Neuronal/glial, neuronal|2007
20+|0.0|0.0|0.0|Malignant|45|218481776|Male and Female|Neuronal/glial, neuronal|2007
20+|0.2|0.2|0.2|Benign/Borderline|421|220975702|Male and Female|Neuronal/glial, neuronal|2008
20+|0.0|0.0|0.0|Malignant|50|220975702|Male and Female|Neuronal/glial, neuronal|2008
20+|0.2|0.2|0.2|Benign/Borderline|443|223491138|Male and Female|Neuronal/glial, neuronal|2009
20+|0.0|0.0|0.0|Malignant|42|223491138|Male and Female|Neuronal/glial, neuronal|2009
20+|0.2|0.2|0.2|Benign/Borderline|485|226154695|Male and Female|Neuronal/glial, neuronal|2010
20+|0.0|0.0|0.0|Malignant|32|226154695|Male and Female|Neuronal/glial, neuronal|2010
20+|0.2|0.2|0.2|Benign/Borderline|441|228805985|Male and Female|Neuronal/glial, neuronal|2011
20+|0.0|0.0|0.0|Malignant|40|228805985|Male and Female|Neuronal/glial, neuronal|2011
20+|0.2|0.2|0.2|Benign/Borderline|427|231483500|Male and Female|Neuronal/glial, neuronal|2012
20+|0.0|0.0|0.0|Malignant|44|231483500|Male and Female|Neuronal/glial, neuronal|2012
20+|0.2|0.2|0.2|Benign/Borderline|400|233942819|Male and Female|Neuronal/glial, neuronal|2013
20+|0.0|0.0|0.0|Malignant|33|233942819|Male and Female|Neuronal/glial, neuronal|2013
20+|0.2|0.2|0.2|Benign/Borderline|470|236444496|Male and Female|Neuronal/glial, neuronal|2014
20+|0.0|0.0|0.0|Malignant|35|236444496|Male and Female|Neuronal/glial, neuronal|2014
20+|0.2|0.2|0.2|Benign/Borderline|506|238861655|Male and Female|Neuronal/glial, neuronal|2015
20+|0.0|0.0|0.0|Malignant|32|238861655|Male and Female|Neuronal/glial, neuronal|2015
20+|0.2|0.2|0.2|Benign/Borderline|497|241188135|Male and Female|Neuronal/glial, neuronal|2016
20+|0.0|0.0|0.0|Malignant|47|241188135|Male and Female|Neuronal/glial, neuronal|2016
20+|0.2|0.2|0.2|Benign/Borderline|528|243306804|Male and Female|Neuronal/glial, neuronal|2017
20+|0.0|0.0|0.0|Malignant|35|243306804|Male and Female|Neuronal/glial, neuronal|2017
20+|0.2|0.2|0.2|Benign/Borderline|474|245213263|Male and Female|Neuronal/glial, neuronal|2018
20+|0.0|0.0|0.0|Malignant|25|245213263|Male and Female|Neuronal/glial, neuronal|2018
20+|0.2|0.2|0.2|Benign/Borderline|2357|1242099918|Male and Female|Neuronal/glial, neuronal|2018-2022
20+|0.0|0.0|0.0|Malignant|184|1242099918|Male and Female|Neuronal/glial, neuronal|2018-2022
20+|0.2|0.2|0.2|Benign/Borderline|503|247018299|Male and Female|Neuronal/glial, neuronal|2019
20+|0.0|0.0|0.0|Malignant|34|247018299|Male and Female|Neuronal/glial, neuronal|2019
20+|0.2|0.2|0.2|Benign/Borderline|455|248653501|Male and Female|Neuronal/glial, neuronal|2020
20+|0.0|0.0|0.0|Malignant|30|248653501|Male and Female|Neuronal/glial, neuronal|2020
20+|0.2|0.2|0.2|Benign/Borderline|490|249847104|Male and Female|Neuronal/glial, neuronal|2021
20+|0.0|0.0|0.0|Malignant|43|249847104|Male and Female|Neuronal/glial, neuronal|2021
20+|0.2|0.2|0.2|Benign/Borderline|435|251367751|Male and Female|Neuronal/glial, neuronal|2022
20+|0.0|0.0|0.0|Malignant|52|251367751|Male and Female|Neuronal/glial, neuronal|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Oligodendroglioma|2004
20+|0.4|0.4|0.4|Malignant|832|211050944|Male and Female|Oligodendroglioma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Oligodendroglioma|2005
20+|0.4|0.4|0.4|Malignant|812|213511339|Male and Female|Oligodendroglioma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Oligodendroglioma|2006
20+|0.4|0.4|0.4|Malignant|868|216055494|Male and Female|Oligodendroglioma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Oligodendroglioma|2007
20+|0.4|0.4|0.4|Malignant|817|218481776|Male and Female|Oligodendroglioma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Oligodendroglioma|2008
20+|0.3|0.4|0.4|Malignant|793|220975702|Male and Female|Oligodendroglioma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Oligodendroglioma|2009
20+|0.4|0.4|0.4|Malignant|853|223491138|Male and Female|Oligodendroglioma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Oligodendroglioma|2010
20+|0.3|0.4|0.4|Malignant|820|226154695|Male and Female|Oligodendroglioma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Oligodendroglioma|2011
20+|0.3|0.4|0.3|Malignant|773|228805985|Male and Female|Oligodendroglioma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Oligodendroglioma|2012
20+|0.3|0.3|0.3|Malignant|689|231483500|Male and Female|Oligodendroglioma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Oligodendroglioma|2013
20+|0.3|0.3|0.3|Malignant|728|233942819|Male and Female|Oligodendroglioma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Oligodendroglioma|2014
20+|0.3|0.3|0.3|Malignant|733|236444496|Male and Female|Oligodendroglioma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Oligodendroglioma|2015
20+|0.3|0.3|0.3|Malignant|726|238861655|Male and Female|Oligodendroglioma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Oligodendroglioma|2016
20+|0.3|0.4|0.3|Malignant|751|241188135|Male and Female|Oligodendroglioma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Oligodendroglioma|2017
20+|0.3|0.3|0.3|Malignant|736|243306804|Male and Female|Oligodendroglioma|2017
20+|~|~|~|Benign/Borderline|~|245213263|Male and Female|Oligodendroglioma|2018
20+|0.3|0.3|0.3|Malignant|674|245213263|Male and Female|Oligodendroglioma|2018
20+|~|~|~|Benign/Borderline|~|1242099918|Male and Female|Oligodendroglioma|2018-2022
20+|0.3|0.3|0.3|Malignant|3643|1242099918|Male and Female|Oligodendroglioma|2018-2022
20+|~|~|~|Benign/Borderline|~|247018299|Male and Female|Oligodendroglioma|2019
20+|0.3|0.3|0.3|Malignant|751|247018299|Male and Female|Oligodendroglioma|2019
20+|~|~|~|Benign/Borderline|~|248653501|Male and Female|Oligodendroglioma|2020
20+|0.3|0.3|0.3|Malignant|644|248653501|Male and Female|Oligodendroglioma|2020
20+|~|~|~|Benign/Borderline|~|249847104|Male and Female|Oligodendroglioma|2021
20+|0.3|0.3|0.3|Malignant|741|249847104|Male and Female|Oligodendroglioma|2021
20+|~|~|~|Benign/Borderline|~|251367751|Male and Female|Oligodendroglioma|2022
20+|0.3|0.4|0.4|Malignant|833|251367751|Male and Female|Oligodendroglioma|2022
20+|0.1|0.1|0.1|Benign/Borderline|154|211050944|Male and Female|Other mesenchymal|2004
20+|0.0|0.0|0.0|Malignant|59|211050944|Male and Female|Other mesenchymal|2004
20+|0.1|0.1|0.1|Benign/Borderline|157|213511339|Male and Female|Other mesenchymal|2005
20+|0.0|0.0|0.0|Malignant|65|213511339|Male and Female|Other mesenchymal|2005
20+|0.1|0.1|0.1|Benign/Borderline|159|216055494|Male and Female|Other mesenchymal|2006
20+|0.0|0.0|0.0|Malignant|58|216055494|Male and Female|Other mesenchymal|2006
20+|0.1|0.1|0.1|Benign/Borderline|168|218481776|Male and Female|Other mesenchymal|2007
20+|0.0|0.0|0.0|Malignant|80|218481776|Male and Female|Other mesenchymal|2007
20+|0.1|0.1|0.1|Benign/Borderline|211|220975702|Male and Female|Other mesenchymal|2008
20+|0.0|0.1|0.0|Malignant|101|220975702|Male and Female|Other mesenchymal|2008
20+|0.1|0.1|0.1|Benign/Borderline|202|223491138|Male and Female|Other mesenchymal|2009
20+|0.0|0.0|0.0|Malignant|80|223491138|Male and Female|Other mesenchymal|2009
20+|0.1|0.1|0.1|Benign/Borderline|180|226154695|Male and Female|Other mesenchymal|2010
20+|0.0|0.0|0.0|Malignant|72|226154695|Male and Female|Other mesenchymal|2010
20+|0.1|0.1|0.1|Benign/Borderline|165|228805985|Male and Female|Other mesenchymal|2011
20+|0.0|0.0|0.0|Malignant|78|228805985|Male and Female|Other mesenchymal|2011
20+|0.1|0.1|0.1|Benign/Borderline|203|231483500|Male and Female|Other mesenchymal|2012
20+|0.0|0.0|0.0|Malignant|71|231483500|Male and Female|Other mesenchymal|2012
20+|0.1|0.1|0.1|Benign/Borderline|184|233942819|Male and Female|Other mesenchymal|2013
20+|0.0|0.0|0.0|Malignant|85|233942819|Male and Female|Other mesenchymal|2013
20+|0.1|0.1|0.1|Benign/Borderline|189|236444496|Male and Female|Other mesenchymal|2014
20+|0.0|0.0|0.0|Malignant|84|236444496|Male and Female|Other mesenchymal|2014
20+|0.1|0.1|0.1|Benign/Borderline|202|238861655|Male and Female|Other mesenchymal|2015
20+|0.0|0.0|0.0|Malignant|94|238861655|Male and Female|Other mesenchymal|2015
20+|0.1|0.1|0.1|Benign/Borderline|166|241188135|Male and Female|Other mesenchymal|2016
20+|0.0|0.0|0.0|Malignant|86|241188135|Male and Female|Other mesenchymal|2016
20+|0.1|0.1|0.1|Benign/Borderline|202|243306804|Male and Female|Other mesenchymal|2017
20+|0.0|0.1|0.0|Malignant|120|243306804|Male and Female|Other mesenchymal|2017
20+|0.1|0.1|0.1|Benign/Borderline|187|245213263|Male and Female|Other mesenchymal|2018
20+|0.0|0.1|0.0|Malignant|111|245213263|Male and Female|Other mesenchymal|2018
20+|0.1|0.1|0.1|Benign/Borderline|865|1242099918|Male and Female|Other mesenchymal|2018-2022
20+|0.0|0.0|0.0|Malignant|516|1242099918|Male and Female|Other mesenchymal|2018-2022
20+|0.1|0.1|0.1|Benign/Borderline|162|247018299|Male and Female|Other mesenchymal|2019
20+|0.0|0.0|0.0|Malignant|100|247018299|Male and Female|Other mesenchymal|2019
20+|0.0|0.1|0.0|Benign/Borderline|129|248653501|Male and Female|Other mesenchymal|2020
20+|0.0|0.1|0.0|Malignant|120|248653501|Male and Female|Other mesenchymal|2020
20+|0.1|0.1|0.1|Benign/Borderline|174|249847104|Male and Female|Other mesenchymal|2021
20+|0.0|0.1|0.0|Malignant|111|249847104|Male and Female|Other mesenchymal|2021
20+|0.1|0.1|0.1|Benign/Borderline|213|251367751|Male and Female|Other mesenchymal|2022
20+|0.0|0.0|0.0|Malignant|74|251367751|Male and Female|Other mesenchymal|2022
20+|~|~|~|Benign/Borderline|~|211050944|Male and Female|Pilocytic astrocytoma|2004
20+|0.1|0.1|0.1|Malignant|279|211050944|Male and Female|Pilocytic astrocytoma|2004
20+|~|~|~|Benign/Borderline|~|213511339|Male and Female|Pilocytic astrocytoma|2005
20+|0.1|0.2|0.1|Malignant|310|213511339|Male and Female|Pilocytic astrocytoma|2005
20+|~|~|~|Benign/Borderline|~|216055494|Male and Female|Pilocytic astrocytoma|2006
20+|0.1|0.2|0.1|Malignant|308|216055494|Male and Female|Pilocytic astrocytoma|2006
20+|~|~|~|Benign/Borderline|~|218481776|Male and Female|Pilocytic astrocytoma|2007
20+|0.1|0.2|0.1|Malignant|309|218481776|Male and Female|Pilocytic astrocytoma|2007
20+|~|~|~|Benign/Borderline|~|220975702|Male and Female|Pilocytic astrocytoma|2008
20+|0.1|0.2|0.1|Malignant|292|220975702|Male and Female|Pilocytic astrocytoma|2008
20+|~|~|~|Benign/Borderline|~|223491138|Male and Female|Pilocytic astrocytoma|2009
20+|0.1|0.1|0.1|Malignant|274|223491138|Male and Female|Pilocytic astrocytoma|2009
20+|~|~|~|Benign/Borderline|~|226154695|Male and Female|Pilocytic astrocytoma|2010
20+|0.1|0.2|0.2|Malignant|335|226154695|Male and Female|Pilocytic astrocytoma|2010
20+|~|~|~|Benign/Borderline|~|228805985|Male and Female|Pilocytic astrocytoma|2011
20+|0.1|0.2|0.2|Malignant|338|228805985|Male and Female|Pilocytic astrocytoma|2011
20+|~|~|~|Benign/Borderline|~|231483500|Male and Female|Pilocytic astrocytoma|2012
20+|0.1|0.1|0.1|Malignant|274|231483500|Male and Female|Pilocytic astrocytoma|2012
20+|~|~|~|Benign/Borderline|~|233942819|Male and Female|Pilocytic astrocytoma|2013
20+|0.1|0.2|0.1|Malignant|309|233942819|Male and Female|Pilocytic astrocytoma|2013
20+|~|~|~|Benign/Borderline|~|236444496|Male and Female|Pilocytic astrocytoma|2014
20+|0.1|0.1|0.1|Malignant|302|236444496|Male and Female|Pilocytic astrocytoma|2014
20+|~|~|~|Benign/Borderline|~|238861655|Male and Female|Pilocytic astrocytoma|2015
20+|0.1|0.1|0.1|Malignant|302|238861655|Male and Female|Pilocytic astrocytoma|2015
20+|~|~|~|Benign/Borderline|~|241188135|Male and Female|Pilocytic astrocytoma|2016
20+|0.1|0.1|0.1|Malignant|303|241188135|Male and Female|Pilocytic astrocytoma|2016
20+|~|~|~|Benign/Borderline|~|243306804|Male and Female|Pilocytic astrocytoma|2017
20+|0.1|0.1|0.1|Malignant|277|243306804|Male and Female|Pilocytic astrocytoma|2017
20+|0.0|0.0|0.0|Benign/Borderline|16|245213263|Male and Female|Pilocytic astrocytoma|2018
20+|0.1|0.1|0.1|Malignant|283|245213263|Male and Female|Pilocytic astrocytoma|2018
20+|0.0|0.0|0.0|Benign/Borderline|100|1242099918|Male and Female|Pilocytic astrocytoma|2018-2022
20+|0.1|0.1|0.1|Malignant|1362|1242099918|Male and Female|Pilocytic astrocytoma|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|24|247018299|Male and Female|Pilocytic astrocytoma|2019
20+|0.1|0.1|0.1|Malignant|293|247018299|Male and Female|Pilocytic astrocytoma|2019
20+|0.0|0.0|0.0|Benign/Borderline|18|248653501|Male and Female|Pilocytic astrocytoma|2020
20+|0.1|0.1|0.1|Malignant|269|248653501|Male and Female|Pilocytic astrocytoma|2020
20+|0.0|0.0|0.0|Benign/Borderline|23|249847104|Male and Female|Pilocytic astrocytoma|2021
20+|0.1|0.1|0.1|Malignant|263|249847104|Male and Female|Pilocytic astrocytoma|2021
20+|0.0|0.0|0.0|Benign/Borderline|19|251367751|Male and Female|Pilocytic astrocytoma|2022
20+|0.1|0.1|0.1|Malignant|254|251367751|Male and Female|Pilocytic astrocytoma|2022
20+|0.0|0.0|0.0|Benign/Borderline|27|211050944|Male and Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Malignant|31|211050944|Male and Female|Pineal parenchymal|2004
20+|0.0|0.0|0.0|Benign/Borderline|50|213511339|Male and Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Malignant|31|213511339|Male and Female|Pineal parenchymal|2005
20+|0.0|0.0|0.0|Benign/Borderline|48|216055494|Male and Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Pineal parenchymal|2006
20+|0.0|0.0|0.0|Benign/Borderline|47|218481776|Male and Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Malignant|44|218481776|Male and Female|Pineal parenchymal|2007
20+|0.0|0.0|0.0|Benign/Borderline|70|220975702|Male and Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Malignant|43|220975702|Male and Female|Pineal parenchymal|2008
20+|0.0|0.0|0.0|Benign/Borderline|44|223491138|Male and Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Malignant|48|223491138|Male and Female|Pineal parenchymal|2009
20+|0.0|0.0|0.0|Benign/Borderline|56|226154695|Male and Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Malignant|41|226154695|Male and Female|Pineal parenchymal|2010
20+|0.0|0.0|0.0|Benign/Borderline|64|228805985|Male and Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Malignant|44|228805985|Male and Female|Pineal parenchymal|2011
20+|0.0|0.0|0.0|Benign/Borderline|63|231483500|Male and Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Malignant|41|231483500|Male and Female|Pineal parenchymal|2012
20+|0.0|0.0|0.0|Benign/Borderline|68|233942819|Male and Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Malignant|71|233942819|Male and Female|Pineal parenchymal|2013
20+|0.0|0.0|0.0|Benign/Borderline|66|236444496|Male and Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Malignant|34|236444496|Male and Female|Pineal parenchymal|2014
20+|0.0|0.0|0.0|Benign/Borderline|64|238861655|Male and Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Malignant|59|238861655|Male and Female|Pineal parenchymal|2015
20+|0.0|0.0|0.0|Benign/Borderline|65|241188135|Male and Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Malignant|66|241188135|Male and Female|Pineal parenchymal|2016
20+|0.0|0.0|0.0|Benign/Borderline|57|243306804|Male and Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Malignant|53|243306804|Male and Female|Pineal parenchymal|2017
20+|0.0|0.0|0.0|Benign/Borderline|61|245213263|Male and Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Malignant|43|245213263|Male and Female|Pineal parenchymal|2018
20+|0.0|0.0|0.0|Benign/Borderline|243|1242099918|Male and Female|Pineal parenchymal|2018-2022
20+|0.0|0.0|0.0|Malignant|231|1242099918|Male and Female|Pineal parenchymal|2018-2022
20+|0.0|0.0|0.0|Benign/Borderline|46|247018299|Male and Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Malignant|49|247018299|Male and Female|Pineal parenchymal|2019
20+|0.0|0.0|0.0|Benign/Borderline|46|248653501|Male and Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Malignant|46|248653501|Male and Female|Pineal parenchymal|2020
20+|0.0|0.0|0.0|Benign/Borderline|39|249847104|Male and Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Malignant|57|249847104|Male and Female|Pineal parenchymal|2021
20+|0.0|0.0|0.0|Benign/Borderline|51|251367751|Male and Female|Pineal parenchymal|2022
20+|0.0|0.0|0.0|Malignant|36|251367751|Male and Female|Pineal parenchymal|2022
20+|3.6|3.8|3.7|Benign/Borderline|7809|211050944|Male and Female|Pituitary|2004
20+|0.0|0.0|0.0|Malignant|44|211050944|Male and Female|Pituitary|2004
20+|4.1|4.2|4.2|Benign/Borderline|8889|213511339|Male and Female|Pituitary|2005
20+|0.0|0.0|0.0|Malignant|38|213511339|Male and Female|Pituitary|2005
20+|4.4|4.6|4.5|Benign/Borderline|9672|216055494|Male and Female|Pituitary|2006
20+|0.0|0.0|0.0|Malignant|31|216055494|Male and Female|Pituitary|2006
20+|4.6|4.8|4.7|Benign/Borderline|10303|218481776|Male and Female|Pituitary|2007
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Pituitary|2007
20+|5.0|5.2|5.1|Benign/Borderline|11203|220975702|Male and Female|Pituitary|2008
20+|~|~|~|Malignant|~|220975702|Male and Female|Pituitary|2008
20+|5.3|5.5|5.4|Benign/Borderline|12178|223491138|Male and Female|Pituitary|2009
20+|0.0|0.0|0.0|Malignant|25|223491138|Male and Female|Pituitary|2009
20+|5.4|5.6|5.5|Benign/Borderline|12501|226154695|Male and Female|Pituitary|2010
20+|0.0|0.0|0.0|Malignant|34|226154695|Male and Female|Pituitary|2010
20+|5.5|5.7|5.6|Benign/Borderline|12891|228805985|Male and Female|Pituitary|2011
20+|0.0|0.0|0.0|Malignant|33|228805985|Male and Female|Pituitary|2011
20+|5.9|6.1|6.0|Benign/Borderline|13978|231483500|Male and Female|Pituitary|2012
20+|0.0|0.0|0.0|Malignant|34|231483500|Male and Female|Pituitary|2012
20+|5.8|6.0|5.9|Benign/Borderline|14021|233942819|Male and Female|Pituitary|2013
20+|0.0|0.0|0.0|Malignant|43|233942819|Male and Female|Pituitary|2013
20+|6.0|6.2|6.1|Benign/Borderline|14436|236444496|Male and Female|Pituitary|2014
20+|0.0|0.0|0.0|Malignant|34|236444496|Male and Female|Pituitary|2014
20+|6.2|6.4|6.3|Benign/Borderline|15218|238861655|Male and Female|Pituitary|2015
20+|0.0|0.0|0.0|Malignant|31|238861655|Male and Female|Pituitary|2015
20+|6.3|6.5|6.4|Benign/Borderline|15599|241188135|Male and Female|Pituitary|2016
20+|0.0|0.0|0.0|Malignant|30|241188135|Male and Female|Pituitary|2016
20+|6.5|6.7|6.6|Benign/Borderline|16392|243306804|Male and Female|Pituitary|2017
20+|0.0|0.0|0.0|Malignant|25|243306804|Male and Female|Pituitary|2017
20+|6.6|6.8|6.7|Benign/Borderline|16604|245213263|Male and Female|Pituitary|2018
20+|0.0|0.0|0.0|Malignant|27|245213263|Male and Female|Pituitary|2018
20+|6.3|6.4|6.3|Benign/Borderline|80490|1242099918|Male and Female|Pituitary|2018-2022
20+|0.0|0.0|0.0|Malignant|454|1242099918|Male and Female|Pituitary|2018-2022
20+|6.6|6.8|6.7|Benign/Borderline|16918|247018299|Male and Female|Pituitary|2019
20+|0.0|0.0|0.0|Malignant|24|247018299|Male and Female|Pituitary|2019
20+|5.7|5.9|5.8|Benign/Borderline|14788|248653501|Male and Female|Pituitary|2020
20+|0.0|0.0|0.0|Malignant|38|248653501|Male and Female|Pituitary|2020
20+|6.4|6.6|6.5|Benign/Borderline|16502|249847104|Male and Female|Pituitary|2021
20+|0.0|0.0|0.0|Malignant|51|249847104|Male and Female|Pituitary|2021
20+|6.0|6.1|6.0|Benign/Borderline|15678|251367751|Male and Female|Pituitary|2022
20+|0.1|0.1|0.1|Malignant|314|251367751|Male and Female|Pituitary|2022
20+|16.6|17.0|16.8|Benign/Borderline|35696|211050944|Male and Female|Total|2004
20+|9.0|9.3|9.1|Malignant|19408|211050944|Male and Female|Total|2004
20+|18.7|19.1|18.9|Benign/Borderline|40679|213511339|Male and Female|Total|2005
20+|9.0|9.3|9.2|Malignant|19759|213511339|Male and Female|Total|2005
20+|19.5|19.9|19.7|Benign/Borderline|43134|216055494|Male and Female|Total|2006
20+|8.9|9.2|9.0|Malignant|19846|216055494|Male and Female|Total|2006
20+|20.1|20.5|20.3|Benign/Borderline|45254|218481776|Male and Female|Total|2007
20+|8.9|9.2|9.0|Malignant|20180|218481776|Male and Female|Total|2007
20+|21.3|21.7|21.5|Benign/Borderline|48631|220975702|Male and Female|Total|2008
20+|9.0|9.2|9.1|Malignant|20670|220975702|Male and Female|Total|2008
20+|22.6|23.0|22.8|Benign/Borderline|52435|223491138|Male and Female|Total|2009
20+|8.9|9.1|9.0|Malignant|20859|223491138|Male and Female|Total|2009
20+|22.3|22.7|22.5|Benign/Borderline|52601|226154695|Male and Female|Total|2010
20+|8.7|8.9|8.8|Malignant|20762|226154695|Male and Female|Total|2010
20+|22.7|23.1|22.9|Benign/Borderline|54160|228805985|Male and Female|Total|2011
20+|8.6|8.8|8.7|Malignant|20907|228805985|Male and Female|Total|2011
20+|23.5|23.9|23.7|Benign/Borderline|57001|231483500|Male and Female|Total|2012
20+|8.5|8.8|8.7|Malignant|21173|231483500|Male and Female|Total|2012
20+|23.7|24.1|23.9|Benign/Borderline|58391|233942819|Male and Female|Total|2013
20+|8.6|8.8|8.7|Malignant|21608|233942819|Male and Female|Total|2013
20+|24.2|24.6|24.4|Benign/Borderline|60620|236444496|Male and Female|Total|2014
20+|8.5|8.7|8.6|Malignant|21815|236444496|Male and Female|Total|2014
20+|25.0|25.4|25.2|Benign/Borderline|63461|238861655|Male and Female|Total|2015
20+|8.5|8.7|8.6|Malignant|22110|238861655|Male and Female|Total|2015
20+|25.2|25.6|25.4|Benign/Borderline|65024|241188135|Male and Female|Total|2016
20+|8.5|8.7|8.6|Malignant|22459|241188135|Male and Female|Total|2016
20+|25.9|26.3|26.1|Benign/Borderline|67839|243306804|Male and Female|Total|2017
20+|8.4|8.6|8.5|Malignant|22627|243306804|Male and Female|Total|2017
20+|26.0|26.4|26.2|Benign/Borderline|69104|245213263|Male and Female|Total|2018
20+|8.2|8.4|8.3|Malignant|22471|245213263|Male and Female|Total|2018
20+|25.7|25.9|25.8|Benign/Borderline|349821|1242099918|Male and Female|Total|2018-2022
20+|8.0|8.1|8.1|Malignant|112595|1242099918|Male and Female|Total|2018-2022
20+|26.7|27.1|26.9|Benign/Borderline|72142|247018299|Male and Female|Total|2019
20+|8.1|8.3|8.2|Malignant|22546|247018299|Male and Female|Total|2019
20+|23.9|24.3|24.1|Benign/Borderline|65287|248653501|Male and Female|Total|2020
20+|8.0|8.2|8.1|Malignant|22687|248653501|Male and Female|Total|2020
20+|26.2|26.5|26.4|Benign/Borderline|72093|249847104|Male and Female|Total|2021
20+|7.9|8.1|8.0|Malignant|22496|249847104|Male and Female|Total|2021
20+|25.4|25.8|25.6|Benign/Borderline|71195|251367751|Male and Female|Total|2022
20+|7.7|7.9|7.8|Malignant|22395|251367751|Male and Female|Total|2022
20+|2.3|2.4|2.3|Benign/Borderline|4984|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004
20+|0.0|0.0|0.0|Malignant|46|211050944|Male and Female|Tumors of Cranial and Spinal Nerves|2004
20+|2.5|2.6|2.6|Benign/Borderline|5608|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005
20+|0.0|0.0|0.0|Malignant|52|213511339|Male and Female|Tumors of Cranial and Spinal Nerves|2005
20+|2.5|2.6|2.6|Benign/Borderline|5709|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006
20+|0.0|0.0|0.0|Malignant|40|216055494|Male and Female|Tumors of Cranial and Spinal Nerves|2006
20+|2.5|2.6|2.6|Benign/Borderline|5826|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007
20+|0.0|0.0|0.0|Malignant|59|218481776|Male and Female|Tumors of Cranial and Spinal Nerves|2007
20+|2.5|2.7|2.6|Benign/Borderline|5956|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008
20+|0.0|0.0|0.0|Malignant|51|220975702|Male and Female|Tumors of Cranial and Spinal Nerves|2008
20+|2.6|2.8|2.7|Benign/Borderline|6250|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009
20+|0.0|0.0|0.0|Malignant|37|223491138|Male and Female|Tumors of Cranial and Spinal Nerves|2009
20+|2.5|2.7|2.6|Benign/Borderline|6135|226154695|Male and Female|Tumors of Cranial and Spinal Nerves|2010
20+|0.0|0.0|0.0|Malignant|46|226154695|Male and Female|Tumors of Cranial and Spinal Nerves|2010
20+|2.6|2.8|2.7|Benign/Borderline|6494|228805985|Male and Female|Tumors of Cranial and Spinal Nerves|2011
20+|0.0|0.0|0.0|Malignant|38|228805985|Male and Female|Tumors of Cranial and Spinal Nerves|2011
20+|2.8|2.9|2.8|Benign/Borderline|6920|231483500|Male and Female|Tumors of Cranial and Spinal Nerves|2012
20+|0.0|0.0|0.0|Malignant|51|231483500|Male and Female|Tumors of Cranial and Spinal Nerves|2012
20+|2.9|3.0|2.9|Benign/Borderline|7249|233942819|Male and Female|Tumors of Cranial and Spinal Nerves|2013
20+|0.0|0.0|0.0|Malignant|45|233942819|Male and Female|Tumors of Cranial and Spinal Nerves|2013
20+|3.0|3.1|3.1|Benign/Borderline|7660|236444496|Male and Female|Tumors of Cranial and Spinal Nerves|2014
20+|0.0|0.0|0.0|Malignant|37|236444496|Male and Female|Tumors of Cranial and Spinal Nerves|2014
20+|3.0|3.1|3.1|Benign/Borderline|7814|238861655|Male and Female|Tumors of Cranial and Spinal Nerves|2015
20+|0.0|0.0|0.0|Malignant|41|238861655|Male and Female|Tumors of Cranial and Spinal Nerves|2015
20+|3.0|3.1|3.0|Benign/Borderline|7785|241188135|Male and Female|Tumors of Cranial and Spinal Nerves|2016
20+|0.0|0.0|0.0|Malignant|53|241188135|Male and Female|Tumors of Cranial and Spinal Nerves|2016
20+|2.9|3.1|3.0|Benign/Borderline|7855|243306804|Male and Female|Tumors of Cranial and Spinal Nerves|2017
20+|0.0|0.0|0.0|Malignant|45|243306804|Male and Female|Tumors of Cranial and Spinal Nerves|2017
20+|2.9|3.1|3.0|Benign/Borderline|7946|245213263|Male and Female|Tumors of Cranial and Spinal Nerves|2018
20+|0.0|0.0|0.0|Malignant|30|245213263|Male and Female|Tumors of Cranial and Spinal Nerves|2018
20+|2.8|2.9|2.9|Benign/Borderline|38705|1242099918|Male and Female|Tumors of Cranial and Spinal Nerves|2018-2022
20+|0.0|0.0|0.0|Malignant|206|1242099918|Male and Female|Tumors of Cranial and Spinal Nerves|2018-2022
20+|2.9|3.1|3.0|Benign/Borderline|8058|247018299|Male and Female|Tumors of Cranial and Spinal Nerves|2019
20+|0.0|0.0|0.0|Malignant|37|247018299|Male and Female|Tumors of Cranial and Spinal Nerves|2019
20+|2.5|2.6|2.6|Benign/Borderline|6921|248653501|Male and Female|Tumors of Cranial and Spinal Nerves|2020
20+|0.0|0.0|0.0|Malignant|39|248653501|Male and Female|Tumors of Cranial and Spinal Nerves|2020
20+|2.9|3.0|3.0|Benign/Borderline|8092|249847104|Male and Female|Tumors of Cranial and Spinal Nerves|2021
20+|0.0|0.0|0.0|Malignant|47|249847104|Male and Female|Tumors of Cranial and Spinal Nerves|2021
20+|2.7|2.8|2.8|Benign/Borderline|7688|251367751|Male and Female|Tumors of Cranial and Spinal Nerves|2022
20+|0.0|0.0|0.0|Malignant|53|251367751|Male and Female|Tumors of Cranial and Spinal Nerves|2022
20+|0.4|0.4|0.4|Benign/Borderline|839|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004
20+|7.4|7.7|7.6|Malignant|16082|211050944|Male and Female|Tumors of Neuroepthelial Tissue|2004
20+|0.4|0.5|0.5|Benign/Borderline|973|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005
20+|7.4|7.7|7.5|Malignant|16284|213511339|Male and Female|Tumors of Neuroepthelial Tissue|2005
20+|0.5|0.5|0.5|Benign/Borderline|1055|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006
20+|7.4|7.6|7.5|Malignant|16447|216055494|Male and Female|Tumors of Neuroepthelial Tissue|2006
20+|0.4|0.5|0.5|Benign/Borderline|1018|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007
20+|7.4|7.7|7.5|Malignant|16834|218481776|Male and Female|Tumors of Neuroepthelial Tissue|2007
20+|0.5|0.5|0.5|Benign/Borderline|1088|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008
20+|7.4|7.7|7.5|Malignant|17147|220975702|Male and Female|Tumors of Neuroepthelial Tissue|2008
20+|0.5|0.5|0.5|Benign/Borderline|1119|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009
20+|7.4|7.6|7.5|Malignant|17406|223491138|Male and Female|Tumors of Neuroepthelial Tissue|2009
20+|0.5|0.6|0.5|Benign/Borderline|1211|226154695|Male and Female|Tumors of Neuroepthelial Tissue|2010
20+|7.3|7.5|7.4|Malignant|17400|226154695|Male and Female|Tumors of Neuroepthelial Tissue|2010
20+|0.5|0.6|0.5|Benign/Borderline|1199|228805985|Male and Female|Tumors of Neuroepthelial Tissue|2011
20+|7.2|7.4|7.3|Malignant|17510|228805985|Male and Female|Tumors of Neuroepthelial Tissue|2011
20+|0.5|0.6|0.5|Benign/Borderline|1199|231483500|Male and Female|Tumors of Neuroepthelial Tissue|2012
20+|7.2|7.4|7.3|Malignant|17813|231483500|Male and Female|Tumors of Neuroepthelial Tissue|2012
20+|0.5|0.5|0.5|Benign/Borderline|1155|233942819|Male and Female|Tumors of Neuroepthelial Tissue|2013
20+|7.2|7.4|7.3|Malignant|18189|233942819|Male and Female|Tumors of Neuroepthelial Tissue|2013
20+|0.5|0.6|0.6|Benign/Borderline|1300|236444496|Male and Female|Tumors of Neuroepthelial Tissue|2014
20+|7.1|7.3|7.2|Malignant|18069|236444496|Male and Female|Tumors of Neuroepthelial Tissue|2014
20+|0.5|0.6|0.6|Benign/Borderline|1341|238861655|Male and Female|Tumors of Neuroepthelial Tissue|2015
20+|7.1|7.3|7.2|Malignant|18509|238861655|Male and Female|Tumors of Neuroepthelial Tissue|2015
20+|0.5|0.6|0.6|Benign/Borderline|1355|241188135|Male and Female|Tumors of Neuroepthelial Tissue|2016
20+|7.1|7.3|7.2|Malignant|18876|241188135|Male and Female|Tumors of Neuroepthelial Tissue|2016
20+|0.5|0.6|0.6|Benign/Borderline|1378|243306804|Male and Female|Tumors of Neuroepthelial Tissue|2017
20+|7.0|7.3|7.1|Malignant|18983|243306804|Male and Female|Tumors of Neuroepthelial Tissue|2017
20+|0.5|0.6|0.5|Benign/Borderline|1317|245213263|Male and Female|Tumors of Neuroepthelial Tissue|2018
20+|6.9|7.1|7.0|Malignant|18818|245213263|Male and Female|Tumors of Neuroepthelial Tissue|2018
20+|0.5|0.6|0.5|Benign/Borderline|6665|1242099918|Male and Female|Tumors of Neuroepthelial Tissue|2018-2022
20+|6.7|6.8|6.8|Malignant|93898|1242099918|Male and Female|Tumors of Neuroepthelial Tissue|2018-2022
20+|0.5|0.6|0.6|Benign/Borderline|1368|247018299|Male and Female|Tumors of Neuroepthelial Tissue|2019
20+|6.8|7.0|6.9|Malignant|18862|247018299|Male and Female|Tumors of Neuroepthelial Tissue|2019
20+|0.5|0.5|0.5|Benign/Borderline|1292|248653501|Male and Female|Tumors of Neuroepthelial Tissue|2020
20+|6.6|6.8|6.7|Malignant|18861|248653501|Male and Female|Tumors of Neuroepthelial Tissue|2020
20+|0.5|0.6|0.6|Benign/Borderline|1363|249847104|Male and Female|Tumors of Neuroepthelial Tissue|2021
20+|6.6|6.8|6.7|Malignant|18746|249847104|Male and Female|Tumors of Neuroepthelial Tissue|2021
20+|0.5|0.6|0.5|Benign/Borderline|1325|251367751|Male and Female|Tumors of Neuroepthelial Tissue|2022
20+|6.4|6.6|6.5|Malignant|18611|251367751|Male and Female|Tumors of Neuroepthelial Tissue|2022
20+|3.8|4.0|3.9|Benign/Borderline|8205|211050944|Male and Female|Tumors of Sellar Region|2004
20+|0.0|0.0|0.0|Malignant|44|211050944|Male and Female|Tumors of Sellar Region|2004
20+|4.3|4.4|4.4|Benign/Borderline|9309|213511339|Male and Female|Tumors of Sellar Region|2005
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Tumors of Sellar Region|2005
20+|4.6|4.7|4.7|Benign/Borderline|10074|216055494|Male and Female|Tumors of Sellar Region|2006
20+|0.0|0.0|0.0|Malignant|33|216055494|Male and Female|Tumors of Sellar Region|2006
20+|4.8|5.0|4.9|Benign/Borderline|10727|218481776|Male and Female|Tumors of Sellar Region|2007
20+|0.0|0.0|0.0|Malignant|34|218481776|Male and Female|Tumors of Sellar Region|2007
20+|5.2|5.3|5.2|Benign/Borderline|11632|220975702|Male and Female|Tumors of Sellar Region|2008
20+|0.0|0.0|0.0|Malignant|17|220975702|Male and Female|Tumors of Sellar Region|2008
20+|5.5|5.7|5.6|Benign/Borderline|12612|223491138|Male and Female|Tumors of Sellar Region|2009
20+|0.0|0.0|0.0|Malignant|26|223491138|Male and Female|Tumors of Sellar Region|2009
20+|5.6|5.8|5.7|Benign/Borderline|12947|226154695|Male and Female|Tumors of Sellar Region|2010
20+|0.0|0.0|0.0|Malignant|34|226154695|Male and Female|Tumors of Sellar Region|2010
20+|5.7|5.9|5.8|Benign/Borderline|13312|228805985|Male and Female|Tumors of Sellar Region|2011
20+|0.0|0.0|0.0|Malignant|35|228805985|Male and Female|Tumors of Sellar Region|2011
20+|6.1|6.3|6.2|Benign/Borderline|14425|231483500|Male and Female|Tumors of Sellar Region|2012
20+|0.0|0.0|0.0|Malignant|34|231483500|Male and Female|Tumors of Sellar Region|2012
20+|6.0|6.2|6.1|Benign/Borderline|14505|233942819|Male and Female|Tumors of Sellar Region|2013
20+|0.0|0.0|0.0|Malignant|44|233942819|Male and Female|Tumors of Sellar Region|2013
20+|6.1|6.4|6.2|Benign/Borderline|14878|236444496|Male and Female|Tumors of Sellar Region|2014
20+|0.0|0.0|0.0|Malignant|38|236444496|Male and Female|Tumors of Sellar Region|2014
20+|6.4|6.6|6.5|Benign/Borderline|15688|238861655|Male and Female|Tumors of Sellar Region|2015
20+|0.0|0.0|0.0|Malignant|32|238861655|Male and Female|Tumors of Sellar Region|2015
20+|6.5|6.7|6.6|Benign/Borderline|16082|241188135|Male and Female|Tumors of Sellar Region|2016
20+|0.0|0.0|0.0|Malignant|31|241188135|Male and Female|Tumors of Sellar Region|2016
20+|6.7|6.9|6.8|Benign/Borderline|16891|243306804|Male and Female|Tumors of Sellar Region|2017
20+|0.0|0.0|0.0|Malignant|26|243306804|Male and Female|Tumors of Sellar Region|2017
20+|6.7|6.9|6.8|Benign/Borderline|17082|245213263|Male and Female|Tumors of Sellar Region|2018
20+|0.0|0.0|0.0|Malignant|27|245213263|Male and Female|Tumors of Sellar Region|2018
20+|6.5|6.6|6.5|Benign/Borderline|82843|1242099918|Male and Female|Tumors of Sellar Region|2018-2022
20+|0.0|0.0|0.0|Malignant|456|1242099918|Male and Female|Tumors of Sellar Region|2018-2022
20+|6.8|7.0|6.9|Benign/Borderline|17408|247018299|Male and Female|Tumors of Sellar Region|2019
20+|0.0|0.0|0.0|Malignant|24|247018299|Male and Female|Tumors of Sellar Region|2019
20+|5.9|6.1|6.0|Benign/Borderline|15249|248653501|Male and Female|Tumors of Sellar Region|2020
20+|0.0|0.0|0.0|Malignant|39|248653501|Male and Female|Tumors of Sellar Region|2020
20+|6.5|6.7|6.6|Benign/Borderline|16951|249847104|Male and Female|Tumors of Sellar Region|2021
20+|0.0|0.0|0.0|Malignant|52|249847104|Male and Female|Tumors of Sellar Region|2021
20+|6.1|6.3|6.2|Benign/Borderline|16153|251367751|Male and Female|Tumors of Sellar Region|2022
20+|0.1|0.1|0.1|Malignant|314|251367751|Male and Female|Tumors of Sellar Region|2022
20+|9.3|9.6|9.4|Benign/Borderline|20036|211050944|Male and Female|Tumors of the Meninges|2004
20+|0.2|0.3|0.2|Malignant|510|211050944|Male and Female|Tumors of the Meninges|2004
20+|10.4|10.6|10.5|Benign/Borderline|22716|213511339|Male and Female|Tumors of the Meninges|2005
20+|0.2|0.3|0.2|Malignant|502|213511339|Male and Female|Tumors of the Meninges|2005
20+|10.9|11.2|11.0|Benign/Borderline|24223|216055494|Male and Female|Tumors of the Meninges|2006
20+|0.2|0.2|0.2|Malignant|471|216055494|Male and Female|Tumors of the Meninges|2006
20+|11.3|11.5|11.4|Benign/Borderline|25510|218481776|Male and Female|Tumors of the Meninges|2007
20+|0.2|0.3|0.2|Malignant|530|218481776|Male and Female|Tumors of the Meninges|2007
20+|12.0|12.2|12.1|Benign/Borderline|27600|220975702|Male and Female|Tumors of the Meninges|2008
20+|0.2|0.2|0.2|Malignant|473|220975702|Male and Female|Tumors of the Meninges|2008
20+|12.7|13.0|12.9|Benign/Borderline|29834|223491138|Male and Female|Tumors of the Meninges|2009
20+|0.2|0.2|0.2|Malignant|443|223491138|Male and Female|Tumors of the Meninges|2009
20+|12.4|12.7|12.5|Benign/Borderline|29595|226154695|Male and Female|Tumors of the Meninges|2010
20+|0.2|0.2|0.2|Malignant|408|226154695|Male and Female|Tumors of the Meninges|2010
20+|12.5|12.8|12.6|Benign/Borderline|30341|228805985|Male and Female|Tumors of the Meninges|2011
20+|0.2|0.2|0.2|Malignant|410|228805985|Male and Female|Tumors of the Meninges|2011
20+|12.8|13.0|12.9|Benign/Borderline|31530|231483500|Male and Female|Tumors of the Meninges|2012
20+|0.2|0.2|0.2|Malignant|431|231483500|Male and Female|Tumors of the Meninges|2012
20+|13.0|13.3|13.1|Benign/Borderline|32643|233942819|Male and Female|Tumors of the Meninges|2013
20+|0.2|0.2|0.2|Malignant|476|233942819|Male and Female|Tumors of the Meninges|2013
20+|13.3|13.5|13.4|Benign/Borderline|33938|236444496|Male and Female|Tumors of the Meninges|2014
20+|0.2|0.2|0.2|Malignant|482|236444496|Male and Female|Tumors of the Meninges|2014
20+|13.8|14.1|13.9|Benign/Borderline|35921|238861655|Male and Female|Tumors of the Meninges|2015
20+|0.2|0.2|0.2|Malignant|451|238861655|Male and Female|Tumors of the Meninges|2015
20+|14.1|14.4|14.3|Benign/Borderline|37266|241188135|Male and Female|Tumors of the Meninges|2016
20+|0.1|0.2|0.2|Malignant|434|241188135|Male and Female|Tumors of the Meninges|2016
20+|14.6|14.9|14.7|Benign/Borderline|39255|243306804|Male and Female|Tumors of the Meninges|2017
20+|0.2|0.2|0.2|Malignant|459|243306804|Male and Female|Tumors of the Meninges|2017
20+|14.7|15.0|14.9|Benign/Borderline|40322|245213263|Male and Female|Tumors of the Meninges|2018
20+|0.1|0.2|0.2|Malignant|439|245213263|Male and Female|Tumors of the Meninges|2018
20+|15.0|15.1|15.0|Benign/Borderline|209988|1242099918|Male and Female|Tumors of the Meninges|2018-2022
20+|0.2|0.2|0.2|Malignant|2205|1242099918|Male and Female|Tumors of the Meninges|2018-2022
20+|15.5|15.8|15.6|Benign/Borderline|43014|247018299|Male and Female|Tumors of the Meninges|2019
20+|0.1|0.2|0.2|Malignant|417|247018299|Male and Female|Tumors of the Meninges|2019
20+|14.0|14.3|14.1|Benign/Borderline|39465|248653501|Male and Female|Tumors of the Meninges|2020
20+|0.1|0.2|0.2|Malignant|433|248653501|Male and Female|Tumors of the Meninges|2020
20+|15.2|15.5|15.4|Benign/Borderline|43438|249847104|Male and Female|Tumors of the Meninges|2021
20+|0.2|0.2|0.2|Malignant|478|249847104|Male and Female|Tumors of the Meninges|2021
20+|15.1|15.3|15.2|Benign/Borderline|43749|251367751|Male and Female|Tumors of the Meninges|2022
20+|0.1|0.2|0.2|Malignant|438|251367751|Male and Female|Tumors of the Meninges|2022
20+|0.7|0.8|0.8|Benign/Borderline|1589|211050944|Male and Female|Unclassified Tumors|2004
20+|0.6|0.6|0.6|Malignant|1283|211050944|Male and Female|Unclassified Tumors|2004
20+|0.9|1.0|0.9|Benign/Borderline|2002|213511339|Male and Female|Unclassified Tumors|2005
20+|0.6|0.7|0.6|Malignant|1331|213511339|Male and Female|Unclassified Tumors|2005
20+|0.9|1.0|0.9|Benign/Borderline|2005|216055494|Male and Female|Unclassified Tumors|2006
20+|0.6|0.6|0.6|Malignant|1303|216055494|Male and Female|Unclassified Tumors|2006
20+|0.9|1.0|0.9|Benign/Borderline|2098|218481776|Male and Female|Unclassified Tumors|2007
20+|0.5|0.6|0.6|Malignant|1225|218481776|Male and Female|Unclassified Tumors|2007
20+|1.0|1.1|1.0|Benign/Borderline|2286|220975702|Male and Female|Unclassified Tumors|2008
20+|0.6|0.6|0.6|Malignant|1393|220975702|Male and Female|Unclassified Tumors|2008
20+|1.1|1.2|1.1|Benign/Borderline|2536|223491138|Male and Female|Unclassified Tumors|2009
20+|0.6|0.7|0.6|Malignant|1432|223491138|Male and Female|Unclassified Tumors|2009
20+|1.1|1.2|1.1|Benign/Borderline|2649|226154695|Male and Female|Unclassified Tumors|2010
20+|0.5|0.6|0.5|Malignant|1263|226154695|Male and Female|Unclassified Tumors|2010
20+|1.1|1.2|1.2|Benign/Borderline|2749|228805985|Male and Female|Unclassified Tumors|2011
20+|0.5|0.6|0.5|Malignant|1284|228805985|Male and Female|Unclassified Tumors|2011
20+|1.2|1.2|1.2|Benign/Borderline|2858|231483500|Male and Female|Unclassified Tumors|2012
20+|0.5|0.6|0.5|Malignant|1292|231483500|Male and Female|Unclassified Tumors|2012
20+|1.1|1.2|1.1|Benign/Borderline|2783|233942819|Male and Female|Unclassified Tumors|2013
20+|0.5|0.5|0.5|Malignant|1289|233942819|Male and Female|Unclassified Tumors|2013
20+|1.1|1.2|1.1|Benign/Borderline|2783|236444496|Male and Female|Unclassified Tumors|2014
20+|0.5|0.6|0.6|Malignant|1434|236444496|Male and Female|Unclassified Tumors|2014
20+|1.0|1.1|1.1|Benign/Borderline|2632|238861655|Male and Female|Unclassified Tumors|2015
20+|0.5|0.6|0.5|Malignant|1388|238861655|Male and Female|Unclassified Tumors|2015
20+|1.0|1.0|1.0|Benign/Borderline|2468|241188135|Male and Female|Unclassified Tumors|2016
20+|0.5|0.5|0.5|Malignant|1281|241188135|Male and Female|Unclassified Tumors|2016
20+|0.9|1.0|0.9|Benign/Borderline|2397|243306804|Male and Female|Unclassified Tumors|2017
20+|0.5|0.5|0.5|Malignant|1286|243306804|Male and Female|Unclassified Tumors|2017
20+|0.9|1.0|0.9|Benign/Borderline|2388|245213263|Male and Female|Unclassified Tumors|2018
20+|0.5|0.5|0.5|Malignant|1381|245213263|Male and Female|Unclassified Tumors|2018
20+|0.8|0.9|0.9|Benign/Borderline|11350|1242099918|Male and Female|Unclassified Tumors|2018-2022
20+|0.5|0.5|0.5|Malignant|7108|1242099918|Male and Female|Unclassified Tumors|2018-2022
20+|0.8|0.9|0.9|Benign/Borderline|2220|247018299|Male and Female|Unclassified Tumors|2019
20+|0.5|0.6|0.5|Malignant|1451|247018299|Male and Female|Unclassified Tumors|2019
20+|0.8|0.9|0.9|Benign/Borderline|2310|248653501|Male and Female|Unclassified Tumors|2020
20+|0.5|0.6|0.6|Malignant|1543|248653501|Male and Female|Unclassified Tumors|2020
20+|0.8|0.9|0.8|Benign/Borderline|2200|249847104|Male and Female|Unclassified Tumors|2021
20+|0.5|0.5|0.5|Malignant|1403|249847104|Male and Female|Unclassified Tumors|2021
20+|0.8|0.9|0.8|Benign/Borderline|2232|251367751|Male and Female|Unclassified Tumors|2022
20+|0.4|0.5|0.5|Malignant|1330|251367751|Male and Female|Unclassified Tumors|2022
20+|0.1|0.1|0.1|Benign/Borderline|154|211050944|Male and Female|Unique astrocytoma variants|2004
20+|0.0|0.0|0.0|Malignant|36|211050944|Male and Female|Unique astrocytoma variants|2004
20+|0.1|0.1|0.1|Benign/Borderline|159|213511339|Male and Female|Unique astrocytoma variants|2005
20+|0.0|0.0|0.0|Malignant|40|213511339|Male and Female|Unique astrocytoma variants|2005
20+|0.1|0.1|0.1|Benign/Borderline|190|216055494|Male and Female|Unique astrocytoma variants|2006
20+|0.0|0.0|0.0|Malignant|50|216055494|Male and Female|Unique astrocytoma variants|2006
20+|0.1|0.1|0.1|Benign/Borderline|188|218481776|Male and Female|Unique astrocytoma variants|2007
20+|0.0|0.0|0.0|Malignant|50|218481776|Male and Female|Unique astrocytoma variants|2007
20+|0.1|0.1|0.1|Benign/Borderline|215|220975702|Male and Female|Unique astrocytoma variants|2008
20+|0.0|0.0|0.0|Malignant|57|220975702|Male and Female|Unique astrocytoma variants|2008
20+|0.1|0.1|0.1|Benign/Borderline|243|223491138|Male and Female|Unique astrocytoma variants|2009
20+|0.0|0.0|0.0|Malignant|66|223491138|Male and Female|Unique astrocytoma variants|2009
20+|0.1|0.1|0.1|Benign/Borderline|261|226154695|Male and Female|Unique astrocytoma variants|2010
20+|0.0|0.0|0.0|Malignant|46|226154695|Male and Female|Unique astrocytoma variants|2010
20+|0.1|0.1|0.1|Benign/Borderline|275|228805985|Male and Female|Unique astrocytoma variants|2011
20+|0.0|0.0|0.0|Malignant|62|228805985|Male and Female|Unique astrocytoma variants|2011
20+|0.1|0.1|0.1|Benign/Borderline|286|231483500|Male and Female|Unique astrocytoma variants|2012
20+|0.0|0.0|0.0|Malignant|59|231483500|Male and Female|Unique astrocytoma variants|2012
20+|0.1|0.1|0.1|Benign/Borderline|276|233942819|Male and Female|Unique astrocytoma variants|2013
20+|0.0|0.0|0.0|Malignant|69|233942819|Male and Female|Unique astrocytoma variants|2013
20+|0.1|0.1|0.1|Benign/Borderline|286|236444496|Male and Female|Unique astrocytoma variants|2014
20+|0.0|0.0|0.0|Malignant|79|236444496|Male and Female|Unique astrocytoma variants|2014
20+|0.1|0.1|0.1|Benign/Borderline|295|238861655|Male and Female|Unique astrocytoma variants|2015
20+|0.0|0.0|0.0|Malignant|51|238861655|Male and Female|Unique astrocytoma variants|2015
20+|0.1|0.1|0.1|Benign/Borderline|330|241188135|Male and Female|Unique astrocytoma variants|2016
20+|0.0|0.0|0.0|Malignant|69|241188135|Male and Female|Unique astrocytoma variants|2016
20+|0.1|0.1|0.1|Benign/Borderline|321|243306804|Male and Female|Unique astrocytoma variants|2017
20+|0.0|0.0|0.0|Malignant|74|243306804|Male and Female|Unique astrocytoma variants|2017
20+|0.1|0.2|0.1|Benign/Borderline|347|245213263|Male and Female|Unique astrocytoma variants|2018
20+|0.0|0.0|0.0|Malignant|67|245213263|Male and Female|Unique astrocytoma variants|2018
20+|0.1|0.1|0.1|Benign/Borderline|1826|1242099918|Male and Female|Unique astrocytoma variants|2018-2022
20+|0.0|0.0|0.0|Malignant|308|1242099918|Male and Female|Unique astrocytoma variants|2018-2022
20+|0.1|0.2|0.1|Benign/Borderline|378|247018299|Male and Female|Unique astrocytoma variants|2019
20+|0.0|0.0|0.0|Malignant|58|247018299|Male and Female|Unique astrocytoma variants|2019
20+|0.1|0.1|0.1|Benign/Borderline|354|248653501|Male and Female|Unique astrocytoma variants|2020
20+|0.0|0.0|0.0|Malignant|63|248653501|Male and Female|Unique astrocytoma variants|2020
20+|0.1|0.2|0.1|Benign/Borderline|376|249847104|Male and Female|Unique astrocytoma variants|2021
20+|0.0|0.0|0.0|Malignant|52|249847104|Male and Female|Unique astrocytoma variants|2021
20+|0.1|0.2|0.1|Benign/Borderline|371|251367751|Male and Female|Unique astrocytoma variants|2022
20+|0.0|0.0|0.0|Malignant|68|251367751|Male and Female|Unique astrocytoma variants|2022
